<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD004467.pub3" GROUP_ID="VASC" ID="355503031212300104" MERGED_FROM="" MODIFIED="2017-07-26 16:49:16 +0100" MODIFIED_BY="Nicole Martin" REVIEW_NO="0114W" REVMAN_SUB_VERSION="5.3.5 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2017-07-26 16:49:08 +0100" MODIFIED_BY="Nicole Martin">
<TITLE MODIFIED="2014-11-19 13:58:41 +0000" MODIFIED_BY="[Empty name]">Low glycaemic index diets for the prevention of cardiovascular disease</TITLE>
<CONTACT MODIFIED="2017-07-26 16:49:08 +0100" MODIFIED_BY="Nicole Martin"><PERSON ID="8938" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Rees</LAST_NAME><POSITION>Principal Research Fellow</POSITION><EMAIL_1>Karen.Rees@warwick.ac.uk</EMAIL_1><EMAIL_2>rees_karen@yahoo.co.uk</EMAIL_2><ADDRESS><DEPARTMENT>Division of Health Sciences</DEPARTMENT><ORGANISATION>Warwick Medical School, University of Warwick</ORGANISATION><CITY>Coventry</CITY><ZIP>CV4 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>02476 151186</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2017-07-26 16:49:08 +0100" MODIFIED_BY="Nicole Martin"><PERSON ID="19622" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Christine</FIRST_NAME><LAST_NAME>Clar</LAST_NAME><POSITION>Researcher in Systematic Reviews</POSITION><EMAIL_1>clar@cc-archie.de</EMAIL_1><ADDRESS><ORGANISATION>Freelance</ORGANISATION><ADDRESS_1>Hasenheide 67</ADDRESS_1><CITY>Berlin</CITY><ZIP>10967</ZIP><COUNTRY CODE="DE">Germany</COUNTRY><PHONE_1>+49 30 69040459</PHONE_1><PHONE_2>+49 3061286521</PHONE_2></ADDRESS></PERSON><PERSON ID="z1406100956146432182784063495826" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lena</FIRST_NAME><LAST_NAME>Al-Khudairy</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>Lena.al-khudairy@warwick.ac.uk</EMAIL_1><EMAIL_2>LalkhudairI@hotmail.com</EMAIL_2><ADDRESS><DEPARTMENT>Division of Health Sciences</DEPARTMENT><ORGANISATION>Warwick Medical School, University of Warwick</ORGANISATION><CITY>Coventry</CITY><ZIP>CV4 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="14702" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Emma</FIRST_NAME><LAST_NAME>Loveman</LAST_NAME><POSITION>Partner</POSITION><EMAIL_1>emma.loveman@effectiveevidence.org</EMAIL_1><ADDRESS><ORGANISATION>Effective Evidence LLP</ORGANISATION><ADDRESS_1>26 The Curve</ADDRESS_1><CITY>Waterlooville</CITY><ZIP>PO8 9SE</ZIP><REGION>Hampshire</REGION><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="13872" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sarah</FIRST_NAME><MIDDLE_INITIALS>AM</MIDDLE_INITIALS><LAST_NAME>Kelly</LAST_NAME><POSITION>Research Associate</POSITION><EMAIL_1>sak65@medschl.cam.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Public Health</DEPARTMENT><ORGANISATION>University of Cambridge</ORGANISATION><ADDRESS_1>Forvie Site</ADDRESS_1><ADDRESS_2>School of Clinical Medicine, Box 113 Cambridge Biomedical Campus</ADDRESS_2><CITY>Cambridge</CITY><ZIP>CB2 0SR</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0)1223 746557</PHONE_1></ADDRESS></PERSON><PERSON ID="71031742632037279824110616111954" ROLE="AUTHOR"><FIRST_NAME>Louise</FIRST_NAME><LAST_NAME>Hartley</LAST_NAME><POSITION>Senior Evidence Based Medicine Specialist</POSITION><EMAIL_1>lhartley@rti.org</EMAIL_1><EMAIL_2>lu_hartley@yahoo.co.uk</EMAIL_2><ADDRESS><ORGANISATION>RTI Health Solutions</ORGANISATION><CITY>Manchester</CITY><ZIP>M20 2LS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>01614476032</PHONE_1></ADDRESS></PERSON><PERSON ID="89230921248567425432120220131732" ROLE="AUTHOR"><FIRST_NAME>Nadine</FIRST_NAME><LAST_NAME>Flowers</LAST_NAME><EMAIL_1>N.J.Flowers@warwick.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>Division of Health Sciences</DEPARTMENT><ORGANISATION>Warwick Medical School, University of Warwick</ORGANISATION><CITY>Coventry</CITY><ZIP>CV4 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON><PERSON ID="z1409151032008051496211898286941" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Roberta</FIRST_NAME><LAST_NAME>Germanò</LAST_NAME><SUFFIX>MD</SUFFIX><EMAIL_1>rob.germano@yahoo.it</EMAIL_1><ADDRESS><DEPARTMENT>Division of Nutrition, Department of Clinical Medicine and Surgery</DEPARTMENT><ORGANISATION>University of Naples Federico II</ORGANISATION><CITY>Naples</CITY><COUNTRY CODE="IT">Italy</COUNTRY></ADDRESS></PERSON><PERSON ID="13852" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gary</FIRST_NAME><LAST_NAME>Frost</LAST_NAME><POSITION>Head of Nutrition and Dietetics</POSITION><EMAIL_1>g.frost@imperial.ac.uk</EMAIL_1><EMAIL_2>gfrost@ic.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>Department of Nutrition and Dietetics</DEPARTMENT><ORGANISATION>Hammersmith Hospital</ORGANISATION><ADDRESS_1>Duncane Road</ADDRESS_1><CITY>London</CITY><ZIP>W12 0HS</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 20 8383 3048</PHONE_1><FAX_1>+44 20 8383 3379</FAX_1></ADDRESS></PERSON><PERSON ID="8938" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Karen</FIRST_NAME><LAST_NAME>Rees</LAST_NAME><POSITION>Principal Research Fellow</POSITION><EMAIL_1>Karen.Rees@warwick.ac.uk</EMAIL_1><EMAIL_2>rees_karen@yahoo.co.uk</EMAIL_2><ADDRESS><DEPARTMENT>Division of Health Sciences</DEPARTMENT><ORGANISATION>Warwick Medical School, University of Warwick</ORGANISATION><CITY>Coventry</CITY><ZIP>CV4 7AL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>02476 151186</PHONE_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2017-07-04 13:34:14 +0100" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="31" MONTH="7" YEAR="2016"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="7" YEAR="2016"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="7" YEAR="2018"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="2004"/>
<LAST_CITATION_ISSUE ISSUE="7" YEAR="2017"/>
</DATES>
<WHATS_NEW MODIFIED="2017-07-06 13:50:38 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2017-07-06 13:50:38 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="4" MONTH="7" YEAR="2017"/>
<DESCRIPTION>
<P>18 new studies were added and in contrast to the last version, no changes in lipid levels were found.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2017-07-04 13:34:20 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="31" MONTH="7" YEAR="2016"/>
<DESCRIPTION>
<P>The review was updated and the inclusion criteria were expanded to include all cardiovascular disease (CVD) and not just coronary heart disease. As there are other Cochrane reviews which examine the effect of low glycaemic index diets in obesity and diabetes, studies were only included if they reported blood lipids and/or blood pressure, and studies in participants with diabetes were excluded. Studies in healthy participants were included to capture both primary and secondary prevention of CVD. As more trials are available now, we have excluded short-term studies and included only those of at least 12 weeks duration. This means that only three RCTs of the previous version of the review were retained and 15 new trials were added. The updated search was done in July 2016.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2015-04-15 15:21:31 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-04-08 15:54:29 +0100" MODIFIED_BY="Liz Bickerdike">
<DATE DAY="8" MONTH="4" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2015-04-15 15:21:31 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="15" MONTH="5" YEAR="2006"/>
<DESCRIPTION>
<P>The search was updated to July 2006. Six new studies were identified and added to the review. There is no change to the conclusions of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2017-06-28 01:48:10 +0100" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2015-03-17 10:37:45 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-03-17 10:37:45 +0000" MODIFIED_BY="[Empty name]">
<NAME>Warwick Medical School, University of Warwick</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2017-06-28 01:48:10 +0100" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2015-03-17 10:37:54 +0000" MODIFIED_BY="[Empty name]">
<NAME>NIHR Cochrane Programme Grant</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2017-06-28 01:48:10 +0100" MODIFIED_BY="[Empty name]">
<NAME>Karen Rees is also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West, Midlands at University Hospitals, Birmingham NHS Foundation Trust</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" VERIFIED="NO"/>
<KEYWORDS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2017-07-26 16:47:43 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2017-06-30 19:44:05 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2015-01-06 19:51:57 +0000" MODIFIED_BY="[Empty name]">Low glycaemic index diets for cardiovascular disease</TITLE>
<SUMMARY_BODY MODIFIED="2017-06-30 19:44:05 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Background</B>
</P>
<P>The glycaemic index (GI) is a measure of the ability of a carbohydrate (for example sugar or starch) to affect blood sugar levels.</P>
<P>
<B>Study characteristics</B>
</P>
<P>In this review update, we examined 21 randomised studies that assessed the effects of low GI diets compared to diets with a similar composition but a higher GI on cardiovascular disease events and levels of cholesterol in the blood or blood pressure (major risk factors for cardiovascular disease, such as heart attacks or stroke). Studies were included up to July 2016.</P>
<P>
<B>Results</B>
</P>
<P>Participants were adults with a mean age of between 19 and 69 years. In most studies, participants had cardiovascular risk factors such as overweight or obesity or abnormal blood fat levels, and one study included participants with existing heart disease. The diets were followed for at least 12 weeks but most studies had unclear of bias and some of the compared diets only had small differences in GI. Cardiovascular disease events were not reported and no evidence of differences in effects of the diets on blood cholesterol and blood pressure were seen. Most studies did not report harms but the two that did found no harmful effects of the diets, however the evidence was poor.</P>
<P>
<B>Conclusions</B>
</P>
<P>There was insufficient evidence from randomised controlled trials to recommend consumption of low GI diets for the purpose of improving blood lipids or blood pressure.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2017-07-06 13:50:10 +0100" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2017-07-06 13:50:10 +0100" MODIFIED_BY="[Empty name]">
<P>The glycaemic index (GI) is a physiological measure of the ability of a carbohydrate to affect blood glucose. Interest is growing in this area for the clinical management of people at risk of, or with, established cardiovascular disease. There is a need to review the current evidence from randomised controlled trials (RCTs) in this area. This is an update of the original review published in 2008.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2017-06-22 05:41:31 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effect of the dietary GI on total mortality, cardiovascular events, and cardiovascular risk factors (blood lipids, blood pressure) in healthy people or people who have established cardiovascular disease or related risk factors, using all eligible randomised controlled trials.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2017-06-30 18:52:57 +0100" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL, MEDLINE, Embase and CINAHL in July 2016. We also checked reference lists of relevant articles. No language restrictions were applied.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2017-06-22 05:42:41 +0100" MODIFIED_BY="[Empty name]">
<P>We selected RCTs that assessed the effects of low GI diets compared to diets with a similar composition but a higher GI on cardiovascular disease and related risk factors. Minimum trial duration was 12 weeks. Participants included were healthy adults or those at increased risk of cardiovascular disease, or previously diagnosed with cardiovascular disease. Studies in people with diabetes mellitus were excluded.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2017-07-04 11:06:29 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently screened and selected studies. Two review authors independently assessed risk of bias, evaluated the overall quality of the evidence using GRADE, and extracted data following the <I>Cochrane Handbook for Systematic Reviews of Interventions</I>. We contacted trial authors for additional information. Analyses were checked by a second reviewer. Continuous outcomes were synthesized using mean differences and adverse events were synthesized narratively.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2017-06-30 17:02:51 +0100" MODIFIED_BY="[Empty name]">
<P>Twenty-one RCTs were included, with a total of 2538 participants randomised to low GI intervention (1288) or high GI (1250). All 21 included studies reported the effect of low GI diets on risk factors for cardiovascular disease, including blood lipids and blood pressure.</P>
<P>Twenty RCTs (18 of which were newly included in this version of the review) included primary prevention populations (healthy individuals or those at high risk of CVD, with mean age range from 19 to 69 years) and one RCT was in those diagnosed with pre-existing CVD (a secondary prevention population, with mean age 26.9 years). Most of the studies did not have an intervention duration of longer than six months. Difference in GI intake between comparison groups varied widely from 0.6 to 42.</P>
<P>None of the included studies reported the effect of low GI dietary intake on cardiovascular mortality and cardiovascular events such as fatal and nonfatal myocardial infarction, unstable angina, coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, and stroke. The unclear risk of bias of most of the included studies makes overall interpretation of the data difficult. Only two of the included studies (38 participants) reported on adverse effects and did not observe any harms (low-quality evidence).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2017-06-30 19:36:48 +0100" MODIFIED_BY="[Empty name]">
<P>There is currently no evidence available regarding the effect of low GI diets on cardiovascular disease events. Moreover, there is currently no convincing evidence that low GI diets have a clear beneficial effect on blood lipids or blood pressure parameters. </P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2017-07-04 11:08:18 +0100" MODIFIED_BY="[Empty name]">
<P>This was an update of the original review published in 2004 (<LINK REF="REF-Kelly-2004" TYPE="REFERENCE">Kelly 2004</LINK>).</P>
<CONDITION MODIFIED="2017-07-04 11:07:24 +0100" MODIFIED_BY="[Empty name]">
<P>Cardiovascular diseases (CVD) are a group of conditions that affect the heart and blood vessels and include coronary heart disease, cerebrovascular disease, and peripheral arterial disease (<LINK REF="REF-WHO-2013" TYPE="REFERENCE">WHO 2013</LINK>). One of the main mechanisms thought to cause CVD is atherosclerosis, where the arteries become clogged by atheromas or plaques (<LINK REF="REF-NHS-2012" TYPE="REFERENCE">NHS 2012</LINK>). CVD occurs when the arteries are completely blocked or when blood flow is restricted by a narrowed artery, limiting the amount of blood and oxygen delivered to organs or tissue (<LINK REF="REF-BHF-2014" TYPE="REFERENCE">BHF 2014</LINK>). Arteries may naturally become harder and narrower with age, although this process may be accelerated by such factors as a sedentary lifestyle, obesity, diet, diabetes, ethnicity, smoking, high cholesterol, and high blood pressure (<LINK REF="REF-NHS-2012" TYPE="REFERENCE">NHS 2012</LINK>). Another cause of CVD is unstable plaque rupturing. It is thought that unstable plaques activate an inflammatory response in the body that causes the structure of atherosclerotic plaque to weaken and rupture, leading to the formation of blood clots (<LINK REF="REF-Spagnoli-2007" TYPE="REFERENCE">Spagnoli 2007</LINK>).</P>
<P>CVD is the number one cause of death and disability (<LINK REF="REF-WHO-2013" TYPE="REFERENCE">WHO 2013</LINK>) globally. Around 30% of total global deaths can be attributed to CVD (<LINK REF="REF-WHO-2013" TYPE="REFERENCE">WHO 2013</LINK>), and it is estimated to cause 17 million deaths per year (<LINK REF="REF-Bovet-2012" TYPE="REFERENCE">Bovet 2012</LINK>). The World Health Organization (WHO) reports that by 2030, CVDs will account for almost 23.3 million deaths per year (<LINK REF="REF-WHO-2013" TYPE="REFERENCE">WHO 2013</LINK>). This burden is set to increase as a consequence of ageing populations and increasing levels of sedentary lifestyles, and obesity.</P>
<P>One key public health priority in the prevention of CVD is targeting modifiable risk factors. One such risk factor is diet, which plays a major role in the aetiology of many chronic conditions, including CVD. A number of dietary factors are thought to lower CVD risk, such as a low sodium intake (<LINK REF="REF-Aburto-2013" TYPE="REFERENCE">Aburto 2013</LINK>), a low-carbohydrate diet (<LINK REF="REF-Hu-2014" TYPE="REFERENCE">Hu 2014</LINK>), intake of whole grains (<LINK REF="REF-Ye-2012" TYPE="REFERENCE">Ye 2012</LINK>), and a high consumption of fruits and vegetables (<LINK REF="REF-Oude-2010" TYPE="REFERENCE">Oude 2010</LINK>). Such risk factors are important, not only because they have been linked to CVD development, but also because they can be modified, which makes them one of the main targets for interventions aimed at primary prevention and management of CVD.</P>
</CONDITION>
<INTERVENTION MODIFIED="2017-06-22 06:17:56 +0100" MODIFIED_BY="[Empty name]">
<P>An association between cardiovascular disease and dietary fat intake is well-documented (e.g. <LINK REF="REF-Vafeiadou-2012" TYPE="REFERENCE">Vafeiadou 2012</LINK>) but the role of dietary carbohydrate in cardiovascular disease is not. There is increasing evidence from observational nonrandomised studies that the glycaemic index (GI) of dietary carbohydrates may be important in disease prevention and control (<LINK REF="REF-Brand_x002d_Miller-2002" TYPE="REFERENCE">Brand-Miller 2002</LINK>; <LINK REF="REF-Frost-2000" TYPE="REFERENCE">Frost 2000</LINK>; <LINK REF="REF-Leeds-2002" TYPE="REFERENCE">Leeds 2002</LINK>; <LINK REF="REF-Rizkalla-2002" TYPE="REFERENCE">Rizkalla 2002</LINK>). A 2008 meta-analysis of 37 prospective cohort studies (<LINK REF="REF-Barclay-2008" TYPE="REFERENCE">Barclay 2008</LINK>) investigating the association between GI and chronic diseases (including diabetes, colorectal cancer, cardiovascular disease, and eye diseases) found a positive association between GI and chronic disease (relative risk for coronary heart disease 1.25, 95% CI 1.00 to 1.56; relative risk for all diseases combined 1.14, 95% CI 1.09 to 1.19). The World Health Organisation (WHO) recommended in 1997 that dietary carbohydrates be classified according to their GI and that the methodology for assessing the GI should be standardised (<LINK REF="REF-FAO_x002f_WHO-1997" TYPE="REFERENCE">FAO/WHO 1997</LINK>). In 2007, the WHO published a scientific update on carbohydrates in nutrition, where it was acknowledged that the GI can be a useful means to choose carbohydrate food, but that this should always be considered in the context of other nutritional indicators and should not be based solely on the basis of the GI (<LINK REF="REF-FAO_x002f_WHO-2007a" TYPE="REFERENCE">FAO/WHO 2007a</LINK>; <LINK REF="REF-FAO_x002f_WHO-2007b" TYPE="REFERENCE">FAO/WHO 2007b</LINK>).</P>
<P>The concept of GI was first proposed in 1981 (<LINK REF="REF-Jenkins-1981" TYPE="REFERENCE">Jenkins 1981</LINK>). The GI of a dietary carbohydrate is an assessment of its postprandial effect on blood glucose. The lower the GI, the smaller the effect of the carbohydrate on postprandial glucose levels. The GI classification is a standardised comparison of the 2-hour postprandial glucose response to 50g of a carbohydrate with that of 50g of white bread or glucose, calculated from the area under the glucose response curve. The GI of white bread and of glucose is 100 and all other carbohydrate foods have a GI between 0 and 100. The GI of a carbohydrate depends on its rate of intestinal absorption, which can be influenced by its composition and ease of digestion (<LINK REF="REF-Frost-2000" TYPE="REFERENCE">Frost 2000</LINK>). Low GI carbohydrates have lower 2-hour areas under the glucose curve than white bread.</P>
<P>Cooking and food preparation can modify the GI of foods. Highly processed convenience foods tend to have a high GI. Cooked pulse vegetables (legumes, e.g. lentils, peas, kidney beans) have a low GI as their cell walls are resistant to cooking. The intact cereal grains of rye and granary bread all have low GIs. However, when granary bread is processed to wholemeal bread, the grains are disrupted, resulting in a higher GI. Some examples of GI of common carbohydrate foods are given in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> (<LINK REF="REF-Frost-2000" TYPE="REFERENCE">Frost 2000</LINK>).</P>
<P>In 1995, the first international tables of GI of individual foods were published (<LINK REF="REF-Foster_x002d_Powell-1995" TYPE="REFERENCE">Foster-Powell 1995</LINK>) and updated in 2002 (<LINK REF="REF-Foster_x002d_Powell-2002" TYPE="REFERENCE">Foster-Powell 2002</LINK>) and 2008 (<LINK REF="REF-Atkinson-2008" TYPE="REFERENCE">Atkinson 2008</LINK>), and the methodology on their derivation has also been reported (<LINK REF="REF-Jenkins-1981" TYPE="REFERENCE">Jenkins 1981</LINK>; <LINK REF="REF-Wolever-1990" TYPE="REFERENCE">Wolever 1990</LINK>). The GI of a mixed meal can be calculated from the different proportions of each of the carbohydrate-containing foods and their individual GI values. For example, when bread and beans are mixed in equal quantities, the resulting glycaemic response is midway between that of bread alone and beans alone (<LINK REF="REF-Wolever-1985" TYPE="REFERENCE">Wolever 1985</LINK>; <LINK REF="REF-Wolever-1986" TYPE="REFERENCE">Wolever 1986</LINK>). The addition of fat to a mixed meal reduces the glycaemic response (<LINK REF="REF-Bornet-1987" TYPE="REFERENCE">Bornet 1987</LINK>; <LINK REF="REF-Coulston-1987" TYPE="REFERENCE">Coulston 1987</LINK>; <LINK REF="REF-Wolever-1988" TYPE="REFERENCE">Wolever 1988</LINK>), but the relative response of one carbohydrate to another remains.</P>
<P>Another measure often used is the glycaemic load which puts the GI in relation to the total amount of carbohydrate actually consumed. The glycaemic load of a food is calculated as the carbohydrate content (g) multiplied by the GI value of the food and divided by 100 (<LINK REF="STD-Ebbeling-2003" TYPE="STUDY">Ebbeling 2003</LINK>). So for example, a watermelon is a high GI food but has a low glycaemic load for the amount typically consumed.</P>
</INTERVENTION>
<THEORY MODIFIED="2017-07-04 11:08:18 +0100" MODIFIED_BY="[Empty name]">
<P>Lower GI foods cause lower peaks and fewer fluctuations in postprandial blood glucose levels than foods with high GI values. Increases in fasting and postprandial glucose concentrations promote oxidative stress, inflammation and endothelial dysfunction thereby predisposing to cardiovascular disease and type 2 diabetes (<LINK REF="REF-Blaak-2012" TYPE="REFERENCE">Blaak 2012</LINK>). Type 2 diabetes is also associated with increased cardiovascular risk and there is a suggestion that low GI foods may play a role in the prevention of type 2 diabetes and also improve the blood glucose control in people with type 2 diabetes (<LINK REF="REF-Du-2006" TYPE="REFERENCE">Du 2006</LINK>).</P>
<P>Abnormal levels of serum lipids also represent a risk factor for cardiovascular disease and two cross-sectional studies found a significant negative correlation between dietary GI and high density lipoprotein (HDL) cholesterol concentrations (<LINK REF="REF-Ford-2001" TYPE="REFERENCE">Ford 2001</LINK>; <LINK REF="STD-Frost-1999" TYPE="STUDY">Frost 1999</LINK>). Two systematic reviews also suggested that low glycaemic index diets can significantly lower total and low density lipoprotein (LDL) cholesterol levels (<LINK REF="REF-Fleming-2013" TYPE="REFERENCE">Fleming 2013</LINK>; <LINK REF="REF-Goff-2013" TYPE="REFERENCE">Goff 2013</LINK>). Obesity is also a risk factor for cardiovascular disease. Diets based on low GI foods produced greater weight loss in overweight or obese populations than did diets based on high GI foods (<LINK REF="REF-Thomas-2007" TYPE="REFERENCE">Thomas 2007</LINK>). One hypothesis is that low GI diets lead to increased satiety and decreased sensations of hunger, thus leading to a lower energy intake. However, results from studies were inconsistent. While some short-term studies reported a reduction in satiety with low GI diets, this did not lead to a long term reduction in energy intake (<LINK REF="REF-Bornet-2007" TYPE="REFERENCE">Bornet 2007</LINK>; <LINK REF="REF-Niwano-2009" TYPE="REFERENCE">Niwano 2009</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2017-06-22 06:24:16 +0100" MODIFIED_BY="[Empty name]">
<P>Three recent meta-analyses summarised the effects of GI and glycaemic load on coronary heart disease or cardiovascular events or both (<LINK REF="REF-Dong-2012" TYPE="REFERENCE">Dong 2012</LINK>; <LINK REF="REF-Ma-2012" TYPE="REFERENCE">Ma 2012</LINK>; <LINK REF="REF-Mirrahimi-2012" TYPE="REFERENCE">Mirrahimi 2012</LINK>). The studies summarised between eight and 14 prospective cohort studies (large overlap between reviews) involving between 229,213 and 240,936 participants. Cohorts were followed for six to 25 years and the dietary GI and glycaemic load were largely assessed using food frequency questionnaires. GI and glycaemic load levels were divided into categories and cardiovascular events compared between the highest and the lowest categories. <LINK REF="REF-Mirrahimi-2012" TYPE="REFERENCE">Mirrahimi 2012</LINK> reported dietary composition in their review of ten studies and both carbohydrate and fibre content tended to be higher in the higher glycaemic load categories. All three reviews agreed that the evidence showed that women in the highest GI and glycaemic load categories had a significantly higher risk of cardiovascular or coronary heart disease (or both) events than women in the lowest categories, but this effect was not shown for men. <LINK REF="REF-Dong-2012" TYPE="REFERENCE">Dong 2012</LINK> also found that the unfavourable effects of high GI or glycaemic load may be more pronounced in overweight and obese participants.</P>
<P>As described, recent meta-analyses examining GI and CVD events included only prospective cohort studies. There is evidence that high GI diets may contribute to a greater risk of CVD. There appears to be suggestive evidence of benefit of low GI diets on CVD risk factors (<LINK REF="REF-Augustin-2015" TYPE="REFERENCE">Augustin 2015</LINK>); however, evidence has largely been from observational studies which may be prone to confounding and other biases. We undertook this systematic review to examine evidence on the effects of GI on CVD from randomised controlled trials. An update was necessary to include newly published relevant RCTs and to distinguish the review from other relevant Cochrane reviews.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2017-06-22 06:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effect of the dietary GI on total mortality, cardiovascular events, and cardiovascular risk factors (blood lipids, blood pressure) in healthy people or people who have established cardiovascular disease or related risk factors, using all eligible randomised controlled trials.</P>
</OBJECTIVES>
<METHODS MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2017-06-22 06:27:43 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled studies (RCTs). Cross-over trials were eligible but only the first half was used before cross-over took place, treating it as a parallel group design. Minimum study duration was 12 weeks.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]">
<P>Free-living adults (age &#8805;18 years) were eligible for inclusion if they were healthy, had established cardiovascular disease, or one or more of the following risk factors: abnormal blood lipid levels (high and low density lipoprotein (HDL, LDL) cholesterol, triglycerides and total cholesterol), raised blood pressure/hypertension, overweight (body mass index (BMI) &gt; 25 kg/m<SUP>2</SUP>), or obesity (BMI &gt; 30 kg/m<SUP>2</SUP>).</P>
<P>A separate Cochrane review is concerned with the effects of low GI diets in people with diabetes mellitus (<LINK REF="REF-Thomas-2009" TYPE="REFERENCE">Thomas 2009</LINK>) and another Cochrane review has focused on low GI diets in overweight and obesity (<LINK REF="REF-Thomas-2007" TYPE="REFERENCE">Thomas 2007</LINK>). Hence, we excluded studies in people with type 2 diabetes and studies which only focused on weight loss if they did not also measure other cardiovascular risk factors.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2017-06-28 03:28:04 +0100" MODIFIED_BY="[Empty name]">
<P>Interventions were eligible if they were advice on diet or dietary carbohydrate or a prescribed diet. Diets with a lower GI had to be compared with a diet with a higher GI and the GI of the diets had to be reported. Compared diets had to have similar overall energy levels and levels of carbohydrate, fat, and protein. Studies manipulating any other components of the diet were included if this was similar for the low and high GI groups.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2017-07-06 13:51:05 +0100" MODIFIED_BY="[Empty name]">
<P>
<BR/>
</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2015-09-16 17:56:41 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Total and cardiovascular mortality</LI>
<LI>Cardiovascular events (e.g. fatal and nonfatal myocardial infarction, unstable angina, coronary artery bypass graft surgery, percutaneous transluminal coronary angioplasty, stroke)</LI>
<LI>Adverse events (e.g. bloating, nausea, weight gain, difficulty in eating out)</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2017-07-06 13:51:05 +0100" MODIFIED_BY="[Empty name]">
<OL>
<LI>Blood lipid levels (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) (mmol/L)</LI>
<LI>Systolic and diastolic blood pressure (mmHg)</LI>
<LI>Quality of life (using validated instruments)</LI>
<LI>Attitudes to diets, satisfaction, appetite, satiety, or similar (as reported by the studies, using validated instruments)</LI>
</OL>
<P>Weight (Kg) and BMI (Kg/m<SUP>2</SUP>) were recorded as additional potentially effect-modifying parameters. Studies had to report at least one of the outcomes of interest to be eligible for inclusion.</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2017-07-05 16:05:10 +0100" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2017-07-05 16:05:10 +0100" MODIFIED_BY="[Empty name]">
<P>For this update, the searches from the previously published review (<LINK REF="REF-Kelly-2004" TYPE="REFERENCE">Kelly 2004</LINK>) were updated (to adjust for the broadened inclusion criteria) and re-run on 31 July 2016. Searches were conducted in the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 7 of 12, 2016) in the Cochrane Library, MEDLINE (Ovid, 1946 to 31 July 2016) and Embase Classic and Embase (Ovid, 1947 to 30 July 2016) and CINAHL (EBSCO, 1937 to 31 July 2016).</P>
<P>See <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> for details of search strategies. The sensitivity-maximising version of the Cochrane RCT filter (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>) was applied to MEDLINE and adaptations of it to the other databases, except CENTRAL. No language restrictions were applied.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2017-01-06 17:44:34 +0000" MODIFIED_BY="[Empty name]">
<P>The reference lists of all relevant studies were checked. Relevant published reviews were also sought as a source of RCTs. We contacted authors of potentially relevant publications for further studies. </P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2017-07-06 13:52:03 +0100" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2017-06-30 19:27:53 +0100" MODIFIED_BY="[Empty name]">
<P>The titles and abstracts of retrieved records were scanned independently by two reviewers (CC, NF, LH, SK, LA-K) and were only rejected if the reviewer could determine that they definitely did not meet the inclusion criteria. Full texts were obtained for any that could not be rejected with certainty. Each paper was then assessed independently by two reviewers (CC, RG, SK, LA-K). An in/out form was used to assess the inclusion (or otherwise) of full papers into the review. If a trial was excluded after the full paper has been obtained, a record of the study and reason for exclusion was recorded. Differences in selection of the final full text articles were resolved by discussion or by consulting a third reviewer (KR).</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2017-06-30 19:27:56 +0100" MODIFIED_BY="[Empty name]">
<P>Original reports of trial results were extracted by one reviewer (CC, EL, LA-K) and checked by a second reviewer (KR, EL, SK).</P>
<P>Data were extracted as follows and are reported in the characteristics of included studies table:</P>
<OL>
<LI>General information: published/unpublished, title, authors, source, country, year of publication, trial dates, additional publications;</LI>
<LI>Trial characteristics: design, setting, duration, randomisation (and method), allocation concealment (and method), blinding (outcome assessors), check of blinding, funding/conflict of interest;</LI>
<LI>Participants: inclusion criteria, exclusion criteria, total number and number in comparison groups, sex/age, ethnicity, BMI, lipid levels, blood pressure, similarity of groups at baseline, withdrawals/losses to follow-up, assessment of adherence, medications used, smoking status, when provided;</LI>
<LI>Intervention: dietary information/diet provided, length of intervention, comparison interventions, macronutrient composition of diets and GI;</LI>
<LI>Outcomes: outcomes as specified above, the main outcome assessed in the study, other events, length of follow-up;</LI>
<LI>Results: for outcomes and times of assessment.</LI>
</OL>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2017-06-30 19:28:05 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed risk of bias according to the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We categorised risk of bias as &#8217;low&#8217;, &#8217;unclear&#8217; or &#8217;high&#8217;. The risk of bias was assessed by one reviewer (CC, LA-K) and checked by a second (EL, SK, KR).</P>
<P>Studies were not excluded on the basis of a high 'risk of bias' score. In particular, the following factors were examined:</P>
<OL>
<LI>Method of randomisation;</LI>
<LI>Allocation concealment;</LI>
<LI>Blinding of outcome assessment (detection bias);</LI>
<LI>Incomplete outcome data (attrition bias);</LI>
<LI>Intention-to-treat analysis;</LI>
<LI>Selective reporting (reporting bias);</LI>
<LI>Groups comparable at baseline;</LI>
<LI>Other (e.g. power analysis, analysis issues).</LI>
</OL>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2017-07-06 13:52:03 +0100" MODIFIED_BY="[Empty name]">
<P>We processed data in accordance with the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We expressed dichotomous outcomes as hazard ratios (HRs), with 95% confidence intervals (CIs). For continuous outcomes, we compared net changes (i.e. intervention group minus control group differences) and calculated a mean difference (MD) and standard deviation difference for each study.</P>
<P>Where necessary, we imputed standard deviation differences from baseline to follow-up, as these data were not available in the papers. To do this, we followed the guidelines in the Cochrane Handbook of obtaining standard deviations from standard errors (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, chapter 7.3.3) and we used a correlation coefficient of 0.5 in these calculations, as recommended by Follman (<LINK REF="REF-Follman-1992" TYPE="REFERENCE">Follman 1992</LINK>). We included studies reporting multiple comparison groups in this review. In studies that found a difference between groups, we used the data for the control group for each intervention group comparison and reduced the weight assigned to the control group by dividing the number of participants in the control group by the number of intervention groups (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>, chapter 7.7.3).</P>
<P>Three studies reported results as medians and interquartile range (<LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>, <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>) - these data could not be converted to means and standard deviations and could therefore not be included in the meta-analyses, but were included in the narrative summary of the results.</P>
<P>We included cluster-randomised trials in this review by using the unit of randomisation (cluster) as the number of observations. Where necessary, we utilised individual level means and standard deviations adjusted for clustering together with the number of clusters in the denominator, in order to weight the trials appropriately.</P>
<P>We entered data presented as a scale with a consistent direction of effect, with the exception of HDL cholesterol where an increase in this outcome was a positive finding.</P>
</EFFECT_MEASURES>
<HETEROGENEITY_ASSESSMENT MODIFIED="2017-06-22 06:42:40 +0100" MODIFIED_BY="[Empty name]">
<P>For each outcome, we conducted tests of heterogeneity using the Chi<SUP>2</SUP> test of heterogeneity and the I<SUP>2</SUP> statistic. Where there was no heterogeneity, we performed a fixed-effect meta-analysis. If substantial heterogeneity was detected (I<SUP>2 </SUP>= 50% or greater), we looked for possible explanations for this (e.g. difference in GI between study groups, study duration, weight loss versus weight maintenance interventions) and used a random-effects model with appropriate cautious interpretation.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2017-06-28 03:38:31 +0100" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using Cochrane&#8217;s statistical software, Review Manager 2014. We entered continuous data as the change in means and standard deviations from baseline to follow-up measurements.</P>
<P>Studies in primary prevention populations (healthy individuals or those at high risk of CVD) or secondary prevention populations (defined as those with a pre-existing diagnosis of CVD) were analysed separately.</P>
<P>Data were pooled using a fixed-effect model and the results for the longest follow-up. Data were pooled for the studies categorised as primary prevention. Only one study in a secondary prevention population was included and this was reported in the narrative synthesis only.</P>
<P>Studies reported results either as absolute values at the endpoint or as change from baseline. For the pooled analysis, change from baseline values were reported. Where papers did not report results as change from baseline, we calculated this and for the standard deviation differences, we followed the methods presented in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> for imputing these (16.1.3.2 Imputing standard deviations for changes from baseline <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>), and assumed a correlation of 0.5 between baseline and follow-up measures, as suggested by Follman (<LINK REF="REF-Follman-1992" TYPE="REFERENCE">Follman 1992</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="3">Quality of evidence</HEADING>
<P>We presented the overall quality of the evidence for each primary outcome (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>; <LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>) according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, which takes into account issues not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity such as directness of results. Two review authors (LA, KR) rated the quality for each outcome. We presented summaries of the evidence in 'Summary of findings' tables, which provide key information about the best estimate of the magnitude of the effect, in relative terms for each relevant comparison of alternative management strategies, numbers of participants and trials addressing each important outcome, and the rating of the overall confidence in effect estimates for each outcome. We created the 'Summary of findings' tables based on the methods described in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We presented results on the outcomes as described in <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>.</P>
<P>In addition, we established an appendix 'Checklist to aid consistency and reproducibility of GRADE assessments' (<LINK REF="REF-Meader-2014" TYPE="REFERENCE">Meader 2014</LINK>) to help with standardisation of 'Summary of findings' tables (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</SUBSECTION>
</DATA_SYNTHESIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2017-07-04 11:37:45 +0100" MODIFIED_BY="[Empty name]">
<P>The study flow is shown in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>. The searches resulted in the identification of 18614 potentially relevant records. 18036 of these were excluded based on titles and abstracts as clearly not relevant and 578 full text articles were assessed for eligibility. Twelve additional records were identified through screening reference lists of systematic reviews, other potentially relevant articles and contacting authors; of these, nine studies were excluded and three were included. In total, five studies are awaiting classification, one study is ongoing and 21 studies were included in the analysis of this review. Three of these had been included in the previous version of this review (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>); the other RCTs included in the previous version of the review no longer fulfilled the updated inclusion criteria. Nineteen studies could be included in the meta-analysis. Four studies included four eligible comparison groups (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) with different cointerventions and therefore two independent comparisons per study could be included in the analysis. However, the RISCK study (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) only reported medians and interquartile range and could therefore not be included in the pooled analysis. The pooled analyses therefore included up to 17 comparisons.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<P>Detailed study characteristics are shown in <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<SUBSECTION>
<HEADING LEVEL="4">Study design</HEADING>
<P>All included studies were parallel group RCTs. Most used individual randomisation, while one randomised Weight Watchers classes (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>) and one randomised families (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>). Most RCTs were single centre studies, while two were multicentre studies (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>). One multicentre study was carried out in eight European countries; five came from the UK, four from the USA, and one each from Australia, New Zealand, Brazil, Canada, France, Italy, Germany, and Mexico. Nine studies had a duration of 12 weeks (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>), two of four months (<LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>), six of between 24 weeks and 6 months (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>), one of 36 weeks (<LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>), one of one year (<LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>) and two of 18 months (<LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). Most of the studies did not report on postintervention follow-up periods. One study mentioned a 12-month weight maintenance phase after the main intervention, but results were not reported (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>). One study reported an extension up to one year in two of the eight centres taking part in the main six-month study (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of participants</HEADING>
<P>The included studies had a total of 2538 participants (n = 2233 included in meta-analysis). Sample sizes ranged between 18 and 773, with more than half of the studies having fewer than 100 participants (median 60). Sample sizes per comparison group ranged from 6 to 159.</P>
<P>The inclusion criterion for over half of the studies was overweight or obesity, or both. Four studies included participants who were overweight or obese and had additional cardiovascular risk factors or the metabolic syndrome (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>). Two studies included participants with at least one recognised heart disease risk factor (<LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>). One study included participants with hyperlipidaemia (<LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>), and one included participants with impaired glucose tolerance (<LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>). One study included participants with coronary heart disease (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>).</P>
<P>Where reported (15 studies), the mean age of participants was between 30 and 67 years. One study did not report on the sex of participants, four included only women, one only men, the rest included between 12% and 88.5% men.</P>
<P>At baseline, the mean BMI of participants ranged from 26.7 kg/m<SUP>2</SUP> to 36.5 kg/m<SUP>2</SUP> (reported by 19 studies). Mean total cholesterol was between 4.1 and 6.1 mmol/L and between 6.1 and 6.3 mmol/L in the study restricted to hyperlipidaemic participants (reported by 19 studies). Mean HDL cholesterol levels were between 1.1 and 1.9 mmol/L (reported by 20 studies) and mean LDL cholesterol levels between 2.4 and 4.4 mmol/L (reported by 19 studies). Mean systolic blood pressure was between 112 and 141 mmHg and mean diastolic blood pressure between 71 and 84 mmHg (reported by 13 studies). Medication use was not reported by twelve studies, participants in five studies used no medication for cardiovascular disorders (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>), and four studies reported on medication use for cardiovascular disorders (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of interventions</HEADING>
<P>Recommendations regarding high or low GI diets were generally based on standard tables or on specific high or low GI food groups. In some trials, relevant foods were provided to the participants (<LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>), and/or participants received prescribed diets or eating plans (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>), and/or menu lists and recipes (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). In one trial (<LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>), a feeding phase with diet prepared by a metabolic kitchen (12 weeks) was followed by a 12 week phase where participants prepared their own meals. In the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>), a lab-based shop system was used in two of eight centres. Trials also included written information (information booklets/instructions) (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>), dietary counselling or staff being available for questions (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>), cooking and behavioural advice (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>), cooking classes (<LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>), reminders (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>), and group instructions (<LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>). Two trials were based on the Weight Watchers programme (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>). Several trials specifically based their recommendations on current healthy eating guidelines (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>), in one trial, a Mediterranean diet was followed (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>), one trial was based on a traditional Mexican diet (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>), and one was based one a low GI diet of wholegrains and pulses (<LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK> compared a low GI diet with a portion control group (with similar nutritional composition) and a high carbohydrate diet was used in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>.</P>
<P>In most trials, the diet was energy-reduced in all participants (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>) or in participants with a BMI above a certain level (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>). Several trials did not specifically report that the diet was energy-reduced, but the energy content of the actual intervention diets consumed was lower than the energy content of the baseline diets (<LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). Other studies specifically used a weight-maintenance diet (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>).</P>
<P>Two studies included a weight loss phase before randomisation and randomisation was based on a defined level of weight loss during that phase (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>). Of the trials with multiple dietary interventions, the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>) compared high and low GI groups receiving concomitant high or low protein diets, and other trials compared high and low GI diets in the context of high carbohydrate and low protein diets (<LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>), or low fat and high monounsaturated fatty acid diets (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>).</P>
<P>One trial included exercise sessions (<LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>) and others recommended increased physical activity (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>). Dietary adherence was generally checked using food records or food diaries (e.g. 3-day food records) (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>); some trials used food choice checklists (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>), a computer-based check of consumption (<LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>), or food-container weigh-backs (<LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>).</P>
<P>Where reported (20 studies, see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), daily energy intake of the intervention diets varied widely between 5335 and 14,000 kJ per day. Despite aiming for a similar energy content of diets, the low GI diet in the trial by <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK> had a significantly higher energy content than the high GI diet (8506 (SE 473) kJ/day versus 7360 (SE 331) kJ/day, P = 0.04). Carbohydrate content of diets varied between 143 g and 258 g per day (7 studies) or 40% and 62% of energy (15 studies), fat content between 32 g and 73 g per day (7 studies) or 19% and 39.6% of energy (15 studies), protein content between 57 g and 95 g per day (7 studies) or 15% and 28% of energy (13 studies), and fibre content between 8 g and 44.5 g per day (14 studies).</P>
<P>GI was clearly reported for 19 studies (see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). Mean GI ranged between 30 and 71 in the low GI groups (mean 49) and between 47 and 81 in the high GI groups (mean 63). The GI difference between groups varied widely between 0.6 and 42 (mean 13.5).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Types of outcomes</HEADING>
<P>None of the studies reported on mortality (total or cardiovascular) or cardiovascular events. All studies reported weight, BMI, or both. Most studies reported on blood lipids (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides). A range of studies reported systolic and diastolic blood pressure (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). Only a small number of studies reported on adverse events (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>), satisfaction (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>), hunger/satiety (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>), or appetite/desire to eat (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>).</P>
<P>Most studies also reported on variables related to blood glucose values and insulin sensitivity (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>), but these outcomes are not reported here. <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK> also reported flow-mediated dilatation and carotid intima thickness.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Funding</HEADING>
<P>Nine studies reported noncommercial funding (<LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). Four studies had both noncommercial and commercial funding (the latter partially for sponsoring of food products)(<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>). One study was sponsored by Weight Watchers International (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>), one study reported that a slimming product used in the weight loss phase was provided by the manufacturer (<LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>) and one study was funded by the United States Potato Board (<LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>). Four studies did not report the source of funding (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>) and one reported that there was no specific funding (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>).</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2017-07-04 11:35:38 +0100" MODIFIED_BY="[Empty name]">
<P>Reasons for study exclusion (<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>) included: the study was not an RCT, study duration was less than 12 weeks, not relevant intervention, not relevant participants (participants with diabetes or of children or adolescents), or the study reported no eligible outcomes. The <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table includes both excluded studies from this version of the review and of the previous version of this review.</P>
<SUBSECTION>
<HEADING LEVEL="3">Ongoing studies</HEADING>
<P>The PREVIEW study (<LINK REF="STD-Brand_x002d_Miller-2013" TYPE="STUDY">Brand-Miller 2013</LINK>) is an ongoing 3-year RCT that includes 2500 adults and children who are overweight (BMI &#8805; 25.0 kg/m<SUP>2</SUP>) and prediabetic. The study compares high-protein, low-glycaemic index diet to a high-carbohydrate, medium-glycaemic index diet in combination with moderate or high intensity physical activity on the incidence of type 2 diabetes and CVD outcomes. There was insufficient information about the intervention and study completion is in 2018 (<LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Studies awaiting classification</HEADING>
<P>Five studies are awaiting classification (<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>). Three studies did not clearly report if CVD outcomes were collected (<LINK REF="STD-Boyadjieva-2015" TYPE="STUDY">Boyadjieva 2015</LINK>; <LINK REF="STD-Giroux-2015" TYPE="STUDY">Giroux 2015</LINK>; <LINK REF="STD-Karl-2015" TYPE="STUDY">Karl 2015</LINK>), and the diet composition was not clear in one study (<LINK REF="STD-Cayanan-2015" TYPE="STUDY">Cayanan 2015</LINK>). The authors of the three studies were contacted for further details but the authors did not respond (<LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK>). The library could not track down one study (<LINK REF="STD-Weinhold-2015" TYPE="STUDY">Weinhold 2015</LINK>).</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]">
<P>Risk of bias was generally unclear (see <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> and <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>). Three studies were at high risk of bias for at least three domains (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>) while eight studies were at low risk of bias for at least three domains (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). </P>
<ALLOCATION MODIFIED="2017-01-06 18:15:25 +0000" MODIFIED_BY="[Empty name]">
<P>Nine of 21 studies reported an adequate method of randomisation (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>), while none of the studies clearly reported allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2017-06-23 01:21:24 +0100" MODIFIED_BY="[Empty name]">
<P>Adequate blinding of outcome assessment was only reported by four of the 21 trials (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>) and were at low risk of bias. The other trials did not report whether outcome assessment was blinded.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2017-06-23 01:22:09 +0100" MODIFIED_BY="[Empty name]">
<P>Many studies had high levels of dropouts or losses to follow-up (reported by 19 studies). The attrition rate ranged between 0 and 41.5% (mean 23.8%) in the low GI groups and between 0 and 70.4% (mean 26.6%) in the high GI groups.</P>
<P>Five trials reported an intention-to-treat analysis (low risk of bias: <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>), while 12 trials clearly included only participants completing the trial in the analysis (high risk of bias: <LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>).</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2017-06-23 01:24:03 +0100" MODIFIED_BY="[Empty name]">
<P>In the study by <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>, there was only very limited reporting of outcomes for the second phase of their trial (i.e. the phase where participants prepared their own meals, after the initial phase where food was obtained from a metabolic kitchen). The study by <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK> did not report postintervention blood pressure parameters. Most other studies appeared to report all outcomes as intended, however, not enough information was available to check (protocols were not available) and these have been judged as at unclear risk of bias.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2017-06-23 01:26:24 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Comparability at baseline</HEADING>
<P>Differences at baseline are indicative of selection bias. In most trials, comparison groups were similar at baseline, although in a number of studies, baseline characteristics were reported only for participants that completed the study. In the study by <LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>, significantly fewer participants took a statin or aspirin in the low GI group than in the high GI group. In the study by <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>, triglycerides were significantly lower at baseline in the low GI group than in the control group. <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK> reported a significantly higher level of triglycerides, a significantly lower fibre intake and significantly lower blood glucose in the low GI group compared to the portion control group at baseline. <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK> did not report age or sex and the RISCK (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) trial only reported baseline data for men versus women, but not for the different comparison groups. <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK> reported that baseline characteristics between comparison groups were similar, but only limited data were shown.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Power analysis</HEADING>
<P>Seven studies reported a power analysis and the study was adequately powered (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>). However, some of these studies did not base their power analyses on outcomes relevant for the present review, so it was unclear if they were adequately powered for measuring these outcomes (<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>; <LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>; <LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>; <LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>; <LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>).</P>
<P>Six studies reported a power analysis but the study was underpowered - this was partially due to an underestimation of dropouts (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>; <LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>; <LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>; <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>). Three studies reported a power analysis but it was unclear if the study was adequately powered (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>). Six studies reported no power analysis (<LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>; <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>; <LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>; <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other</HEADING>
<P>The study by <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK> was cluster randomised but this does not appear to have been taken account of in the analysis.</P>
</SUBSECTION>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]">
<P>Results are reported separately for primary prevention studies and the secondary prevention study.</P>
<SUBSECTION>
<HEADING LEVEL="3">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Total and cardiovascular mortality:</HEADING>
<P>None of the included studies reported on total cardiovascular mortality.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cardiovascular disease events - fatal and nonfatal myocardial infarction:</HEADING>
<P>None of the included studies reported on fatal and nonfatal myocardial infarction.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cardiovascular disease events - unstable angina:</HEADING>
<P>None of the included studies reported on unstable angina.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cardiovascular disease events - coronary artery bypass graft surgery:</HEADING>
<P>None of the included studies reported on coronary artery bypass graft surgery.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cardiovascular disease events - percutaneous transluminal coronary angioplasty:</HEADING>
<P>None of the included studies reported on percutaneous transluminal coronary angioplasty.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cardiovascular disease events - stroke:</HEADING>
<P>None of the included studies reported on stroke.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events</HEADING>
<P>Two trials reported adverse effects (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>), low-quality evidence (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). In one study (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>) no side effects were observed with the diets (0/24). In another study (<LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>) no participant withdrew due to side effects or health complications (0/14). The remaining trials did not report on adverse events.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Blood lipids</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary Prevention Studies</HEADING>
<P>Pooled summaries for the effects of low GI diets on blood lipids are shown in <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK> to <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>. Studies in the analyses are sorted by magnitude of GI difference between study groups, with the study with the largest GI difference listed first and the studies with an unclearly reported GI difference listed last.</P>
<SUBSECTION>
<HEADING LEVEL="6">Total cholesterol</HEADING>
<P>Seventeen studies reported total cholesterol and 14 of these could be summarised in a meta-analysis (17 comparisons). Including all studies reporting this outcome, the change in total cholesterol from baseline to study end varied between -0.80 and +1.5 mmol/L in the low GI groups and between -0.67 and +1.5 mmol/L in the control groups.</P>
<P>The pooled analysis showed no evidence for a difference between comparison groups (mean difference (MD) -0.12 mmol/L, 95% CI -0.26 to 0.02, P = 0.10, 1277 participants, 14 studies, 17 comparisons, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). However, there was substantial heterogeneity (I<SUP>2 </SUP>= 61%), but no evidence for an effect of the magnitude of the difference in GI between comparison diets, of study duration or of weight loss versus weight maintenance studies could be seen.</P>
<P>Of the trials that could not be included in the pooled analysis, the RISCK trial (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) did not show evidence for a difference in total cholesterol between the low and high GI groups after 24 weeks of intervention. Similarly, there was no evidence for a difference in total cholesterol between the low and high GI groups after 12 weeks of intervention in the trial by <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>, after 4 months in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>, and after one year in a subgroup of participants of the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>). <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK> reported a significant reduction in total cholesterol in all comparison groups over 12 weeks (P &lt; 0.001), but there was no evidence for a difference between groups, and numeric values were not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">HDL cholesterol</HEADING>
<P>Seventeen studies reported HDL cholesterol and 14 of these could be summarised in a meta-analysis (17 comparisons). Including all studies reporting this outcome, the change in HDL cholesterol from baseline to study end varied between -0.6 and +0.4 mmol/L in the low GI groups and between -0.7 and +0.6 mmol/L in the control groups.</P>
<P>The pooled analysis showed no evidence for a difference between comparison groups (MD -0.00 mmol/L, 95% CI -0.03 to 0.02, P = 0.69, 1329 participants, 14 studies, 17 comparisons, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). No evidence for an effect of the magnitude of the difference in GI between comparison diets, of study duration or of weight loss versus weight maintenance studies could be seen. There was no substantial heterogeneity (I<SUP>2</SUP>= 0%).</P>
<P>Of the trials that could not be included in the pooled analysis, the RISCK trial (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) did not show evidence of a difference in HDL cholesterol between the low and high GI groups after 24 weeks of intervention. Similarly, there was no evidence of a difference in HDL cholesterol between the low and high GI groups after 12 weeks of intervention in the trial by <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>, after 4 months in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>, and after one year in a subgroup of participants of the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>). <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK> reported a significant overall reduction in HDL cholesterol over 12 weeks (P &lt; 0.001), but there was no evidence of a difference between groups, and numeric values were not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">LDL cholesterol.</HEADING>
<P>Seventeen studies reported LDL cholesterol and 14 of these could be summarised in a meta-analysis (17 comparisons). Including all studies reporting this outcome, the change in LDL cholesterol from baseline to study end varied between -0.45 and +0.5 mmol/L in the low GI groups and between -0.44 and +0.52 mmol/L in the control groups.</P>
<P>The pooled analysis showed no evidence for a difference between comparison groups (MD -0.03 mmol/L, 95% CI -0.10 to 0.04, P = 0.46, 1274 participants, 14 studies, 17 comparisons, <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). No evidence of an effect of the magnitude of the difference in GI between comparison diets, of study duration or of weight loss versus weight maintenance studies could be seen. There was no substantial heterogeneity (I<SUP>2</SUP>= 4%).</P>
<P>Of the trials that could not be included in the pooled analysis, the RISCK trial (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) did not find a significant difference in LDL cholesterol between the low and high GI groups after 24 weeks of intervention. Similarly, there was no significant difference in LDL cholesterol between the low and high GI groups after 12 weeks of intervention in the trial by <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>, after 4 months in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>, and after one year in a subgroup of participants of the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>). <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK> reported a significant reduction in LDL cholesterol in all comparison groups after 12 weeks (P &lt; 0.001), but no significant difference between groups, and numeric values were not reported.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="6">Triglycerides</HEADING>
<P>Seventeen studies reported triglyceride levels and 13 of these could be summarised in a meta-analysis (16 comparisons). Including all studies reporting this outcome, the change in triglycerides from baseline to study end varied between -0.61 and +0.28 mmol/L in the low GI groups and between -2.34 and +0.36 mmol/L in the control groups.</P>
<P>The pooled analysis showed no evidence for a difference between comparison groups (MD 0.03 mmol/L, 95% CI -0.03 to 0.09, P = 0.32, 1252 participants, 13 studies, 16 comparisons, <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>). No effect of the magnitude of the difference in GI between comparison diets, of study duration or of weight loss versus weight maintenance studies could be seen. There was no substantial heterogeneity (I<SUP>2 </SUP>= 9%).</P>
<P>Of the trials that could not be included in the pooled analysis, the RISCK trial (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) did not show evidence of a difference in triglycerides between the low and high GI groups after 24 weeks of intervention. Similarly, there was no evidence of a difference in triglycerides between the low and high GI groups after 12 weeks of intervention in the trial by <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>, after 4 months in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>, and after one year in a subgroup of participants of the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>). One study (<LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>) reported change in triglyceride levels as median and interquartile range (IQR); there was a nonsignificant difference (P = 0.516) between low (median 0.27 mmol/L, 41 participants) and high GI groups (median -0.26 mmol/L, 40 participants) after six months.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary Prevention study</HEADING>
<P>In the one study (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>) including participants with CHD, there were no evidence of differences seen between groups in the change from baseline values for total cholesterol (MD -0.10, 95% CI -0.59 to 0.39, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>); HDL cholesterol (MD -0.03 mmol/L, 95% CI -0.18 to 0.12, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>); LDL cholesterol (MD -0.06 mmol/L, 95% CI -0.47 to 0.35, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>); and triglycerides (MD -0.29 mmol/L, 95% CI -0.73 to 0.15, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blood pressure</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary Prevention studies</HEADING>
<P>Eleven studies reported blood pressure and nine of these could be summarised in a meta-analysis (10 comparisons). Including all studies reporting this outcome, the change in systolic blood pressure from baseline to study end varied between -10 and +4.5 mmHg (mean -3.44 mmHg) in the low GI groups and between -14 and +5.1 mmHg (mean -4.14 mmHg) in the control groups. The change in diastolic blood pressure from baseline to study end varied between -8 and +1.9 mmHg (mean -1.85 mmHg) in the low GI groups and between -8 and +3.6 mmHg (mean -2.37 mmHg) in the control groups.</P>
<P>The pooled analysis showed no evidence of a difference between comparison groups in systolic blood pressure (MD 0.52 mmHg, 95% CI -1.21 to 2.25, P = 0.55, 786 participants, 9 studies, 10 comparisons, <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>) with no substantial heterogeneity (I<SUP>2 </SUP>= 7%). The pooled analysis showed no evidence of a difference between comparison groups in diastolic blood pressure (MD -0.23 mmHg, 95% CI -1.42 to 0.96, P = 0.71, 786 participants, 9 studies, 10 comparisons, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) where there was moderate heterogeneity (I<SUP>2 </SUP>= 38%). No evidence of an effect of the magnitude of the difference in GI between comparison diets, of study duration or of weight loss versus weight maintenance studies could be seen.</P>
<P>Of the trials that could not be included in the pooled analysis, the RISCK trial (<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>; <LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>) did not show evidence of a difference in systolic or diastolic blood pressure between the low and high GI groups after 24 weeks of intervention. Similarly, there was no evidence of a difference in systolic or diastolic blood pressure between the low and high GI groups after one year in a subgroup of participants of the DiOGenes trial (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>) and no evidence of a difference in diastolic blood pressure after four months of intervention in the trial by <LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary Prevention study</HEADING>
<P>In the one study (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>) including participants with CHD, there was no evidence of any differences seen between groups in systolic blood pressure (MD -2.00 mmHg, 95% CI -14.97 to 10.97, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) and diastolic blood pressure (MD -4.00 mmHg, 95% CI -13.41 to 5.41, <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other secondary outcomes (health-related quality of life, attitudes to diets, satisfaction)</HEADING>
<P>None of the studies reported on health-related quality of life. Two studies (<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>; <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>) reported on behaviour change, both studies reported no difference between the intervention and control (see <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). In the study by <LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>, both the 12 week low GI and the control diet produced a similar increase in dietary restraint, and a similar decrease in disinhibition, hunger sensations, emotionality and externality. In the study by <LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>, there was no no significant change in physical activity observed. </P>
<P>Five studies (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>; <LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>; <LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>; <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>) reported on hunger/desire to eat parameters (see <LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). In one study (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>) participants in the low GI group had significantly lower intensity of hunger (P &lt; 0.001) and desire to eat than participants of the control group (P &lt; 0.001). In one study (<LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>), the low GI group reported lower hunger sensation in comparison to the control. <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK> and <LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK> reported no evidence of a difference in hunger/fullness between the low GI and the control groups after the intervention (four, six and 18 months respectively). </P>
<P>Three studies (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>; <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>) reported on participants satisfaction (see <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). In one study (<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>) participants of both the low GI and the control group were equally satisfied with the dietary programme and that both 12 week diets were perceived to be equally effective but they found the low GI diet significantly easier to follow than the control diet. The <LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK> and <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK> studies reported mean scores of intervention acceptability for the overall (high protein and low protein) low GI group (n = 273) and the overall (high protein and low protein) high GI group (n = 255). Both low GI and high GI groups reported similar scores and there was no difference between groups for satisfaction with the program, convenience of the program, ease of adherence to the program, motivation to continue the program, and enjoying the dietary intervention.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Weight change as a potential confounder</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Primary Prevention studies</HEADING>
<P>Most studies reported some weight loss in both the low and high GI groups. Weight loss ranged from 0.26 kg to 9.95 kg in the weight loss studies and from a weight loss of 9 kg to a weight gain of 1.45 kg in the weight maintenance studies. In the studies with an initial weight loss phase before a weight maintenance phase, participants had a mean weight loss of 11.2 kg (SD 3.5) in the DiOGenes study (<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>; <LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>) and a median weight loss of 6.1% body weight in the study by <LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>. There was no evidence for a difference in weight loss between the low and the high GI groups (MD -0.16 kg, 95% CI -0.54 to 0.21, P = 0.40, 1403 participants, 14 studies, 17 comparisons, <LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). There was no substantial heterogeneity. There was also no evidence for a difference in change in recorded BMI between low and high GI groups at the end of the interventions (MD -0.0 kg/m<SUP>2</SUP>, 95% CI -0.26 to 0.26, P = 0.98, 525 participants, 11 studies, 11 comparisons, <LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>). There was no substantial heterogeneity (I<SUP>2 </SUP>= 0%). In the studies that could not be included in the meta-analysis, weight change was between +0.3 and -4 kg in the low GI groups and between -0.3 and -8.4 kg in the high GI groups. There was no evidence for a difference between high and low GI comparison groups in weight change in these studies. One study (<LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>) reported significant changes according to weight loss between the beginning and the end of the intervention, mostly in the high GI group that showed a significant decrease in BMI compared to the high GI group.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary Prevention study</HEADING>
<P>In the one study (<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>) including participants with CHD, there was no evidence for differences in weight loss between the low and high GI groups (MD 0.70 kg, 95% CI -6.77 to 8.17, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>) or change in BMI (MD 0.30 kg, 95% CI -1.75 to 2.35, 55 participants, 1 study, 1 comparison, <LINK REF="CMP-002.08" TYPE="ANALYSIS">Analysis 2.8</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2017-07-04 11:39:27 +0100" MODIFIED_BY="[Empty name]">
<P>This systematic review summarised 21 RCTs, with 2538 randomised participants, examining the effect of low GI diets or foods compared with higher GI diets or foods on risk factors for cardiovascular disease over 12 weeks or more. Twenty RCTs were in a primary prevention population and one RCT in a secondary prevention population. None of the studies reported on mortality (total or cardiovascular) or cardiovascular events. Risk of bias was high, with none of the studies fulfilling more than half of the criteria. Most of the studies did not have an intervention duration of longer than six months. Difference in GI between comparison groups varied widely from 0.6 to 42.</P>
<P>Overall, in the primary prevention studies, no evidence of a difference between low GI and high GI groups was seen for blood lipid parameters and blood pressure parameters: total cholesterol (MD -0.12 mmol/L, 95% CI -0.26 to 0.02, P = 0.10), HDL cholesterol (MD -0.00 mmol/L, 95% CI -0.03 to 0.02, P = 0.78), LDL cholesterol (MD -0.03 mmol/L, 95% CI -0.10 to 0.04, P = 0.46), triglycerides (MD 0.03 mmol/L, 95% CI -0.03 to 0.09, P = 0.32), systolic blood pressure (MD 0.52 mmHg, 95% CI -1.21 to 2.25, P = 0.55), and diastolic blood pressure (MD -0.23 mmHg, 95% CI -1.42 to 0.96, P = 0.90). Similarly, no differences were seen in body weight or BMI (as a potential confounder): weight (MD 0.16 kg, 95% CI -0.54 to 0.21, P = 0.40), BMI (MD -0.00 kg/m<SUP>2</SUP>, 95% CI -0.26 to 0.26, P = 0.98). Hunger or satiety, or both, were only reported by five studies and evidence of a difference in favour of the low GI group was only reported by one of these studies.</P>
<P>In the secondary prevention study, no evidence of any differences were observed between low and high GI groups on any reported outcomes of this review.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<P>The GI of compared diets varied considerably between comparison groups for the included studies from 2.5 to 42 (see <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). It is unclear therefore whether the apparent lack of effect on CVD risk factors was due to small differences in GI between intervention and control groups. Most diets were energy-reduced (with associated weight loss) and followed some form of healthy eating recommendations. We examined the effects of the diets on weight and BMI as potential confounders and, whilst no differences were seen between low GI and comparison groups, the small sample sizes and short follow-up periods may not have allowed the separation of the true effect of low GI foods compared to the effects produced by weight loss and general healthy eating, especially in view of the fact that, in some studies, GI differences were very small.</P>
<P>It should be noted that the GI of the low and high GI diets were measured in most of the studies by food diaries and showed considerable variation. The method of measuring the GI of individual foods was standardised in 1997 (<LINK REF="REF-FAO_x002f_WHO-1997" TYPE="REFERENCE">FAO/WHO 1997</LINK>), and all included trials were published after that date. There is some debate about the accurate measurement of GI in the diet. Most of the low GI diets used in the studies in this review were based on mixed meals. It has been demonstrated that the GI of mixed meals predicted by table values does not predict the measured GI, and that the fat and protein content, or energy content of mixed meals are more strongly correlated with the GI of mixed meals than carbohydrate content (<LINK REF="REF-Flint-2004" TYPE="REFERENCE">Flint 2004</LINK>). Additionally, it has been reported that most current food frequency questionnaires are not constructed for the purpose of measuring GI and have not been validated for this purpose (<LINK REF="REF-Barclay-2006" TYPE="REFERENCE">Barclay 2006</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2017-07-03 17:30:04 +0100" MODIFIED_BY="[Empty name]">
<P>The unclear risk of bias (according to Cochrane criteria) of most of the included studies makes overall interpretation of the data difficult. Sample sizes were small and durations of follow-up were short and many trials had a large number of dropouts. Adverse events (including useful information about how easy it was to make the dietary changes) were generally not reported. Differences between studies in measuring the GI of the diets consumed may also have contributed some bias (<LINK REF="REF-Du-2006" TYPE="REFERENCE">Du 2006</LINK>).</P>
<P>We aimed to assess the overall quality of the evidence for each primary outcome according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach which takes into account issues not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity such as directness of results<I>. </I>We presented two tables; for the primary prevention of CVD and the secondary prevention of CVD. For the primary prevention of CVD, the majority of the included randomised controlled trials did not report the primary outcomes (n = 6) of this review, therefore we could not assess the overall quality (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>). Adverse events (one of the primary outcomes) was downgraded by one level for risk of bias because of a high attrition rate, adverse events not reported consistently and potentially underpowered studies. Adverse events was downgraded by one level for imprecision because of the small number of participants and included studies. Overall, inconsistency was difficult to evaluate because the majority of the domains were not applicable (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>). For the secondary prevention of CVD, there was one included study which did not measure primary outcomes (<LINK REF="SOF-02" TYPE="SOF">Summary of findings table 2</LINK>).</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2017-06-25 03:33:00 +0100" MODIFIED_BY="[Empty name]">
<P>The inclusion criteria for this update were expanded to include all cardiovascular disease and not just coronary heart disease. We also included studies with healthy participants to capture a primary prevention subset. As there are other Cochrane reviews which examine the effect of low GI diets in obesity (<LINK REF="REF-Thomas-2007" TYPE="REFERENCE">Thomas 2007</LINK>) and diabetes (<LINK REF="REF-Thomas-2009" TYPE="REFERENCE">Thomas 2009</LINK>), studies were only included if they reported blood lipids or blood pressure, or both, and studies in participants with diabetes were excluded. We also excluded studies reporting weight-related outcomes, but if studies reported weight change and blood lipids and/or blood pressure, we abstracted this information since weight change is a potential confounder. We chose to include studies of at least 12 weeks duration and therefore excluded many short-term studies. However, by selecting studies of longer duration, we were able to determine if these effects were sustained, which is more relevant for public health interventions.</P>
<P>There was substantial heterogeneity in the composition of diets between studies so what drives the effects of low GI across studies might be different; for example, if the intake of fibre was controlled, this might make a difference to the outcome. Low GI diets are often characterised by a higher fibre content which may confound the effect of low GI per se, although data have shown that the effects of low GI diets can be seen in the absence of difference in fibre content (<LINK REF="REF-Bjorck-2003" TYPE="REFERENCE">Bjorck 2003</LINK>). Where reported, the studies included in this review had no significant difference in fibre content when comparing the high and the low GI diets. The inclusion criteria required a similar dietary composition between the intervention and control groups with the exception of low GI within each study, but the composition of diets between studies varied widely and studies were variable in the level of detail provided. There may also be different effects seen for advice to consume low GI foods and provision of low GI foods. Currently, there were insufficient studies included in the review to explore this in subgroup analyses.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2017-06-25 03:36:14 +0100" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="REF-Thomas-2007" TYPE="REFERENCE">Thomas 2007</LINK> summarised six RCTs (duration five weeks to six months) of the effects of low GI diets in overweight or obese participants (n = 202). They found a significantly greater weight loss in low GI groups (WMD -1.1 kg, 95% CI: -2.0, -0.2, P &lt; 0.05, n = 163) and also a significantly greater decrease in total cholesterol (WMD -0.22 mmol/L, 95% CI: -0.43, -0.02, P &lt; 0.05) and LDL cholesterol (WMD -0.24 mmol/L, 95% CI: -0.44, -0.05, P &lt; 0.05). However, the comparison diets in this review were not matched for macronutrient composition, and so other dietary factors may have contributed to the effect seen.</P>
<P>
<LINK REF="REF-Goff-2013" TYPE="REFERENCE">Goff 2013</LINK> assessed the effects of low GI diets on blood lipids in 28 RCTs lasting at least four weeks (n = 1272). Studies comparing intended macronutrient differences of diets were excluded but differences in fibre content were allowed. The authors also found a significant reduction in total (WMD -0.13 mmol/L, 95% CI: -0.22, -0.04, P &lt; 0.004, n = 1441) and LDL cholesterol (WMD -0.16 mmol/L, 95% CI: -0.24, -0.08, P &lt; 0.0001, n = 1281) in the low GI groups. This may have been due to the larger number of short term studies included in that review; the meta-analyses suggest that few of the individual trials found significant differences in cholesterol levels.</P>
<P>The review by <LINK REF="REF-Kristo-2013" TYPE="REFERENCE">Kristo 2013</LINK> focused on controlled feeding studies (i.e. all food and drinks provided throughout the study) of low versus high GI diets (with similar macronutrient composition). They included five studies lasting between four and 12 weeks and reported inconsistent results regarding the effects of the diets on blood lipids.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2017-06-30 19:36:11 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2017-06-30 19:36:11 +0100" MODIFIED_BY="[Empty name]">
<P>There is currently no evidence available regarding the effect of low GI diets on cardiovascular disease events. Moreover, there is currently no convincing evidence that low GI diets have a clear beneficial effect on blood lipids or blood pressure parameters. </P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2017-06-25 03:37:26 +0100" MODIFIED_BY="[Empty name]">
<P>There is a need for well-designed, adequately powered, long-term (follow-up at one year or more) RCTs to assess the effects of low GI diets on cardiovascular risk factors. Measurement of GI and desirable GI differences between diets should be standardised.</P>
<P>Studies are needed assessing the effects of low GI diets on hard cardiovascular outcomes (to reduce the power requirements, this may be best done in populations with an increased cardiovascular risk, such as in patients with existing cardiovascular disease or type 2 diabetes mellitus).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2017-06-25 03:38:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Update:</B>
</P>
<P>We would like to thank Nicole Martin (Cochrane Heart Group) for running the updated searches and extending the search strategy to include primary prevention trials. We would also like to thank Dr Clara Rübner Jørgensen (University of Warwick) for helping with the translation of a Danish trial potentially eligible for inclusion. We would also like to acknowledge the significant contributions of Carolyn Summerbell and Victoria Whittaker to earlier versions of this review.</P>
<P>
<B>Previous review version:</B>
</P>
<P>Margaret Burke (Cochrane Heart Group) for assistance with the development of the search strategy.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2017-07-26 16:47:43 +0100" MODIFIED_BY="[Empty name]">
<P>CC: None known. </P>
<P>LAK: None known.</P>
<P>EL: None known.</P>
<P>SAMK: None known.</P>
<P>LH: None known.</P>
<P>NF: None known.</P>
<P>RG: None known.</P>
<P>GF: None of the relationships described are felt to be a conflict of interest regarding this publication. Consultancy for appetite regulation with Unilever; grant application to Nestle on modified cereal fibre and glycaemic control (awaiting outcome); patent on compounds and their effects on appetite control and insulin sensitivity (WO2014020344 A1).</P>
<P>KR: None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2017-07-04 13:05:33 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Update:</B>
</P>
<P>
<I>
<B>C Clar:</B> </I>study selection, data extraction, update of the review text and tables, data analyses and summaries.</P>
<P>
<I>
<B>L Al-Khudairy:</B>
</I> study selection, data extraction, update of the review text and tables, data analyses.</P>
<P>
<I>
<B>E Loveman:</B>
</I> data extraction, checking analyses, writing results text.</P>
<P>
<I>
<B>L Hartley:</B> </I>study selection.</P>
<P>
<I>
<B>S Kelly: </B>
</I>study selection, data extraction.</P>
<P>
<I>
<B>R Germanò: </B>
</I>study selection.</P>
<P>
<I>
<B>G Frost:</B>
</I> conceived the original idea for the review, critically read the final draft.</P>
<P>
<I>
<B>K Rees:</B>
</I> project management, arbitrator for study inclusions, checking data abstraction, checking completion of final review and critically reading drafts.</P>
<P>
<B>Previous review version:</B>
</P>
<P>
<I>
<B>S Kelly: </B>
</I>prepared and designed the protocol. Developed and ran the search strategy. Organised the retrieval of papers and screened papers for inclusion and exclusion. Extracted data from papers that were included and took the primary role in writing the review. For the update of the review, ran the search strategy, organised the retrieval of papers, screened papers for inclusion and exclusion, extracted data from included papers and took the primary role in writing the review.</P>
<P>
<I>
<B>G Frost: </B>
</I>conceived the review and obtained funding. Provided a methodological, policy and clinical perspective on the data.</P>
<P>
<I>
<B>C Summerbell: </B>
</I>for the original review, screened papers for inclusion and exclusion and extracted data from papers that were included in the review for the purpose of dual data collection. Provided a methodological, policy and clinical perspective on the data.</P>
<P>
<I>
<B>V Whittaker: </B>
</I>advised on meta-analysis and quality assessment of studies. For the update of the review, extracted data from papers and advised on statistics and quality assessment of studies.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2017-06-25 03:56:08 +0100" MODIFIED_BY="[Empty name]">
<P>The inclusion criteria for this review were expanded to include all cardiovascular disease and not just coronary heart disease. As there are other Cochrane reviews which examine the effect of low GI diets in obesity and diabetes, studies were only included if they reported blood lipids or blood pressure or both, and studies in participants with diabetes were excluded. Studies in healthy participants were included to capture both primary and secondary prevention of CVD. As more trials are available now, we have excluded short-term studies and included only those of at least 12 weeks duration. Only adults (age 18 or older) were included.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2017-07-26 16:49:16 +0100" MODIFIED_BY="Nicole Martin">
<STUDIES MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Armendariz_x002d_Anguiano-2011" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Armendariz-Anguiano 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Armendariz-Anguiano AL, Jimenez-Cruz A, Bacardi-Gascon M, Hurtado-Ayala L</AU>
<TI>Effect of a low glycemic load on body composition and Homeostasis Model Assessment (HOMA) in overweight and obese subjects</TI>
<SO>Nutricion Hospitalaria</SO>
<YR>2011</YR>
<VL>26</VL>
<PG>170-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250305"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250304"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellisle-2007" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Bellisle 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-21 23:26:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bellisle F, Dalix AM, De Assis MA, Kupek E, Gerwig U, Slama G, et al</AU>
<TI>Motivational effects of 12-week moderately restrictive diets with or without special attention to the glycaemic Index of foods</TI>
<SO>British Journal of Nutrition</SO>
<YR>2007</YR>
<VL>97</VL>
<PG>790-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250307"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250306"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Buscemi-2013" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Buscemi 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Buscemi S, Cosentino L, Rosafio G, Morgana M, Mattina A, Sprini D, et al</AU>
<TI>Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patients at increased cardiovascular risk</TI>
<SO>Clinical Nutrition</SO>
<YR>2013</YR>
<VL>32</VL>
<PG>346-52</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250309"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250308"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DiOGenes-2011a-high-protein" MODIFIED="2017-07-03 15:48:46 +0100" MODIFIED_BY="[Empty name]" NAME="DiOGenes 2011a high protein" YEAR="2011">
<REFERENCE MODIFIED="2015-11-06 13:01:11 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aller EE, Larsen TM, Claus H, Lindroos AK, Kafatos A, Pfeiffer A, et al</AU>
<TI>Weight loss maintenance in overweight subjects on ad libitum diets with high or low protein content and glycemic index: the DIOGENES trial 12-month results</TI>
<SO>International Journal of Obesity</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>12</NO>
<PG>1511-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250311"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:28:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gogebakan O, Kohl A, Osterhoff MA, Van Baak MA, Jebb SA, Papadaki A, et al</AU>
<TI>Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial</TI>
<SO>Circulation</SO>
<YR>2011</YR>
<VL>124</VL>
<PG>2829-38</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250312"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:29:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goyenechea E, Holst C, Van Baak M, Saris W, Jebb S, Kafatos A, et al</AU>
<TI>Effects of different protein content and glycaemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomized, dietary intervention trial</TI>
<SO>Diabetes/Metabolism Research and Reviews</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>7</NO>
<PG>705-16</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374853"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-26 09:39:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen T M, Dalskov S, van Baak M, Jebb S, Kafatos A, Pfeiffer A, et al</AU>
<TI>The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries - a comprehensive design for long-term intervention</TI>
<SO>Obesity Reviews</SO>
<YR>2010</YR>
<VL>11</VL>
<PG>76-91</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250314"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:29:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen TM, Dalskov SM, Van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al</AU>
<TI>Diets with high or low protein content and glycemic index for weight-loss maintenance</TI>
<SO>New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>363</VL>
<PG>2102-13</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250313"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-03 15:48:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McConnon A, Horgan G, Lawton C, Stubbs J, Shepherd R, Astrup A, et al</AU>
<TI>Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trial</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2013</YR>
<VL>67</VL>
<NO>9</NO>
<PG>990-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374854"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250310"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-DiOGenes-2011-low-protein" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="DiOGenes 2011 low protein" YEAR="2011">
<REFERENCE MODIFIED="2015-11-06 13:01:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aller EE, Larsen TM, Claus H, Lindroos AK, Kafatos A, Pfeiffer A, et al</AU>
<TI>Weight loss maintenance in overweight subjects on ad libitum diets with high or low protein content and glycemic index: the DIOGENES trial 12-month results</TI>
<SO>International Journal of Obesity</SO>
<YR>2014</YR>
<VL>28</VL>
<NO>12</NO>
<PG>1511-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250316"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:31:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gogebakan O, Kohl A, Osterhoff MA, Van Baak MA, Jebb SA, Papadaki A, et al</AU>
<TI>Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial</TI>
<SO>Circulation</SO>
<YR>2011</YR>
<VL>124</VL>
<PG>2829-38</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250317"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:32:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Goyenechea E, Holst C, Van Baak M, Saris W, Jebb S, Kafatos A, et al</AU>
<TI>Effects of different protein content and glycaemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomized, dietary intervention trial</TI>
<SO>Diabetes/Metabolism Research and Reviews</SO>
<YR>2011</YR>
<VL>27</VL>
<NO>7</NO>
<PG>705-16</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374855"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-11-26 09:40:20 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen T M, Dalskov S, van Baak M, Jebb S, Kafatos A, Pfeiffer A, et al</AU>
<TI>The Diet, Obesity and Genes (Diogenes) Dietary Study in eight European countries - a comprehensive design for long-term intervention</TI>
<SO>Obesity Reviews</SO>
<YR>2010</YR>
<VL>11</VL>
<PG>76-91</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250319"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:33:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Larsen TM, Dalskov SM, Van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al</AU>
<TI>Diets with high or low protein content and glycemic index for weight-loss maintenance</TI>
<SO>New England Journal of Medicine</SO>
<YR>2010</YR>
<VL>363</VL>
<PG>2102-13</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250318"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:33:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McConnon A, Horgan G, Lawton C, Stubbs J, Shepherd R, Astrup A, et al</AU>
<TI>Experience and acceptability of diets of varying protein content and glycemic index in an obese cohort: results from the Diogenes trial</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2013</YR>
<VL>67</VL>
<NO>9</NO>
<PG>990-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374856"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250315"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-2004" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-06-21 23:34:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost GS, Brynes AE, Bovill-Taylor C, Dornhorst A</AU>
<TI>A prospective randomised trial to determine the efficacy of a low glycaemic index diet given in addition to healthy eating and weight loss advice in patients with coronary heart disease</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>58</VL>
<PG>121-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250321"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250320"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghani-2014a-high-insulin" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ghani 2014a high insulin" YEAR="">
<REFERENCE MODIFIED="2017-06-21 23:35:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fatimah A, Rohana AG, Norasyikin AW, Karuthan C, Nik Shanita S, Mohd Yusof BN, et al</AU>
<TI>Lowering dietary glycaemic index through nutrition education among Malaysian women with a history of gestational diabetes mellitus</TI>
<SO>Malaysian Journal of Nutrition</SO>
<YR>2013</YR>
<VL>19</VL>
<NO>1</NO>
<PG>9-23</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374858"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:35:52 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ghani RA, Shyam S, Arshad F, Wahab NA, Chinna K, Safii NS, et al</AU>
<TI>The influence of fasting insulin level in post-gestational diabetes mellitus women receiving low-glycaemic-index diets</TI>
<SO>Nutrition &amp; Diabetes</SO>
<YR>2014</YR>
<VL>4</VL>
<NO>2</NO>
<PG>e107</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374859"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:36:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Shyam S, Arshad F, Abdul Ghani R, Abdul Wahab N, Barakatun Nisak M, Safii N, et al</AU>
<TI>Women with previous gestational diabetes mellitus achieve clinically significant weight loss on low glycaemic index diets</TI>
<SO>Obesity Reviews</SO>
<YR>2014</YR>
<VL>15</VL>
<PG>92</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374860"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374857"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghani-2014--low-insulin" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ghani 2014  low insulin" YEAR="2014">
<REFERENCE MODIFIED="2017-06-21 23:37:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fatimah A, Rohana AG, Norasyikin AW, Karuthan C, Nik Shanita S, Mohd Yusof BN, et al</AU>
<TI>Lowering dietary glycaemic index through nutrition education among Malaysian women with a history of gestational diabetes mellitus</TI>
<SO>Malaysian Journal of Nutrition</SO>
<YR>2013</YR>
<VL>19</VL>
<NO>1</NO>
<PG>9-23</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374862"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:39:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ghani RA, Shyam S, Arshad F, Wahab NA, Chinna K, Safii NS, et al</AU>
<TI>The influence of fasting insulin level in post-gestational diabetes mellitus women receiving low-glycaemic-index diets</TI>
<SO>Nutrition &amp; Diabetes</SO>
<YR>2014</YR>
<VL>4</VL>
<NO>2</NO>
<PG>e107</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374863"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-21 23:40:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Shyam S, Arshad F, Abdul Ghani R, Abdul Wahab N, Barakatun Nisak M, Safii N, et al</AU>
<TI>Women with previous gestational diabetes mellitus achieve clinically significant weight loss on low glycaemic index diets</TI>
<SO>Obesity Reviews</SO>
<YR>2014</YR>
<VL>15</VL>
<PG>92</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374864"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374861"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-H_x00f6_nemann-2010" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Hönemann 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 00:22:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hönemann I, Ranke C, Austel A, Jarzemski S, Deeken I, Pleyer I, et al</AU>
<TI>Changes of cardiovascular risk factors while following one of three currently discussed dietetic weight-reducing strategies</TI>
<TO>Veränderungen kardiovaskulärer Risikofaktoren unter drei aktuell diskutierten Ernährungsstrategien zur Gewichtsreduktion</TO>
<SO>Aktuelle Ernahrungsmedizin</SO>
<YR>2010</YR>
<VL>35</VL>
<PG>227-35</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250323"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250322"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Juanola_x002d_Falgarona-2014" MODIFIED="2017-06-30 18:03:57 +0100" MODIFIED_BY="[Empty name]" NAME="Juanola-Falgarona 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-06-30 18:03:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Giardina S, Hernandez Alonso P, Salas Salvado J, Bullo M</AU>
<TI>Effects of Glycemic index on the expression of selected miRNAs in adipose tissue: the GLYNDIET study</TI>
<SO>Obesity facts</SO>
<YR>2016</YR>
<VL>9</VL>
<PG>223</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374866"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:23:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Juanola-Falgarona M, Ibarrola N, Salvadó JS, Soler AR, Bulló M</AU>
<TI>Design and methods of the GLYNDIET study; assessing the role of glycemic index on weight loss and metabolic risk markers</TI>
<SO>Nutrición Hospitalaria</SO>
<YR>2013</YR>
<VL>28</VL>
<NO>2</NO>
<PG>382-90</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374867"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:23:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Juanola-Falgarona M, Salas-Salvadó J, Ibarrola-Jurado N, Rabassa-Soler A, Bulló M</AU>
<TI>Effect of dietary glycemic index and glycemic load on body weight and cardiovascular risk factors: the GLYNDIET Study</TI>
<SO>Obesity Facts</SO>
<YR>2013</YR>
<VL>6</VL>
<PG>111</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374868"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:24:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Juanola-Falgarona M, Salas-Salvadó J, Ibarrola-Jurado N, Rabassa-Soler A, Díaz-López A, Guasch-Ferré M, et al</AU>
<TI>Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2014</YR>
<VL>11</VL>
<NO>1</NO>
<PG>27-35</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374869"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-08-24 14:47:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374865"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McMillan_x002d_Price-2006-high-CHO" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="McMillan-Price 2006 high CHO" YEAR="2006">
<REFERENCE MODIFIED="2017-06-22 00:25:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McMillan-Price J, Petocz P, Atkinson F, O'Neill K, Samman S, Steinbeck K, et al</AU>
<TI>Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2006</YR>
<VL>166</VL>
<PG>1466-75</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250325"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250324"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-McMillan_x002d_Price-2006-high-protein" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="McMillan-Price 2006 high protein" YEAR="2006">
<REFERENCE MODIFIED="2017-06-22 00:25:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>McMillan-Price J, Petocz P, Atkinson F, O'Neill K, Samman S, Steinbeck K, et al</AU>
<TI>Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2006</YR>
<VL>166</VL>
<PG>1466-75</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250327"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250326"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Melanson-2012" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Melanson 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-06 13:02:46 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Melanson KJ, Summers A, Nguyen V, Brosnahan J, Lowndes J, Angelopoulos TJ, et al</AU>
<TI>Body composition, dietary composition, and components of metabolic syndrome in overweight and obese adults after a 12-week trial on dietary treatments focused on portion control, energy density, or glycemic index</TI>
<SO>Nutrition Journal</SO>
<YR>2012</YR>
<VL>11</VL>
<PG>57</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250329"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250328"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philippou-2008" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Philippou 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-06-22 00:27:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philippou E, McGowan BM, Brynes AE, Dornhorst A, Leeds AR, Frost GS</AU>
<TI>The effect of a 12-week low glycaemic index diet on heart disease risk factors and 24 h glycaemic response in healthy middle-aged volunteers at risk of heart disease: a pilot study</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>62</VL>
<PG>145-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250331"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250330"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philippou-2009" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Philippou 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-06-22 00:27:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philippou E, Bovill-Taylor C, Rajkumar C, Vampa ML, Ntatsaki E, Brynes AE, et al</AU>
<TI>Preliminary report: the effect of a 6-month dietary glycemic index manipulation in addition to healthy eating advice and weight loss on arterial compliance and 24-hour ambulatory blood pressure in men: a pilot study</TI>
<SO>Metabolism: Clinical and Experimental</SO>
<YR>2009</YR>
<VL>58</VL>
<PG>1703-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250333"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250332"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philippou-2009a" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Philippou 2009a" YEAR="2009">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philippou E, Neary NM, Chaudhri O, Brynes AE, Dornhorst A, Leeds AR, et al</AU>
<TI>The effect of dietary glycemic index on weight maintenance in overweight subjects: a pilot study</TI>
<SO>Obesity</SO>
<YR>2009</YR>
<VL>17</VL>
<PG>396-401</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250335"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250334"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Raatz-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Raatz 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-22 00:28:29 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raatz SK, Torkelson CJ, Redmon JB, Reck KP, Kwong CA, Swanson JE, et al</AU>
<TI>Reduced glycemic index and glycemic load diets do not increase the effects of energy restriction on weight loss and insulin sensitivity in obese men and women</TI>
<SO>Journal of Nutrition</SO>
<YR>2005</YR>
<VL>135</VL>
<PG>2387-91</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250337"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250336"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Randolph-2014" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Randolph 2014" YEAR="2014">
<REFERENCE MODIFIED="2017-06-22 00:29:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01186393</AU>
<TI>Effects of potatoes in a weight loss program (BBFUSPB)</TI>
<SO>clinicaltrials.gov/ct2/show/NCT01186393?term=NCT01186393&amp;rank=1</SO>
<YR>(accessed on June 2016)</YR>
<IDENTIFIERS MODIFIED="2016-08-24 14:59:47 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374871"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:30:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Randolph J, Edirisinghe I, Kappagoda CT, Burton-Freeman B</AU>
<TI>Glycemic index and potato consumption: effects on glucose metabolism and body composition</TI>
<SO>Obesity</SO>
<YR>2010</YR>
<VL>18</VL>
<PG>S91</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374872"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:29:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Randolph JM, Edirisinghe I, Masoni AM, Kappagoda T, Burton-Freeman B</AU>
<TI>Potatoes, glycemic index, and weight loss in free-living individuals: practical implications</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2014</YR>
<VL>33</VL>
<NO>5</NO>
<PG>375-84</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374873"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374870"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RISCK-2010-high-MUFA" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="RISCK 2010 high MUFA" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 00:31:06 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD, et al</AU>
<TI>Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>748-58</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250339"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:31:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore C, Gitau R, Goff L, Lewis FJ, Griffin MD, Chatfield MD, et al</AU>
<TI>Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model</TI>
<SO>Journal of Nutrition</SO>
<YR>2009</YR>
<VL>139</VL>
<PG>1534-40</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250340"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250338"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-RISCK-2010-low-fat" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="RISCK 2010 low fat" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 00:32:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Jebb SA, Lovegrove JA, Griffin BA, Frost GS, Moore CS, Chatfield MD, et al</AU>
<TI>Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>748-58</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250342"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:32:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Moore C, Gitau R, Goff L, Lewis FJ, Griffin MD, Chatfield MD, et al</AU>
<TI>Successful manipulation of the quality and quantity of fat and carbohydrate consumed by free-living individuals using a food exchange model</TI>
<SO>Journal of Nutrition</SO>
<YR>2009</YR>
<VL>139</VL>
<PG>1534-40</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250343"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250341"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shikany-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Shikany 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-22 00:32:47 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shikany JM, Goudie A, Oberman A</AU>
<TI>Comparison of a low-fat/low-glycemic index diet to a low-fat only diet in the treatment of adults with hypercholesterolemia</TI>
<SO>Nutrition Research</SO>
<YR>2005</YR>
<VL>25</VL>
<PG>971-81</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250345"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250344"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sichieri-2007" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Sichieri 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-22 00:32:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mediano MF, Sichieri R</AU>
<TI>Insulin resistance predicts the effectiveness of different glycemic index diets on weight loss in non-obese women</TI>
<SO>Obesity Facts</SO>
<YR>2012</YR>
<VL>5</VL>
<PG>641-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250347"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 00:33:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sichieri R, Moura AS, Genelhu V, Hu F, Willett WC</AU>
<TI>An 18-mo randomized trial of a low-glycemic-index diet and weight change in Brazilian women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>86</VL>
<PG>707-13</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250348"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250346"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Solomon-2010" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Solomon 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malin SK, Niemi N, Haus JM, Kelly KR, Filion J, Rocco M, et al</AU>
<TI>Exercise training with weight loss and either a high- or low-glycemic index diet reduces metabolic syndrome severity in older adults</TI>
<SO>Annals of Nutrition &amp; Metabolism</SO>
<YR>2012</YR>
<VL>61</VL>
<PG>135-41</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250350"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Solomon TP, Haus JM, Kelly KR, Cook MD, Filion J, Rocco M, et al</AU>
<TI>A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>1359-68</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250351"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250349"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Venn-2010" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Venn 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Venn BJ, Perry T, Green TJ, Skeaff CM, Aitken W, Moore NJ, et al</AU>
<TI>The effect of increasing consumption of pulses and wholegrains in obese people: a randomized controlled trial</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2010</YR>
<VL>29</VL>
<PG>365-72</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250353"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250352"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Wolever-2002" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TMS, Mehling C</AU>
<TI>High carbohydrate-low glycaemic index dietary advice improves glucose disposition index in subjects with impaired glucose tolerance</TI>
<SO>British Journal of Nutrition</SO>
<YR>2002</YR>
<VL>87</VL>
<PG>477-87</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250355"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-15 10:28:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TMS, Mehling C</AU>
<TI>Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol and free fatty acid concentrations in subjects with impaired glucose tolerance</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>77</VL>
<NO>3</NO>
<PG>612-21</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250356"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250354"/></IDENTIFIERS>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Abbasi-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Abbasi 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-06-22 00:38:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abbasi F, McLaughlin T, Lamendola C, Kim HS, Tanaka A, Wang T, et al</AU>
<TI>High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk</TI>
<SO>American Journal of Cardiology</SO>
<YR>2000</YR>
<VL>85</VL>
<PG>45-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250358"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250357"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Abete-2008" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Abete 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-06-22 00:38:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Abete I, Parra D, Martinez JA</AU>
<TI>Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response</TI>
<SO>Clinical Nutrition</SO>
<YR>2008</YR>
<VL>27</VL>
<PG>545-51</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250360"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250359"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Agus-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Agus 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-07 18:07:32 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Agus MSD, Swain JF, Larson CL, Eckert EA, Ludwig DS</AU>
<TI>Dietary composition and physiologic adaptations to energy restriction</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>4</NO>
<PG>901-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250362"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250361"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alfenas-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Alfenas 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-07 18:07:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfenas RCG, Mattes RD</AU>
<TI>Influence of glycemic index/load on glycemic response, appetite, and food intake in healthy humans</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>9</NO>
<PG>2123-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250364"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250363"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Alfenas-2012" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Alfenas 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Alfenas RCG</AU>
<TI>The consumption of low glycemic meals reduces abdominal obesity in subjects with excess body weight</TI>
<SO>Nutricion Hospitalaria</SO>
<YR>2012</YR>
<VL>27</VL>
<PG>1178-83</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250366"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250365"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Amano-2007" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Amano 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-22 00:42:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Amano Y, Sugiyama M, Lee JS, Kawakubo K, Mori K, Tang AC, et al</AU>
<TI>Glycemic index-based nutritional education improves blood glucose control in Japanese adults: a randomized controlled trial</TI>
<SO>Diabetes Care</SO>
<YR>2007</YR>
<VL>30</VL>
<PG>1874-6</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250368"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250367"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Argiana-2011" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Argiana 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Argiana V, Kanellos P, Elefteriadou I, Alexiadou K, Grigoropoulou P, Tsitsinakis G, et al</AU>
<TI>The role of glycaemic index and glycaemic load on weight loss and on the metabolic parameters of adults with type 2 diabetes</TI>
<SO>Diabetologia</SO>
<YR>2011</YR>
<VL>54</VL>
<PG>S354</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250370"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250369"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aston-2008" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Aston 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-06-22 00:43:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aston LM, Stokes CS, Jebb SA</AU>
<TI>No effect of a diet with a reduced glycaemic index on satiety, energy intake and body weight in overweight and obese women</TI>
<SO>International Journal of Obesity</SO>
<YR>2008</YR>
<VL>32</VL>
<PG>160-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250372"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250371"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bahadori-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Bahadori 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-07 18:08:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bahadori B, Yazdani-Biuki B, Krippl P, Brath H, Uitz E, Wascher TC</AU>
<TI>Low-fat, high carbohydrate (low glycaemic index) diet induces weight loss and preserves lean body mass in obese healthy subjects: results of a 24 week study</TI>
<SO>Diabetes, Obesity and Metabolism</SO>
<YR>2005</YR>
<VL>7</VL>
<PG>290-3</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250374"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250373"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barakatun-2010" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Barakatun 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barakatun Nisak MY, Ruzita AT, Norimah AK, Gilbertson H, Nor Azmi K</AU>
<TI>Improvement of dietary quality with the aid of a low glycemic index diet in Asian patients with type 2 diabetes mellitus</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2010</YR>
<VL>29</VL>
<PG>161-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250376"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250375"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barkoukis-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Barkoukis 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 18:13:00 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barkoukis H, Fiedler KM, Lerner E</AU>
<TI>A combined high-fiber, low-glycemic index diet normalizes glucose tolerance and reduces hyperglycemia and hyperinsulinemia in adults with hepatic cirrhosis</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>2002</YR>
<VL>102</VL>
<PG>1503-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250378"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250377"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bouche-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Bouche 2002" YEAR="2002">
<REFERENCE MODIFIED="2014-10-09 14:31:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bouche C, Rizkalla SW, Luo J, Vidal H, Veronese A, Pacher N, et al</AU>
<TI>Five-week, low glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men</TI>
<SO>Diabetes Care</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>5</NO>
<PG>822-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250380"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250379"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brand-1991" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Brand 1991" YEAR="1991">
<REFERENCE MODIFIED="2014-10-09 14:31:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DCK, Truswell AS</AU>
<TI>Low-glycemic index foods improve long-term glycemic control in NIDDM</TI>
<SO>Diabetes Care</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>2</NO>
<PG>95-101</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250382"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250381"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Brynes-2003" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Brynes 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-07-07 18:13:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Brynes AE, Edwards CM, Ghatei MA, Dornhorst A, Morgan LM, Bloom SR, et al</AU>
<TI>A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men</TI>
<SO>British Journal of Nutrition</SO>
<YR>2003</YR>
<VL>89</VL>
<PG>207-18</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250384"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250383"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Calle_x002d_Pascual-1988" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Calle-Pascual 1988" YEAR="1988">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Calle-Pascual AL, Gomez V, Leon E, Bordiu E</AU>
<TI>Foods with a low glycemic index do not improve glycemic control of both type 1 and type 2 diabetic patients after one month of therapy</TI>
<SO>Diabete et Metabolisme</SO>
<YR>1988</YR>
<VL>14</VL>
<NO>5</NO>
<PG>629-33</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250386"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250385"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carels-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Carels 2005" YEAR="2005">
<REFERENCE MODIFIED="2014-10-13 14:48:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carels RA, Darby LA, Douglass OM, Cacciapaglia HM, Rydin S</AU>
<TI>Education on the glycemic index of foods fails to improve treatment outcomes in a behavioral weight loss program</TI>
<SO>Eating Behaviours</SO>
<YR>2005</YR>
<VL>5</VL>
<PG>145-50</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250388"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250387"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chanteleau-1985" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Chanteleau 1985" YEAR="1985">
<REFERENCE MODIFIED="2014-10-14 10:41:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chanteleau E, Sonnenburg GE, Kunze K, Berger M</AU>
<TI>Importance of the glycaemic index of carbohydrate-containing foods for metabolic control of type 1 diabetics under insulin pump therapy</TI>
<TO>Die Bedeutung des glykämischen Index kohlenhydrathaltiger Lebensmittel für die Stoffwechselkontrolle von Typ1 Diabetikern unter Insulinpumpentherapie</TO>
<SO>Aktuelle Ernährungsmedizin Klinik und Praxis</SO>
<YR>1985</YR>
<VL>10</VL>
<PG>236-40</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250390"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250389"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cheong-2009" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Cheong 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cheong SH, McCargar LJ, Paty BW, Tudor-Locke C, Bell RC</AU>
<TI>The First Step First Bite Program: guidance to increase physical activity and daily intake of low-glycemic index foods</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>2009</YR>
<VL>109</VL>
<PG>1411-6</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250392"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250391"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chiavaroli-2016" MODIFIED="2017-06-30 17:53:16 +0100" MODIFIED_BY="[Empty name]" NAME="Chiavaroli 2016" YEAR="2016">
<REFERENCE MODIFIED="2017-06-30 17:53:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chiavaroli L, Mirrahimi A, Ireland C, Mitchell S, Sahye-Pudaruth S, Coveney J, Olowoyeye O, Maraj T, Patel D, de Souza RJ, Augustin LS</AU>
<TI>Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial</TI>
<SO>BMJ open</SO>
<YR>2016</YR>
<VL>6</VL>
<NO>7</NO>
<PG>e012220</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374875"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374874"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clapp-1998" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Clapp 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-07-07 18:15:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clapp JF</AU>
<TI>Effect of dietary carbohydrate on the glucose and insulin response to mixed caloric intake and exercise in both nonpregnant and pregnant women</TI>
<SO>Diabetes Care</SO>
<YR>1998</YR>
<VL>21</VL>
<PG>106-13</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250394"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250393"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Colagiuri-1986" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Colagiuri 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-07-07 18:16:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Colagiuri S, Miller JJ, Holliday JL, Phelan E</AU>
<TI>Comparison of plasma glucose, serum Insulin, and C-peptide responses to three isocaloric breakfasts in non-insulin-dependant diabetic subjects</TI>
<SO>Diabetes Care</SO>
<YR>1986</YR>
<VL>9</VL>
<PG>250-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250396"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250395"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Collier-1986" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Collier 1986" YEAR="1986">
<REFERENCE MODIFIED="2008-07-07 18:16:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Collier GR, Wolever TMS, Wong GS, Josse RG</AU>
<TI>Prediction of glycemic response to mixed meals in noninsulin-dependant diabetic subjects</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>44</VL>
<PG>349-52</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250398"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250397"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Collier-1988" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Collier 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-07-07 18:31:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Collier GR, Giudici S, Kalmusky J, Wolever TMS, Helman G, Wesson V, et al</AU>
<TI>Low glycaemic index starchy foods improve glucose control and lower serum cholesterol in diabetic children</TI>
<SO>Diabetes, Nutrition and Metabolism - Clinical and Experimental</SO>
<YR>1988</YR>
<VL>1</VL>
<PG>11-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250400"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250399"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Coulston-1984" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Coulston 1984" YEAR="1984">
<REFERENCE MODIFIED="2017-06-22 00:46:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Coulston AM, Hollenbeck CB, Liu GC, Williams RA, Starich GH, Mazzaferri EL, et al</AU>
<TI>Effect of source of dietary carbohydrate on plasma glucose, insulin, and gastric inhibitory polypeptide responses to test meals in subjects with noninsulin-dependant diabetes mellitus</TI>
<SO>American Society of Clinical Nutrition</SO>
<YR>1984</YR>
<VL>40</VL>
<PG>965-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250402"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250401"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Crapo-1981" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Crapo 1981" YEAR="1981">
<REFERENCE MODIFIED="2008-07-07 18:32:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Crapo PA, Insel J, Sperling M, Kolterman OG</AU>
<TI>Comparison of serum glucose, insulin, and glucagon responses to different types of complex carbohydrate in noninsulin-dependant diabetic patients</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<PG>184-90</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250404"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250403"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Rougemont-2007" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="De Rougemont 2007" YEAR="2007">
<REFERENCE MODIFIED="2017-06-22 00:47:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Rougemont A, Normand S, Nazare JA, Skilton MR, Sothier M, Vinoy S, et al</AU>
<TI>Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular risk factors in overweight non-diabetic subjects</TI>
<SO>British Journal of Nutrition</SO>
<YR>2007</YR>
<VL>98</VL>
<PG>1288-98</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250406"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250405"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dumesnil-2001" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Dumesnil 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-07 18:33:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dumesnil JG, Turgeon J, Tremblay A, Poirer P, Gilbert M, Gagnon L, et al</AU>
<TI>Effect of a low-glycaemic Index-low-fat-high protein diet on the atherogenic metabolic risk profile of abdominally obese men</TI>
<SO>British Journal of Nutrition</SO>
<YR>2001</YR>
<VL>86</VL>
<PG>557-68</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250408"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250407"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ebbeling-2003" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ebbeling 2003" YEAR="2003">
<REFERENCE MODIFIED="2008-07-07 18:35:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ebbeling CB, Leidig MM, Sinclair KB, Hangen JP, Ludwig DS</AU>
<TI>A reduced glycemic load diet in the treatment of adolescent obesity</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2003</YR>
<VL>157</VL>
<PG>773-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250410"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250409"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ebbeling-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ebbeling 2005" YEAR="2005">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ebbeling CB, Leidig MM, Sinclair KB, Seger-Shippee LG, Feldman HA, Ludwig DS</AU>
<TI>Effects of an ad libitum low glycemic load diet on cardiovascular disease risk factors in obese young adults</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2005</YR>
<VL>81</VL>
<PG>976-82</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250412"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250411"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fontvielle-1988" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Fontvielle 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-07-07 18:37:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fontvieille AM, Acosta M, Rizkalla SW, Bornet F, David P, Letanoux M, et al</AU>
<TI>A moderate switch from high to low glycaemic-index foods for 3 weeks improves the metabolic control of Type I (IDDM) diabetic subjects</TI>
<SO>Diabetes, Nutrition and Metabolism - Clinical and Experimental</SO>
<YR>1988</YR>
<VL>1</VL>
<PG>139-43</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250414"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250413"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fontvielle-1992" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Fontvielle 1992" YEAR="1992">
<REFERENCE MODIFIED="2014-10-09 14:31:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fontvielle AM, Rizkalla SW, Penfornis A, Acosta M, Bornet FRJ, Slama G</AU>
<TI>The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks</TI>
<SO>Diabetic Medicine</SO>
<YR>1992</YR>
<VL>9</VL>
<PG>444-50</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250416"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250415"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-1994" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 1994" YEAR="1994">
<REFERENCE MODIFIED="2014-10-09 14:31:20 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost G, Wilding J, Beecham J</AU>
<TI>Dietary advice based on the glycaemic index improves dietary profile and metabolic control in type 2 diabetic patients</TI>
<SO>Diabetic Medicine</SO>
<YR>1994</YR>
<VL>11</VL>
<PG>397-401</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250418"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250417"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-1996" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 1996" YEAR="1996">
<REFERENCE MODIFIED="2014-10-10 16:41:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost G, Keogh B, Smith D, Akinsanya K, Leeds A</AU>
<TI>The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease</TI>
<SO>Metabolism</SO>
<YR>1996</YR>
<VL>45</VL>
<NO>6</NO>
<PG>669-72</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250420"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2016-08-24 14:48:15 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2016-08-24 14:48:15 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250419"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-1998a" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 1998a" YEAR="1998">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost G, Leeds A, Trew G, Margara R, Dornhurst A</AU>
<TI>Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet</TI>
<SO>Metabolism</SO>
<YR>1998</YR>
<VL>47</VL>
<NO>10</NO>
<PG>1245-51</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250422"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250421"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-1998b" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 1998b" YEAR="1998">
<REFERENCE MODIFIED="2017-06-22 00:52:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost GE, Keogh BE, Smith D, Leeds AR, Dornhorst A</AU>
<TI>Reduced adipocyte insulin sensitivity in Caucasian and Asian subjects with coronary heart disease</TI>
<SO>Diabetic Medicine</SO>
<YR>1998</YR>
<VL>15</VL>
<PG>1003-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250424"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250423"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Frost-1999" MODIFIED="2017-06-28 12:20:50 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-07-07 18:38:03 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frost G, Leeds AA, Dore CJ, Madeiros S, Brading S, Dornhurst A</AU>
<TI>Glycaemic index as a determinant of serum HDL-cholesterol concentration</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>353</VL>
<PG>1045-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250426"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250425"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fuh-1990" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Fuh 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-07-07 18:42:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fuh MMT, Lee MMS, Jeng CY, Ma F, Chen I, Reavem GM</AU>
<TI>Effect of low fat-high carbohydrate diets in hypertensive patients with non-insulin-dependent diabetes mellitus</TI>
<SO>American Journal of Hypertension</SO>
<YR>1990</YR>
<VL>3</VL>
<PG>527-32</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250428"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250427"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-1988" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Garg 1988" YEAR="1988">
<REFERENCE MODIFIED="2008-07-07 18:42:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garg A, Bonanome A, Grundy SM, Zhang ZU, Unger RH</AU>
<TI>Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus</TI>
<SO>New England Journal of Medicine</SO>
<YR>1988</YR>
<VL>13</VL>
<PG>828-35</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250430"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250429"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-1992" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Garg 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-07 18:45:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garg A, Grundy SM, Unger RH</AU>
<TI>Comparison of effects of high and low carbohydrate diets on plasma lipoproteins and insulin sensitivity in patients with mild NIDDM</TI>
<SO>Diabetes</SO>
<YR>1992</YR>
<VL>41</VL>
<PG>1278-85</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250432"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250431"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Garg-1994" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Garg 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-07-07 18:46:24 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, et al</AU>
<TI>Effects of varying carbohydrate content of diet in patients with non-insulin-dependant diabetes mellitus</TI>
<SO>JAMA</SO>
<YR>1994</YR>
<VL>271</VL>
<PG>1420-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250434"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250433"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giacco-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Giacco 2000" YEAR="2000">
<REFERENCE MODIFIED="2014-10-09 14:31:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L, et al</AU>
<TI>Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients</TI>
<SO>Diabetes Care</SO>
<YR>2000</YR>
<VL>23</VL>
<NO>10</NO>
<PG>1461-6</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250436"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250435"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilbertson-2001" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Gilbertson 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-07 18:47:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilbertson HR, Brand-Miller JC, Thornburn AW, Evans S, Chondros P, Werther GA</AU>
<TI>The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>7</NO>
<PG>1137-43</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250438"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250437"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilbertson-2003" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Gilbertson 2003" YEAR="2003">
<REFERENCE MODIFIED="2017-06-22 00:55:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilbertson HR, Thornburn AW, Brand-Miller JC, Chondros P, Werther GA</AU>
<TI>Effect of low glycaemic-index dietary advice on dietary quality and food choice in children with type 1 diabetes</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2003</YR>
<VL>77</VL>
<PG>83-90</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250440"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250439"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Golay-1992" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Golay 1992" YEAR="1992">
<REFERENCE MODIFIED="2008-07-07 18:48:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Golay A, Koellreutter B, Bloise D, Assal JP, Wursch P</AU>
<TI>The effect of muesli or cornflakes at breakfast on carbohydrate metabolism in type 2 diabetic patients</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>1992</YR>
<VL>15</VL>
<PG>135-42</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250442"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250441"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Grant-2010" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Grant 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Grant S, Wolever TMS, O'Connor DL, Josse RG</AU>
<TI>The effect of a low glycemic index diet on gestational hyperglycemia: a pilot trial</TI>
<SO>Federation of the American Societies of Experimental Biology Journal</SO>
<YR>2010</YR>
<VL>19</VL>
<NO>11</NO>
<PG>15-22</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250444"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250443"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gutschall-2009" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Gutschall 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gutschall MD, Miller CK, Mitchell DC, Lawrence FR</AU>
<TI>A randomized behavioural trial targeting glycaemic index improves dietary, weight and metabolic outcomes in patients with type 2 diabetes</TI>
<SO>Public Health Nutrition</SO>
<YR>2009</YR>
<VL>12</VL>
<PG>1846-54</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250446"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250445"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Heilbronn-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Heilbronn 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-06-22 00:59:12 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Heilbronn LK, Noakes M, Clifton PM</AU>
<TI>The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>2</NO>
<PG>120-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250448"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250447"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Herrmann-2001" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Herrmann 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-07-07 18:55:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Herrmann TS, Bean ML, Black TM, Wang P, Coleman RA</AU>
<TI>High glycemic index carbohydrate diet alters the diurnal rhythm of leptin but not insulin concentrations</TI>
<SO>Experimental Biology &amp; Medicine</SO>
<YR>2001</YR>
<VL>226</VL>
<PG>1037-44</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250450"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250449"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hollenbeck-1985" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Hollenbeck 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-07 18:56:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hollenbeck CB, Riddle MC, Connor WE, Leklem JE</AU>
<TI>The effects of subject-selected high carbohydrate, low fat diets on glycemic control in insulin dependant diabetes mellitus</TI>
<SO>American Society for Clinical Nutrition</SO>
<YR>1985</YR>
<VL>41</VL>
<PG>293-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250452"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250451"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jarvi-1995" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jarvi 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-07-07 18:58:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IME, Vessby BOH, Asp LN</AU>
<TI>The influence of food structure on postprandial metabolism in patients with non-insulin-dependant diabetes mellitus</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>61</VL>
<PG>837-43</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250454"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250453"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jarvi-1999" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jarvi 1999" YEAR="1999">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jarvi A, Karlstrom B, Granfeldt Y, Bjorck I, Asp NG, Vessby B</AU>
<TI>Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low glycemic index diet in type 2 diabetic patients</TI>
<SO>Diabetes Care</SO>
<YR>1999</YR>
<VL>22</VL>
<PG>10-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250456"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250455"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1985" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 1985" YEAR="1985">
<REFERENCE MODIFIED="2008-07-07 18:58:59 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Wolever TMS, Kalmusky J, Giudici S, Giordano C, Wong GS, et al</AU>
<TI>Low glycemic index carbohydrate foods in the management of hyperlipidemia</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1985</YR>
<VL>42</VL>
<PG>604-17</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250458"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250457"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1987a" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 1987a" YEAR="1987">
<REFERENCE MODIFIED="2008-07-07 19:19:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Wolever TMS, Collier GR, Ocana A, Rao AV, Buckley G, et al</AU>
<TI>Metabolic effects of a low-glycemic-index diet</TI>
<SO>American Society for Clinical Nutrition</SO>
<YR>1987</YR>
<VL>46</VL>
<PG>968-75</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250460"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250459"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1987b" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 1987b" YEAR="1987">
<REFERENCE MODIFIED="2008-07-07 19:19:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Wolever TMS, Kalmusky J, Guidici S, Giordano C, Patten R, et al</AU>
<TI>Low glycemic index diet in hyperlipidemia: use of traditional starchy foods</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1987</YR>
<VL>46</VL>
<PG>66-71</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250462"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250461"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-1988" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 1988" YEAR="1988">
<REFERENCE MODIFIED="2017-06-22 01:00:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Wolever TMS, Buckley G, Lam KY, Giudici S, Kalmusky J, et al</AU>
<TI>Low glycemic index starchy foods in the diabetic diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1988</YR>
<VL>48</VL>
<PG>248-54</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250464"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250463"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-2002a" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 2002a" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:20:45 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJA, Kendall CWC, Augustin LSA, Martini MC, Axelsen M, Faulkner D, et al</AU>
<TI>Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2002</YR>
<VL>25</VL>
<PG>1522-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250466"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250465"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-2002b" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 2002b" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:20:58 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins AL, Jenkins DJA, Zdravkovic U, Wursch P, Vuksan V</AU>
<TI>Depression of the glycemic index by high levels of B-glucan fiber in two functional foods tested in type 2 diabetes</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>56</VL>
<PG>622-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250468"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250467"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jenkins-2008" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL, et al</AU>
<TI>Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial</TI>
<SO>JAMA</SO>
<YR>2008</YR>
<VL>300</VL>
<PG>2742-53</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250470"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250469"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jensen-2008" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jensen 2008" YEAR="2008">
<REFERENCE MODIFIED="2014-10-15 11:15:42 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jensen L, Sloth B, Krog-Mikkelsen I, Flint A, Raben A, Tholstrup T, et al</AU>
<TI>A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2008</YR>
<VL>87</VL>
<PG>97-105</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250472"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250471"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jeppesen-1997" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jeppesen 1997" YEAR="1997">
<REFERENCE MODIFIED="2017-06-22 01:04:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jeppensen J, Schaaf P, Jones C, Zhou MY, Chen IYD, Reaven GM</AU>
<TI>Effects of low-fat, high-carbohydrate diets on risk factors for ischemic heart disease in postmenopausal women</TI>
<SO>American Society for Clinical Nutrition</SO>
<YR>1997</YR>
<VL>65</VL>
<PG>1027-33</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250474"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250473"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jimenez_x002d_Cruz-2003a" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jimenez-Cruz 2003a" YEAR="2003">
<REFERENCE MODIFIED="2017-06-22 01:04:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jimenez-Cruz A, Bacardi-Gascon M, Turnbull WH, Rosales G, Severino-Lugo I</AU>
<TI>A flexible, low-glycemic index Mexican-style diet in overweight and obese subjects with type 2 diabetes improves metabolic parameters during a 6-week treatment period</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>7</NO>
<PG>1967-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250476"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250475"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiminez_x002d_Cruz-2003b" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jiminez-Cruz 2003b" YEAR="2003">
<REFERENCE MODIFIED="2008-07-07 20:19:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiminez-Cruz A, Seimandi-Mora H, Bacardi-Gascon M</AU>
<TI>Effect of low glycemic index diet in hyperlipidemia</TI>
<TO>Efecto de dietas con bajo indice glucemico en hiperlipidemicos</TO>
<SO>Nutricion Hospitalaria</SO>
<YR>2003</YR>
<VL>18</VL>
<NO>6</NO>
<PG>331-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250478"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250477"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jiminez_x002d_Cruz-2004" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Jiminez-Cruz 2004" YEAR="2004">
<REFERENCE MODIFIED="2008-07-07 20:16:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jiminez-Cruz A, Turnbull WH, Bacardi-Gascon MB, Rosales-Garay P</AU>
<TI>A high fiber, moderate-glycemic index, Mexican style diet improves dyslipidemia in individuals with type 2 diabetes</TI>
<SO>Nutrition Research</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>1</NO>
<PG>19-27</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250480"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250479"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kabir-2002" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kabir 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kabir M, Oppert J-M, Vidal H, Bruzzo F, Fiquet C, Wursch P, et al</AU>
<TI>Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men</TI>
<SO>Metabolism</SO>
<YR>2002</YR>
<VL>51</VL>
<NO>7</NO>
<PG>819-26</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250482"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-09 14:31:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kabir M, Rizkalla SW, Oppert J-M, Wursch P, Bruzzo F, Slama G</AU>
<TI>Chronic effects of a low glycemic index starch breakfast on glucose and lipid metabolism in type 2 diabetic men: results of a controlled study</TI>
<SO>Diabetes</SO>
<YR>1999</YR>
<VL>48</VL>
<NO>Suppl 1</NO>
<PG>A461</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250483"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250481"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kelly-2011" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kelly 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kelly KR, Haus JM, Solomon TP, Patrick-Melin AJ, Cook M, Rocco M, et al</AU>
<TI>A low-glycemic index diet and exercise intervention reduces TNF(alpha) in isolated mononuclear cells of older, obese adults</TI>
<SO>Journal of Nutrition</SO>
<YR>2011</YR>
<VL>141</VL>
<PG>1089-94</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250485"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250484"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kendall-2012" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kendall 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kendall CWC, Augustin LS, Mitchell S, Sahye-Pudaruth S, Coveney J, Cerovic A, et al</AU>
<TI>Effect of pulses as part of a low glycemic index diet compared to a high fiber diet on HbA1c and blood lipids in type 2 diabetes</TI>
<SO>Federation of the American Societies of Experimental Biology Journal</SO>
<YR>2012</YR>
<VL>26</VL>
<PG>5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250487"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250486"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kiens-1996" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Kiens 1996" YEAR="1996">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kiens B, Richter EA</AU>
<TI>Types of carbohydrate in an ordinary diet affect insulin action and muscle substrates in humans</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1996</YR>
<VL>63</VL>
<PG>47-53</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250489"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250488"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Komindr-2001" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Komindr 2001" YEAR="2001">
<REFERENCE MODIFIED="2014-10-09 14:31:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Komindr S, Ingsriswang S, Lerdvuthisopon N, Boontawee A</AU>
<TI>Effect of long-term intake of Asian food with different glycaemic indices on diabetic control and protein conservation in type 2 diabetic patients</TI>
<SO>Journal of the Medical Association of Thailand</SO>
<YR>2001</YR>
<VL>84</VL>
<NO>1</NO>
<PG>85-97</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250491"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250490"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krog_x002d_Mikkelsen-2011" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Krog-Mikkelsen 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krog-Mikkelsen I, Sloth B, Dimitrov D, Tetens I, Bjorck I, Flint A, et al</AU>
<TI>A low glycemic index diet does not affect postprandial energy metabolism but decreases postprandial insulinemia and increases fullness ratings in healthy women</TI>
<SO>Journal of Nutrition</SO>
<YR>2011</YR>
<VL>141</VL>
<PG>1679-84</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250493"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250492"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kwak-2012" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Kwak 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kwak JH, Paik JK, Kim HI, Kim OY, Shin DY, Kim HJ, et al</AU>
<TI>Dietary treatment with rice containing resistant starch improves markers of endothelial function with reduction of postprandial blood glucose and oxidative stress in patients with prediabetes or newly diagnosed type 2 diabetes</TI>
<SO>Atherosclerosis</SO>
<YR>2012</YR>
<VL>224</VL>
<PG>457-64</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250495"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250494"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lafrance-1998" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Lafrance 1998" YEAR="1998">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lafrance L, Rabasa-Lhoret R, Poisson D, Ducros F, Chiasson J-L</AU>
<TI>The effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy</TI>
<SO>Diabetic Medicine</SO>
<YR>1998</YR>
<VL>15</VL>
<PG>972-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250497"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250496"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-LaHaye-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="LaHaye 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-07 19:23:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>LaHaye SA, Hollett PM, Vyselaar JR, Shakchi M, Lahey KA, Day AG</AU>
<TI>Comparison between a low glycemic load diet and a Canada Food Guide diet in cardiac rehabilitation patients in Ontario</TI>
<SO>Canadian Journal of Cardiology</SO>
<YR>2005</YR>
<VL>21</VL>
<NO>6</NO>
<PG>489-94</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250499"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250498"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laitinen-1993" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Laitinen 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-07 19:25:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laitinen JH, Ahola IE, Sarkkinen ES, Winberg RL, Harmaakorpi-IIvonen PA, Uusitupa MI</AU>
<TI>Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependant diabetes mellitus</TI>
<SO>Diabetes Spectrum</SO>
<YR>1995</YR>
<VL>8</VL>
<PG>102-3</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250501"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250500"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leinonen-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Leinonen 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leinonen KS, Poutanen KS, Mykkanen HM</AU>
<TI>Rye bread decreases serum total and LDL cholesterol in men with moderately elevated serum cholesterol</TI>
<SO>Journal of Nutrition</SO>
<YR>2000</YR>
<VL>130</VL>
<PG>164-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250503"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250502"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lerman_x002d_Garber-1995" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Lerman-Garber 1995" YEAR="1995">
<REFERENCE MODIFIED="2008-07-07 19:26:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lerman-Garber I, Gulias-Herrero A, Palma ME, Valles VE, Guerrero LA, Garcia EG, et al</AU>
<TI>Response to high carbohydrate and high monounsaturated fat diets in hypertriglyceridemic non-insulin dependent diabetic patients with poor glycemic control</TI>
<SO>Diabetes, Nutrition and Metabolism - Clinical and Experimental</SO>
<YR>1995</YR>
<VL>8</VL>
<PG>339-45</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250505"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250504"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lieberman-2003" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Lieberman 2003" YEAR="2002">
<REFERENCE MODIFIED="2017-06-22 01:10:37 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lieberman S</AU>
<TI>Natural methods for accelerating weight loss: the low glycemic index diet, green tea, chromium, and 5-hydroxytryptophan</TI>
<SO>Alternative and Complementary Therapies</SO>
<YR>2003</YR>
<VL>9</VL>
<NO>6</NO>
<PG>307-11</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250507"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250506"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2000" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:26:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, et al</AU>
<TI>A prospective study of dietary glycemic load, carbohydrate intake and risk of coronary heart disease in US women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>71</VL>
<NO>6</NO>
<PG>1455-61</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250509"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250508"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Liu-2002" MODIFIED="2017-06-28 12:18:54 +0100" MODIFIED_BY="[Empty name]" NAME="Liu 2002" YEAR="2002">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM</AU>
<TI>Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>75</VL>
<NO>3</NO>
<PG>492-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250511"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250510"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ludwig-1999" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ludwig 1999" YEAR="1999">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I, Roberts SB</AU>
<TI>High glycemic index foods, overeating, and obesity</TI>
<SO>Pediatrics</SO>
<YR>1999</YR>
<VL>103</VL>
<NO>3</NO>
<PG>E26</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250513"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250512"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lunetta-1996" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Lunetta 1996" YEAR="1996">
<REFERENCE MODIFIED="2008-07-07 19:28:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lunetta M, Mauro MD</AU>
<TI>Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non-insulin dependent diabetic patients</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>1996</YR>
<VL>33</VL>
<PG>53-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250515"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250514"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luscombe-1999" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Luscombe 1999" YEAR="1999">
<REFERENCE MODIFIED="2014-10-09 14:31:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Luscombe ND, Noakes M, Clifton PM</AU>
<TI>Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>1999</YR>
<VL>53</VL>
<PG>473-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250517"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250516"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marsh-2010" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Marsh 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 01:12:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marsh KA, Steinbeck KS, Atkinson FS, Petocz P, Brand-Miller JC</AU>
<TI>Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>83-92</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250519"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250518"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Morales-1997" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Morales 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-07 19:29:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Morales LM, Semprun-Fereira M, Ryder E, Valbuena H, Rincon E, Fernandez V, et al</AU>
<TI>Improved triglyceride control with low glycaemic index-high carbohydrate modified-lipid diet in a hypertriglyceridaemic child</TI>
<SO>Acta Paediatrica</SO>
<YR>1997</YR>
<VL>86</VL>
<PG>772-4</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250521"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250520"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nazare-2010" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Nazare 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 01:12:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nazare JA, De Rougemont A, Normand S, Sauvinet V, Sothier M, Vinoy S, et al</AU>
<TI>Effect of postprandial modulation of glucose availability: short-and long-term analysis</TI>
<SO>British Journal of Nutrition</SO>
<YR>2010</YR>
<VL>103</VL>
<PG>1461-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250523"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250522"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pacy-1984" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Pacy 1984" YEAR="1984">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pacy PJ, Dodson PM, Kubicki AJ, Fletcher RF, Taylor KG</AU>
<TI>Effect of a high fibre, high carbohydrate dietary regimen on serum lipids and lipoproteins in type II hypertensive diabetic patients</TI>
<SO>Diabetes Research</SO>
<YR>1984</YR>
<VL>1</VL>
<PG>159-63</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250525"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250524"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2004" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Patel 2004" YEAR="2004">
<REFERENCE MODIFIED="2014-10-10 16:41:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel VC, Aldridge RD, Leeds A, Dornhorst A, Frost GS</AU>
<TI>Retrospective analysis of the impact of a low glycaemic index diet on hospital stay following coronary artery bypass grafting: a hypothesis</TI>
<SO>Journal of Human Nutrition and Dietetics</SO>
<YR>2004</YR>
<VL>17</VL>
<NO>3</NO>
<PG>241-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250527"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250526"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Patel-2011a" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Patel 2011a" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Patel JV, Hughes EA, Lip GY, Gill PS</AU>
<TI>Diabetes Health, Residence &amp; Metabolism in Asians: the DHRMA study, research into foods from the Indian subcontinent - a blinded, randomised, placebo controlled trial</TI>
<SO>BMC Cardiovascular Disorders</SO>
<YR>2011</YR>
<VL>11</VL>
<PG>70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250529"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250528"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Percheron-1997" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Percheron 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-07 19:30:34 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Percheron C, Colette C, Avignon A, Monnier L</AU>
<TI>Metabolic responses to high carbohydrate breakfasts in obese patients with impaired glucose tolerance. Comparison of meals containing dairy products and fruits versus bread</TI>
<SO>Nutrition Research</SO>
<YR>1997</YR>
<VL>17</VL>
<PG>797-806</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250531"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250530"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pereira-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Pereira 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:30:50 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL, et al</AU>
<TI>Effext of whole grains on insulin sensitivity in overweight hyperinsulinemic adults</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>75</VL>
<NO>5</NO>
<PG>848-55</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250533"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250532"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pereira-2004" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Pereira 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS</AU>
<TI>Effects of a low glycemic index load diet on resting energy expenditure and heart disease risk factors during weight loss</TI>
<SO>JAMA</SO>
<YR>2004</YR>
<VL>292</VL>
<NO>20</NO>
<PG>2482-90</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250535"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250534"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perichart_x002d_Perera-2012" MODIFIED="2017-06-28 12:20:13 +0100" MODIFIED_BY="[Empty name]" NAME="Perichart-Perera 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-06-28 12:20:13 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perichart-Perera O, Balas-Nakash M, Rodriguez-Cano A, Legorreta-Legorreta J, Parra-Covarrubias A, Vadillo-Ortega F</AU>
<TI>Low glycemic index carbohydrates versus all types of carbohydrates for treating diabetes in pregnancy: a randomized clinical trial to evaluate the effect of glycemic control</TI>
<SO>International Journal of Endocrinology</SO>
<YR>2012</YR>
<VL>Epub 2012 Nov 29</VL>
<PG>296017</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250537"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250536"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pittas-2005" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Pittas 2005" YEAR="2005">
<REFERENCE MODIFIED="2008-07-07 19:31:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pittas AG, Das SK, Hajduk CL, Golden J, Saltzman E, Stark PC, et al</AU>
<TI>A low glycemic load diet facilitates greater weight loss in overweight adults with high insulin secretion but not in overweight adults with low insulin secretion in the CALERIE trial</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>12</NO>
<PG>2939-41</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250539"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250538"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Poppitt-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Poppitt 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:32:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Poppitt SD, Keogh GF, Prentice AM, Williams DEM, Sonnemans HMW, Valk EEJ, et al</AU>
<TI>Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome</TI>
<SO>American Society for Clinical Nutrition</SO>
<YR>2002</YR>
<VL>75</VL>
<PG>11-20</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250541"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250540"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rabasa_x002d_Lhoret-1999" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Rabasa-Lhoret 1999" YEAR="1999">
<REFERENCE MODIFIED="2008-07-07 19:33:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rabasa-Lhoret R, Garon J, Langelier H, Poisson D, Chiasson JL</AU>
<TI>Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente- regular) insulin regimen</TI>
<SO>Diabetes Care</SO>
<YR>1999</YR>
<VL>22</VL>
<PG>667-73</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250543"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250542"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rasmussen-1993" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Rasmussen 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-07 19:34:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rasmussen OW, Thomsen C, Hansen KW, Vesterlund M, Winther E, Hermansen K</AU>
<TI>Effects on blood pressure, glucose, and lipid levels of a high-monounsaturated fat diet compared with a high-carbohydrate diet in NIDDM subjects</TI>
<SO>Diabetes Care</SO>
<YR>1993</YR>
<VL>16</VL>
<PG>1564-71</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250545"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250544"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Runchey-2012" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Runchey 2012" YEAR="2012">
<REFERENCE MODIFIED="2017-06-22 01:42:10 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Runchey SS, Pollak MN, Valsta LM, Coronado GD, Schwarz Y, Breymeyer KL, et al</AU>
<TI>Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2012</YR>
<VL>66</VL>
<PG>1146-52</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250547"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250546"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Runchey-2013" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Runchey 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-06-22 01:42:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Runchey SS, Valsta LM, Schwarz Y, Wang C, Song X, Lampe JW, et al</AU>
<TI>Effect of low- and high-glycemic load on circulating incretins in a randomized clinical trial</TI>
<SO>Metabolism: Clinical and Experimental</SO>
<YR>2013</YR>
<VL>62</VL>
<PG>188-95</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250549"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250548"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sacks-2013" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Sacks 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sacks FM, Appel LJ, Carey VJ, Anderson CA, Charleston J, Copeland P, et al</AU>
<TI>Effect of dietary carbohydrate (amount and type) on risk factors for cardiovascular disease and diabetes: the omnicarb trial</TI>
<SO>Circulation</SO>
<YR>2013</YR>
<VL>127</VL>
<NO>Suppl 12</NO>
<PG>A016</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250551"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250550"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salmeron-1997" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Salmeron 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-07 19:34:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ, et al</AU>
<TI>Dietary fiber, glycemic load, and risk of NIDDM in men</TI>
<SO>Diabetes Care</SO>
<YR>1997</YR>
<VL>20</VL>
<NO>4</NO>
<PG>545-50</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250553"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250552"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Santacroce-1990" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Santacroce 1990" YEAR="1990">
<REFERENCE MODIFIED="2008-07-07 19:36:11 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Santacroce G, Forlani G, Giangiulio S, Galuppi V, Pagani M, Vannini P</AU>
<TI>Long-term effects of eating sucrose on metabolic control of type 1 (insulin-dependent) diabetic outpatients</TI>
<SO>Acta Diabetologica Latina</SO>
<YR>1990</YR>
<VL>27</VL>
<PG>365-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250555"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250554"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scholz-2003" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Scholz 2003" YEAR="2003">
<REFERENCE MODIFIED="2015-01-15 17:58:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Scholz S, Chantelau E</AU>
<TI>Glycemic index and insulin dosage on intensive insulin therapy</TI>
<TO>Glykämischer Index und Insulindosierung bei intensivierter Insulin-Therapie</TO>
<SO>Interistische Praxis</SO>
<YR>2003</YR>
<VL>43</VL>
<NO>2</NO>
<PG>389-96</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250557"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250556"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sciarrone-1993" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Sciarrone 1993" YEAR="1993">
<REFERENCE MODIFIED="2008-07-07 19:37:17 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sciarrone SEG, Martin T, Strahan LJ, Beilin VB, Burke V, Rogers P, et al</AU>
<TI>Ambulatory blood pressure and heart rate responses to vegetarian meals</TI>
<SO>Journal of Hypertension</SO>
<YR>1993</YR>
<VL>11</VL>
<PG>227-85</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250559"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250558"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sharafetdinov-1997" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Sharafetdinov 1997" YEAR="1997">
<REFERENCE MODIFIED="2008-07-07 19:39:04 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sharafetdinov KhKh, Meshcheriakova VA, Plotnikova OA</AU>
<TI>Change in postprandial glycemia as affected by various carbohydrate-containing products in patients with type II diabetes mellitus</TI>
<TO>Izmenenie poslepishchevoi glikemii pod vliianiem nekotorykh uglevodsoderzhashchikh produktov u bol'nykh sakharnym diabetom II tipa</TO>
<SO>Voprosny Pitania</SO>
<YR>1997</YR>
<VL>1</VL>
<PG>27-30</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250561"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250560"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shikany-2009" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Shikany 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-06-22 01:51:57 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shikany JM, Phadke RP, Redden DT, Gower BA</AU>
<TI>Effects of low- and high-glycemic index/glycemic load diets on coronary heart disease risk factors in overweight/obese men</TI>
<SO>Metabolism: Clinical and Experimental</SO>
<YR>2009</YR>
<VL>58</VL>
<PG>1793-801</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250563"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250562"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shyam-2013" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Shyam 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shyam S, Arshad F, Abdul Ghani R, Wahab NA, Safii NS, Nisak MY, et al</AU>
<TI>Low glycaemic index diets improve glucose tolerance and body weight in women with previous history of gestational diabetes: a six months randomized trial</TI>
<SO>Nutrition Journal</SO>
<YR>2013</YR>
<VL>12</VL>
<PG>68</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250565"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250564"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Singh-1991" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Singh 1991" YEAR="1991">
<REFERENCE MODIFIED="2017-06-22 01:52:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Singh RB, Rastogi SS, Sircar AR, Mehta PJ, Sharma KK</AU>
<TI>Dietary strategies for risk factor modification to prevent cardiovascular diseases</TI>
<SO>Nutrition</SO>
<YR>1991</YR>
<VL>7</VL>
<PG>210-5</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250567"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250566"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Slabber-1994" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Slabber 1994" YEAR="1994">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Slabber M, Barnard HC, Kuyl JM, Dannhauser A, Schall R</AU>
<TI>Effects of a low-insulin response, energy restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1994</YR>
<VL>60</VL>
<PG>48-53</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250569"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250568"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sloth-2004" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Sloth 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sloth B, Krog-Mikkelson I, Flint A, Tetens I, Bjorck I, Vinoy S, et al</AU>
<TI>No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low glycemic-index diet</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2004</YR>
<VL>80</VL>
<PG>337-47</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250571"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250570"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Spieth-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Spieth 2000" YEAR="2000">
<REFERENCE MODIFIED="2008-07-07 19:41:41 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Spieth LE, Harnish JD, Lenders CM, Raezer LB, Pereira MA, Hangen SJ, et al</AU>
<TI>A low glycemic index diet in the treatment of pediatric obesity</TI>
<SO>Archives of Pediatrics and Adolescent Medicine</SO>
<YR>2000</YR>
<VL>154</VL>
<PG>947-51</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250573"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250572"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Taghrid-2004" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Taghrid 2004" YEAR="2004">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Huet D, Rizkalla SW, Rigoir A, Veronese A, Pacher N, Slama G</AU>
<TI>Metabolic effects of chronic low glycemic index diet in type 2 diabetes</TI>
<SO>Diabetes</SO>
<YR>2001</YR>
<VL>50</VL>
<NO>Suppl 2</NO>
<PG>A367</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250575"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, et al</AU>
<TI>Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>8</NO>
<PG>1866-72</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250576"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2014-10-09 14:31:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Taghrid L, Rizkalla SW, Huet D, Rigoir A, Veronese A, Slama G</AU>
<TI>Improvement of glycemic control and plasma lipid levels by chronic low glycemic index diet in type 2 diabetes</TI>
<SO>Diabetes</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>Suppl 1</NO>
<PG>A72</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250577"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250574"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tovar-2012" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Tovar 2012" YEAR="2012">
<REFERENCE MODIFIED="2015-11-06 13:06:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tovar J, Nilsson A, Johansson M, Ekesbo R, Aberg AM, Johansson U, et al</AU>
<TI>A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjects</TI>
<SO>Nutrition and Metabolism</SO>
<YR>2012</YR>
<VL>9</VL>
<PG>29</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250579"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250578"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Tsihlias-2000" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Tsihlias 2000" YEAR="2000">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tsihlias EB, Gibbs AL, McBurney MI, Wolever TMS</AU>
<TI>Comparison of high-and low-glycemic index breakfast cereals with monounsaturated fat in the long-term dietary management of type 2 diabetes</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2000</YR>
<VL>72</VL>
<NO>2</NO>
<PG>439-49</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250581"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250580"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Van-Horn-1991" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Van Horn 1991" YEAR="1991">
<REFERENCE MODIFIED="2008-07-07 19:41:54 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Van Horn L, Moag-Stahlberg A, Liu K, Ballew C, Ruth K, Hughes R, et al</AU>
<TI>Effects on serum lipids of adding instant oats to usual American diets</TI>
<SO>American Journal of Public Health</SO>
<YR>1991</YR>
<VL>81</VL>
<NO>2</NO>
<PG>183-4</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250583"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250582"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Visek-2011" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Visek 2011" YEAR="2011">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Visek J, Lacigova S, Cechurova D, Blaha V, Rusavy Z</AU>
<TI>Comparison of the impact of a low-glycemic index diet and a commonly used diabetic diet - a randomized crossover study</TI>
<SO>Clinical Nutrition Supplements</SO>
<YR>2011</YR>
<VL>6</VL>
<NO>1</NO>
<PG>117</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250585"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250584"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vrolix-2010" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Vrolix 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 02:01:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vrolix R, Mensink RP</AU>
<TI>Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2010</YR>
<VL>92</VL>
<PG>366-74</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250587"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250586"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolever-1992a" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1992a" YEAR="1992">
<REFERENCE MODIFIED="2014-10-09 14:30:36 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Wong GS, Josse RG</AU>
<TI>Beneficial effect of low-glycemic index diet in overweight NIDDM subjects</TI>
<SO>Diabetes Care</SO>
<YR>1992</YR>
<VL>15</VL>
<NO>4</NO>
<PG>562-4</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250589"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250588"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolever-1992b" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1992b" YEAR="1992">
<REFERENCE MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Wong GS, Josse RG</AU>
<TI>Beneficial effect of low-glycaemic index diet in type 2 diabetes</TI>
<SO>Diabetic Medicine</SO>
<YR>1992</YR>
<VL>9</VL>
<PG>451-8</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250591"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250590"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolever-1995" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1995" YEAR="1995">
<REFERENCE MODIFIED="2017-06-22 02:02:26 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolever T, Bentum-Williams AM, Jenkins DJA</AU>
<TI>Physiological modulation of plasma free fatty acid concenrations by diet: metabolic implications in nondiabetic subjects</TI>
<SO>Diabetes Care</SO>
<YR>1995</YR>
<VL>18</VL>
<PG>962-70</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250593"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250592"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolever-2008" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 2008" YEAR="2008">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TM, Mehling C, Chiasson JL, Josse RG, Leiter LA, Maheux P, et al</AU>
<TI>Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial</TI>
<SO>Diabetologia</SO>
<YR>2008</YR>
<VL>51</VL>
<PG>1607-15</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250595"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250594"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yang-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Yang 2002" YEAR="2002">
<REFERENCE MODIFIED="2008-07-07 19:43:01 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yang EJ, Chung HK, Kim WY, Kerver JM, Song WO</AU>
<TI>Carbohydrate intake is associated with diet quality and risk factors for cardiovascular disease in US adults: NHANES III</TI>
<SO>Journal of the American College of Nutrition</SO>
<YR>2002</YR>
<VL>22</VL>
<PG>71-9</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250597"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250596"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yusof-2009" MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" NAME="Yusof 2009" YEAR="2009">
<REFERENCE MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yusof BN, Talib RA, Kamaruddin NA, Karim NA, Chinna K, Gilbertson H</AU>
<TI>A low-GI diet is associated with a short-term improvement of glycaemic control in Asian patients with type 2 diabetes</TI>
<SO>Diabetes, Obesity &amp; Metabolism</SO>
<YR>2009</YR>
<VL>11</VL>
<PG>387-96</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250599"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250598"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zhang-2010" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Zhang 2010" YEAR="2010">
<REFERENCE MODIFIED="2017-06-22 02:04:05 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zhang Z, Lanza E, Kris-Etherton PM, Colburn NH, Bagshaw D, Rovine MJ, et al</AU>
<TI>A high legume low glycemic index diet improves serum lipid profiles in men</TI>
<SO>Lipids</SO>
<YR>2010</YR>
<VL>45</VL>
<PG>765-75</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="3250601"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="3250600"/></IDENTIFIERS>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2017-06-30 18:29:22 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Boyadjieva-2015" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Boyadjieva 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-22 02:04:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Boyadjieva N, Handjieva-Darlenska T, Karamfilova V, Kamenov Z</AU>
<TI>No effect of glycemic index (low vs. high) on ghrelin and leptin in obesity</TI>
<SO>Obesity Facts</SO>
<YR>2015</YR>
<VL>8</VL>
<PG>39</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374877"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374876"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cayanan-2015" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Cayanan 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-22 02:08:46 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cayanan E , Marhsall N, Yee B, Wong K, Djavadkhani Y, Grunstein R, Hoyos C</AU>
<TI>Effectiveness of two maintenance diets following a very low energy diet to reduce cardio-metabolic risk In obese sleep apnea patients: a randomized controlled trial</TI>
<SO>Sleep and Biological Rhythms</SO>
<YR>2015</YR>
<VL>13</VL>
<PG>56</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374879"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374878"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Giroux-2015" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Giroux 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-22 02:09:14 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Giroux I, Azzi S, Lavigne-Robichaud M, Comtois E, Blaine S, Whebby B, et al</AU>
<TI>The effect of a 6-month lifestyle education program on dietary behaviors in rural adults with prediabetes</TI>
<SO>Canadian Journal of Dietetic Practice &amp; Research</SO>
<YR>2015</YR>
<VL>73</VL>
<PG>e2</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374881"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374880"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karl-2015" MODIFIED="2017-06-30 18:27:24 +0100" MODIFIED_BY="[Empty name]" NAME="Karl 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-30 18:27:22 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karl JP, Roberts SB, Schaefer EJ, Gleason JA, Fuss P, Rasmussen H, Saltzman E, Das SK</AU>
<TI>Effects of carbohydrate quantity and glycemic index on resting metabolic rate and body composition during weight loss</TI>
<SO>Obesity</SO>
<YR>2015</YR>
<VL>23</VL>
<NO>11</NO>
<PG>2190-2198</PG>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374883"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374882"/></IDENTIFIERS>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Weinhold-2015" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Weinhold 2015" YEAR="2015">
<REFERENCE MODIFIED="2017-06-22 02:11:33 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Weinhold K, Miller CK, Marrero DG, Nagaraja H, Focht B</AU>
<TI>Worksite diabetes prevention trial improves outcomes among employees with prediabetes</TI>
<SO>Diabetes</SO>
<YR>2015</YR>
<VL>64</VL>
<PG>A216</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374885"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374884"/></IDENTIFIERS>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Brand_x002d_Miller-2013" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Brand-Miller 2013" YEAR="2013">
<REFERENCE MODIFIED="2017-06-22 02:13:49 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Raben A, Fogelholm M, Feskens E, Westerterp-Plantenga M, Schlicht W, Brand-Miller J</AU>
<TI>PREVIEW: PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World</TI>
<SO>Obesity Facts</SO>
<YR>2013</YR>
<VL>6</VL>
<PG>194</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374887"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 02:14:28 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Raben A, Fogelholm M, Larsen TM, Drummens M, Poppitt S, Formiguera JA, et al</AU>
<TI>PREVIEW: Prevention of diabetes through lifestyle intervention and population studies in Europe and around the world. Over 2,000 volunteers randomized to the 3-y RCT</TI>
<SO>Obesity Facts</SO>
<YR>2015</YR>
<VL>8</VL>
<PG>126</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374888"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2017-06-22 02:17:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Silvestre M, Poppitt S, Liu A, Folgelholm M, Freskens E, Westerterp-Plantenga M, et al</AU>
<TI>PREVIEW: PREVention of diabetes through lifestyle Intervention in Europe and around the World &#8211; Where are we now?</TI>
<SO>Obesity Research &amp; Clinical Practice</SO>
<YR>2014</YR>
<VL>8</VL>
<PG>93-4</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSREF" TYPE="OTHER" VALUE="6374889"/></IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER OTHERTYPE="CRSSTD" TYPE="OTHER" VALUE="6374886"/></IDENTIFIERS>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2017-06-22 05:38:51 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2017-06-22 05:38:51 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Aburto-2013" MODIFIED="2015-03-16 16:02:42 +0000" MODIFIED_BY="[Empty name]" NAME="Aburto 2013" TYPE="JOURNAL_ARTICLE">
<AU>Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ</AU>
<TI>Effect of lower sodium intake on health: systematic review and meta-analyses</TI>
<SO>British Medical Journal</SO>
<YR>2013</YR>
<VL>346</VL>
<PG>f1326</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Atkinson-2008" MODIFIED="2015-03-13 08:03:41 +0000" MODIFIED_BY="[Empty name]" NAME="Atkinson 2008" TYPE="JOURNAL_ARTICLE">
<AU>Atkinson FS, Foster-Powell K, Brand-Miller JC</AU>
<TI>International tables of glycaemic index and glycaemic load values: 2008</TI>
<SO>Diabetes Care</SO>
<YR>2008</YR>
<VL>31</VL>
<PG>2281-3</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Augustin-2015" MODIFIED="2017-06-22 03:57:54 +0100" MODIFIED_BY="[Empty name]" NAME="Augustin 2015" TYPE="JOURNAL_ARTICLE">
<AU>Augustin L, Kendall C, Jenkins D, Willett W, Astrup A, Barclay A, et al</AU>
<TI>Glycemic index, glycemic load and glycemic response: an International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC)</TI>
<SO>Nutrition, Metabolism and Cardiovascular Diseases</SO>
<YR>2015</YR>
<VL>25</VL>
<NO>9</NO>
<PG>795-815</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Barclay-2006" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Barclay 2006" TYPE="JOURNAL_ARTICLE">
<AU>Barclay AW, Brand-Miller JC</AU>
<TI>Validity of glycemic index estimates in the insulin resistance atherosclerosis study</TI>
<SO>Diabetes Care</SO>
<YR>2006</YR>
<VL>29</VL>
<NO>7</NO>
<PG>1718</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Barclay-2008" MODIFIED="2017-06-22 03:58:44 +0100" MODIFIED_BY="[Empty name]" NAME="Barclay 2008" TYPE="JOURNAL_ARTICLE">
<AU>Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al</AU>
<TI>Glycemic index, glycemic load, and chronic disease risk - a meta-analysis of observational studies</TI>
<SO>American Journal of Clinical Nutrition.</SO>
<YR>2008</YR>
<VL>87</VL>
<PG>627-37</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-BHF-2014" MODIFIED="2017-06-22 05:03:35 +0100" MODIFIED_BY="[Empty name]" NAME="BHF 2014" TYPE="OTHER">
<TI>Cardiovascular Disease 2014</TI>
<SO>www.bhf.org.uk/heart-health/conditions/cardiovascular-disease.aspx</SO>
<YR>(accessed January 2014)</YR>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Bjorck-2003" MODIFIED="2017-06-22 05:03:51 +0100" MODIFIED_BY="[Empty name]" NAME="Bjorck 2003" TYPE="JOURNAL_ARTICLE">
<AU>Bjorck I, Elmstahl HL</AU>
<TI>The glycaemic index: importance of dietary fibre and other food properties</TI>
<SO>Proceedings of the Nutrition Society</SO>
<YR>2003</YR>
<VL>62</VL>
<NO>1</NO>
<PG>201-6</PG>
<IDENTIFIERS MODIFIED="2015-07-08 12:58:52 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="12749347"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Blaak-2012" MODIFIED="2017-06-22 05:04:30 +0100" MODIFIED_BY="[Empty name]" NAME="Blaak 2012" TYPE="JOURNAL_ARTICLE">
<AU>Blaak EE, Antoine JM, Benton D, Bjorck I, Bozzetto L, Brouns F, et al</AU>
<TI>Impact of postprandial glycaemia on health and prevention of disease</TI>
<SO>Obesity Reviews</SO>
<YR>2012</YR>
<VL>13</VL>
<NO>10</NO>
<PG>923-84</PG>
<IDENTIFIERS MODIFIED="2015-07-09 18:25:13 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22780564"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bornet-1987" MODIFIED="2017-06-22 05:07:05 +0100" MODIFIED_BY="[Empty name]" NAME="Bornet 1987" TYPE="JOURNAL_ARTICLE">
<AU>Bornet FR, Costagliola D, Rizkalla SW, Blayo A, Fontvielle AM, Haardt MJ, et al</AU>
<TI>Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1987</YR>
<VL>45</VL>
<PG>588-95</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Bornet-2007" MODIFIED="2015-01-15 09:16:38 +0000" MODIFIED_BY="[Empty name]" NAME="Bornet 2007" TYPE="JOURNAL_ARTICLE">
<AU>Bornet FR, Jardy-Gennetier AE, Jacquet N, Stowell J</AU>
<TI>Glycaemic response to foods: impact on satiety and long-term weight regulation</TI>
<SO>Appetite</SO>
<YR>2007</YR>
<VL>49</VL>
<NO>3</NO>
<PG>535-53</PG>
<IDENTIFIERS MODIFIED="2015-01-15 09:16:36 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="17610996"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Bovet-2012" MODIFIED="2015-03-16 15:59:05 +0000" MODIFIED_BY="[Empty name]" NAME="Bovet 2012" TYPE="JOURNAL_ARTICLE">
<AU>Bovet P, Paccaud F</AU>
<TI>Cardiovascular disease and the changing face of global public health: a focus on low and middle income countries</TI>
<SO>Public Health Reviews</SO>
<YR>2012</YR>
<VL>33</VL>
<NO>2</NO>
<PG>397-415</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Brand_x002d_Miller-2002" MODIFIED="2008-07-07 19:43:50 +0100" MODIFIED_BY="[Empty name]" NAME="Brand-Miller 2002" TYPE="JOURNAL_ARTICLE">
<AU>Brand-Miller JC, Holt SHA, Pawlak DB, McMillan J</AU>
<TI>Glycemic index and obesity</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<NO>1</NO>
<PG>281S-5S</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Coulston-1987" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Coulston 1987" TYPE="JOURNAL_ARTICLE">
<AU>Coulston AM, Hollenbeck CB, Swislocki AL, Reaven GM</AU>
<TI>Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM</TI>
<SO>Diabetes Care</SO>
<YR>1987</YR>
<VL>10</VL>
<PG>395-400</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Dong-2012" MODIFIED="2017-06-22 05:08:28 +0100" MODIFIED_BY="[Empty name]" NAME="Dong 2012" TYPE="JOURNAL_ARTICLE">
<AU>Dong JY, Zhang YH, Wang P, Qin LQ</AU>
<TI>Meta-analysis of dietary glycemic load and glycemic index in relation to risk of coronary heart disease</TI>
<SO>American Journal of Cardiology</SO>
<YR>2012</YR>
<VL>109</VL>
<NO>11</NO>
<PG>1608-13</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:57:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22440121"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Du-2006" MODIFIED="2015-01-15 10:15:52 +0000" MODIFIED_BY="[Empty name]" NAME="Du 2006" TYPE="OTHER">
<AU>Du H, Van der A DL, Feskens EJ</AU>
<TI>Dietary glycaemic index: a review of the physiological mechanisms and observed health impacts</TI>
<SO>Acta Cardiologica</SO>
<YR>2006</YR>
<VL>61</VL>
<NO>4</NO>
<PG>383-97</PG>
<IDENTIFIERS MODIFIED="2015-01-15 10:15:23 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="16970047"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-FAO_x002f_WHO-1997" MODIFIED="2017-06-22 05:13:22 +0100" MODIFIED_BY="[Empty name]" NAME="FAO/WHO 1997" TYPE="BOOK">
<AU>FAO/WHO Expert Committee</AU>
<SO>Carbohydrates in Human Nutrition</SO>
<YR>1998</YR>
<PB>FAO</PB>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-FAO_x002f_WHO-2007a" MODIFIED="2017-06-22 05:15:38 +0100" MODIFIED_BY="[Empty name]" NAME="FAO/WHO 2007a" TYPE="JOURNAL_ARTICLE">
<AU>Venn BJ, Green TJ</AU>
<TI>Glycemic index and glycemic load: measurement issues and their effect on diet&#8211;disease relationships</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>61 Suppl 1</VL>
<PG>S122&#8211;31</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-FAO_x002f_WHO-2007b" MODIFIED="2017-06-22 05:15:10 +0100" MODIFIED_BY="[Empty name]" NAME="FAO/WHO 2007b" TYPE="JOURNAL_ARTICLE">
<AU>Mann J, Cummings JH, Englyst HN, Key T, Liu S, Riccardi G, et al</AU>
<TI>FAO/WHO Scientific Update on carbohydrates in human nutrition: conclusions</TI>
<SO>European Journal of Clinical Nutrition</SO>
<YR>2007</YR>
<VL>61 Suppl 1</VL>
<PG>S132-7</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Fleming-2013" MODIFIED="2017-06-22 05:16:04 +0100" MODIFIED_BY="[Empty name]" NAME="Fleming 2013" TYPE="JOURNAL_ARTICLE">
<AU>Fleming P, Godwin M</AU>
<TI>Low-glycaemic index diets in the management of blood lipids: a systematic review and meta-analysis</TI>
<SO>Family Practice</SO>
<YR>2013</YR>
<VL>30</VL>
<NO>5</NO>
<PG>485-91</PG>
<IDENTIFIERS MODIFIED="2015-07-09 18:41:30 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23804161"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Flint-2004" MODIFIED="2008-07-07 19:58:04 +0100" MODIFIED_BY="[Empty name]" NAME="Flint 2004" TYPE="JOURNAL_ARTICLE">
<AU>Flint A, Moller BK, Raben A, Pedersen D, Tetens I, Holst JJ, et al</AU>
<TI>The use of glycaemic index tables to predict glycaemic index of composite breakfast meals</TI>
<SO>British Journal of Nutrition</SO>
<YR>2004</YR>
<VL>91</VL>
<PG>979-89</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Follman-1992" MODIFIED="2017-06-22 05:17:07 +0100" MODIFIED_BY="[Empty name]" NAME="Follman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Follmann D, Elliot P, Suh I, Cutler J</AU>
<TI>Variance imputation for overviews of clinical trials with continuous response</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>1992</YR>
<VL>45</VL>
<NO>7</NO>
<PG>769-73</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ford-2001" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Ford 2001" TYPE="JOURNAL_ARTICLE">
<AU>Ford ES, Liu S</AU>
<TI>Glycemic index and serum high density lipoprotein cholesterol concentration among US adults</TI>
<SO>Archives of Internal Medicine</SO>
<YR>2001</YR>
<VL>161</VL>
<PG>572-6</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Foster_x002d_Powell-1995" MODIFIED="2008-07-07 20:00:06 +0100" MODIFIED_BY="[Empty name]" NAME="Foster-Powell 1995" TYPE="JOURNAL_ARTICLE">
<AU>Foster-Powell K, Miller JB</AU>
<TI>International tables of glycaemic index</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1995</YR>
<VL>62</VL>
<NO>4</NO>
<PG>871S-90S</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Foster_x002d_Powell-2002" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Foster-Powell 2002" TYPE="JOURNAL_ARTICLE">
<AU>Foster-Powell K, Holt SH, Brand-Miller JB</AU>
<TI>International tables of glycemic index and glycemic load values</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<PG>5-56</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Frost-2000" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Frost 2000" TYPE="JOURNAL_ARTICLE">
<AU>Frost G, Dornhorst A</AU>
<TI>The relevance of the glycaemic index to our understanding of dietary carbohydrates</TI>
<SO>Diabetic Medicine</SO>
<YR>2000</YR>
<VL>17</VL>
<PG>336-45</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Goff-2013" MODIFIED="2017-06-22 05:18:59 +0100" MODIFIED_BY="[Empty name]" NAME="Goff 2013" TYPE="JOURNAL_ARTICLE">
<AU>Goff LM, Cowland DE, Hooper L, Frost GS</AU>
<TI>Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials</TI>
<SO>Nutrition, Metabolism and Cardiovascular Diseases</SO>
<YR>2013</YR>
<VL>23</VL>
<NO>1</NO>
<PG>1-10</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:57:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22841185"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2017-06-22 05:21:31 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editor(s)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Hu-2014" MODIFIED="2015-03-16 16:04:37 +0000" MODIFIED_BY="[Empty name]" NAME="Hu 2014" TYPE="JOURNAL_ARTICLE">
<AU>Hu T, Bazzano LA</AU>
<TI>The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies</TI>
<SO>Nutrition, Metabolism and Cardiovascular Diseases</SO>
<YR>2014</YR>
<VL>24</VL>
<NO>4</NO>
<PG>337-43</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Jenkins-1981" MODIFIED="2017-06-22 05:21:55 +0100" MODIFIED_BY="[Empty name]" NAME="Jenkins 1981" TYPE="JOURNAL_ARTICLE">
<AU>Jenkins D, Wolever T, Taylor H, Barker H, Fielden H, Baldwin AM, et al</AU>
<TI>Glycemic index of foods. A physiological basis for carbohydrate exchange</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1981</YR>
<VL>34</VL>
<PG>362-6</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Kristo-2013" MODIFIED="2015-01-14 18:57:12 +0000" MODIFIED_BY="[Empty name]" NAME="Kristo 2013" TYPE="JOURNAL_ARTICLE">
<AU>Kristo AS, Matthan NR, Lichtenstein AH</AU>
<TI>Effect of diets differing in glycemic index and glycemic load on cardiovascular risk factors: review of randomized controlled-feeding trials</TI>
<SO>Nutrients</SO>
<YR>2013</YR>
<VL>5</VL>
<NO>4</NO>
<PG>1071-80</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:57:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23538939"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leeds-2002" MODIFIED="2008-07-07 20:01:23 +0100" MODIFIED_BY="[Empty name]" NAME="Leeds 2002" TYPE="JOURNAL_ARTICLE">
<AU>Leeds AR</AU>
<TI>Glycemic index and heart disease</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>2002</YR>
<VL>76</VL>
<NO>1</NO>
<PG>286S-9S</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2017-06-22 05:25:37 +0100" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011</TI>
<SO>Available from handbook.cochrane.org</SO>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ma-2012" MODIFIED="2015-01-14 18:57:12 +0000" MODIFIED_BY="[Empty name]" NAME="Ma 2012" TYPE="JOURNAL_ARTICLE">
<AU>Ma XY, Liu JP, Song ZY</AU>
<TI>Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies</TI>
<SO>Atherosclerosis</SO>
<YR>2012</YR>
<VL>223</VL>
<NO>2</NO>
<PG>491-6</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:57:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22727193"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Meader-2014" MODIFIED="2017-06-22 05:28:43 +0100" MODIFIED_BY="[Empty name]" NAME="Meader 2014" TYPE="JOURNAL_ARTICLE">
<AU>Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al</AU>
<TI>A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation</TI>
<SO>Systematic Reviews</SO>
<YR>2014</YR>
<VL>3</VL>
<NO>1</NO>
<PG>82</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Mirrahimi-2012" MODIFIED="2017-06-22 05:28:54 +0100" MODIFIED_BY="[Empty name]" NAME="Mirrahimi 2012" TYPE="JOURNAL_ARTICLE">
<AU>Mirrahimi A, De Souza RJ, Chiavaroli L, Sievenpiper JL, Beyene J, Hanley AJ, et al</AU>
<TI>Associations of glycemic index and load with coronary heart disease events: a systematic review and meta-analysis of prospective cohorts</TI>
<SO>Journal of the American Heart Association</SO>
<YR>2012</YR>
<VL>1</VL>
<NO>5</NO>
<PG>e000752</PG>
<IDENTIFIERS MODIFIED="2015-01-14 18:57:06 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="23316283"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-NHS-2012" MODIFIED="2017-06-22 05:30:27 +0100" MODIFIED_BY="[Empty name]" NAME="NHS 2012" TYPE="OTHER">
<AU>National Health Service</AU>
<TI>Atherosclerosis 2012.</TI>
<SO>www.nhs.uk/conditions/Atherosclerosis/Pages/Introduction.aspx#commentCountLink</SO>
<YR>(accessed January 2014)</YR>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Niwano-2009" MODIFIED="2017-06-22 05:30:54 +0100" MODIFIED_BY="[Empty name]" NAME="Niwano 2009" TYPE="JOURNAL_ARTICLE">
<AU>Niwano Y, Adachi T, Kashimura J, Sakata T, Sasaki H, Sekine K, et al</AU>
<TI>Is glycemic index of food a feasible predictor of appetite, hunger, and satiety?</TI>
<SO>Journal of Nutritional Science and Vitaminology</SO>
<YR>2009</YR>
<VL>55</VL>
<NO>3</NO>
<PG>201-7</PG>
<IDENTIFIERS MODIFIED="2015-01-15 09:16:36 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19602827"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Oude-2010" MODIFIED="2017-06-22 05:32:07 +0100" MODIFIED_BY="[Empty name]" NAME="Oude 2010" TYPE="JOURNAL_ARTICLE">
<AU>Oude Griep LM, Gelejinse JM, Kronhout D, Ocke MC, Verschuern WM</AU>
<TI>Raw and processed fruit and vegetable consumption and 10-year coronary heart disease incidence in a population-based cohort study in the Netherlands</TI>
<SO>PLOS One</SO>
<YR>2010</YR>
<VL>5</VL>
<PG>e13609</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Rizkalla-2002" MODIFIED="2008-07-07 20:04:12 +0100" MODIFIED_BY="[Empty name]" NAME="Rizkalla 2002" TYPE="JOURNAL_ARTICLE">
<AU>Rizkalla SW, Bellisle F, Slama G</AU>
<TI>Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals</TI>
<SO>British Journal of Nutrition</SO>
<YR>2002</YR>
<VL>88</VL>
<NO>Suppl 3</NO>
<PG>S255-S262</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Spagnoli-2007" MODIFIED="2015-03-16 15:57:38 +0000" MODIFIED_BY="[Empty name]" NAME="Spagnoli 2007" TYPE="JOURNAL_ARTICLE">
<AU>Spagnoli LG, Bonanno E, Sangiorgi G, Mauriello A</AU>
<TI>Role of inflammation in atherosclerosis</TI>
<SO>Journal of Nuclear Medicine</SO>
<YR>2007</YR>
<VL>48</VL>
<NO>11</NO>
<PG>1800-15</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Thomas-2007" MODIFIED="2017-06-22 05:32:49 +0100" MODIFIED_BY="[Empty name]" NAME="Thomas 2007" TYPE="COCHRANE_REVIEW">
<AU>Thomas DE, Elliot EJ, Baur L</AU>
<TI>Low glycaemic index, or low glycaemic load, diets for overweight and obesity</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2015-11-06 13:09:03 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-11-06 13:09:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD005105.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thomas-2009" MODIFIED="2017-06-22 05:33:34 +0100" MODIFIED_BY="[Empty name]" NAME="Thomas 2009" TYPE="COCHRANE_REVIEW">
<AU>Thomas D, Elliott EJ</AU>
<TI>Low glycaemic index, or low glycaemic load, diets for diabetes mellitus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2015-11-06 13:09:58 +0000" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-11-06 13:09:58 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD006296.pub2"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Vafeiadou-2012" MODIFIED="2017-06-22 05:34:11 +0100" MODIFIED_BY="[Empty name]" NAME="Vafeiadou 2012" TYPE="JOURNAL_ARTICLE">
<AU>Vafeiadou K, Weech M, Sharma V, Yaqoob P, Todd S, Williams CM, et al</AU>
<TI>A review of the evidence for the effects of total dietary fat, saturated, monounsaturated and n-6 polyunsaturated fatty acids on vascular function, endothelial progenitor cells and microparticles</TI>
<SO>British Journal of Nutrition</SO>
<YR>2012</YR>
<VL>107</VL>
<NO>3</NO>
<PG>303-24</PG>
<IDENTIFIERS MODIFIED="2015-07-09 12:20:49 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="22182347"/></IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-2013" MODIFIED="2017-06-22 05:35:31 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2013" TYPE="OTHER">
<AU>World Health Organization</AU>
<TI>Cardiovascular diseases (CVDs)</TI>
<SO>http://www.who.int/mediacentre/factsheets/fs317/en/index.html</SO>
<YR>(accessed January 2014)</YR>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wolever-1985" MODIFIED="2017-06-22 05:38:51 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1985" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TM, Jenkins DJ</AU>
<TI>Application of glycaemic index to mixed meals [letter]</TI>
<SO>Lancet</SO>
<YR>1985</YR>
<VL>2</VL>
<PG>944</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wolever-1986" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1986" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TM, Jenkins DJ</AU>
<TI>The use of the glycemic index in predicting the blood glucose response to mixed meals</TI>
<SO>American Journal of Clinical Nutrition</SO>
<YR>1986</YR>
<VL>43</VL>
<PG>167-72</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wolever-1988" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1988" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TM, Jenkins DJ, Collier GR, Lee R</AU>
<TI>Metabolic response to test meals containing different carbohydrate foods. 1. Relationship between rate of digestion and plasma insulin</TI>
<SO>Nutrition Reviews</SO>
<YR>1988</YR>
<VL>8</VL>
<PG>573-81</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Wolever-1990" MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]" NAME="Wolever 1990" TYPE="JOURNAL_ARTICLE">
<AU>Wolever TM</AU>
<TI>The glycaemic index</TI>
<SO>World Review in Nutrition and Dietetics</SO>
<YR>1990</YR>
<VL>62</VL>
<PG>120-85</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Ye-2012" MODIFIED="2015-03-16 16:08:17 +0000" MODIFIED_BY="[Empty name]" NAME="Ye 2012" TYPE="JOURNAL_ARTICLE">
<AU>Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S</AU>
<TI>Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain</TI>
<SO>Journal of Nutrition</SO>
<YR>2012</YR>
<VL>142</VL>
<NO>7</NO>
<PG>1304-13</PG>
<IDENTIFIERS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2017-01-11 09:30:17 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Kelly-2004" MODIFIED="2015-04-15 15:33:17 +0100" MODIFIED_BY="[Empty name]" NAME="Kelly 2004" TYPE="COCHRANE_REVIEW">
<AU>Kelly SAM, Frost G, Whittaker V, Summerbell CD</AU>
<TI>Low glycaemic index diets for coronary heart disease</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2015-04-15 15:33:17 +0100" MODIFIED_BY="[Empty name]"><IDENTIFIER MODIFIED="2015-04-15 15:33:17 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004467.pub2"/></IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2014-10-10 14:04:41 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="YES" USER_DEF_1_NAME="Funding / conflict of interest" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2017-07-04 11:02:28 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<CHAR_METHODS MODIFIED="2017-06-25 03:57:25 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Mexico; single centre; details of setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>trial dates not reported.</P>
<P>
<B>Intervention duration:</B> 6 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to compare the effects of different glycaemic load diets on biochemical data and body composition in overweight and obese participants.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-25 04:02:17 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 54 (16/27 completers in the intervention group and 8/27 in the control group).</P>
<P>
<B>Inclusion criteria: </B>overweight or obese adults.</P>
<P>
<B>Exclusion criteria:</B> pregnancy, diabetes, cancer, psychiatric disorders, physical disabilities.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>36.9 (SD 9.0) (22 to 57); <I>control:</I> 33.8 (SD 8.2) (21 to 53)</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>33.4%; <I>control:</I> 32.2%.</P>
<P>
<B>Ethnicity: </B>Mexican.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>30.7 (SD 4.0) (24 to 42); <I>control:</I> 32.5 (SD 5.9) (26 to 46).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.5 (SD 1.2); <I>control:</I> 6.1 (SD 3.0).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.6 (SD 0.4); <I>control:</I> 1.7 (SD 0.4).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.8 (SD 0.8); <I>control:</I> 4.4 (SD 2.7).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:02:28 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 27):</B> low glycaemic load diet.</P>
<P>
<B>Control (n = 27):</B> high glycaemic load diet.</P>
<P>
<B>Description of dietary intervention:</B> high and low glycaemic load diets were designed according to the food habits of Mexicans living in the Tijuana area; GI values of each food were estimated from the tables by <LINK REF="REF-Foster_x002d_Powell-2002" TYPE="REFERENCE">Foster-Powell 2002</LINK>; participants were given menus with the high or low glycaemic load diets at the start of the intervention; a research assistant was available by phone or mail for questions during the whole intervention; emails were sent as reminders and diet reinforcements every 2 weeks.</P>
<P>
<B>Incentives:</B> not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>3-day dietary records (2 weekdays and one weekend day); only participants who completed these were included in the analysis.</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>both groups significantly decreased their caloric intake by 468 to 500 kcal/day from baseline to 6 months, no significant difference between groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 04:04:59 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> waist circumference, BMI, fat mass, serum glucose, serum insulin, insulin resistance (HOMA), total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides; physical activity (International Physical Activity Questionnaire), adverse events.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 04:05:03 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-10-29 14:26:46 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-03 18:48:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bellisle-2007">
<CHAR_METHODS MODIFIED="2017-06-25 04:10:21 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> France; 16 Weight Watchers classes in Paris; visits of the Hotel-Dieu hospital for anthropometric and biochemical assessments.</P>
<P>
<B>Design:</B> cluster randomisation (Weight Watchers classes randomised), parallel group.</P>
<P>
<B>Dates: </B>classes attended January to March 2004.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess whether the Weight Watchers weight loss system could be improved by encouraging dieters to select low GI, high carbohydrate foods.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-25 04:41:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 96 (35/51 completers in the intervention group and 30/45 in the control group).</P>
<P>
<B>Inclusion criteria: </B>female, age 18 years or over, BMI &gt; 25 kg/m<SUP>2</SUP>; recruited among first time applicants to the Weight Watchers programme.</P>
<P>
<B>Exclusion criteria:</B> chronic disease (diabetes mellitus, eating disorders, psychiatric disorders), pharmacological treatment.</P>
<P>
<B>Age (years) (mean (SE)): </B>
<I>intervention: </I>46.1 (SE 2.3); <I>control:</I> 45.3 (SE 2.2).</P>
<P>
<B>Sex:</B> <I>intervention: </I>100% women; <I>control:</I> 100% women.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SE)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>30.2 (SE 0.7); <I>control:</I> 30.4 (SE 0.8).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.64 (SE 0.19); <I>control:</I> 5.88 (SE 0.16).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.9 (SE 0.07); <I>control:</I> 1.81 (SE 0.09).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.56 (SE 0.19); <I>control:</I> 3.91 (SE 0.14).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>intervention: </I>systolic 120.6 (SE 2.5), diastolic 74.1 (SE 1.8); <I>control:</I> systolic 118.6 (SE 3.0), diastolic 72.8 (SE 2.2).</P>
<P>
<B>Medications used:</B> not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-03 18:48:36 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 51):</B> standard Weight Watchers POINTS Weight Loss System plus additional information about the GI of foods based on the International Table of Glycaemic Index and Glycaemic Load Values (<LINK REF="REF-Foster_x002d_Powell-2002" TYPE="REFERENCE">Foster-Powell 2002</LINK>); Weight Watchers booklets modified to emphasise low GI foods, participants encouraged to include at least one low GI food (GI &lt; 55) at each meal.</P>
<P>
<B>Control (n = 45):</B> standard Weight Watchers POINTS Weight Loss System with additional information about the French National Nutrition and Health Programme, not specifically dealing with GI (advice similar to that of Weight Watchers programme).</P>
<P>
<B>Description of dietary intervention:</B> booklets with information on food selection, weekly Weight Watchers class, increased consumption of fruit and vegetables, Ca and carbohydrate, reduced total fat, increased daily physical activity; special training for class leaders.</P>
<P>
<B>Incentives:</B> all costs associated with hospital visits were covered; participants were offered three coupons for one free weekly attendance at Weight Watchers classes.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>food choice checklist completed for 3 days during a randomly selected week of the 12 week programme (2 weekdays and one weekend day).</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>no details of diet composition, difference in food selection based on GI reported, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>diets of both groups tended to be rich in low GI foods (mainly fruit and vegetables), but the low GI group included fewer high GI choices.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 04:46:45 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> weight (basis of power analysis), BMI, blood pressure, fasting glucose, insulin, blood lipids, insulin sensitivity (HOMA); behavioural and motivational questionnaires (Three Factor Eating Questionnaire, Dutch Eating Questionnaire); hunger (VAS), desire to eat (VAS).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 04:46:48 +0100" MODIFIED_BY="[Empty name]">
<P>Research grant by Weight Watchers International.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2015-03-17 10:08:47 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-03 18:48:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Buscemi-2013">
<CHAR_METHODS MODIFIED="2017-06-25 04:49:24 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Italy; medical centre.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>study period November 2010 to February 2012.</P>
<P>
<B>Intervention duration:</B> 3 months.</P>
<P>
<B>Follow-up:</B> intervention phase followed by 12 month weight maintenance phase, but results not reported.</P>
<P>
<B>Focus: </B>to assess the effects of hypocaloric diets with different glycaemic indexes and glycaemic loads on endothelial function and glycaemic variability in nondiabetic participants at increased cardiovascular risk.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-28 04:25:58 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 47 (19/22 completers in the intervention group and 21/25 in the control group).</P>
<P>
<B>Inclusion criteria: </B>age 18 to 60 years, BMI 25.0 to 49.9 kg/m<SUP>2</SUP>, presence of &#8805; 2 metabolic syndrome diagnostic criteria: waist circumference &gt; 80 cm for women and 94 cm for men, serum triglycerides &gt;150 mg/dL, serum HDL-cholesterol &lt; 50 mg/dL for women or 40 mg/dL for men, blood pressure &gt; 130 mmHg for systolic or &gt; 85 mmHg for diastolic blood pressure, fasting plasma glucose &#8805; 100 mg/dL; recruited through announcement posted at medical centre.</P>
<P>
<B>Exclusion criteria:</B> diabetes mellitus, gastrointestinal or connective diseases, chronic pancreatitis, liver or kidney disease, use of acetylsalicylic acid or other antiplatelet drugs, statins or fibrates, oral hypoglycaemic drugs, nitrates, nonsteroidal anti-inflammatory drugs, corticosteroids, drugs interfering with coagulation, supplementation with vitamins and/or antioxidants, pregnancy or lactation in the last six months, regular sports activity.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>51 (SD 8) (20 to 60); <I>control:</I> 49 (SD 8) (21 to 59).</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>52.6%; <I>control:</I> 42.9%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<I>
<B>BMI (kg/m<SUP>2</SUP>): </B>intervention: </I>34.3 (SD 6.6) (25.1 to 49.6); <I>control:</I> 34.5 (SD 5.1) (27.6 to 47.5).</P>
<P>
<I>
<B>Total cholesterol (mmol/L): </B>intervention: </I>5.48 (SD 1.01); <I>control:</I> 5.69 (SD 1.11).</P>
<P>
<I>
<B>HDL cholesterol (mmol/L): </B>intervention: </I>1.23 (SD 0.31); <I>control:</I> 1.44 (SD 0.43).</P>
<P>
<I>
<B>LDL cholesterol (mmol/L): </B>intervention: </I>3.88 (SD 0.96); <I>control:</I> 3.49 (SD 0.88).</P>
<P>
<I>
<B>Blood pressure (mmHg): </B>intervention: </I>systolic 128 (SD 15), diastolic 77 (SD 8); <I>control:</I> systolic 124 (SD 13), diastolic 76 (SD 11).</P>
<P>
<I>
<B>Smokers: </B>intervention: </I>10.5%; <I>control:</I> 14.3%.</P>
<P>
<I>
<B>Prediabetes: </B>intervention: </I>42.1%; <I>control:</I> 38.1%.</P>
<P>
<I>
<B>Hypertension: </B>intervention: </I>42.1%; <I>control:</I> 42.9%.</P>
<P>
<B>Medications used:</B> <I>intervention: </I>26.3% ACE inhibitors/angiotensin receptor blockers, 15.8% &#946;-blockers, 10.5% Ca channel blockers, 5.3% &#945;-blockers, 15.3% diuretics; <I>control:</I> 14.3% ACE inhibitors/angiotensin receptor blockers, 19.0% &#946;-blockers, 4.8% Ca channel blockers, 0% &#945;-blockers, 23.8% diuretics.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-03 18:48:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 22):</B> hypocaloric low GI diet.</P>
<P>
<B>Control (n = 25):</B> hypocaloric high GI diet.</P>
<P>
<B>Description of dietary intervention:</B> diets were designed using lists of food high or low in GI with participants receiving about 20 kcal per kg of body weight up to 2000 kcal/day (1400, 1600, 1800, and 2000 kcal/day); after the initial 3 month intervention phase, participants were assigned to a weight maintenance phase with the same Mediterranean diet for 12 months (results not reported).</P>
<P>
<B>Incentives:</B> no incentives.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>participants met with a registered dietitian weekly (maximum of 2 missed visits per participant allowed), received nutritional counselling, and compiled a 3-day food diary (Friday, Saturday and Sunday) every 2 weeks; adherence with prescribed diets was &gt; 90% for both groups.</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>prescribed diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 05:00:21 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> flow-mediated dilatation (basis of power analysis), body composition and fat distribution, carotid intima thickness, renal ultrasound analysis, 48-h continuous subcutaneous glucose monitoring, lipid levels, uric acid, plasma glucose, plasma insulin, HbA1c, insulin resistance (HOMA)</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 05:00:02 +0100" MODIFIED_BY="[Empty name]">
<P>No funding, authors declared that they had no financial or other conflict of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-10-30 10:47:23 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-03 18:49:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-DiOGenes-2011-low-protein">
<CHAR_METHODS MODIFIED="2017-06-25 05:02:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> 8 European countries (Netherlands, Denmark, UK, Greece, Spain, Germany, Bulgaria, Czech Republic); research centres.</P>
<P>
<B>Design:</B> cluster randomisation (by family), parallel group.</P>
<P>
<B>Dates: </B>enrolment November 2005 to April 2007.</P>
<P>
<B>Intervention duration:</B> 26 weeks, extension to 1 year in 2 centres (Copenhagen, Maastricht).</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to examine the effects of weight loss or diets varying in protein content and GI without further changes in body weight on cardiovascular risk factors.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-28 12:47:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 773 adults (95/150 analysed in the low GI/low protein group, 84/155 high GI/low protein, 108/159 low GI/high protein, 96/155 high GI/high protein, 104/154 control (not considered here)).</P>
<P>
<B>Inclusion criteria: </B>generally healthy families (two parents or single parent) with at least 1 parent overweight (BMI &#8805; 27 kg/m<SUP>2</SUP>) and aged &lt; 65 years and with at least 1 child aged between 5 and 18 years.</P>
<P>
<B>Exclusion criteria:</B> (for adults) BMI &gt; 45 kg/m<SUP>2</SUP>, liver or kidney diseases, cardiovascular diseases, diabetes mellitus, special diets/eating disorders, systemic infections/chronic diseases, cancer within the last 10 years, weight change &gt; 3 kg within the previous 3 months, other clinical disorders or use of prescription medication that might interfere with the outcome of the study, planned major changes in physical activity, pregnancy/lactation, individuals following special diet; recruitment through various strategies (referrals from GPs, flyers and posters, radio, TV, newspapers, internet).</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>low GI/low protein: </I>42.1 (SD 5.8); <I>high GI/low protein:</I> 41.6 (SD 5.9); <I>low GI/high protein: </I>42.6 (SD 6.3); <I>high GI/high protein:</I>
 42.2 (SD 5.6) (all numbers based on study completers).</P>
<P>
<B>Sex (% men):</B> <I>low GI/low protein: </I>34.7%; <I>high GI/low protein:</I> 32.2%; <I>low GI/high protein: </I>35.8%; <I>high GI/high protein: </I>38.7% (all numbers based on ITT group).</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>32.5 to 36.1 (only reported for centres), total group 33.8.</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>low GI/low protein: </I>4.14 (SD 0.91); <I>high GI/low protein:</I> 4.12 (SD 0.92); <I>low GI/high protein: </I>4.17 (SD 0.87); <I>high GI/high protein: </I>4.21 (SD 0.98).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>low GI/low protein: </I>1.13 (SD 0.28); <I>high GI/low protein:</I> 1.17 (SD 0.25); <I>low GI/high protein: </I>1.16 (SD 0.29); <I>high GI/high protein: </I>1.14 (SD 0.27).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>low GI/low protein: </I>2.54 (SD 0.76); <I>high GI/low protein:</I> 2.42 (SD 0.79); <I>low GI/high protein: </I>2.54 (SD 0.81); <I>high GI/high protein: </I>2.56 (SD 0.81).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>low GI/low protein: </I>systolic 118.6 (SD 9.4), diastolic 73.9 (SD 13.7); <I>high GI/low protein:</I> systolic 115.5 (SD 13.9), diastolic 71.4 (SD 9.2); <I>low GI/high protein: </I>systolic 118.8 (SD 13.3), diastolic 73.5 (SD 9.6); <I>high GI/high protein: </I>systolic 120.1 (SD 15.0), diastolic 73.4 (SD 10.3).</P>
<P>
<B>Medications used:</B> not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-03 18:49:00 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI/low protein (n = 150):</B> low GI (difference 15 points between high and low GI diets), low protein diet (10 to 15% energy from protein, 57 to 62% from carbohydrate).</P>
<P>
<B>High GI/low protein (n = 155):</B> high GI, low protein diet (10 to 15% energy from protein, 57 to 62% from carbohydrate).</P>
<P>
<B>Low GI/high protein (n = 159):</B> low GI, high protein diet (23 to 28% energy from protein, 45 to 50% from carbohydrate).</P>
<P>
<B>High GI/high protein (n = 155): </B>high GI, high protein diet (23 to 28% energy from protein, 45 to 50% from carbohydrate).</P>
<P>
<B>(Control diet (n = 154):</B> control diet according to accepted national guidelines (12 to 15% energy from protein, 55 to 63% from carbohydrate) <B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> eligible adults followed an 8-week low calorie diet (800 kcal/day, Modifast); about 200 g (up to 400 g) of additional raw vegetables per day were allowed; the families of adults achieving a weight loss of &#8805; 8% (mean weight loss 11.2 (SD 3.5 kg)) were randomised to one of the 5 ad libitum diets above; participants were instructed to maintain weight loss during ad libitum phase; the average amount of plant protein intake of total protein was 36%; dietary counselling every 2 weeks during first 6 weeks (with children, where possible), then monthly; families were provided with recipes, cooking and behavioural advice; point-based system to achieve desired macronutrient composition; in 2 centres ('shop centres', Copenhagen and Maastricht), adherence to dietary compositions (food lists) was optimised during the first 6 months by providing &gt; 80% of all relevant foods for each of the diet groups at no cost through a lab-based shop system.</P>
<P>
<B>Incentives:</B> free food in 'shop centres'.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>(adults) 3-day food diaries (2 weekdays, 1 weekend day) before study visit 1, 2 to 4 weeks after randomisation and before study visits 3 and 4.</P>
<P>
<B>Was the diet energy-reduced?</B> no.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy reduced in all groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 05:22:35 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcomes:</B> weight, body composition, proportion maintaining &gt; 5% or &gt; 10% of initial weight loss, dropout rate.</P>
<P>
<B>Secondary outcomes: </B>abdominal fat mass, risk factors for type 2 diabetes and cardiovascular disease (including blood lipids, blood pressure), appetite and satiety hormones, physical activity, fat tissue mRNA, certain blood peptide and protein biomarkers; genetic profiles, measurements of basal metabolic rate, free-living energy expenditure; psychological features (appetite and food preferences, health promoting behaviour, attitudes towards eating, social support).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 05:22:57 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by European Commission Food Quality and Safety Priority of the 6th Framework Programme (contract FP6-2005-513946); local sponsors made financial contributions to the shop centres and local food manufacturers provided a number of foods free of charge (but had no influence on the selection of foods found in the two shops, nor were they in any other way involved in the study).</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-22 10:34:00 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-06-25 05:30:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<CHAR_METHODS MODIFIED="2017-06-25 05:30:52 +0100" MODIFIED_BY="[Empty name]">
<P>See previous - study has two independent relevant comparisons.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-01 06:43:39 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_INTERVENTIONS MODIFIED="2014-11-01 06:43:39 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2014-11-01 06:43:39 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_USER_DEF_1 MODIFIED="2014-11-01 06:43:39 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2014-11-01 06:43:39 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:02:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-2004">
<CHAR_METHODS MODIFIED="2017-06-25 05:33:16 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> UK; Hammersmith Hospital, London.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>unclear, patients entered on a cardiac intervention database for coronary bypass grafting or cardiac angioplasty in 1997 and 1998 were selected and received a letter of invitation to participate.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess whether low GI diets improve the metabolic profile of patients having undergone coronary artery bypass grafting (CABG).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-28 02:13:04 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 57 (55/57 completed the study).</P>
<P>
<B>Inclusion criteria: </B>age 30 to 70 years with coronary heart disease (myocardial infarction, unstable angina, or angiographically proven coronary artery disease).</P>
<P>
<B>Exclusion criteria:</B> cardiomyopathy, serious organ disease, systemic illness, chronic alcohol abuse, serious psychiatric illness, poor compliance with food diaries or failed medical screening.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>63.6 (SD 9.4); <I>control:</I> 61.8 (SD 9.0).</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>88.5%; <I>control:</I> 86.2%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD or SE)): </B>
</P>
<P>
<I>
<B>BMI (kg/m<SUP>2</SUP>): </B>intervention: </I>26.9 (SD 3.3); <I>control:</I> 28.7 (SD 4.6).</P>
<P>
<I>
<B>Total cholesterol (mmol/L): </B>intervention: </I>4.77 (SE 0.15); <I>control:</I> 4.94 (SE 0.20).</P>
<P>
<I>
<B>HDL cholesterol (mmol/L): </B>intervention: </I>1.11 (SE 0.04); <I>control:</I> 1.09 (SE 0.05).</P>
<P>
<I>
<B>LDL cholesterol (mmol/L): </B>intervention: </I>2.89 (SE 0.13); <I>control:</I> 3.04 (SE 0.16).</P>
<P>
<I>
<B>Blood pressure (mmHg): </B>intervention: </I>systolic 141 (SE 6), diastolic 81 (SE 5); <I>control:</I> systolic 140 (SE 4), diastolic 80 (SE 2).</P>
<P>
<I>
<B>Smokers: </B>intervention: </I>38.5% never, 53.8% ex-smoker, 7.7% smoker; <I>control:</I> 31.0% never, 62.1% ex-smoker, 6.9% smoker.</P>
<P>
<I>
<B>CABG: </B>intervention: </I>84.6%; <I>control:</I> 89.7%.</P>
<P>
<I>
<B>Angioplasty: </B>intervention: </I>7.7%; <I>control:</I> 6.9%.</P>
<P>
<I>
<B>CABG and angioplasty: </B>intervention: </I>7.7%; <I>control:</I> 3.4%. 
</P>
<P>
<I>
<B>Length of diagnosis CABG (years) (mean (SD)): </B>intervention: </I>7.0 (SD 6.5); <I>control:</I> 6.5 (SD 6.5).</P>
<P>
<B>Medications used:</B> <I>intervention: </I>58% statins, 23% ACE inhibitors, 19% diuretics, 73% aspirin; <I>control:</I> 86% statins, 28% ACE inhibitors, 28% diuretics, 100% aspirin.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:02:46 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 26):</B> healthy eating advice emphasising low GI carbohydrates (GI &lt; 85).</P>
<P>
<B>Control (n = 29):</B> healthy eating advice only.</P>
<P>
<B>Description of dietary intervention:</B> one-to-one nutritional counselling, participants supported by regular visits to the unit (weeks 0, 4 and 8) and telephone calls; advice based on current health education guidelines advocated by the COMA panel; aim to provide a diet with 50% carbohydrate and 35% of total energy as fat; unrefined high cereal fibre carbohydrates were encouraged and fat content specified to be &lt; 10% saturated fat, 10% polyunsaturated fat and 15% monounsaturated fat; daily target of five portions of fruit and vegetables; all patients with BMI &gt; 28 kg/m<SUP>2</SUP> were given advice to lose weight with target 1 kg weight loss per month. Low GI also at least 1 low GI food at each meal. Liberal use of carbohydrates (pasta, basmati rice, wholegrains foods, granary breads, whole fruit, beans, vegetables, pulses or milk).</P>
<P>
<B>Incentives:</B> not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>participants were asked to keep a 7-day diet diary on four occasions during the study period.</P>
<P>
<B>Was the diet energy-reduced?</B> weight loss targeted in participants with BMI &gt; 28 kg/m<SUP>2</SUP>.</P>
<P>
<B>Comparability of diet composition: </B>significant difference in daily energy, see<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>
<I>intervention: </I>GI decreased, fibre increased, sucrose decreased; <I>control:</I> reduced energy intake (P = 0.04 versus low GI) and sugar and GI.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 05:42:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> total cholesterol (basis of power analysis), weight, BMI, HbA1c, fasting glucose, insulin, HOMA, fasting lipids, blood pressure.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 05:42:54 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-10-31 07:28:28 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:03:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghani-2014--low-insulin">
<CHAR_METHODS MODIFIED="2017-06-25 06:55:28 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> not clear.</P>
<P>
<B>Design: </B>individual randomisation (1:1 ratio).</P>
<P>
<B>Dates: </B>not reported (all GDM deliveries registered in the institution between January and September were screened for eligibility).</P>
<P>
<B>Intervention duration:</B> 1 year.</P>
<P>
<B>Follow-up:</B> no follow-up (end of intervention).</P>
<P>
<B>Focus: </B>the effects of a lowering glycaemic index diet on fasting blood glucose , serum lipids, body weight and composition of post-GDM women with varying fasting insulin levels.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-25 07:01:28 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 77 (39 in the low GI group, 38 in the conventional dietary recommendations group).</P>
<P>
<B>Inclusion criteria: </B>BMI &gt; 23 kg/m<SUP>2</SUP>, WC &gt; 80 cm, increased risk of T2DM, dysglycaemia, 20 to 40 year old Asian women, previous history of GDM after a lapse of at least 2 months of their last GDM delivery, family history of diabetes.</P>
<P>
<B>Exclusion criteria: </B>current diagnosis of diabetes, BMI &gt; 40 kg/m<SUP>2</SUP>, BMI &lt; 19 kg/m<SUP>2</SUP>, enrolled in weight loss programmes, underlying health complications or those on drugs altering study outcomes, subjects who became pregnant during trial.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention (low fasting insulin): </I>31.2 (SD 4.2), <I>intervention (high fasting insulin):</I> 31.5 (SD 5.2); <I>control (low fasting insulin):</I> 31.0 (SD 3.8); <I>control (low fasting insulin):</I> 31.8 (SD 5.1).</P>
<P>
<B>Sex:</B> <I>intervention: </I>100% women; <I>control:</I> 100% women.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention (low fasting insulin): </I>5.0 (SD 0.98), <I>intervention (high fasting insulin):</I> 5.2 (SD 0.7); <I>control (low fasting insulin):</I> 5.3 (SD 0.81), <I>control (low fasting insulin): </I>5.2 (SD 0.77).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention (low fasting insulin): </I>1.5 (SD 0.4), <I>intervention (high fasting insulin): </I>1.2 (SD 0.3); <I>control (low fasting insulin):</I> 1.5 (SD 0.5), <I>control (high fasting insulin): </I>1.3 (SD 0.2).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention (low fasting insulin): </I>3.2 (SD 1.0), <I>intervention (high fasting insulin): </I>3.4 (SD 0.8); <I>control (low fasting insulin):</I> 3.3 (SD 0.7), <I>control (high fasting insulin): </I>3.3 (SD 0.7).</P>
<P>
<B>Triglyceride (mmol/L)<I>: </I>
</B>
<I>intervention (low fasting insulin): </I>0.7 (SD 0.2), <I>intervention (high fasting insulin): </I>1.3 (SD 0.5) ; <I>control (low fasting insulin):</I> 0.93 (SD 2.8), <I>control (high fasting insulin): </I>1.1 (SD 0.5).</P>
<P>
<B>Weight (kg): </B>
<I>intervention (low fasting insulin): </I>61.7 (SD 10.2), <I>intervention (high fasting insulin): </I>71.1 (SD 11.3); <I>control (low fasting insulin):</I> 57.9 (SD 10.1), <I>control (high fasting insulin): </I>72.1 (SD 10.6).</P>
<P>
<B>Medications used:</B> not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:03:00 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low-GI education + conventional dietary recommendations:</B> emphasis on reducing GI intake along with nutrition education to lower CVD and T2DM was provided.</P>
<P>
<B>Conventional dietary recommendations:</B> nutrition education to lower CVD and T2DM was provided. They provided a sample high GI menu.</P>
<P>
<B>Description of dietary intervention: </B>received GI education to substitute high GI foods with low GI options. Substituting high GI staple food (rice, bread, breakfast cereal) with low GI such as Basmati or brown rice and low GI multigrain bread. Restricting rice consumption to once per day, opting for low GI staple options like noodles or spaghetti and increasing consumption of legumes. Foods were classified as high, moderate and low GI to enable easy comprehension.</P>
<P>Energy intake was individually calculated and a 500 calorie deficit was carried out. Prescribed diets were provided. Vouchers for low GI breads were provided. Nutrition education to lower CVD and T2DM was provided (minimise salt, sugar, and oil and more fruit and vegetables). Take home educational material was provided. Frequency of contact between the two groups was kept similar.</P>
<P>
<B>Incentives:</B> not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>not reported.</P>
<P>
<B>Was the diet energy-reduced?</B> individually calculated with a 500 calorie deficit carried out.</P>
<P>
<B>Comparability of diet composition: </B>not clear, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>GI was significantly lower in the intervention group in comparison to the control.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-25 07:05:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> total cholesterol, triglyceride, fasting lipids, blood pressure.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-25 07:05:17 +0100" MODIFIED_BY="[Empty name]">
<P>Noncommercial.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-07-03 18:03:17 +0100" MODIFIED_BY="[Empty name]">
<P>Outcomes were stratified by insulin levels (low fasting insulin INS &lt; 2 &#956;IU ml, high fasting insulin INS &#8805; &#956;IU ml)</P>
<P>Author contacted on 24.06.2016 for risk of bias, CVD outcomes and further details on control. Author reply provided published paper </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-06-25 07:10:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ghani-2014a-high-insulin">
<CHAR_METHODS MODIFIED="2017-06-25 07:10:39 +0100" MODIFIED_BY="[Empty name]">
<P>See previous - study stratified analysis by fasting insulin levels.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_INTERVENTIONS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:03:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-H_x00f6_nemann-2010">
<CHAR_METHODS MODIFIED="2017-06-27 01:01:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Germany; Institute of Nutritional Psychology, Göttingen.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 6 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of several popular nutritional weight-reducing strategies on cardiovascular risk factors.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 01:05:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 160 (31/53 completers in the low GI/low fat group, 27/54 in the low fat group, 26/53 in the low CHO group).</P>
<P>
<B>Inclusion criteria: </B>female, age 25 to 70 years, BMI 25 to 42 kg/m<SUP>2</SUP>, no serious comorbidities; recruited through newspaper advertisements.</P>
<P>
<B>Exclusion criteria:</B> dieting attempts/weight reduction in the past 6 months, extreme low fat or low carbohydrate nutrition before the start of the study.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>51.1 (SD 8.6); <I>control:</I> 49.6 (SD 11.4).</P>
<P>
<B>Sex:</B> <I>intervention: </I>100% women; <I>control:</I> 100% women.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>Weight (kg): </I>
</B>
<I>intervention: </I>84.1 (SD 9.8); <I>control:</I> 83.0 (SD 10.8).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.35 (SD 0.77); <I>control:</I> 5.38 (SD 1.00).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.45 (SD 0.24); <I>control:</I> 1.48 (SD 0.33).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.59 (SD 0.66); <I>control:</I> 3.54 (SD 0.86).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>intervention: </I>systolic 129.8 (SD 18.4), diastolic 82.9 (SD 8.7); <I>control:</I> systolic 127.7 (SD 16.7), diastolic 82.7 (SD 9.4).</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:03:13 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 53):</B> low fat and reduction of glycaemic load, maximum 30 g fat per day in first 4 weeks, then maximum 45 g fat per day for 5 months; maximum 50 g carbohydrates with high glycaemic load.</P>
<P>
<B>Control (n = 54):</B> low fat only, maximum 30 g fat per day in first 4 weeks, then maximum 45 g fat per day for 5 months.</P>
<P>
<B>(Low CHO group (n = 53): </B>maximum 30 g carbohydrates per day in first 4 weeks, then maximum 60 g carbohydrates per day for 5 months <B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> written information about the different diets according to study group; written instructions for behaviour change including increase in physical activity; other macronutrients could be consumed ad libitum.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>weekly appointments for weight control, analysis of consumption using computer system at time 0, 1 month and 6 months; adherence intervention 69.8%, control 64.8%.</P>
<P>
<B>Was the diet energy-reduced?</B> not reported.</P>
<P>
<B>Comparability of diet composition: </B>unclear, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>
<I>intervention: </I>carbohydrate increased, fat decreased, small increase in fibre (+ 3.8 (SD 10.6) g/day); <I>control:</I> carbohydrate increased, fat decreased.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 01:08:08 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> weight (basis of power analysis), blood pressure, blood lipids, blood glucose, B vitamins, homocysteine.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 01:08:24 +0100" MODIFIED_BY="[Empty name]">
<P>Funded by Stifterverband für die Deutsche Wissenschaft; authors declared that they had no conflicts of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-10-31 07:29:57 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:03:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<CHAR_METHODS MODIFIED="2017-06-27 01:12:07 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting: </B>Spain, community-dwelling, setting not clearly reported.</P>
<P>
<B>Design: </B>Parallel group design.</P>
<P>
<B>Dates: </B>Recruitment from 2010 to 2012. Enrolment: completed at the end of May 2012.</P>
<P>
<B>Intervention duration: </B>6 months, February 2010 to November 2012.</P>
<P>
<B>Follow-up: </B>No follow-up (end of intervention at 6 months).</P>
<P>
<B>Focus: </B>to assess the efficacy of 2 moderate-carbohydrate diets and an LF diet with different GIs on weight loss and the modulation of satiety, inflammation, and other metabolic risk markers.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 01:18:53 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N: </B>121 (37/41 completers in the low GI group, 36/41 completers in the high GI group, 31/40 completers in the low fat group).</P>
<P>
<B>Inclusion criteria: </B>community-dwelling, females and males, age 30 to 60 years, BMI between 27 and 35 kg/m<SUP>2.</SUP>
</P>
<P>
<B>Exclusion criteria: </B>noncontrolled type 2 diabetes defined as glycated hemoglobin 8%, systolic blood pressure 159 mm Hg or diastolic blood pressure 99 mm Hg, plasma LDL cholesterol concentration 160 mg/dL, plasma triglyceride concentration 400 mg/dL, suspicion of secondary obesity, presence of any inflammatory or chronic obstructive pulmonary disease, infection, active neoplastic, endocrine, or hematologic disease at the time of the study, blood leukocyte count &#8805; 11 × 10<SUP>6</SUP> cells, use of anti-inflammatory drugs, steroids, hormones or antibiotics that could affect the variables analysed in the study, changes in medication for lipid profile, diabetes, or hypertension in the previous 3 months, active alcoholism or drug dependence, excluding tobacco use, a restrictive diet 3 months before the study or weight loss 0.5 kg in the previous 3 months, any medical condition that advised against being included in the study, problems understanding the study or anticipated difficulty in making dietary changes according to the Prochaska and DiClemente model.</P>
<P>
<B>Age (years) (mean (SE)): </B>
<I>low GI group:</I> 42.5 (SE 1.1); <I>high GI group: </I>44 (SE 1.3).</P>
<P>
<B>Sex (% men):</B> <I>low GI group: 
</I>19%; <I>high GI group: </I>17%<I>.</I>
</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SE)): </B>
</P>
<P>
<B>
<I>Weight (kg): </I>
</B>
<I>low GI group: </I>82.7 (SE 1.5); <I>high GI group: </I>82.7 (SE 1.6).</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>low GI group: </I>31.2 (SE 0.3); <I>high GI group: </I>30.8 (SE 0.3).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>low GI group: </I>4.99 (SE 0.13); <I>high GI group: </I>5.13 (SE 0.13).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>low GI group: </I>1.45 (SE 0.05); <I>high GI group: </I>1.47 (SE 0.05).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>low GI group: </I>3.05 (SE 0.11); <I>high GI group: </I>3.15 (SE 0.10).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>low GI group: </I>systolic 128.0 (SE 2.7), diastolic 80.2 (SE 1.7); <I>high GI group: </I>systolic 128.0 (SE 2.4), diastolic 81.2 (SE 1.5).</P>
<P>
<B>Medications used: </B>not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:03:24 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 41): </B>encouraged to eat whole grain cereals and pulses as the base of their diet, avoid rice and potatoes, and were also recommended to select specific type of fruit (apple, orange, peach) and vegetables (courgette, tomato, onion) with low GI, avoiding the ripe pieces. They were advised to reduce the time cooking of carbohydrate-rich foods in order to maintain the low GI of the foods. The principal animal protein sources of the diet were white fish and white meat..</P>
<P>
<B>High GI group (n = 41): </B>encouraged to eat refined grain cereals, fruits (banana, kiwi, melon) and vegetables (carrot, green bean, cabbage) with high GI, and avoid pulses. Were advised to increase the time cooking in order to raise the GI of the foods. In this intervention group, intake of white fish and white meat were the main animal sources of protein.</P>
<P>
<B>(Low fat group (n = 40): </B>maintain a high-GI diet but with lower fat content. They were encouraged to avoid red meat and blue fish due its high fat content and also recommended to eat low-fat dairy products.<B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention: </B>a booklet, biweekly menus and seasonal receipts.</P>
<P>
<B>Cointerventions in both groups: </B>diets were designed at 1500, 1700, 2000, and 2500 kcal/d, and all participants were categorized as having one of the 4 categories of dietary energy content after subtracting 500 kcal/d of the total estimated energy intake to achieve a desired weight loss.</P>
<P>
<B>Assessment of dietary adherence: </B>not reported.</P>
<P>
<B>Was the diet-energy reduced? </B>subtracting 500 kcal/d of the total estimated energy intake to achieve a desired weight loss.</P>
<P>
<B>Comparability of diet composition: </B>not clear, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: 
</B>
<I>low GI: </I>energy, % of energy from carbohydrates, % of energy from fat and GI decreased; % of energy from protein and fibre increased. <I>high GI</I>: energy and % of energy from fat decreased; % of energy from carbohydrates, % of energy from protein, fibre, and GI increased.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 01:22:56 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome: </B>weight loss (power calculations based on body weight).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 01:23:04 +0100" MODIFIED_BY="[Empty name]">
<P>Grant from the Institut d&#8217;Investigació Sanitaria Pere Virgili (PV11059S) and Fondo de Investigación Sanitaria (PI120153). None of the authors had a personal or financial conflict of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-01-06 17:09:34 +0000" MODIFIED_BY="[Empty name]">
<P>Author contacted on 15.08.2016 to clarify risk of bias. Author did not reply. </P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:03:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<CHAR_METHODS MODIFIED="2017-06-27 01:28:59 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Australia; setting not clearly reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>screening July 2002 to July 2004.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the relative effects of low GI and high protein diets on weight loss and cardiovascular risk factors.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 01:38:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 129 (30/32 completers in the low GI/high CHO group, 27/32 in the high GI/high CHO group, 28/33 in the low GI/high protein group, 31/32 in the high GI/high protein group).</P>
<P>
<B>Inclusion criteria: </B>18 to 40 years, BMI &#8805; 25 kg/m<SUP>2</SUP>, body weight &lt; 150 kg, weight fluctuations &lt; 5 kg in past 2 months, willing to eat red meat and maintain current physical activity; recruited using notice boards and newspaper advertisements.</P>
<P>
<B>Exclusion criteria:</B> chronic illness, regular medication other than birth control pills, eating disorders, special diets, pregnancy, food allergy, and insufficient command of English.</P>
<P>
<B>Age (years) (mean (SE)): </B>
<I>low GI/high CHO: </I>30.5 (SE 1.4); <I>high GI/high CHO:</I> 31.8 (SE 1.7); <I>low GI/high protein: </I>34.6 (SE 1.5); <I>high GI/high protein: </I>30.2 (SE1.5).</P>
<P>
<B>Sex (% men):</B> <I>low GI/high CHO: </I>28%; <I>high GI/high CHO:</I> 22%; <I>low GI/high protein: </I>21%; <I>high GI/high protein: </I>25%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SE)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>low GI/high CHO: </I>30.6 (SE 0.8; <I>high GI/high CHO:</I> 30.9 (SE 0.6); <I>low GI/high protein: </I>32.1 (SE 0.9); <I>high GI/high protein: </I>31.3 (SE 0.8).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>low GI/high CHO: </I>4.71 (SE 0.19); <I>high GI/high CHO:</I> 4.79 (SE 0.19); <I>low GI/high protein: </I>4.83 (SE 0.14); <I>high GI/high protein: </I>5.15 (SE 0.18).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>low GI/high CHO: </I>1.17 (SE 0.05); <I>high GI/high CHO:</I> 1.29 (SE 0.07); <I>low GI/high protein: </I>1.36 (SE 0.08); <I>high GI/high protein: </I>1.16 (SE 0.05).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>low GI/high CHO: </I>2.90 (SE 0.14); <I>high GI/high CHO:</I> 2.87 (SE 0.16); <I>low GI/high protein: </I>2.89 (SE 0.14); <I>high GI/high protein: </I>3.33 (SE 0.15).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> none.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:03:33 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI/high CHO (n = 32):</B> high carbohydrate (55% of energy), average protein (15% of energy), based on low GI foods.</P>
<P>
<B>High GI/high CHO (n = 32):</B> high carbohydrate (55% of energy), average protein (15% of energy), based on high GI wholegrains.</P>
<P>
<B>Low GI/high protein (n = 33):</B> higher protein (25% of energy), reduced carbohydrate (45% of energy), based on lean red meat and low GI foods.</P>
<P>
<B>High GI/high protein (n = 32):</B> higher protein (25% of energy), reduced carbohydrate (45% of energy), based on lean red meat and high GI wholegrains.</P>
<P>
<B>Description of dietary intervention:</B> reduced energy, reduced fat (30% of energy), moderate fibre (30 g/day) eating plans; eating plans were devised to achieve the desired macronutrients and to provide 1400 kcal/day for women and 1900 kcal/day for men; additional lists of appropriate meals and snacks provided; all key carbohydrate and protein foods and some prepared meals were provided using a colour-coded 'shop' system where participants could collect the respective food each week; participants met with a dietitian on the same day who encouraged adherence and answered queries.</P>
<P>
<B>Incentives</B>: as above.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>3-day food diaries (2 weekdays, 1 weekend day) kept at baseline and during weeks 4 and 8.</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>change in energy and nutrient intake, as intended.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 01:41:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes:</B> weight, fat mass, blood lipids, blood glucose, blood insulin, insulin sensitivity (HOMA), leptin.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 01:41:24 +0100" MODIFIED_BY="[Empty name]">
<P>Funded by the National Heart Foundation and Meat and Livestock Australia.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-01 06:47:06 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-06-27 01:44:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<CHAR_METHODS MODIFIED="2017-06-27 01:44:31 +0100" MODIFIED_BY="[Empty name]">
<P>See previous - study had two independent relevant comparisons.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-01 06:38:54 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_INTERVENTIONS MODIFIED="2014-11-01 06:38:54 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2014-11-01 06:38:54 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_USER_DEF_1 MODIFIED="2014-11-01 06:38:54 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2014-11-01 06:38:54 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-06 13:52:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Melanson-2012">
<CHAR_METHODS MODIFIED="2017-06-27 01:47:04 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> USA; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of multidisciplinary weight loss programmes on chronic disease prevention.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-06 13:52:08 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 157 (49/59 completers in the low GI group, 41/41 in the portion control group, 45/57 in the low energy density group).</P>
<P>
<B>Inclusion criteria: </B>age 25 to 50 years, BMI 27 to 35 kg/m<SUP>2</SUP>, sedentary (&lt; 150 min physical activity per week), weight stable; recruited through newspaper advertisements.</P>
<P>
<B>Exclusion criteria:</B> taking prescription medication or over-the-counter supplements for weight loss; diabetes, uncontrolled hypertension, orthopaedic limitations, eating disorders, pregnancy or lactation, surgical medical conditions, recent weight loss, excess alcohol intake, serious medical conditions; current enrolment in commercial weight loss programme.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>low GI: </I>39.1 (SD 7.1); <I>portion control:</I> 37.9 (SD 7.0).</P>
<P>
<B>Sex (% men):</B> <I>low GI: </I>11.9%; <I>portion</I> <I>control:</I> 12.2%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>low GI: </I>31.13 (SD 2.50); <I>portion control:</I> 31.83 (SD 2.18).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>low GI: </I>5.22 (SD 1.05); <I>portion control:</I> 5.29 (SD 1.29).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>low GI: </I>1.42 (SD 0.33); <I>portion control:</I> 1.44 (SD 0.31).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>low GI: </I>3.07 (SD 0.76); <I>portion control:</I> 3.32 (SD 1.27).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>low GI: </I>systolic 113.02 (SD 10.11), diastolic 72.42 (SD 7.13); <I>portion control:</I> systolic 112.39 (SD 8.69), diastolic 71.12 (SD 7.27).</P>
<P>
<B>Medications used:</B> none.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-06 13:52:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 59):</B> followed a dietary plan based on foods from the Low Glycaemic Index Pyramid; no prescription of specific portions or food tracking; encouraged to eat unrefined grains; instructions to eat prior to getting too hungry and stopping before feeling too full.</P>
<P>
<B>Portion control (n = 41):</B> instructed on an approach assigning point values to foods based on energy content, dietary fibre, total fat in defined serving sizes; individual target amount of point values to consume assigned to each participant, based on current weight and a target weight loss of about 0.5 to 1 kg/week; participants kept track of the point values of foods consumed, to assure that their daily intake was within their points limit; guidelines regarding food choices to ensure nutritional adequacy provided.</P>
<P>
<B>(Low energy density (n = 57): </B>instructed to follow a plan based on wholesome low energy density foods; guidelines about making food choices encouraging balanced intake; instructions to eat prior to getting too hungry and stopping before feeling too full <B>(not considered here as GI not different from low GI group)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> participation in Weight Watchers programme with weekly meetings to encourage regular physical activity, cognitive skills; weekly one-hour meetings included weigh-ins, social support, discussions, education; at baseline, all groups received individual counselling from a registered dietitian on how to follow the assigned dietary plans, including education materials; distribution of recipes, shopping lists, and other guidelines specific to the respective diets; adherence to diets emphasised.</P>
<P>
<B>Incentives</B>: not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>3-day food diaries (2 weekdays, 1 weekend day) before baseline and week 12 visit.</P>
<P>
<B>Was the diet energy-reduced?</B> not reported.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>all groups significantly decreased their energy intake.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 01:55:13 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> weight (basis of power analysis), BMI, body composition, waist circumference, blood pressure, blood lipids, blood glucose, blood insulin, insulin sensitivity (HOMA), hunger/satiety (VAS).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 01:55:19 +0100" MODIFIED_BY="[Empty name]">
<P>Funding not reported; one author had received consulting fees and research grants from Weight Watchers International.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-01 12:34:09 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:03:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Philippou-2008">
<CHAR_METHODS MODIFIED="2017-06-27 01:57:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> UK; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of two energy-restricted health diets with or without low GI on heart disease risk factors in participants at risk of heart disease.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 02:00:03 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 18 (13/18 completers, not reported for comparison groups).</P>
<P>
<B>Inclusion criteria: </B>age 35 to 65 years, at least one recognised heart disease risk factor (BMI 27 to 35 kg/m<SUP>2</SUP>, waist circumference &#8805; 88 cm for women and &#8805; 94 cm for men, total cholesterol:HDL ratio &#8805; 5.0 mmol/L, blood pressure systolic &gt; 130 mmHg or diastolic &gt; 85 mmHg).</P>
<P>
<B>Exclusion criteria:</B> major illnesses, lipid lowering, and weight loss medication.</P>
<P>
<B>Age (years): </B>
<I>intervention: </I>54 (49 to 58); <I>control:</I> 45 (39 to 50).</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>42.9%; <I>control:</I> 33.3%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status: </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>28.6 (28.1 to 29.8); <I>control:</I> 33.2 (28.2 to 34.2).</P>
<P>
<B>
<I>Total cholesterol (mmol/L, median, IQR): </I>
</B>
<I>intervention: </I>5.7 (4.9 to 6.1); <I>control:</I> 5.3 (5.0 to 6.1).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L, median, IQR): </I>
</B>
<I>intervention: </I>1.5 (1.1 to 1.6); <I>control:</I> 1.3 (1.2 to 1.4).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L, median, IQR): </I>
</B>
<I>intervention: </I>3.7 (3.0 to 4.3); <I>control:</I> 3.4 (3.1 to 3.9).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:03:53 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 7):</B> healthy eating advice plus advice to have one low GI food with meals and snacks from a list of food choices.</P>
<P>
<B>Control (n = 6):</B> healthy eating advice plus advice to have one high GI food with meals and snacks from a list of food choices.</P>
<P>
<B>Description of dietary intervention:</B> individual advice on healthy eating for heart disease prevention aiming for 50 to 55% of energy intake from carbohydrates, &lt; 30% energy from total fat (of which &lt; 10% saturated fat, replacing saturated fats by monounsaturated fats, consuming oily fish twice a week), and limiting alcohol and salt intake; overweight participants were advised on weight loss by aiming for a 500 kcal/day energy deficit.</P>
<P>
<B>Incentives</B>: not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>regular visits, telephone calls, 7-day food diaries.</P>
<P>
<B>Was the diet energy-reduced?</B> yes, for overweight participants.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy intake decreased in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 02:01:46 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> weight, fasting glucose, fasting blood lipids.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 02:01:49 +0100" MODIFIED_BY="[Empty name]">
<P>Funding not reported.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-01 13:59:15 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:04:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Philippou-2009">
<CHAR_METHODS MODIFIED="2017-06-27 02:47:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> UK; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 6 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of altering GI, in addition to healthy eating and weight loss advice, on heart disease risk factors.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 02:52:34 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 56 (38/56 completers, not reported for comparison groups).</P>
<P>
<B>Inclusion criteria: </B>men, age 35 to 65 years, at least one recognised heart disease risk factor (BMI 27 to 35 kg/m<SUP>2</SUP>, waist circumference &#8805; 94 cm, total cholesterol:HDL ratio &#8805; 5.0 mmol/L, raised blood pressure to a maximum of 140/90 mmHg); in good health.</P>
<P>
<B>Exclusion criteria:</B> medication use.</P>
<P>
<B>Age (years): </B>not reported.</P>
<P>
<B>Sex (% men):</B> all men.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>20/22 had BMI &gt; 25 kg/m<SUP>2</SUP>; <I>control:</I> all had BMI &gt; 25 kg/m<SUP>2</SUP>; no further details.</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.61 (SD 0.79); <I>control:</I> 5.19 (SD 0.91).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L, median, IQR): </I>
</B>
<I>intervention: </I>1.1 (1.01 to 1.26); <I>control:</I> 1.1 (0.96 to 1.37).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.62 (SD 0.63); <I>control:</I> 3.34 (SD 0.80).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>intervention: </I>systolic 130 (SD 15), diastolic 81 (SD 11); <I>control:</I> systolic 132 (SD 13), diastolic 81 (SD 10).</P>
<P>
<B>Medications used:</B> not on medication.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:01 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 22):</B> healthy eating advice plus advice to have one low GI food with meals and snacks.</P>
<P>
<B>Control (n = 16):</B> healthy eating advice plus advice to have one high GI food with meals and snacks.</P>
<P>
<B>Description of dietary intervention:</B> advice on healthy eating for heart disease prevention and weight loss if BMI &gt; 25 kg/m (energy reduced by 500 kcal with respect to the estimated needs); supported by behavioural techniques; groups were asked to avoid foods of the opposite GI; dietetic consultations and anthropometric measurements were carried out monthly.</P>
<P>
<B>Incentives</B>: not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>monthly 3-day food diaries.</P>
<P>
<B>Was the diet energy-reduced?</B> yes, for overweight participants.</P>
<P>
<B>Comparability of diet composition: </B>significant difference in carbohydrate, fat/protein/fibre not reported but stated that no other difference in dietary composition; see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy intake decreased in both groups.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 02:55:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> arterial compliance (pulse wave velocity), 24-h blood pressure, fasting blood lipids, fasting glucose and insulin, weight.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 02:55:47 +0100" MODIFIED_BY="[Empty name]">
<P>Funded by the British Heart Foundation.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2015-03-17 10:23:13 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:04:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Philippou-2009a">
<CHAR_METHODS MODIFIED="2017-06-27 02:57:39 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> UK; Hammersmith Hospital, London.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 4 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of altering diet GI on weight loss maintenance.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 03:00:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 42 completers (not reported how many started the study).</P>
<P>
<B>Inclusion criteria: </B>age 18 to 65 years, BMI 27 to 45 kg/m<SUP>2</SUP>, good health status assessed by blood tests, medical examination and ECG.</P>
<P>
<B>Exclusion criteria:</B> not reported.</P>
<P>
<B>Age (years): </B>not reported.</P>
<P>
<B>Sex (% men):</B> not reported.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>32.5 (SD 4.8); <I>control:</I> 31.3 (SD 4.8).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>4.67 (SD 0.93); <I>control:</I> 4.87 (SD 0.67).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.26 (SD 0.21); <I>control:</I> 1.19 (SD 0.16).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.01 (SD 0.81); <I>control:</I> 3.21 (SD 0.58).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 23):</B> low GI diet.</P>
<P>
<B>Control (n = 19):</B> high GI diet.</P>
<P>
<B>Description of dietary intervention:</B> the study consisted of a nonrandomised weight loss phase which was the prerequisite to being randomised to a low or high GI diet for weight maintenance; the weight loss phase aimed to achieve a 500 to 1000 kcal/day deficit and a 5% reduction in body weight (including use of Slimfast); participants who lost 5% body weight were then randomised to the second part of the study (median weight loss achieved was 6.1 (IQR 5.2 to 7.1)% body weight); during the randomised phase, participants were asked to include at least one low or high GI food with each of their meals or snacks; participants were asked to eat to satisfy their appetite and follow healthy eating guidelines (e.g. avoid high fat foods, consume 5 portions of fruit and vegetables a day) and continue exercising for at least half and hour a day.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>participants seen monthly for dietetic assessment; adherence assessed using semiquantitative 3-day food diaries.</P>
<P>
<B>Was the diet energy-reduced?</B> no, weight maintenance after weight loss.</P>
<P>
<B>Comparability of diet composition: </B>yes; see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>not reported with respect to weight loss phase or study start.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 03:03:31 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome:</B> weight change during weight maintenance phase.</P>
<P>
<B>Secondary outcomes: </B>BMI, waist circumference, % body fat, fasting blood lipids, fasting blood glucose and insulin, insulin sensitivity (HOMA), appetite/hunger/fullness (VAS).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 03:03:42 +0100" MODIFIED_BY="[Empty name]">
<P>Not reported; Slimfast used during the weight loss phase provided by Unilever; one of the authors was a consultant to Unilever.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-02 15:14:39 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:04:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Raatz-2005">
<CHAR_METHODS MODIFIED="2017-06-27 03:05:17 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> USA; research centre.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 36 weeks (two phases of 12 and 24 weeks).</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of a reduced GI hypocaloric diet on weight loss.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 03:07:01 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 29 in second phase (6/10 completers in low GI group, 8/9 in high GI group).</P>
<P>
<B>Inclusion criteria: </B>age 18 to 70 years, BMI 30 to 40 kg/m<SUP>2</SUP>, habitually consumed regular diets with no food restrictions.</P>
<P>
<B>Exclusion criteria:</B> taking prescription medication, existing medical conditions, pregnancy.</P>
<P>
<B>Age (years): </B>not reported.</P>
<P>
<B>Sex (% men):</B> <I>low GI:</I> 30%; <I>high GI:</I> 22.2%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status: </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>) (mean (SE)): </I>
</B>
<I>low GI: </I>36.5 (SE 1.8); <I>high GI:</I> 34.6 (SE 1.4).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>not reported.</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>not reported.</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>not reported.</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> no prescription medication.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:21 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 10):</B> hypocaloric low GI diet.</P>
<P>
<B>High GI group (n = 9):</B> hypocaloric high GI diet.</P>
<P>
<B>(High fat group (n = 10):</B> hypocaloric high fat diet <B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> two phases: 12-week feeding phase where individualised energy-restricted diets were prepared by Metabolic Kitchen and participants were required to eat all foods provided and consume no additional foods; in the second phase (weeks 13 to 24), diet assignment was maintained but participants prepared their own meals, receiving intensive dietary instructions regarding their assigned dietary regimen and sample menus and recipes; ongoing nutrition counselling every 2 weeks; energy levels designed to promote weight loss 0.7 kg/week for each participant; fatty acid distribution of the diets was 1:1:1 for the ratio of polyunsaturated to monounsaturated to saturated fatty acids; cholesterol content constant at 100 g/4184 kJ.</P>
<P>
<B>Incentives: </B>as above.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>daily questionnaires during first 12 weeks; 5-day food diaries at weeks 24 and 26.</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>yes, data only given for the first 12 weeks, no numeric data for the 24 weeks participants prepared their own meals (only significance levels for GI); see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>prescribed diets.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 03:09:52 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome:</B> weight.</P>
<P>
<B>Secondary outcomes:</B>, BMI, % body fat, lean body mass, serum insulin, plasma glucose, plasma triglycerides, insulin sensitivity (HOMA).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 03:09:57 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by National Institutes of Health and Allan Foundation of Midland, MI.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-03 10:18:45 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-06 14:35:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Randolph-2014">
<CHAR_METHODS MODIFIED="2017-06-27 03:13:53 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> USA; setting not reported.</P>
<P>
<B>Design: </B>parallel group design.</P>
<P>
<B>Dates: </B>recruitment July 2008 to June 2010.</P>
<P>
<B>Intervention duration:</B> 12-week intervention.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>assess the role of glycemic index on measures of body weight, body composition, and metabolic indices in a free-living overweight population and to assess the compliance of prescribed diets based on the GI system in free-living individuals.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 03:20:03 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 90 (24/31 completers for the low GI group, 25/30 completers for the high GI group, 24/29 completers for the control group).</P>
<P>
<B>Inclusion criteria: </B>females and males, age over 18 years, BMI 25 to 37 kg/m<SUP>2</SUP>, light to moderate exercise, normal fasting plasma glucose, able to meet the time and effort requirements required for study participation.</P>
<P>
<B>Exclusion criteria: </B>total cholesterol not greater than 300 mg/dL, fasting triglyceride not greater than 300 mg/dL, LDL cholesterol (LDL-C) not greater than 180 mg/dL, smokers, female subjects who were pregnant or lactating, subjects taking any medications that would interfere with outcomes of the study, subjects with unusual dietary habits (eg. pica), subjects who were actively losing weight or trying to lose weight, subjects who were addicted to drugs or alcohol or who are &lt; 1 y in a recovery program, subjects who presented with significant psychiatric or neurological disturbances, subjects with known allergy or intolerance to potato products, subjects with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, uncontrolled hypertension ( 140/90 mm Hg), chronic lung, renal or liver disease, presence of other health problems requiring ongoing intervention by their personal physician, excessive exercisers or trained athletes, intolerance to potatoes.</P>
<P>
<B>Age (years) (mean SD)): </B>low GI group: 47.8 (SD 14.1), high GI group: 51.4 ( SD14.7).</P>
<P>
<B>Sex (% men):</B> 18.9% male over both intervention and control group.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>low GI group: 29.5 (SD 4.1), high GI group: 29.7 (SD 4.0).</P>
<P>
<B>
<I>Total cholesterol (mg/dL): </I>
</B>
<I>low GI-energy restricted group: </I>192.8 (SD 38.5), <I>high GI-energy restricted group: </I>189.1 (SD 31.9).</P>
<P>
<B>
<I>HDL cholesterol (mg/dL): </I>
</B>
<I>low GI-energy restricted group: </I>50.5 (SD 11.9), <I>high GI-energy restricted group: </I>53.8 (SD 15.2).</P>
<P>
<B>
<I>LDL cholesterol (mg/dL): </I>
</B>
<I>low GI-energy restricted group: </I>122.9 (SD 35.8), <I>high GI-energy restricted group: </I>118.5 (SD 28.1).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>low GI-energy restricted group: </I>systolic
 
121.6 (SD 2.9), diastolic 77.1 (SD 2.0); <I>high GI-energy restricted group:</I> systolic 119.3 (SD 2.4), diastolic 75.4 (SD 1.2).</P>
<P>
<B>Medications used: </B>not reported.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI, energy-restricted group (n = 31): </B>the targeted average GI was 30 for the low GI energy-restricted group. They were provided with potatoes (6 russet and 3 red potato varieties) on a weekly basis. Customized food lists of low GI foods were provided. Received a customized recipe booklet for potato preparation, cooking methods, and specific recipes to comply with low GI dietary preparation.</P>
<P>
<B>High GI, energy-restricted (n = 30): </B>the targeted average GI was 80 for the high GI energy-restricted group. Customized food lists of high GI foods were provided. Received a customized recipe booklet for potato preparation, cooking methods and specific recipes to comply with high GI dietary preparation.</P>
<P>(<B>Control diet (n = 29): </B>prescribed for weight maintenance with no energy reduction (not considered here))<B>.</B>
</P>
<P>
<B>Description of dietary intervention: </B>weekly counselling visits by a registered dietitian for the first 6 weeks, then every other week until week 12.</P>
<P>
<B>Cointerventions in both groups: </B>They were provided with potatoes (6 russet and 3 red potato varieties) on a weekly basis. They were required 5 to 7 servings of potatoes each week such as one medium potato or ½ cup of cooked potato, providing approximately 110 kcal of potato/serving.</P>
<P>
<B>Assessment of dietary adherence: </B>weekly potato consumption was based on review of food records and verbal interview.</P>
<P>
<B>Was the diet energy-reduced? </B>Diets were energy-restricted (~ 500 kcal deficit/d) for weight loss. Participants received a new energy prescription with each 5 kg drop in weight.</P>
<P>
<B>Comparability of diet composition: </B>yes; see 
<LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy, carbohydrates and fat intakes significantly decreased in the low GI, energy-restricted group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 03:25:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome: </B>weight loss.</P>
<P>
<B>Secondary outcomes: </B>glucose tolerance, blood pressure, and body composition.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 03:25:55 +0100" MODIFIED_BY="[Empty name]">
<P>Funding for this project was provided by the United States Potato Board.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2017-06-27 03:26:03 +0100" MODIFIED_BY="[Empty name]">
<P>Author was contacted on 15.08.2016 to clarify risk of bias and blood pressure measurements.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:04:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-RISCK-2010-high-MUFA">
<CHAR_METHODS MODIFIED="2017-06-27 03:44:31 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> UK; clinic at five research centres (Reading, Imperial College, Surrey, Cambridge, Kings College).</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>baseline assessments made between August 2004 and April 2006.</P>
<P>
<B>Intervention duration:</B> 24 weeks (after 4 week run-in).</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of replacing saturated fatty acids with monounsaturated fatty acids or carbohydrates and of lowering GI on insulin sensitivity and other cardiovascular risk factors in participants at risk of developing a metabolic syndrome.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 03:52:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 720 (116/144 completers in MUFA/low GI group, 111/145 in MUFA/high GI group, 121/149 in low fat/low GI group, 116/145 in low fat/high GI group, 85/137 in control group).</P>
<P>
<B>Inclusion criteria: </B>age 30 to 70 years, BMI 30 to 40 kg/m<SUP>2</SUP>; a score of &#8805; 4 was required for entry, according to the following point system: fasting glucose concentration &gt; 5.5 mmol/L or insulin concentration &gt; 40 pmol/L = 3 points; BMI &gt; 30 kg/m<SUP>2 </SUP>or waist &gt; 102 cm for men and &gt; 88 cm for women = 2 points; BMI of 25 to 30 kg/m<SUP>2 </SUP>or waist &gt; 94 cm for men and &gt; 80 cm (women) = 1 point; treated hypertension = 2 points; systolic blood pressure &gt; 140 mmHg = 1 point; diastolic blood pressure &gt; 90 mm Hg = 1 point; HDL cholesterol concentration &lt; 1.0 mmol/L for men and &lt; 1.3 mmol/L for women = 2 points; and serum triacylglycerol concentration &gt; 1.3 mmol/L = 1 point; recruited from the general population (undefined).</P>
<P>
<B>Exclusion criteria:</B> history of ischaemic heart disease; a &gt; 30% 10-year risk of cardiovascular disease; diabetes mellitus; cancer, pancreatitis, cholestatic liver disease, renal disease; use of lipid-lowering drugs, systemic corticosteroids, androgens, phenytoin, erythromycin, or drugs for regulating haemostasis (excluding aspirin); exposure to any investigational agent 30 days before the study; presence of gastrointestinal disorder or use of a drug likely to alter gastrointestinal motility or nutrient absorption; history of substance misuse or alcoholism; pregnancy, planned pregnancy, or given birth in the past 12 months; allergy or intolerance to intervention foods; unwillingness to follow the protocol or to give informed consent; weight change of &gt; 3 kg in the 2 months before the study; intake of &gt; 1 g eicosapentaenoic and docosahexaenoic acids/day, smoking &gt; 20 cigarettes/day</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>men:</I> 52 (SD 10); <I>women:</I> 51 (SD 9).</P>
<P>
<B>Sex (% men):</B> 42%.</P>
<P>
<B>Ethnicity: </B>
<I>men:</I> 83.5% White, 9.1% South Asian, 5.2% Black, 2.2% other; <I>women:</I> 78.3% White, 9.7% South Asian, 8.8% Black, 3.2% other.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>men:</I> 28.3 (SD 3.8); <I>women:</I> 28.6 (SD 5.3).</P>
<P>
<B>
<I>Smoking: </I>
</B>
<I>men:</I> 7.8%; <I>women:</I> 5.6%.</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>men:</I> 5.5 (SD 0.9); <I>women:</I> 5.5 (SD 1.0).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>men:</I> 1.2 (SD 0.3); <I>women:</I> 1.5 (SD 0.4).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>not reported.</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>men:</I> systolic 138 (SD 16), diastolic 84 (SD 10); <I>women:</I> systolic 129 (SD 17), diastolic 80 (SD 9.3).</P>
<P>
<B>Medications used:</B> <I>men:</I> 19.1% on blood pressure medication; <I>women:</I> 16.3% on blood pressure medication.</P>
<P>Baseline values only reported for men and women, not for separate comparison groups.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:42 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>MUFA/low GI (n = 144):</B> high monounsaturated fatty acids and low GI diet.</P>
<P>
<B>MUFA/high GI (n = 145):</B> high monounsaturated fatty acids and high GI diet.</P>
<P>
<B>Low fat/low GI (n = 149): </B>low fat and low GI diet.</P>
<P>
<B>Low fat/high GI (n = 145): </B>low fat and low GI diet.</P>
<P>
<B>(High SFA/high GI (n = 137):</B> high saturated fatty acids and high GI diet (control) <B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> run-in with a diet of high saturated fatty acids and high GI; intervention: provision of key sources of fat (spreads, cooking oils, margarine) and carbohydrates (bread, pasta, rice, cereals) with additional dietary information tailored to study group (given in writing and reinforced by counselling at 12 individual study visits); target for total fat intakes was 38% of energy in the MUFA groups and 28% of energy in the low fat groups with carbohydrate intakes of 45% and 55% of energy, respectively; saturated fatty acids were reduced to 10% of energy with a planned MUFA intake of 20% of energy in the high MUFA group and 12% in the low fat group; the target difference in GI was about 11 points in the MUFA comparison and 13 points in the low fat comparison; dietary targets were achieved using a food exchange model; participants were offered sufficient quantities of study foods for their whole household on a fortnightly basis.</P>
<P>
<B>Incentives: </B>see below.</P>
<P>
<B>Cointerventions in both groups:</B> advice to engage in exercise, avoid alcohol.</P>
<P>
<B>Assessment of dietary adherence: </B>unweighed 4-day food records (3 weekdays and 1 weekend day) before run-in and during the 3rd and the final month of the intervention; a small remuneration was given for participation.</P>
<P>
<B>Was the diet energy-reduced?</B> no, participants were told that diets were designed for weight maintenance.</P>
<P>
<B>Comparability of diet composition: </B>yes; see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>decrease in reported energy intake.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 03:56:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcome:</B> insulin sensitivity.</P>
<P>
<B>Secondary outcomes:</B> blood lipids, blood pressure, weight.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 03:56:50 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by UK Food Standards Agency (project NO2031); foods supplied by Unilever Food and Health Research Institute, Cereal Partners UK, Grampian, Weetabix Ltd, Sainsbury&#8217;s Supermarkets Ltd.<BR/>
</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-19 13:23:51 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-06-27 03:59:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-RISCK-2010-low-fat">
<CHAR_METHODS MODIFIED="2017-06-27 03:59:16 +0100" MODIFIED_BY="[Empty name]">
<P>See previous - study had two independent relevant comparisons.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-11-03 15:47:28 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_INTERVENTIONS MODIFIED="2014-11-03 15:47:28 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_OUTCOMES MODIFIED="2014-11-03 15:47:28 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_USER_DEF_1 MODIFIED="2014-11-03 15:47:28 +0000" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES MODIFIED="2014-11-03 15:47:28 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:04:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shikany-2005">
<CHAR_METHODS MODIFIED="2017-06-27 04:02:11 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> USA; University of Alabama Division of Preventive Medicine clinic and classrooms.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of a low fat/low GI diet on serum lipids.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 04:06:49 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 62 (57/62 completers, distribution by comparison group not reported).</P>
<P>
<B>Inclusion criteria: </B>age 19 to 70 years, serum LDL-C &#8805; 160 mg/dL with less than two heart disease risk factors or &#8805; 130 mg/dL with two or more heart disease risk factors.</P>
<P>
<B>Exclusion criteria:</B> serum triglycerides &#8805; 400 mg/dL; use of cholesterol-lowering medications; use of low-fat or other specialised diets; &#8805; 8 meals per week consumed away from home; history of serious illness, including coronary heart disease, stroke, diabetes, cancer, severe renal or liver disease.</P>
<P>
<B>Age (years): </B>
<I>intervention: </I>29%: 19 to 39 yrs, 25.8%: 40 to 49 yrs, 45.2%: 50 to 69 yrs; <I>control:</I> 11.5%: 19 to 39 yrs, 34.6%: 40 to 49 yrs, 53.8%: 50 to 69 yrs.</P>
<P>
<B>Sex (% men):</B> <I>intervention:</I> 61.3%; <I>control:</I> 65.4%.</P>
<P>
<B>Ethnicity: </B>
<I>intervention:</I> 71.0% White, 22.6% African American, 6.5% Asian, 0 Native American; <I>control:</I> 76.9% White, 15.4% African American, 0 Asian, 7.7% Native American.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention:</I> 30.1 (SE 1.0); <I>control:</I> 30.4 (SE 1.1).</P>
<P>
<B>
<I>Current smoker: </I>
</B>
<I>intervention:</I> 9.7%; <I>control:</I> 0.</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention:</I> 6.13 (SE 0.10); <I>control:</I> 6.26 (SE 0.10).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention:</I> 1.14 (SE 0.05); <I>control:</I> 1.14 (SE 0.05).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention:</I> 4.19 (SE 0.10); <I>control:</I> 4.32 (SE 0.10).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:04:50 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 31):</B> low fat/low GI diet; National Cholesterol Education Program TLC diet, replacement of high GI carbohydrates with low carbohydrate alternatives (including information on factors influencing GI such as food processing and cooking time), encouraged to increase intake in fruit, vegetables and legumes; low GI cookbook provided.</P>
<P>
<B>High GI group (n = 26):</B> low fat only diet; National Cholesterol Education Program TLC diet, no recommendations on types of carbohydrate to consume.</P>
<P>
<B>Description of dietary intervention:</B> 7 sessions held over a 12 week period; the first 4 sessions were held weekly, then biweekly over the final 8 weeks; all sessions were conducted by registered dietitians and were 60 mins long for the low fat only group and 90 min for the low fat plus low GI group; sessions included group instruction and individual counselling; participants who missed sessions were mailed session materials and offered individual advice by person or over the phone; session topics included goal setting, label reading, food shopping, challenges associated with dining out.</P>
<P>
<B>Incentives: </B>not reported.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>food diaries completed for a minimum of 5 days a week throughout 12 weeks; reviewed by dietitian at each session who gave individual feedback; additional 3-day food records at baseline, 4 weeks and 12 weeks.</P>
<P>
<B>Was the diet energy-reduced?</B> unclear.</P>
<P>
<B>Comparability of diet composition: </B>yes; see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>total energy intake, carbohydrate intake, fat intake reduced significantly in both groups, but no significant difference between groups.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 04:09:22 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Primary outcomes:</B> serum lipids.</P>
<P>
<B>Secondary outcomes: </B>BMI, serum glucose, serum insulin, HbA1c.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 04:09:26 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by the American Heart Association.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-03 16:22:38 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:05:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sichieri-2007">
<CHAR_METHODS MODIFIED="2017-06-27 04:11:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Brazil; primary care centres.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>recruitment October 2003 to September 2004.</P>
<P>
<B>Intervention duration:</B> 18 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to investigate the long term effect of a low GI diet compared with a high GI diet, with all other dietary components being equal, on weight and satiety.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 04:14:30 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 203 (61/101 completers in the intervention group and 46/102 in the control group).</P>
<P>
<B>Inclusion criteria: </B>healthy women; overweight (BMI 23 to 29.9 kg/m<SUP>2</SUP>), age 25 to 45 years, not pregnant or breastfeeding, with at least one child.</P>
<P>
<B>Exclusion criteria:</B> physician-diagnosed thyroid disease; diabetes; menopausal women; not being able to eat beans on a daily basis or having a particular dislike for them.</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>37.2 (SD 5.4); <I>control:</I> 37.5 (SD 5.6).</P>
<P>
<B>Sex:</B> <I>intervention: </I>100% women; <I>control:</I> 100% women.</P>
<P>
<B>Ethnicity: </B>
<I>intervention: </I>54.5% White, 19.8% Black, 25.7% Mulatto; <I>control:</I> 52.0% White, 15.0% Black, 33.0% Mulatto.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>26.9 (SD 1.8); <I>control:</I> 26.7 (SD 2.1).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>4.88 (SD 0.90); <I>control:</I> 5.02 (SD 0.96).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.11 (SD 0.4); <I>control:</I> 1.12 (SD 0.41).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.30 (SD 0.85); <I>control:</I> 3.44 (SD 0.95).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>not reported.</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:05:00 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 101):</B> low GI diet.</P>
<P>
<B>Control (n = 102):</B> high GI diet.</P>
<P>
<B>Description of dietary intervention:</B> study started with a 6 week run-in phase (2 weeks low GI diet, 4 weeks high GI diet) after completion of which participants were randomised to intervention or control; main intervention: dietary counselling based on a small energy restriction (100 to 300 kcal/day), skipping the diet 1 day/week was allowed; individual nutritional counselling every month with menus and exchange lists; both diets designed with 26% to 28% of energy as fat; low GI diets for each meal designed to maintain an average difference of 40 GI units compared to high GI diet (major determinant was sticky rice versus parboiled rice and amount of beans); participants were instructed to eat 3 meals and 3 snacks per day according to a 6 day menu plan; instructions also included limiting to a minimum all candies, added sugar, sodas, except for the weekly day free of diet; portions of staple foods were reduced monthly if the participants reported that they were prescribed too much food.</P>
<P>
<B>Incentives</B>: see above.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>food frequency questionnaire at the beginning of the run-in and 3, 6, 12 and 18 months after the start of the intervention; adherence in the low GI group was greater than in the high GI group (61% versus 46%, P = 0.0006).</P>
<P>
<B>Was the diet energy-reduced?</B> yes.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy reduced in both groups, no significant difference.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 04:17:31 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> BMI (basis of power analysis), serum lipids, fasting serum glucose, fasting serum insulin, insulin sensitivity (HOMA), hunger/satiety. Abstract suggested weight change was the primary outcome and yet this was not reported.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 04:17:43 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by National Institutes of Health and Brazilian Research Council; authors stated that they had no conflicts of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-06 10:22:12 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:05:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Solomon-2010">
<CHAR_METHODS MODIFIED="2017-06-27 04:21:23 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> USA; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 12 weeks.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to assess the effects of exercise training with a low or high GI diet on metabolic syndrome severity.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 04:26:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 24 (10/12 completers in the intervention group (11 in Malin 2012) and 12/12 in the control group (10 in Malin 2012)).</P>
<P>
<B>Inclusion criteria: </B>older (mean age 66 years) obese (BMI = 35.5 kg/m<SUP>2</SUP>) (34.4 in Solomon) adults meeting the National Cholesterol Education Program Adult Treatment Panel (ATP) III criteria for metabolic syndrome; non-smokers, sedentary, weight-stable (&lt; 2 kg weight change in previous 6 months); recruited through advertisements.</P>
<P>
<B>Exclusion criteria:</B> heart, kidney, liver, thyroid, intestinal, pulmonary disease; taking medications affecting the primary outcomes; contraindications to increments in physical activity (based on exercise ECG).</P>
<P>
<B>Age (years) (mean (SE)): </B>
<I>intervention: </I>67 (SE 2); <I>control:</I> 64 (SE 1).</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>30%; <I>control:</I> 41.7%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SE)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>34.9 (SE 1.1); <I>control:</I> 34.1 (SE 1.1).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.55 (SE 0.29); <I>control:</I> 5.36 (SE 0.21).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.38 (SE 0.09); <I>control:</I> 1.29 (SE 0.11).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.32 (SE 0.24); <I>control:</I> 3.40 (SE 0.17).</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>intervention: </I>systolic 127 (SE 3,) diastolic 76 (SE 3); <I>control:</I> systolic 133 (SE 5), diastolic 79 (SE 3).</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:05:06 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 12):</B> low GI diet (GI 40) plus exercise.</P>
<P>
<B>Control (n = 12):</B> high GI (GI 80) diet plus exercise.</P>
<P>
<B>Description of dietary intervention:</B> measurements of resting metabolic rate to ascertain caloric requirements; all meals, snacks, and beverages were provided to participants on a daily basis; diets designed by a registered dietitian and isocaloric to the individual requirements of participants; dietary macronutrient composition (including fibre) matched between groups.</P>
<P>
<B>Incentives</B>: as above.</P>
<P>
<B>Cointerventions in both groups:</B> 60 min of aerobic exercise 5 days/week (treadmill walking and cycle ergometry) at about 85% of the maximum heart rate obtained during an incremental maximal aerobic-exercise test; sessions supervised by exercise physiologist.</P>
<P>
<B>Assessment of dietary adherence: </B>daily food-container weigh backs; weekly counselling session with a research dietitian; adherence 98% (SE 1) low GI group, 96% (SE 1) control group.</P>
<P>
<B>Was the diet energy-reduced?</B> no.</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>prescribed diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 04:29:57 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> body composition, aerobic fitness, insulin sensitivity, plasma lipids, plasma insulin, plasma glucose, HbA1c, metabolic syndrome severity (Z-score).</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 04:30:06 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by National Institutes of Health Grants RO1 AG-12834 and National Institutes of Health National Center for Research Resources 1UL1RR024989; authors stated that they had no financial or other conflicts of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-10-31 11:00:41 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:05:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Venn-2010">
<CHAR_METHODS MODIFIED="2017-06-27 04:32:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> New Zealand; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 18 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to compare weight loss, metabolic outcomes, and nutrient intakes in obese people assigned to a diet rich in pulses and wholegrains or to a control diet.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 04:36:04 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 108 (43/53 completers in the intervention group and 30/55 in the control group).</P>
<P>
<B>Inclusion criteria: </B>BMI &#8805;28 kg/m<SUP>2</SUP>.</P>
<P>
<B>Exclusion criteria:</B> pregnancy, lactation; chronic disease (diabetes mellitus, cancer, coronary heart disease).</P>
<P>
<B>Age (years) (mean (SD)): </B>
<I>intervention: </I>42 (SD 11.2); <I>control:</I> 42 (SD 10.3).</P>
<P>
<B>Sex (% men):</B> <I>intervention: </I>16%; <I>control:</I> 12%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SD)): </B>
</P>
<P>
<B>
<I>BMI (kg/m<SUP>2</SUP>): </I>
</B>
<I>intervention: </I>36.1 (SD 6.5); <I>control:</I> 34.7 (SD 4.6).</P>
<P>
<B>
<I>Total cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>5.3 (SD 1.0); <I>control:</I> 5.2 (SD 1.0).</P>
<P>
<B>
<I>HDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>1.2 (SD 0.3); <I>control:</I> 1.3 (SD 0.3).</P>
<P>
<B>
<I>LDL cholesterol (mmol/L): </I>
</B>
<I>intervention: </I>3.3 (SD 0.8); <I>control:</I> 3.2 (SD 0.8)</P>
<P>
<B>
<I>Blood pressure (mmHg): </I>
</B>
<I>intervention: </I>systolic 132 (SD 15.4), diastolic 83 (SD 8.7); <I>control:</I> systolic 133 (SD 13.2), diastolic 83 (SD 9.0).</P>
<P>
<B>
<I>Hypertension: </I>
</B>
<I>intervention: </I>10%; <I>control:</I> 12%.</P>
<P>
<B>Medications used:</B> not reported.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:05:14 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 53):</B> diet emphasising pulses and wholegrains; similar advice as given to the control group below but specifically instructed to consume 2 servings of pulses as a substitute for 2 servings of breads and cereals and all other breads were to be wholegrain.</P>
<P>
<B>Control (n = 55):</B> diet based on guidelines produced by the National Heart Foundation of New Zealand (see below).</P>
<P>
<B>Description of dietary intervention:</B> diet based on guidelines produced by the National Heart Foundation of New Zealand: instructions to eat each day 3 servings of vegetables and 2 servings of fruit, at least 6 servings of breads and cereals; 1 to 2 servings of protein-rich foods; 1 to 2 tablespoons of monounsaturated fats and oil products; small amounts of nuts and seeds; instructed to stay within the portion size guidelines of the National Heart Foundation of New Zealand; counselling sessions in pairs every 2 weeks for the first 6 months and provision of key foods, followed by 12 months with monthly contacts with study investigators; cooking classes and supermarket tours during first 6 months, as well as dietary advice and recipe cards.</P>
<P>
<B>Incentives</B>: as above.</P>
<P>
<B>Cointerventions in both groups:</B> encouraged to exercise half an hour a day and given a pedometer.</P>
<P>
<B>Assessment of dietary adherence: </B>daily dietary check sheets discussed with the dietitian every 2 weeks during the first 6 months; 3-day weighed diet records (2 weekdays and 1 weekend day) recorded by participants on 4 occasions (before randomisation, 2, 6, 12 months).</P>
<P>
<B>Was the diet energy-reduced?</B> no (based on National Heart Foundation of New Zealand guidelines of 7.2 MJ/day).</P>
<P>
<B>Comparability of diet composition: </B>yes, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>energy reduced in both groups, no significant difference.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 04:38:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> weight (basis of power analysis), BMI, waist circumference, plasma lipids, fasting glucose, blood pressure.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 04:38:29 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by New Zealand Foundation for Research, Science and Technology and the Lifestyle foods programme; the authors declared that they had no conflicts of interest.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-06 13:06:49 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2017-07-04 11:05:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolever-2002">
<CHAR_METHODS MODIFIED="2017-06-27 04:41:27 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Setting:</B> Canada; setting not reported.</P>
<P>
<B>Design:</B> individual randomisation, parallel group.</P>
<P>
<B>Dates: </B>not reported.</P>
<P>
<B>Intervention duration:</B> 4 months.</P>
<P>
<B>Follow-up:</B> no postintervention follow-up.</P>
<P>
<B>Focus: </B>to examine the optimal amount and source of dietary carbohydrate for managing insulin resistance.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-28 02:18:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>N:</B> 37 (13/13 completers in the low GI group and 11/13 in the high GI group).</P>
<P>
<B>Inclusion criteria: </B>age 30 to 65 years, impaired glucose tolerance, BMI &lt; 40 kg/m<SUP>2</SUP>, serum triacylglycerol &lt; 10 mmol/L.</P>
<P>
<B>Exclusion criteria:</B> pregnancy.</P>
<P>
<B>Age (years) (mean (SE)): </B>
<I>low GI: </I>55.2 (SE 3.0); <I>high GI:</I> 58.8 (SE 4.0).</P>
<P>
<B>Sex (% men):</B> <I>low GI: </I>23%; <I>high GI:</I> 18%.</P>
<P>
<B>Ethnicity: </B>not reported.</P>
<P>
<B>Cardiovascular risk status (mean (SE)): </B>
</P>
<P>
<I>
<B>BMI (kg/m<SUP>2</SUP>): </B>low GI: </I>29.7 (SE 1.2); <I>high GI:</I> 29.3 (SE 2.2).</P>
<P>
<I>
<B>Total cholesterol (mmol/L): </B>whole study population:</I> 5.24 (SE 0.16).</P>
<P>
<I>
<B>HDL cholesterol (mmol/L): </B>whole study population:</I> 1.21 (SE 0.06).</P>
<P>
<I>
<B>LDL cholesterol (mmol/L): </B>whole study population:</I> 3.18 (SE 0.13).</P>
<P>
<I>
<B>Blood pressure (mmHg): </B>low GI: </I>systolic 129 (SE 4), diastolic 80 (SE 2); <I>high GI:</I> systolic 126 (SE 6), diastolic 78 (SE 3).</P>
<P>
<B>Medications used:</B> thiazide diuretics were used by one high GI participant; &#946;-blockers were taken by one low GI participant at stable doses throughout the study.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 11:05:50 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Low GI group (n = 13):</B> high carbohydrate, low GI (at least one serving of low GI food at each meal).</P>
<P>
<B>High GI group (n = 11):</B> high carbohydrate, high GI (at least one serving of high GI food at each meal).</P>
<P>
<B>(MUFA group (n = 11):</B> low carbohydrate, high monounsaturated fatty acid (MUFA) <B>(not considered here)).</B>
</P>
<P>
<B>Description of dietary intervention:</B> weight-maintaining ad libitum diet; baseline 3-day food records were used as a basis for individualised dietary advice; high carbohydrate diets contained 55% of energy from carbohydrate and 30% from fat; lists of high and low GI foods provided, along with specified foods to be used in the diet.</P>
<P>
<B>Cointerventions in both groups:</B> none.</P>
<P>
<B>Assessment of dietary adherence: </B>participants were seen monthly for consultation with the dietitian and to hand in 3-day food records.</P>
<P>
<B>Was the diet energy-reduced?</B> no.</P>
<P>
<B>Comparability of diet composition: </B>significantly more protein (% of energy) in the low GI group, see <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
<P>
<B>Change in diet over time: </B>small decrease in energy intake in the low GI group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 04:46:39 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Outcomes (not clearly divided into primary and secondary):</B> insulin sensitivity (basis of power analysis), body weight, fasting lipids, blood pressure, fasting plasma glucose, HbA1c, glucose effectiveness, pancreatic responsivity, glucose disposition index, postprandial plasma glucose, insulin.</P>
</CHAR_OUTCOMES>
<CHAR_USER_DEF_1 MODIFIED="2017-06-27 04:46:43 +0100" MODIFIED_BY="[Empty name]">
<P>Funding by the Canadian Diabetes Association and the International Olive Oil Council.</P>
</CHAR_USER_DEF_1>
<CHAR_NOTES MODIFIED="2014-11-08 20:09:21 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<SUP>ACE: Angiotensin-converting-enzyme; ATP: Adenosine triphosphate; BMI: Body mass index; Ca: Calcium; CHO: Carbohydrates ; CVD: Cardiovascular disease; ECG: Electrocardiogram; Es: Effect size; GDM: Gestational diabetes mellitus; GI: Glycaemic index; HbA1c: Glycated hemoglobin a1c; HDL: HIgh density lipoprotein; HOMA: Homeostatic model assessment; INS: Fasting insulin levels; kcal: Kilocalories; Kg: Killograms; LDL: Low-density lipoprotein ; LF: Low fat; LGI: Low glycaemic index; mRNA: Messenger ribonucleic acid; <SUB>MUFA: Mono-unsaturated fatty acids; </SUB>RD: Registered dietitian; T2DM: Type 2 diabetes mellitis; TLC: Theraputic lifestyle changes; VAS: Visual analogue scale; WC: Waist circumference </SUP>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2017-07-04 12:58:59 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:18:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abbasi-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:18:50 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>GI of the diet not reported or compared.<BR/>Intervention &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Abete-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:02 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Agus-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:13 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alfenas-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:31 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.<BR/>Participants not diagnosed with CHD or at risk of CHD.<BR/>Participants not free-living.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Alfenas-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:47 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Amano-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:54 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:19:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Argiana-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:19:57 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-04 12:55:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aston-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-04 12:55:08 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported (primary and/or secondary outcomes) </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:20:20 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bahadori-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:20:20 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:20:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barakatun-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:20:27 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:20:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Barkoukis-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:20:41 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:20:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bouche-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:20:51 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:20:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brand-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:20:58 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:21:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brynes-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:21:15 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:21:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Calle_x002d_Pascual-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:21:22 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with diabetes mellitus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-04 12:55:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carels-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-04 12:55:31 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported (primary and/or secondary outcomes).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:21:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chanteleau-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:21:46 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:21:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cheong-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:21:53 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-30 17:53:49 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chiavaroli-2016">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-30 17:53:49 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:22:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Clapp-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:22:15 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>Participants pregnant.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:22:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Colagiuri-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:22:32 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.<BR/>GI of diets not reported or compared.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:23:00 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Collier-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:23:00 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar overall energy and macronutrient contents.<BR/>Intervention duration &lt; 12 weeks.<BR/>CHD mortality, morbidity or risk factor outcomes not reported.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:23:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Collier-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:23:09 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention in children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:23:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Coulston-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:23:19 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:23:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Crapo-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:23:42 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Participants not free-living.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:23:53 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-De-Rougemont-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:23:53 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dumesnil-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:12 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient contents.<BR/>Participants not free-living.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ebbeling-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:26 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient contents.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ebbeling-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:34 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient contents.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fontvielle-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:44 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fontvielle-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:50 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with diabetes mellitus.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:24:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:24:56 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:25:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:25:06 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:25:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-1998a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:25:16 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:25:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-1998b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:25:23 +0100" MODIFIED_BY="[Empty name]">
<P>Not a dietary intervention.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:25:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Frost-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:25:29 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:25:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fuh-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:25:57 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not free-living.<BR/>GI of diets not reported or compared.<BR/>Comparison not between diets with similar overall energy and macronutrient levels.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:26:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garg-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:26:06 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Participants not free-living.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:26:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garg-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:26:27 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Comparison not between diets with similar overall energy and macronutrient intakes.<BR/>Participants not free-living.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:26:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Garg-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:26:34 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:26:40 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giacco-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:26:40 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 1 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:26:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gilbertson-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:26:54 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:27:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gilbertson-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:27:08 +0100" MODIFIED_BY="[Empty name]">
<P>Study did not report CHD risk factors or outcomes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:27:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Golay-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:27:25 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:27:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Grant-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:27:33 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women, gestational hyperglycaemia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:27:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gutschall-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:27:42 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:27:48 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Heilbronn-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:27:48 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Herrmann-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:01 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hollenbeck-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:11 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Comparisons not between diets with similar overall energy and macronutrient levels.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jarvi-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:22 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jarvi-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:32 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1985">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:38 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:28:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1987a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:28:57 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1987b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:04 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:15 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-2002a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:24 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Participants not free-living.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:35 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-2002b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:35 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:41 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jenkins-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:41 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:29:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jensen-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:29:52 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:30:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jeppesen-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:30:14 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>GI of diets not reported or compared.<BR/>Comparisons not between diets with similar overall energy and macronutrient contents.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:30:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jimenez_x002d_Cruz-2003a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:30:26 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:30:37 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiminez_x002d_Cruz-2003b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:30:37 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:30:46 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jiminez_x002d_Cruz-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:30:46 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:30:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kabir-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:30:52 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-04 12:57:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kelly-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-04 12:57:16 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported (primary and/or secondary outcomes). </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:31:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kendall-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:31:10 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:31:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kiens-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:31:16 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:31:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Komindr-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:31:23 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:31:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krog_x002d_Mikkelsen-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:31:33 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:18:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kwak-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:18:57 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:31:58 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lafrance-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:31:58 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-LaHaye-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:12 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:18 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Laitinen-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:18 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:24 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leinonen-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:24 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diet not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lerman_x002d_Garber-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:33 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Comparison not between diets with similar overall energy and macronutrient contents.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lieberman-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:39 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:45 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:32:52 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Liu-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:32:52 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:33:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ludwig-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:33:09 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lunetta-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:02 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.<BR/>Participants not free-living.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:33:26 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Luscombe-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:33:26 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:33:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Marsh-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:33:33 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with polycystic ovary syndrome.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:33:54 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Morales-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:33:54 +0100" MODIFIED_BY="[Empty name]">
<P>Not RCT or CCT.<BR/>Participants were children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:06 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nazare-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:06 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:34:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pacy-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:34:13 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Comparison not between diets with similar overall energy and macronutrient contents.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patel-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:10 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Patel-2011a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:14 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Percheron-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:17 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient levels.<BR/>Participants not free-living.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:34:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pereira-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:34:51 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:34:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pereira-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:34:57 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient levels.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:35:04 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perichart_x002d_Perera-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:35:04 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnant women with diabetes or gestational diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:35:12 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pittas-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:35:12 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar energy and macronutrient levels.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:35:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Poppitt-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:35:17 +0100" MODIFIED_BY="[Empty name]">
<P>GI of the diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rabasa_x002d_Lhoret-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:21 +0100" MODIFIED_BY="[Empty name]">
<P>Comparison not between diets with similar overall energy and macronutrient levels..<BR/>Participants not free-living.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:35:44 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rasmussen-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:35:44 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.<BR/>Comparison not between diets with similar overall energy and macronutrient contents.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Runchey-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:25 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Runchey-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:29 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:33 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sacks-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:33 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:36:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Salmeron-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:36:11 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT or CCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:36:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Santacroce-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:36:16 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:38 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Scholz-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:38 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:36:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sciarrone-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:36:29 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sharafetdinov-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:42 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:45 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shikany-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:45 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-07-04 12:58:59 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shyam-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-07-04 12:58:59 +0100" MODIFIED_BY="[Empty name]">
<P>No relevant outcomes reported (primary and/or secondary outcomes). </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:37:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Singh-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:37:11 +0100" MODIFIED_BY="[Empty name]">
<P>GI of the diets not reported or compared.<BR/>Comparison not between diets of similar energy and macronutrient intake.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:37:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Slabber-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:37:19 +0100" MODIFIED_BY="[Empty name]">
<P>GI of the diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:50 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sloth-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:50 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:37:36 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Spieth-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:37:36 +0100" MODIFIED_BY="[Empty name]">
<P>Participants were children.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:37:43 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Taghrid-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:37:43 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:19:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tovar-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:19:57 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:37:55 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tsihlias-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:37:55 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:38:10 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Van-Horn-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:38:10 +0100" MODIFIED_BY="[Empty name]">
<P>GI of diets not reported or compared.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:38:15 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Visek-2011">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:38:15 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:20:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vrolix-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:20:03 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:38:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolever-1992a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:38:29 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes and overweight/obese.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:20:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolever-1992b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:20:08 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:20:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolever-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:20:11 +0100" MODIFIED_BY="[Empty name]">
<P>Participants not diagnosed with CHD or at risk of CHD.<BR/>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:38:51 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wolever-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:38:51 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:39:02 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yang-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:39:02 +0100" MODIFIED_BY="[Empty name]">
<P>Not an RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-27 23:39:08 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yusof-2009">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-27 23:39:08 +0100" MODIFIED_BY="[Empty name]">
<P>Participants with type 2 diabetes.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2017-06-28 02:20:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zhang-2010">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2017-06-28 02:20:16 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention duration &lt; 12 weeks.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>
<SUP>CHD: Coronary heart disease; GI: Glycaemic index </SUP>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2017-07-04 13:02:55 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2017-07-04 13:00:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Boyadjieva-2015">
<CHAR_METHODS MODIFIED="2017-07-04 13:00:17 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-07-04 13:00:12 +0100" MODIFIED_BY="[Empty name]">
<P>30 obese adults (males and females).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-04 13:00:12 +0100" MODIFIED_BY="[Empty name]">
<P>16 weeks dietary intervention: low GI vs high GI.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-07-04 13:00:11 +0100" MODIFIED_BY="[Empty name]">
<P>Plasma ghrelin, leptin, and anthropometric parameters.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-04 13:00:10 +0100" MODIFIED_BY="[Empty name]">
<P>Not clear if they collected CVD outcomes.</P>
<P>Contacted authors (23.06.2016) to clarify the measurement of CVD outcomes. Authors did not respond.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-07-04 13:00:16 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Cayanan-2015">
<CHAR_METHODS MODIFIED="2017-07-04 13:00:16 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-28 02:06:46 +0100" MODIFIED_BY="[Empty name]">
<P>44 obese adults with obstructive sleep apnea.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-07-03 10:59:10 +0100" MODIFIED_BY="[Empty name]">
<P>Low glycaemic index high protein diet.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 23:51:27 +0100" MODIFIED_BY="[Empty name]">
<P>Cardio-metabolic markers (such as blood pressure).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-06-27 23:51:31 +0100" MODIFIED_BY="[Empty name]">
<P>Diet composition not clear.</P>
<P>Contacted authors (18.08.2016) to clarify intervention and control diet composition. Authors did not respond.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-07-04 13:00:13 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Giroux-2015">
<CHAR_METHODS MODIFIED="2017-07-04 13:00:13 +0100" MODIFIED_BY="[Empty name]">
<P>Design not clear.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 23:53:21 +0100" MODIFIED_BY="[Empty name]">
<P>26 rural adults with prediabetes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-06-27 23:51:53 +0100" MODIFIED_BY="[Empty name]">
<P>6-month lifestyle education program.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 23:51:57 +0100" MODIFIED_BY="[Empty name]">
<P>Eating behaviour and anthropometric measures.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-07-03 17:50:12 +0100" MODIFIED_BY="[Empty name]">
<P>Study design and CVD outcomes are not clear.</P>
<P>Contacted authors (23.06.2106) to clarify study design and measured outcomes. Author did not respond.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-06-30 18:40:34 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karl-2015">
<CHAR_METHODS MODIFIED="2017-06-30 18:30:46 +0100" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-30 18:34:40 +0100" MODIFIED_BY="[Empty name]">
<P>91 obese adults. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-06-30 18:38:30 +0100" MODIFIED_BY="[Empty name]">
<P>17 weeks of four food provided diets: moderate carbohydrate/low GI; moderate carbohydrate/high GI; high carbohydrate/low GI; high carbohydrate/low GI </P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-30 18:40:17 +0100" MODIFIED_BY="[Empty name]">
<P>Anthropometric measures and metabolic adaptation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-06-30 18:40:34 +0100" MODIFIED_BY="[Empty name]">
<P>CVD outcomes not available. </P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2017-06-30 18:30:42 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Weinhold-2015">
<CHAR_METHODS MODIFIED="2017-06-30 18:30:42 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 23:52:25 +0100" MODIFIED_BY="[Empty name]">
<P>Employees 18 to 65 years old with prediabetes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-06-27 23:52:36 +0100" MODIFIED_BY="[Empty name]">
<P>Intervention: 16-week group based lifestyle intervention adapted from the Diabetes Prevention Program.</P>
<P>Control: usual care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 23:52:44 +0100" MODIFIED_BY="[Empty name]">
<P>Weight loss, glucose control, blood pressure, and food intake.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2017-06-27 23:52:48 +0100" MODIFIED_BY="[Empty name]">
<P>Library unable to locate.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>
<SUP>RCT: Randomised controlled trial; GI: Glycaemic index; CVD: Cardiovascular disease</SUP>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2017-07-04 13:01:56 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2017-07-04 13:01:56 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Brand_x002d_Miller-2013">
<CHAR_STUDY_NAME MODIFIED="2017-07-04 13:01:56 +0100" MODIFIED_BY="[Empty name]">
<P>PREVIEW.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2017-07-04 13:01:56 +0100" MODIFIED_BY="[Empty name]">
<P>RCT.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2017-06-27 23:53:54 +0100" MODIFIED_BY="[Empty name]">
<P>2500 adults and children, overweight (BMI &#8805; 25.0 kg/m2) and prediabetic will be recruited.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2017-06-28 02:08:09 +0100" MODIFIED_BY="[Empty name]">
<P>3 years high-protein, low-glycaemic index diet vs a high-carbohydrate, medium-glycaemic index diet in combination with moderate or high intensity physical activity.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2017-06-27 23:54:14 +0100" MODIFIED_BY="[Empty name]">
<P>Incidence of type 2 diabetes and related outcomes including CVD outcomes.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2016-08-25 14:07:57 +0100" MODIFIED_BY="[Empty name]">
<P>2013</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2017-06-27 23:55:00 +0100" MODIFIED_BY="[Empty name]">
<P>Author response 'Indeed the PREVIEW intervention study is ongoing, and the data will not be analysed for the whole data set until late 2018. We are including CVD risk factors".</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2017-06-27 23:55:07 +0100" MODIFIED_BY="[Empty name]">
<P>6-year EU project (2013&#8211;2018).</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>
<SUP>RCT: Randomised controlled trial; BMI: Body mass index; CVD: Cardiovascular disease; EU: European Unioin</SUP>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2017-07-03 18:07:00 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:05:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:47:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Classes were randomised, but method not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:00:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Computer-generated random list.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:23:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>Web-based randomisation programme; block randomisation with stratification according to centre, number of eligible parents within the family, number of parents with BMI &gt; 34 kg/m<SUP>2</SUP>.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:30:58 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above - study has two independent relevant comparisons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:43:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Randomisation by random numbers.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:06:36 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>&#8220;eligible subjects were randomised according to an allocation list (allocation 1:1) generated using randomisation software from John Hopkins Division of Biostatics&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:10:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:08:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:23:14 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>'Subjects fulfilling the inclusion criteria were randomly assigned to three equally sized different dietary intervention groups, by using a computer generated random-number sequence&#8217;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:41:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Stratified according to weight (&lt; 80 kg, 80 to 100 kg, &gt; 100 kg) and sex; allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:45:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above - study had two independent relevant comparisons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:55:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:02:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:55:51 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:03:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:57:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Computer-based minimisation procedure to balance assignment by age, sex, waist circumference, HDL cholesterol.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:59:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above - study had two independent relevant comparisons.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:10:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:36:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>Author response 'Randomization was computer generated'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:09:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:17:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>Computer-generated randomisation list with blocking.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:30:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:38:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-03 18:07:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Coin toss; stratification by age, sex, BMI.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2017-06-27 04:47:02 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:05:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:47:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:00:33 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Not reported, random number list was generated by one of the investigators.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:23:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:31:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:43:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:06:39 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:11:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:08:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:23:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:41:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:45:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:55:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:02:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:55:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:03:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:57:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:59:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:10:14 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:37:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>Author response 'Allocation was blinded to subjects in the sense that the arms were coded/named with nonidentifying titles as to what diets they would follow. The coordinator of subject schedules and allocation was not blinded and held the key in sealed envelope. After subject was randomized this information was given to RD to carry out counselling'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:09:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:17:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:30:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:38:40 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>Allocation method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:47:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2014-10-29 14:16:40 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-10-30 07:14:46 +0000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2017-06-27 04:47:05 +0100" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 04:05:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Blinding method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 04:47:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Blinding method not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 05:00:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Staff members who obtained outcome measurements were not informed of the diet group assignment and intervention staff members who delivered the intervention did not take outcome measurements.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 05:24:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>The investigators who performed the statistical analysis had not been in contact with the participants; but blinding of outcome assessment unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 05:31:20 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 05:43:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 07:06:45 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>&#8220;Laboratory technicians and physicians reviewing the subjects were blinded to the randomisation&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-25 07:11:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 01:08:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 01:23:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>'Laboratory technicians and statisticians were blinded to group assignments'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 01:41:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 01:45:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 01:55:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 02:02:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 02:56:02 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 03:03:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 03:57:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:00:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 03:10:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 03:37:24 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>Author response 'Nurses, staff, statistician were blinded since everything was coded'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:09:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:18:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:30:21 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:38:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2017-06-27 04:47:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 04:06:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Large number of dropouts/losses to follow-up, reasons not given, imbalance between groups.</P>
<P>
<B>Loss to follow-up/drop-outs:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 11/27 (40.7%).</P>
<P>
<B>
<I>Control:</I>
</B> 19/27 (70.4%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 04:47:56 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>High attrition rate; reasons included lack of time, pregnancy, illness, personal reasons; no difference in anthropometric and biochemical parameters between completers and non-completers but women were younger in the non-completers.</P>
<P>
<B>Loss to follow-up / drop-outs:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 16/51 (31.4%).</P>
<P>
<B>
<I>Control:</I>
</B> 15/45 (33.3%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 05:01:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Reasons for non-completion not reported.</P>
<P>
<B>Loss to follow-up / drop-outs:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 3/22 (13.6%).</P>
<P>
<B>
<I>Control:</I>
</B> 4/25 (16%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 05:25:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>Slightly different numbers given in different papers, following numbers according to Larsen et al. 2010 NEJM; reasons for dropout not given.</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<B>
<I>Low GI/low protein:</I>
</B> 44/150 (29.3%).</P>
<P>
<B>
<I>High GI/low protein:</I>
</B>
 58/155 (37.4%).</P>
<P>
<B>
<I>Low GI/high protein:</I>
</B>
 35/159 (22.0%).</P>
<P>
<B>
<I>High GI/high protein:</I> </B>48/155 (31.0%).</P>
<P>
<B>
<I>(Control diet:</I>
</B>
 40/154 (26.0%))</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 05:31:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 05:43:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Not clearly reported, stated that 57 patients met the inclusion criteria and 55 completed the study, no further detail.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 07:09:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>Outcome data available for all randomized participants (n = 77). However, in an earlier investigation (part of the 1-year study) authors stated attrition rate and reported different numbers (n = 60) to the 1-year study:</P>
<P>Intervention group (low LGI): 7/30 (23%).</P>
<P>Control group (conventional healthy dietary recommendations): 5/30 (17%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-25 07:11:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-28 04:24:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>High attrition rate, reasons for discontinuation not reported; 59/160 (36.9%) discontinued, 17/160 were excluded (12 due to high sensitive reactive C-protein elevation &gt; 8 mg/L, 2 due to lack of adherence).</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<I>
<B>Low GI group:</B> </I>22/53 (41.5%);</P>
<P>
<I>
<B>Control:</B>
</I> 27/54 (50%).</P>
<P>(<I>
<B>Low CHO group:</B> </I>27/53 (50.9%)).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 01:24:13 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>Low GI group: 4/41 (9.8%);</P>
<P>High GI group: 5/41 (12.2%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 01:43:07 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Reasons for discontinuation only reported overall (1 pregnancy, 1 failed to complete the final analysis, 2 moved away, 9 were disappointed with weight loss).</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<B>
<I>Low GI/high CHO:</I>
</B>
 2/32 (6.3%);</P>
<P>
<B>
<I>High GI/high CHO:</I>
</B> 5/32 (16.6%).</P>
<P>
<B>
<I>Low GI/high protein:</I>
</B>
 5/33 (15.2%).</P>
<P>
<B>
<I>High GI/high protein:</I>
</B> 1/32 (3.1%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 01:45:52 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 01:56:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Reasons for discontinuation not reported.</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 10/59 (17%);</P>
<P>
<B>
<I>Portion control:</I>
</B> 41/41 (0%);</P>
<P>
<I>(<B>Low energy density:</B> </I>12/57 (21%))</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 02:02:47 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>High attrition rate, reasons for discontinuation not reported; 4 discontinued, 1 excluded due to high alcohol intake and triglycerides &gt; mean + 2SD.</P>
<P>
<B>Loss to follow-up/drop-outs:</B> only reported for whole group, 5/18 (27.8%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 02:56:27 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>High attrition rate, reasons for discontinuation not reported.</P>
<P>
<B>Loss to follow-up/dropouts:</B> only reported for whole group 18/56 (32.1%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 03:04:01 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Only reported how many participants completed the study, not how many participants started the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 03:58:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Relatively high attrition rate, reasons for loss to follow-up not reported.</P>
<P>
<B>MUFA/low GI:</B> 28/144 (19.4%).</P>
<P>
<B>MUFA/high GI:</B> 34/145 (23.4%).</P>
<P>
<B>Low fat/low GI: </B>28/149 (18.8%).</P>
<P>
<B>Low fat/high GI: </B>29/145 (20.0%).</P>
<P>(<B>High SFA/high GI:</B> 52/137 (38.0%)).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 04:00:28 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 03:11:08 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>42 participants started the study, 13 left the study before completion of the first 12 weeks (31%), 29 started the second phase.</P>
<P>
<B>Loss to follow-up/dropouts during 2nd phase:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 4/10 (40%);</P>
<P>
<B>
<I>High GI control:</I>
</B> 1/9 (11.1%);</P>
<P>
<B>
<I>(High fat group:</I>
</B>
 2/10 (20%))<I>.</I>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 03:38:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>
<B>Loss to follow-up/dropouts: </B>
</P>
<P>Low GI, energy-restricted group: 7/31 (22%).</P>
<P>High GI,energy-restricted group: 5/30 (16%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 04:10:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Reasons for discontinuation/exclusion only reported overall (5 did not complete the 4-week dietary and/or the 12 week session).</P>
<P>
<B>Loss to follow-up/dropouts:</B> not reported by comparison group, 5/62 (8.1%) overall.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 04:19:50 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>
<B>Reasons for non-completion: 
</B>
<I>intervention:</I> n = 39 withdrawn, n = 13 tired of the diet, n = 4 pregnancy, n = 6 moving away, n = 1 death, n = 9 other reasons; <I>control:</I> n = 41 withdrawn, n = 20 tired of the diet, n = 1 pregnancy, n = 5 moving away, n = 15 other reasons.</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 40/101 (39.6%) non-completers; 38/101 (37.6%) did not return for the last visit.</P>
<P>
<B>
<I>Control:</I>
</B> 56/102 (54.9%) non-completers; 42/102 (41.2%) did not return for the last visit.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-07-06 14:36:05 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>24 participants in <LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>, 21 in Malin 2012.</P>
<P>2 exclusions in the low GI group (failure to comply with diet and exercise, refusal of repeated testing).</P>
<P>
<B>Loss to follow-up/dropouts:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 2/12 (16.7%) (11 completers in Malin 2012).</P>
<P>
<B>
<I>Control:</I>
</B> 0/12 (0%) (10 completers in Malin 2012).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 04:40:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>High attrition rate, especially in the control group.</P>
<P>
<B>Reasons for non-completion: 
</B>
<I>intervention:</I> n = 1 moved away, n = 1 achieved their weight loss goals, n = 1 illness, n = 3 family reasons, n = 4 failed to meet their expectations; <I>control:</I> n = 3 moved away, n = 3 achieved their weight loss goals, n = 5 illness/injury, n = 3 family reasons, n = 11 failed to meet their expectations.</P>
<P>
<B>Loss to follow-up/drop-outs:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 10/53 (18.9%).</P>
<P>
<B>
<I>Control:</I>
</B> 25/55 (45.5%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2017-06-27 04:47:30 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Reasons for discontinuation not reported; 1 person participated in 2 arms of the study (MUFA and high GI).</P>
<P>
<B>Loss to follow-up/drop-outs:</B>
</P>
<P>
<B>
<I>Low GI group:</I>
</B>
 0/13 (0%).</P>
<P>
<B>
<I>High GI group:</I>
</B> 2/13 (15.4%).</P>
<P>
<B>
<I>MUFA group:</I>
</B>
 1/12 (8.3%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2017-06-27 04:47:36 +0100" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Intention-to-treat analysis</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:06:14 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>No, only completers analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:48:04 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Not explicitly reported, but probably not as results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:01:25 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Not explicitly reported, results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-01-06 17:06:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>'intention-to-treat analyses were performed including...'</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:31:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:43:34 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Not explicitly reported, but probably not as results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:09:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>Not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:11:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:09:59 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Per-protocol analysis; weight reduction was also analysed in an intention-to-treat analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:24:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>"All statistical analyses were conducted by both intention-to-treat (ITT) and per protocol (PP) approaches. The ITT analysis included all randomly assigned participants. The last observation carried forward was used for handling missing data".</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:43:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Last observation carried forward.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:45:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:56:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Not explicitly reported, but probably not as results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:02:55 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:56:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:04:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Only participants completing the study were analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:58:37 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Probably not, stated that 548/549 participants were analysed (of 720 randomised).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:00:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:11:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>Only participants completing the first phase were analysed (n = 29) but not stated how non-completers of the second phase were handled.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:38:30 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>'Body weight missing data were replaced with the last known value for the ITT analysis. All other results are based on the per protocol data set, which includes only those subjects who completed both 0 and 12 week procedures'.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:10:26 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Only completers included in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-11-06 11:16:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:31:38 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Not explicitly reported, but probably not as results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:40:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>"The data were analyzed according to modified intention to treat...."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:47:36 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Not explicitly reported, but probably not as results were only reported for completers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2017-06-28 02:15:08 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:06:19 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:48:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:01:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>All outcomes stated in protocol reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:26:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>Not enough information to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:31:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:43:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Not enough information to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:09:28 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>Reported outcomes that they intended to measure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:11:33 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:10:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Reported outcomes that the authors intended to measure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:24:50 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>Blood pressure parameters were not reported postintervention. Physical activity was assessed but not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:43:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Not enough information to assess.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:46:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:56:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Unclear, total cholesterol and LDL cholesterol only reported narratively, no data provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:02:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>Not enough information to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:56:52 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:04:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:58:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:00:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:11:32 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>Only very limited reporting of outcomes after phase 2.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:38:59 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>Not all lipids reported at baseline were reported at follow-up (only triglycerides). However, they reported all primary and secondary outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:10:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:19:56 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>BMI at follow-up not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:31:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Different papers reporting different outcomes - unclear what the primary/secondary outcomes of the overall study were.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:40:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>Not enough detail to judge.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-28 02:15:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Selective reporting of numeric values, data mainly reported in graphical form.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2017-07-03 17:43:29 +0100" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Groups comparable at baseline</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:06:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>With respect to demographic variables, body composition and biochemical markers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-03 17:36:32 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>With respect to demographic variables, body composition and biochemical markers but only study completers reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:01:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>With respect to demographic variables, body composition, biochemical markers, medication, comorbidities, but only study completers reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-03 17:36:11 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>With respect to demographic variables, body composition, biochemical markers, but only study completers reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:32:04 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:44:10 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Significantly fewer participants in the low GI group took a statin (58% versus 86%, P = 0.02) and aspirin (73% versus 100%, P = 0.01).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:09:34 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>With respect to demographic variables, anthropometric and biochemical markers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:11:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:10:33 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>With respect to demographic variables, most biochemical markers; triglycerides were significantly lower in the low GI group at baseline than in the control group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:24:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>With respect to demographic variables, anthropometric and biochemical markers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:43:26 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>With respect to demographic variables, anthropometric and biochemical markers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:46:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2015-03-17 10:22:33 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>With respect to demographic variables, anthropometric variables, most biochemical markers; significantly higher blood triglycerides, significantly lower fibre intake and significantly lower blood glucose in the low GI group compared to the portion control group at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:03:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>With respect to demographic variables, anthropometric variables, biochemical markers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:57:01 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>With respect to biochemical and anthropomorphic variables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-03 17:43:29 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>No significant difference in any of the outcomes at randomisation; age and sex not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:58:54 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Baseline data only given for men and women, not for different comparison groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:00:43 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:11:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>For participants completing the first phase, with respect to anthropometric and biochemical variables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-07-03 17:35:49 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>With respect to anthropomorphic and biochemical baseline values for low and high GI groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:10:38 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>With respect to demographic, anthropomorphic and biochemical baseline values.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:20:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>With respect to demographic, anthropometric and biochemical variables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:32:02 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>Not specifically reported, but study characteristics table suggests that there were no significant differences between groups in demographic, anthropometric and biochemical variables at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:40:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>With respect to demographic, anthropometric and biochemical variables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-28 02:15:11 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>With respect to demographic, anthropometric and biochemical variables.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2017-06-28 02:15:16 +0100" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:06:43 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<DESCRIPTION>
<P>Power analysis (80% power to detect a change in waist circumference with 30 participants per group, i.e. study was underpowered).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 04:48:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bellisle-2007">
<DESCRIPTION>
<P>Power analysis (90% power to detect a change in weight with 18 participants per group); randomised as clusters but this was not considered in the analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:01:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Buscemi-2013">
<DESCRIPTION>
<P>Power analysis (80% power to detect a change in flow-mediated dilatation with 17 participants per group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:29:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011-low-protein">
<DESCRIPTION>
<P>Power analysis (97% power to detect a change in weight with 918 participants; slightly underpowered).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:32:13 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-DiOGenes-2011a-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 05:44:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Frost-2004">
<DESCRIPTION>
<P>Power analysis based on total cholesterol, but unclear if the study had adequate power.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:14:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014--low-insulin">
<DESCRIPTION>
<P>"Individual effect size values were calculated for changes in outcomes for each of the two diet groups and compared. ES values between 0.2 to 0.5, 0.5 to 0.8 and &gt; 0.8 were taken to denote &#8216;small&#8217;, &#8216;moderate&#8217; and &#8216;large&#8217; changes in outcomes". Did not report how many participants required to reach this effect size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-25 07:11:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Ghani-2014a-high-insulin">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:10:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-H_x00f6_nemann-2010">
<DESCRIPTION>
<P>Power analysis (80% power to detect a change in weight with 16 participants per group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:28:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<DESCRIPTION>
<P>Power calculations based on body weight not outcomes of interest for this review; so the study may be underpowered for the outcomes of interest, i.e. lipids and blood pressure.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:45:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO">
<DESCRIPTION>
<P>Power analysis (90% power to detect a change in weight with 30 participants per group; but considering dropouts, the study may be underpowered).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:46:22 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 01:57:06 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Melanson-2012">
<DESCRIPTION>
<P>Power analysis (based on weight, but details not reported).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:03:07 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Philippou-2008">
<DESCRIPTION>
<P>No power analysis, small sample size.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 02:57:04 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009">
<DESCRIPTION>
<P>No power analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:04:36 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Philippou-2009a">
<DESCRIPTION>
<P>No power analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:59:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-high-MUFA">
<DESCRIPTION>
<P>Power analysis (80% power to detect a change in insulin sensitivity with 113 participants per group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:00:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-RISCK-2010-low-fat">
<DESCRIPTION>
<P>See above.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:11:44 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Raatz-2005">
<DESCRIPTION>
<P>No power analysis, probably underpowered.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 03:43:47 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Randolph-2014">
<DESCRIPTION>
<P>Power calculations based on body weight (80% power to detect 2 kg change in weight) not on the outcomes of interest for this review i.e. lipids and blood pressure. So, the study may be underpowered for these outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:10:45 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Shikany-2005">
<DESCRIPTION>
<P>No power analysis.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:20:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sichieri-2007">
<DESCRIPTION>
<P>Power analysis (90% power to detect a change in BMI with 206 participants, allowing for 20% loss during follow-up - but more participants did not complete the study, so the study was probably underpowered).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:32:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Solomon-2010">
<DESCRIPTION>
<P>No power analysis reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-27 04:40:46 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Venn-2010">
<DESCRIPTION>
<P>Power analysis (80% power to detect a difference in weight loss with 40 participants per group).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2017-06-28 02:15:16 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wolever-2002">
<DESCRIPTION>
<P>Power analysis (90% power to detect a difference in insulin sensitivity with 12 participants per group, i.e. slightly underpowered).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2017-07-04 11:44:25 +0100" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2017-07-04 11:44:25 +0100" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2017-01-04 14:57:05 +0000" MODIFIED_BY="Grade Profiler">Low GI versus high GI for the primary prevention of cardiovascular disease</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Low GI versus high GI for the primary prevention of cardiovascular disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Overweight or obese adults<BR/>
<B>Settings:</B> Unclear and research centre<BR/>
<B>Intervention:</B> Low GI</P>
<P>
<B>Control: </B>High GI<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>High GI</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Low GI </B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Total and cardiovascular mortality</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported total and CVD mortality for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Fatal and nonfatal myocardial infarction</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported fatal and nonfatal myocardial infarction for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Unstable angina</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported unstable angina for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Coronary artery bypass graft surgery</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported coronary artery bypass graft surgery for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Percutaneous transluminal coronary angioplasty</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported percutaneous transluminal coronary angioplasty for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Stroke</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>No trials reported stroke for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Adverse events</B>
<BR/>Measurement unclear<BR/>Follow-up: 6 months</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>No adverse events</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>No adverse events</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>-</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>38<BR/>(2 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low<SUP>a</SUP>
</B>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK> adverse events checklist for the primary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP> Downgraded by one level because of serious risk of bias and one level for serious imprecision (see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>)<BR/>
</P>
</FOOTNOTES>
</SOF_TABLE>
<SOF_TABLE ID="SOF-02" MODIFIED="2017-01-05 14:43:52 +0000" MODIFIED_BY="[Empty name]" NO="2" READONLY="YES">
<TITLE MODIFIED="2017-01-04 14:59:51 +0000" MODIFIED_BY="Grade Profiler">Low GI versus high GI for the secondary prevention of cardiovascular disease</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Low GI versus high GI for the secondary prevention of cardiovascular disease</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> Adults with coronary heart disease<BR/>
<B>Settings: </B>Clinical setting<BR/>
<B>Intervention:</B> Low GI</P>
<P>
<B>Control:</B> Healthy eating advice</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>High GI</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Low GI </B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Total and cardiovascular mortality</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report total and CVD mortality for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Fatal and nonfatal myocardial infarction</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report fatal and nonfatal myocardial infarction for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Unstable angina</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report unstable angina for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Coronary artery bypass graft surgery</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report coronary artery bypass graft surgery for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Percutaneous transluminal coronary angioplasty</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report percutaneous transluminal coronary angioplasty for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Stroke</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report stroke for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Adverse events</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The trial did not report adverse events for the secondary prevention of CVD</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2017-07-03 18:47:19 +0100" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2015-03-02 09:47:37 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-08 12:04:36 +0100" MODIFIED_BY="Liz Bickerdike">Glycaemic index values for food types</TITLE>
<TABLE COLS="2" ROWS="9">
<TR>
<TD>
<P>
<B>Food type</B>
</P>
</TD>
<TD>
<P>
<B>Glycaemic index</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P>White bread</P>
</TD>
<TD>
<P>100</P>
</TD>
</TR>
<TR>
<TD>
<P>Wholemeal bread</P>
</TD>
<TD>
<P>100</P>
</TD>
</TR>
<TR>
<TD>
<P>Weetabix</P>
</TD>
<TD>
<P>100</P>
</TD>
</TR>
<TR>
<TD>
<P>Cornflakes</P>
</TD>
<TD>
<P>119</P>
</TD>
</TR>
<TR>
<TD>
<P>Porridge</P>
</TD>
<TD>
<P>87</P>
</TD>
</TR>
<TR>
<TD>
<P>Baked beans</P>
</TD>
<TD>
<P>69</P>
</TD>
</TR>
<TR>
<TD>
<P>Digestive biscuits</P>
</TD>
<TD>
<P>84</P>
</TD>
</TR>
<TR>
<TD>
<P>Apple</P>
</TD>
<TD>
<P>52</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2017-07-03 18:47:19 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2017-07-03 18:15:29 +0100" MODIFIED_BY="[Empty name]">Comparibility of diets achieved</TITLE>
<TABLE COLS="5" ROWS="151">
<TR>
<TH>
<P>Study ID</P>
</TH>
<TH>
<P>Dietary component</P>
</TH>
<TH>
<P>Low GI</P>
</TH>
<TH>
<P>Control</P>
</TH>
<TH>
<P>P</P>
</TH>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Armendariz_x002d_Anguiano-2011" TYPE="STUDY">Armendariz-Anguiano 2011</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>5690 (SE 1255) kJ/day</P>
</TD>
<TD>
<P>6460 (SE 2489) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day)</P>
</TD>
<TD>
<P>173 (SE 41) g/day</P>
</TD>
<TD>
<P>197 (SE 82) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day)</P>
</TD>
<TD>
<P>48 (SE 22) g/day</P>
</TD>
<TD>
<P>49 (SE 39) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day)</P>
</TD>
<TD>
<P>67 (SE 18) g/day</P>
</TD>
<TD>
<P>82 (SE 31) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>23 (SE 12) g/day</P>
</TD>
<TD>
<P>14 (SE 7) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>51 (SE 7)</P>
</TD>
<TD>
<P>59 (SE 5)</P>
</TD>
<TD>
<P>0.008</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Bellisle-2007" TYPE="STUDY">Bellisle 2007</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ or kcal/day)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>High GI foods selected over 3 days (n)</P>
</TD>
<TD>
<P>5.8 (SE 0.7)</P>
</TD>
<TD>
<P>10.7 (SE 1.5)</P>
</TD>
<TD>
<P>0.002</P>
</TD>
</TR>
<TR>
<TD>
<P>Low GI foods selected over 3 days (n)</P>
</TD>
<TD>
<P>19.6 (SE 1.3)</P>
</TD>
<TD>
<P>17 (SE 1.3)</P>
</TD>
<TD>
<P>0.18</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Buscemi-2013" TYPE="STUDY">Buscemi 2013</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>set to about 20 kcal/kg BW (83.7 kJ) (1400, 1600, 1800 or 2000 kcal/day (5858, 6694, 7531, 8368 kJ/day)), data below for 1600 kcal/day (6694 kJ/day)</P>
</TD>
<TD>
<P>set to about 83.7 kJ/kg BW (5858, 6694, 7531, 8368 kJ/day), data below for 6694 kJ/day (1600 kcal/day)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>218 g/day</P>
<P>55% of energy</P>
</TD>
<TD>
<P>230 g/day</P>
<P>57% of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>45 g/day</P>
<P>25% of energy</P>
</TD>
<TD>
<P>43 g/day</P>
<P>24% of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>81 g/day</P>
<P>20% of energy</P>
</TD>
<TD>
<P>74 g/day</P>
<P>19% of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>32 g/day</P>
</TD>
<TD>
<P>33 g/day</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>43.8</P>
</TD>
<TD>
<P>54.1</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-DiOGenes-2011-low-protein" TYPE="STUDY">DiOGenes 2011 low protein</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>screening: 9075 (SD 3388) kJ/day</P>
<P>week 26: -2218 (SD 3734) kJ/day</P>
</TD>
<TD>
<P>screening: 9752 (SD 3529) kJ/day</P>
<P>week 26: -2046 (SD 3210) kJ/day</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>screening: 42.2 (SD 9.0) % of energy</P>
<P>week 26: +9.0 (SD 8.6) % of energy</P>
</TD>
<TD>
<P>screening: 44.7 (SD 8.6) % of energy</P>
<P>week 26: +6.0 (SD 10.1) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>screening: 37.4 (SD 7.8) % of energy</P>
<P>week 26: -7.7 (SD 8.8) % of energy</P>
</TD>
<TD>
<P>screening: 36.3 (SD 7.4) % of energy</P>
<P>week 26: -5.5 (SD 10.4) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>screening: 18.3 (SD 5.2) % of energy</P>
<P>week 26: -0.3 (SD 4.7) % of energy</P>
</TD>
<TD>
<P>screening: 17.0 (SD 4.0) % of energy</P>
<P>week 26: -0.7 (SD 4.9) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>screening: 19.3 (SD 8.9) g/day</P>
<P>week 26: +1.7 (SD 14.7) g/day</P>
</TD>
<TD>
<P>screening: 18.7 (SD 8.2) g/day</P>
<P>week 26: +1.6 (SD 10.4) g/day</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>screening: 61.0 (SD 5.7)</P>
<P>week 26: -4.7 (SD 6.8)</P>
</TD>
<TD>
<P>screening: 60.7 (SD 4.7)</P>
<P>week 26: +0.3 (SD 5.6)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-DiOGenes-2011a-high-protein" TYPE="STUDY">DiOGenes 2011a high protein</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>screening: 9657 (SD 2868) kJ/day</P>
<P>week 26: -2259 (SD 2759) kJ/day</P>
</TD>
<TD>
<P>screening: 9492 (SD 3311) kJ/day</P>
<P>week 26: -2609 (SD 2603) kJ/day</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>screening: 43.7 (SD 8.8) % of energy</P>
<P>week 26: +1.4 (SD 10.7) % of energy</P>
</TD>
<TD>
<P>screening: 45.2 (SD 7.3) % of energy</P>
<P>week 26: +0.5 (SD 7.4) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>screening: 36.1 (SD 7.5)% of energy</P>
<P>week 26: -4.9 (SD 9.6) % of energy</P>
</TD>
<TD>
<P>screening: 36.3 (SD 6.7)% of energy</P>
<P>week 26: -5.9 (SD 8.1) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>screening: 17.5 (SD 4.0) % of energy</P>
<P>week 26: +4.2 (SD 4.5) % of energy</P>
</TD>
<TD>
<P>screening: 16.0 (SD 3.6) % of energy</P>
<P>week 26: +6.4 (SD 6.0) % of energy</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>screening: 19.8 (SD 8.6) g/day</P>
<P>week 26: +1.6 (SD 13.5) g/day</P>
</TD>
<TD>
<P>screening: 18.9 (SD 8.1) g/day</P>
<P>week 26: +0.1 (SD 7.6) g/day</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>screening: 61.1 (SD 5.2)</P>
<P>week 26: -4.9 (SD 6.9)</P>
</TD>
<TD>
<P>screening: 61.4 (SD 4.4)</P>
<P>week 26: +0.3 (SD 6.0)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Frost-2004" TYPE="STUDY">Frost 2004</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>8506 (SE 473) kJ/day</P>
</TD>
<TD>
<P>7360 (SE 331) kJ/day</P>
</TD>
<TD>
<P>0.04</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>49 (SE 1) % of energy</P>
</TD>
<TD>
<P>47 (SE 2) % of energy</P>
</TD>
<TD>
<P>0.43</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>31 (SE 1) % of energy</P>
</TD>
<TD>
<P>32 (SE 2) % of energy</P>
</TD>
<TD>
<P>0.36</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>18 (SE 1) % of energy</P>
</TD>
<TD>
<P>18 (SE 1) % of energy</P>
</TD>
<TD>
<P>0.48</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>27 (SE 2) g/day</P>
</TD>
<TD>
<P>21 (SE 2) g/day</P>
</TD>
<TD>
<P>0.03</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>71 (SE 1)</P>
</TD>
<TD>
<P>81 (SE 1)</P>
</TD>
<TD>
<P>0.0001</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Ghani-2014--low-insulin" TYPE="STUDY">Ghani 2014 low insulin</LINK>
</P>
</TH>
<TD>
<P>Energy (kcal)</P>
</TD>
<TD>
<P>At 1 year: 1706 (SD 351)</P>
</TD>
<TD>
<P>At 1 year: 1595 (SD 298)</P>
</TD>
<TD>
<P>At 1 year: 0.298</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g)</P>
</TD>
<TD>
<P>At 1 year: 221 (SD 46)</P>
</TD>
<TD>
<P>At 1 year: 221 (SD 55)</P>
</TD>
<TD>
<P>At 1 year: 0.975</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g)</P>
</TD>
<TD>
<P>At 1 year: 68 (SD 15)</P>
</TD>
<TD>
<P>At 1 year: 60 (SD 13)</P>
</TD>
<TD>
<P>At 1 year: 0.086</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g)</P>
</TD>
<TD>
<P>At 1 year: 59 (SD 17)</P>
</TD>
<TD>
<P>At 1 year: 51 (SD 11)</P>
</TD>
<TD>
<P>At 1 year: 0.093</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g)</P>
</TD>
<TD>
<P>At 1 year: 17 (SD 4)</P>
</TD>
<TD>
<P>At 1 year: 13 (SD 3)</P>
</TD>
<TD>
<P>At 1 year: 0.004</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>At 1 year: 59 (SD 4)</P>
</TD>
<TD>
<P>At 1 year: 65 (SD 4)</P>
</TD>
<TD>
<P>At 1 year: &lt;0.001</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Ghani-2014a-high-insulin" TYPE="STUDY">Ghani 2014a high insulin</LINK>
</P>
</TH>
<TD>
<P>Energy (kcal)</P>
</TD>
<TD>
<P>At 1 year: 1554 (SD 292)</P>
</TD>
<TD>
<P>At 1 year: 1595 (SD 442)</P>
</TD>
<TD>
<P>At 1 year: 0.927</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g)</P>
</TD>
<TD>
<P>At 1 year: 186 (SD 62)</P>
</TD>
<TD>
<P>At 1 year: 208 (SD 48)</P>
</TD>
<TD>
<P>At 1 year: 0.331</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g)</P>
</TD>
<TD>
<P>At 1 year: 70 (SD 11)</P>
</TD>
<TD>
<P>At 1 year: 67 (SD 28)</P>
</TD>
<TD>
<P>At 1 year: 0.259</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g)</P>
</TD>
<TD>
<P>At 1 year: 50 (SD 10)</P>
</TD>
<TD>
<P>At 1 year:55 (SD 20)</P>
</TD>
<TD>
<P>At 1 year: 0.977</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g)</P>
</TD>
<TD>
<P>At 1 year: 17 (SD 4)</P>
</TD>
<TD>
<P>At 1 year: 13 (SD 5)</P>
</TD>
<TD>
<P>At 1 year: 0.048</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>At 1 year: 56 (SD 4)</P>
</TD>
<TD>
<P>At 1 year: 62 (SD 6)</P>
</TD>
<TD>
<P>At 1 year: 0.021</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-H_x00f6_nemann-2010" TYPE="STUDY">Hönemann 2010</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>10769 (SD 2982) kJ/day at baseline; -2481 (SD 2983) kJ/day at 6 months</P>
</TD>
<TD>
<P>10022 (SD 2960) kJ/day at baseline; -1653 (SD 2958) kJ/day at 6 months</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>51.88% of energy</P>
</TD>
<TD>
<P>49.01% of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>32.63% of energy</P>
</TD>
<TD>
<P>33.69% of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>15.49% of energy</P>
</TD>
<TD>
<P>17.30% of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>+3.8 (SD 10.6) g/day</P>
</TD>
<TD>
<P>+2.7 (SD 12.2) g/day</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Juanola_x002d_Falgarona-2014" TYPE="STUDY">Juanola-Falgarona 2014</LINK>
</P>
</TH>
<TD>
<P>Energy (kcal/day)</P>
</TD>
<TD>
<P>baseline: 2076 (SE 89)</P>
<P>6 months: -685 (SE 94)</P>
</TD>
<TD>
<P>baseline: 2036 (SE 101)</P>
<P>6 months: -610 (SE 87)</P>
</TD>
<TD>
<P>NS across all three groups</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>baseline: 41.8 (SE 1.3)</P>
<P>6 months: -2.1 (SE 1.3)</P>
</TD>
<TD>
<P>baseline: 41.0 (SE 1.0)</P>
<P>6 months: 1.6 (SE 1.5)</P>
</TD>
<TD>
<P>0.001 across all 3 groups (for 6-month change) but not reported for low GI vs high GI comparison</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>baseline: 39.6 (SE 1.0)</P>
<P>6 months: -1.5 (SE 1.3)</P>
</TD>
<TD>
<P>baseline: 38.0 (SE 0.9)</P>
<P>6 months: -2.9 (SE 1.2)</P>
</TD>
<TD>
<P>0.014 across all 3 groups (for 6-month change) but not reported for low GI vs high GI comparison</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>baseline: 17.0 (SE 0.4)</P>
<P>6 months: 4.2 (SE 0.7)</P>
</TD>
<TD>
<P>baseline: 18.8 (SE 0.5)</P>
<P>6 months: 2.8 (SE 0.8)</P>
</TD>
<TD>
<P>NS across all three groups</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>baseline: 9.0 (SE 0.7)</P>
<P>6 months: 4.2 (SE 0.7)</P>
</TD>
<TD>
<P>baseline: 10.0 (SE 0.7)</P>
<P>6 months: 2.8 (SE 0.8)</P>
</TD>
<TD>
<P>NS across all three groups</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>baseline: 56.27 (SE 0.87)</P>
<P>6 months: -7.00 (SE 1.08)</P>
</TD>
<TD>
<P>baseline: 56.87 (SE 0.74)</P>
<P>6 months: 0.50 (SE 0.87)</P>
</TD>
<TD>
<P>0.001 across all 3 groups (for 6-month change) but not reported for low GI vs high GI comparison</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-McMillan_x002d_Price-2006-high-CHO" TYPE="STUDY">McMillan-Price 2006 high CHO</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ)</P>
</TD>
<TD>
<P>6150 (SE 190) kJ/day</P>
</TD>
<TD>
<P>6010 (SE 240) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>200 (SE 7) g/day</P>
<P>56 (SE 1) % of energy</P>
</TD>
<TD>
<P>209 (SE 9) g/day</P>
<P>60 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>36 (SE 2) g/day</P>
<P>22 (SE 1) % of energy</P>
</TD>
<TD>
<P>32 (SE 2) g/day</P>
<P>19 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>69 (SE 2) g/day</P>
<P>19 (SE 0) % of energy</P>
</TD>
<TD>
<P>63 (SE 3) g/day</P>
<P>18 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>30 (SE 1) g/day</P>
</TD>
<TD>
<P>23 (SE 1) g/day</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>45 (SE 1)</P>
</TD>
<TD>
<P>70 (SE 1)</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-McMillan_x002d_Price-2006-high-protein" TYPE="STUDY">McMillan-Price 2006 high protein</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ)</P>
</TD>
<TD>
<P>5970 (SE 190) kJ/day</P>
</TD>
<TD>
<P>5950 (SE 170) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>143 (SE 7) g/day</P>
<P>40 (SE 2) % of energy</P>
</TD>
<TD>
<P>146 (SE 6) g/day</P>
<P>42 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>48 (SE 2) g/day</P>
<P>29 (SE 1) % of energy</P>
</TD>
<TD>
<P>44 (SE 2) g/day</P>
<P>27 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>93 (SE 3) g/day</P>
<P>26 (SE 1) % of energy</P>
</TD>
<TD>
<P>95 (SE 2) g/day</P>
<P>28 (SE 1) % of energy</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>24 (SE 1) g/day</P>
</TD>
<TD>
<P>21 (SE 1) g/day</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>44 (SE 1)</P>
</TD>
<TD>
<P>59 (SE 1)</P>
</TD>
<TD>
<P>NR</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Melanson-2012" TYPE="STUDY">Melanson 2012</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>-3270.2 (SD 2734.2) kJ/day</P>
</TD>
<TD>
<P>-2608.3 (SD 2032.6) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>-0.3 (SD 8.0) % of energy</P>
</TD>
<TD>
<P>+1.3 (SD 9.6) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>-3.2 (SD 7.9) % of energy</P>
</TD>
<TD>
<P>-4.3 (SD 7.8) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>+4.4 (SD 5.7) % of energy</P>
</TD>
<TD>
<P>+3.3 (SD 5.3) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>+3.6 (SD 4.5) g/day</P>
</TD>
<TD>
<P>-2.4 (SD 5.6) g/day</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>42.43 (SD 7.35)</P>
</TD>
<TD>
<P>46.69 (SD 7.74)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Philippou-2008" TYPE="STUDY">Philippou 2008</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day, median, IQR)</P>
</TD>
<TD>
<P>7418 (8661 to 10205) kJ/day</P>
</TD>
<TD>
<P>5472 (5129 to 8133) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (%energy, median, IQR)</P>
</TD>
<TD>
<P>46.0 (37.8 to 51.0) % of energy</P>
</TD>
<TD>
<P>49.4 (47.8 to 51.7) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (%energy, median, IQR)</P>
</TD>
<TD>
<P>32.8 (31.3 to 37.1) % of energy</P>
</TD>
<TD>
<P>29.2 (25.2 to 34.5) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy, median, IQR)</P>
</TD>
<TD>
<P>17.1 (15.7 to 17.4) % of energy</P>
</TD>
<TD>
<P>19.6 (14.0 to 23.1) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day, median, IQR)</P>
</TD>
<TD>
<P>8.0 (7.6 to 10.1) g/day</P>
</TD>
<TD>
<P>10.0 (6.1 to 11.1) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI (median, IQR)</P>
</TD>
<TD>
<P>51.3 (51.0 to 52.0)</P>
</TD>
<TD>
<P>59.3 (59.2 to 64.0)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Philippou-2009" TYPE="STUDY">Philippou 2009</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>-1870 (SD 2088) kJ/day compared to baseline</P>
</TD>
<TD>
<P>-987 (SD 2644) kJ/day compared to baseline</P>
</TD>
<TD>
<P>0.3</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>224 (SD 50) g/day</P>
</TD>
<TD>
<P>278 (SD 7) g/day</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>50.6 (SD 4.6)</P>
</TD>
<TD>
<P>63.2 (SD 5.6)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Philippou-2009a" TYPE="STUDY">Philippou 2009a</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>6054 (SD 1590) kJ/day</P>
</TD>
<TD>
<P>6711 (SD 1439) kJ/day</P>
</TD>
<TD>
<P>0.2</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>47.6 (SD 6.7) % of energy</P>
</TD>
<TD>
<P>48.5 (SD 7.0) % of energy</P>
</TD>
<TD>
<P>0.6</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>31.8 (SD 5.8) % of energy</P>
</TD>
<TD>
<P>30.9 (SD 9.0) % of energy</P>
</TD>
<TD>
<P>0.7</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>19.5 (SD 4.2) % of energy</P>
</TD>
<TD>
<P>19.3 (SD 4.9) % of energy</P>
</TD>
<TD>
<P>0.8</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>13.2 (SD 5.7) g/day</P>
</TD>
<TD>
<P>10.8 (SD 4.7) g/day</P>
</TD>
<TD>
<P>0.2</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>49.7 (SD 5.7)</P>
</TD>
<TD>
<P>63.7 (SD 9.4)</P>
</TD>
<TD>
<P>&lt; 0.001</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Raatz-2005" TYPE="STUDY">Raatz 2005</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>mean daily energy level (initial 12 weeks) for whole population 7883 (SE 57.8) kJ/day (range 5021 to 11,297 kJ/day), not reported for groups separately</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>60% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>60% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>25% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>25% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>15% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>15% of energy (initial 12 weeks)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>16.7 g/4184 kJ (initial 12 weeks)</P>
</TD>
<TD>
<P>9.1 g/4184 kJ (initial 12 weeks)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>33 (initial 12 weeks)</P>
<P>at 24 weeks, low GI group at significantly lower GI than high GI group (P = 0.014), no significant difference any more at 36 weeks (P = 0.14)</P>
</TD>
<TD>
<P>63 (initial 12 weeks)</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Randolph-2014" TYPE="STUDY">Randolph 2014</LINK>
</P>
</TH>
<TD>
<P>Energy (kcal/day)</P>
</TD>
<TD>
<P>baseline: 1924.3 (SE 147.7)</P>
<P>mean of weeks 3, 6, 9: 1624.9 (SE 81.4)</P>
</TD>
<TD>
<P>baseline: 1712.3 (SE 76.7)</P>
<P>mean of weeks 3, 6, 9: 1573.9 (SE 102.0)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day)</P>
<P/>
<P/>
<P>Carbohydrate(% energy)</P>
</TD>
<TD>
<P>baseline: 239.2 (SE 20.4)</P>
<P>mean of weeks 3, 6, 9: 219.1 (SE 10.2)</P>
<P/>
<P>baseline: 49.7 (SE 1.8)</P>
<P>mean of weeks 3, 6, 9: 52.3 (SE 2.8)</P>
</TD>
<TD>
<P>baseline: 211.7 (SE 8.8)</P>
<P>mean of weeks 3, 6, 9: 197.4 (SE 11.2)</P>
<P/>
<P>baseline: 50.7 (SE 2.1)</P>
<P>mean of weeks 3, 6, 9: 51.6 (SE 0.9)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day)</P>
<P/>
<P/>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>baseline: 73.1 (SE 7.2)</P>
<P>mean of weeks 3, 6, 9: 49.1 (SE 4.6)</P>
<P/>
<P>baseline: 33.4 (SE 1.8)</P>
<P>mean of weeks 3, 6, 9: 26.6 (SE 1.6)</P>
</TD>
<TD>
<P>baseline: 59.9 (SE 5.1)</P>
<P>mean of weeks 3, 6, 9: 52.6 (SE 6.2)</P>
<P/>
<P>baseline: 30.5 (SE 1.6)</P>
<P>mean of weeks 3, 6, 9: 28.8 (SE 1.4)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/d)</P>
<P/>
<P/>
<P>Protien (% energy)</P>
</TD>
<TD>
<P>baseline: 84.7 (SE 6.1)</P>
<P>mean of weeks 3, 6, 9: 79.2 (SE 5.7)</P>
<P/>
<P>baseline: 18.4 (SE 1.0)</P>
<P>mean of weeks 3, 6, 9: 18.6 (SE 1.2)</P>
</TD>
<TD>
<P>baseline: 76.6 (SE 5.0)</P>
<P>mean of weeks 3, 6, 9: 73.4 (SE 4.9)</P>
<P/>
<P>baseline: 18.0 (SE 0.8)</P>
<P>mean of weeks 3, 6, 9: 19.0 (SE 0.8)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>baseline: 23.9 (SE 2.1)</P>
<P>mean of weeks 3, 6, 9: 23.8 (SE 1.5)</P>
</TD>
<TD>
<P>baseline: 25.2 (SE 1.6)</P>
<P>mean of weeks 3, 6, 9: 23.3 (SE 1.7)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>baseline: 52.6 (SE 1.2)</P>
<P>mean of weeks 3, 6, 9: 52.3 (SE 0.8)</P>
</TD>
<TD>
<P>baseline: 55.4 (SE 1.1)</P>
<P>mean of weeks 3, 6, 9: 53.3 (SE 0.8)</P>
</TD>
<TD>
<P>unclear</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-RISCK-2010-high-MUFA" TYPE="STUDY">RISCK 2010 high MUFA</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>-310 (95% CI: -760 to +150) MJ/day</P>
<P>(8590 (SD 2110) for all during run-in)</P>
</TD>
<TD>
<P>-540 (95% CI: -1000 to -80) kJ/day</P>
<P>(8590 (SD 2110) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (%energy)</P>
</TD>
<TD>
<P>+1.6 (95% CI: -0.2 to +3.4) % of energy</P>
<P>(43.0 (SD 6.5) for all during run-in)</P>
</TD>
<TD>
<P>+1.9 (95% CI: +0.1 to +3.7) % of energy</P>
<P>(43.0 (SD 6.5) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (%energy)</P>
</TD>
<TD>
<P>-2.2 (95% CI: -3.9 to -0.4) % of energy</P>
<P>(37.9 (SD 5.3) for all during run-in)</P>
</TD>
<TD>
<P>-2.3 (95% CI: -4.1 to -0.5) % of energy</P>
<P>(37.9 (SD 5.3) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day)</P>
</TD>
<TD>
<P>+3.4 (95% CI: -1.9 to +8.6) g/day</P>
<P>(80.8 (SD 20.7) for all during run-in)</P>
</TD>
<TD>
<P>-2.2 (95% CI: -7.5 to +3.1) g/day</P>
<P>(80.8 (SD 20.7) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>-8.3 (95% CI: -9.4 to -7.2)</P>
<P>(63.5 (SD 3.6) for all during run-in)</P>
</TD>
<TD>
<P>-0.2 (95% CI: -1.3 to +1.0)</P>
<P>(63.5 (SD 3.6) for all during run-in)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-RISCK-2010-low-fat" TYPE="STUDY">RISCK 2010 low fat</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>-1310 (95% CI: -1750 to -880) kJ/day</P>
<P>(8590 (SD 2110) for all during run-in)</P>
</TD>
<TD>
<P>-830 (95% CI: -1300 to -370) kJ/day</P>
<P>(8590 (SD 2110) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (%energy)</P>
</TD>
<TD>
<P>+8.5 (95% CI: +6.8 to +10.2) % of energy</P>
<P>(43.0 (SD 6.5) for all during run-in)</P>
</TD>
<TD>
<P>+8.1 (95% CI: +6.3 to +9.9) % of energy</P>
<P>(43.0 (SD 6.5) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (%energy)</P>
</TD>
<TD>
<P>-11.8 (95% CI: -13.5 to -10.1) % of energy</P>
<P>(37.9 (SD 5.3) for all during run-in)</P>
</TD>
<TD>
<P>-10.4 (95% CI: -12.2 to -8.6) % of energy</P>
<P>(37.9 (SD 5.3) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day)</P>
</TD>
<TD>
<P>-2.8 (95% CI: -7.8 to +2.2) g/day</P>
<P>(80.8 (SD 20.7) for all during run-in)</P>
</TD>
<TD>
<P>-0.30 (95% CI: -5.7 to +5.1) g/day</P>
<P>(80.8 (SD 20.7) for all during run-in)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>-7.2 (95% CI: -8.3 to -6.1)</P>
<P>(63.5 (SD 3.6) for all during run-in)</P>
</TD>
<TD>
<P>+0.9 (95% CI: -0.3 to +2.0)</P>
<P>(63.5 (SD 3.6) for all during run-in)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Shikany-2005" TYPE="STUDY">Shikany 2005</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>5335 (SE 276) kJ/day</P>
</TD>
<TD>
<P>5565 (SE 305) kcal/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day)</P>
</TD>
<TD>
<P>166 (SE 11) g/day</P>
</TD>
<TD>
<P>190 (SE 12) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day)</P>
</TD>
<TD>
<P>37.9 (SE 2.8) g/day</P>
</TD>
<TD>
<P>40.3 (SE 3.1) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day)</P>
</TD>
<TD>
<P>63.4 (SE 3.4) g/day</P>
</TD>
<TD>
<P>56.9 (SE 3.7) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>55.2 (SE 1.0)</P>
</TD>
<TD>
<P>57.7 (SE 1.1)</P>
</TD>
<TD>
<P>P &lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Sichieri-2007" TYPE="STUDY">Sichieri 2007</LINK>
</P>
</TH>
<TD>
<P>Energy (MJ/day)</P>
</TD>
<TD>
<P>11200 (SD 7000) MJ/day</P>
</TD>
<TD>
<P>14000 (SD 9100) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (%energy)</P>
</TD>
<TD>
<P>59.5 (SD 6.3) % of energy</P>
</TD>
<TD>
<P>61.6 (SD 6.2) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (%energy)</P>
</TD>
<TD>
<P>27.2 (SD 4.6) % of energy</P>
</TD>
<TD>
<P>26.1 (SD 4.7) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (%energy)</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NR</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>36.0 (SD 21) g/day</P>
</TD>
<TD>
<P>44.5 (SD 27) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>30 (SD 54)</P>
</TD>
<TD>
<P>72 (SD 40)</P>
</TD>
<TD>
<P>0.02</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Solomon-2010" TYPE="STUDY">Solomon 2010</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>7364 (SE 456) kJ/day</P>
</TD>
<TD>
<P>7494 (SE 347) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (g/day or % energy)</P>
</TD>
<TD>
<P>247 (SE 16) g/day</P>
<P>54.7 (SE 0.1) % of energy</P>
</TD>
<TD>
<P>258 (SE 12) g/day</P>
<P>55.6 (SE 0.2) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (g/day or % energy)</P>
</TD>
<TD>
<P>56.7 (SE 3.4) g/day</P>
<P>28.3 (SE 0.1) % of energy</P>
</TD>
<TD>
<P>57.3 (SE 2.9) g/day</P>
<P>27.8 (SE 0.2) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (g/day or % energy)</P>
</TD>
<TD>
<P>76.8 (SE 4.8) g/day</P>
<P>17.0 (SE 0.1) % of energy</P>
</TD>
<TD>
<P>76.7 (SE 3.5) g/day</P>
<P>16.6 (SE 0.1) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>28.5 (SE 1.6) g/day</P>
</TD>
<TD>
<P>26.1 (SE 1.4) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>39.8 (SE 0.3)</P>
</TD>
<TD>
<P>80.0 (SE 0.6)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Venn-2010" TYPE="STUDY">Venn 2010</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day, median and IQR)</P>
</TD>
<TD>
<P>6350 (5559, 7297) kJ/day</P>
</TD>
<TD>
<P>6508 (5845, 7311) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy, median and IQR)</P>
</TD>
<TD>
<P>51 (48, 57) % of energy</P>
</TD>
<TD>
<P>52 (46, 56) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy, median and IQR)</P>
</TD>
<TD>
<P>27 (21, 31) % of energy</P>
</TD>
<TD>
<P>26 (22, 29) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy, median and IQR)</P>
</TD>
<TD>
<P>20 (17, 22) % of energy</P>
</TD>
<TD>
<P>20 (18, 23) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day, median and IQR)</P>
</TD>
<TD>
<P>25 (21, 34) g/day</P>
</TD>
<TD>
<P>23 (18, 28) g/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>GI (median and IQR)</P>
</TD>
<TD>
<P>47 (43, 50)</P>
</TD>
<TD>
<P>51 (49, 54)</P>
</TD>
<TD>
<P>0.011</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6">
<P>
<LINK REF="STD-Wolever-2002" TYPE="STUDY">Wolever 2002</LINK>
</P>
</TH>
<TD>
<P>Energy (kJ/day)</P>
</TD>
<TD>
<P>7090 (SE 280) kJ/day</P>
</TD>
<TD>
<P>7170 (SE 390) kJ/day</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Carbohydrate (% energy)</P>
</TD>
<TD>
<P>54.8 (SE 1.7) % of energy</P>
</TD>
<TD>
<P>52.8 (SE 2.0) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Fat (% energy)</P>
</TD>
<TD>
<P>24.7 (SE 1.6) % of energy</P>
</TD>
<TD>
<P>27.9 (SE 1.9) % of energy</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Protein (% energy)</P>
</TD>
<TD>
<P>19.4 (SE 0.5) % of energy</P>
</TD>
<TD>
<P>17.4 (SE 0.7) % of energy</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TD>
<P>Fibre (g/day)</P>
</TD>
<TD>
<P>36.2 (SE 2.6) g/day</P>
</TD>
<TD>
<P>22.7 (SE 2.2) g/day</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
<TR>
<TD>
<P>GI</P>
</TD>
<TD>
<P>54.4 (SE 0.7)</P>
</TD>
<TD>
<P>59.3 (SE 0.6)</P>
</TD>
<TD>
<P>&lt; 0.05</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>KJ: kilojoules; SE: standard error; SD: standard deviation; g: grams; kcal: kilocalories; GI: glycaemic index; IQR: interquartile range; d: day; MJ: microjoule</SUP>
</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2017-07-06 14:35:23 +0100" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2017-07-06 14:35:23 +0100" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Low GI versus control (primary prevention)</NAME>
<CONT_OUTCOME CHI2="40.88654153114738" CI_END="0.023565090919976453" CI_START="-0.25977009278286073" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.11810250093144213" ESTIMABLE="YES" I2="60.86731868037507" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="5.770958446056351E-4" P_Q="1.0" P_Z="0.10227100012485865" Q="0.0" RANDOM="YES" SCALE="1.33" SORT_BY="USER" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.04792825863090927" TOTALS="YES" TOTAL_1="661" TOTAL_2="616" UNITS="" WEIGHT="100.00000000000001" Z="1.6339421407862162">
<NAME>Total cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.18651445573443876" CI_START="-0.3665144557344388" EFFECT_SIZE="-0.09000000000000002" ESTIMABLE="YES" MEAN_1="0.29" MEAN_2="0.38" MODIFIED="2016-12-25 20:35:12 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="0.99" SD_2="1.02" SE="0.14108139634990718" STUDY_ID="STD-Sichieri-2007" TOTAL_1="101" TOTAL_2="102" WEIGHT="7.702094033357462"/>
<CONT_DATA CI_END="0.5656307678729222" CI_START="-0.8256307678729222" EFFECT_SIZE="-0.13" ESTIMABLE="YES" MEAN_1="-0.8" MEAN_2="-0.67" MODIFIED="2016-12-25 20:35:14 +0000" MODIFIED_BY="[Empty name]" ORDER="145" SD_1="0.86" SD_2="0.79" SE="0.3549201788195951" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="3.004372446495604"/>
<CONT_DATA CI_END="0.06399459768100813" CI_START="-0.5239945976810081" EFFECT_SIZE="-0.22999999999999998" ESTIMABLE="YES" MEAN_1="-0.18" MEAN_2="0.05" MODIFIED="2016-12-25 20:35:17 +0000" MODIFIED_BY="[Empty name]" ORDER="146" SD_1="0.6" SD_2="0.6" SE="0.15" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO" TOTAL_1="32" TOTAL_2="32" WEIGHT="7.418188942805533"/>
<CONT_DATA CI_END="-0.45049413305260505" CI_START="-1.0295058669473949" EFFECT_SIZE="-0.74" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="0.24" MODIFIED="2017-01-06 15:43:48 +0000" MODIFIED_BY="[Empty name]" ORDER="147" SD_1="0.6" SD_2="0.6" SE="0.14770978917519928" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein" TOTAL_1="33" TOTAL_2="33" WEIGHT="7.490706709515923"/>
<CONT_DATA CI_END="0.21205984284304913" CI_START="-0.35205984284304914" EFFECT_SIZE="-0.07" ESTIMABLE="YES" MEAN_1="0.39" MEAN_2="0.46" MODIFIED="2017-01-06 14:00:18 +0000" MODIFIED_BY="[Empty name]" ORDER="148" SD_1="0.58" SD_2="0.34" SE="0.1439107274765767" STUDY_ID="STD-Philippou-2009a" TOTAL_1="23" TOTAL_2="19" WEIGHT="7.611613049829644"/>
<CONT_DATA CI_END="-0.09262305954257632" CI_START="-0.8473769404574237" EFFECT_SIZE="-0.47000000000000003" ESTIMABLE="YES" MEAN_1="-0.45" MEAN_2="0.02" MODIFIED="2017-01-06 14:00:34 +0000" MODIFIED_BY="[Empty name]" ORDER="149" SD_1="0.62" SD_2="0.56" SE="0.19254279335443142" STUDY_ID="STD-Philippou-2009" TOTAL_1="22" TOTAL_2="16" WEIGHT="6.146400819740465"/>
<CONT_DATA CI_END="0.8268872911768037" CI_START="-0.4068872911768037" EFFECT_SIZE="0.21000000000000002" ESTIMABLE="YES" MEAN_1="-0.41" MEAN_2="-0.62" MODIFIED="2017-01-06 15:41:44 +0000" MODIFIED_BY="[Empty name]" ORDER="150" SD_1="0.97" SD_2="1.02" SE="0.31474419736420256" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="3.5542718711118804"/>
<CONT_DATA CI_END="0.41854898795487094" CI_START="-1.218548987954871" EFFECT_SIZE="-0.4" ESTIMABLE="YES" MEAN_1="-0.8" MEAN_2="-0.4" MODIFIED="2017-01-06 15:42:02 +0000" MODIFIED_BY="[Empty name]" ORDER="151" SD_1="1.13" SD_2="0.87" SE="0.4176347088066316" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="2.3497061312127396"/>
<CONT_DATA CI_END="0.5096492640091052" CI_START="-0.5096492640091052" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.11" MEAN_2="-0.11" MODIFIED="2017-01-06 15:42:02 +0000" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="0.73" SD_2="0.76" SE="0.26002991280919113" STUDY_ID="STD-Ghani-2014a-high-insulin" TOTAL_1="15" TOTAL_2="18" WEIGHT="4.521662480292787"/>
<CONT_DATA CI_END="0.5145671371472219" CI_START="-0.33456713714722186" EFFECT_SIZE="0.09" ESTIMABLE="YES" MEAN_1="-0.09" MEAN_2="-0.18" MODIFIED="2017-01-06 15:41:59 +0000" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="0.85" SD_2="0.58" SE="0.21661986674048772" STUDY_ID="STD-Ghani-2014--low-insulin" TOTAL_1="24" TOTAL_2="20" WEIGHT="5.508031321263552"/>
<CONT_DATA CI_END="0.3544445538578334" CI_START="-0.03444455385783335" EFFECT_SIZE="0.16000000000000003" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.64" MODIFIED="2017-01-06 15:42:52 +0000" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="0.75" SD_2="0.66" SE="0.09920822800397722" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="107" TOTAL_2="95" WEIGHT="9.043540351388035"/>
<CONT_DATA CI_END="0.1457467329826862" CI_START="-0.32574673298268636" EFFECT_SIZE="-0.09000000000000008" ESTIMABLE="YES" MEAN_1="0.7" MEAN_2="0.79" MODIFIED="2017-01-06 15:42:54 +0000" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="0.72" SD_2="0.87" SE="0.12028115559378968" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="95" TOTAL_2="84" WEIGHT="8.373159790501951"/>
<CONT_DATA CI_END="0.8078073487645017" CI_START="-0.00780734876450162" EFFECT_SIZE="0.4" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.5" MODIFIED="2017-01-06 15:43:12 +0000" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="1.11" SD_2="1.05" SE="0.20806879717241436" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="5.727308400505109"/>
<CONT_DATA CI_END="0.01943612903867098" CI_START="-0.739436129038671" EFFECT_SIZE="-0.36" ESTIMABLE="YES" MEAN_1="-0.23" MEAN_2="0.13" MODIFIED="2017-01-06 15:43:22 +0000" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="0.76" SD_2="0.7" SE="0.19359341907892938" STUDY_ID="STD-Shikany-2005" TOTAL_1="31" TOTAL_2="26" WEIGHT="6.1172052033396"/>
<CONT_DATA CI_END="0.12270956579944009" CI_START="-0.4827095657994401" EFFECT_SIZE="-0.18" ESTIMABLE="YES" MEAN_1="-0.05" MEAN_2="0.13" MODIFIED="2017-01-06 15:43:22 +0000" MODIFIED_BY="[Empty name]" ORDER="158" SD_1="0.7" SD_2="0.69" SE="0.1544464940106933" STUDY_ID="STD-Juanola_x002d_Falgarona-2014" TOTAL_1="41" TOTAL_2="40" WEIGHT="7.278291055107231"/>
<CONT_DATA CI_END="0.9357968622457392" CI_START="-0.9557968622457392" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.39" MEAN_2="-0.38" MODIFIED="2017-01-06 13:59:07 +0000" MODIFIED_BY="[Empty name]" ORDER="159" SD_1="0.98" SD_2="0.95" SE="0.4825582866348893" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="1.8606386192488762"/>
<CONT_DATA CI_END="0.39717351133294715" CI_START="-0.3371735113329472" EFFECT_SIZE="0.02999999999999997" ESTIMABLE="YES" MEAN_1="-0.27" MEAN_2="-0.3" MODIFIED="2017-01-06 13:59:04 +0000" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="0.69" SD_2="0.73" SE="0.18733686650834658" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="6.29280877428363"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="12.711445900153421" CI_END="0.021818715473532535" CI_START="-0.029187077255174866" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.0036841808908211642" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6937272833540138" P_Q="1.0" P_Z="0.7770703685260556" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="USER" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="688" TOTAL_2="641" UNITS="" WEIGHT="100.00000000000006" Z="0.28313889353497235">
<NAME>HDL Cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours High GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Low GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.07042449187461998" CI_START="-0.13042449187461996" EFFECT_SIZE="-0.03" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.24" MODIFIED="2017-01-06 15:43:57 +0000" MODIFIED_BY="[Empty name]" ORDER="138" SD_1="0.36" SD_2="0.37" SE="0.05123792715925168" STUDY_ID="STD-Sichieri-2007" TOTAL_1="101" TOTAL_2="102" WEIGHT="6.449109132544642"/>
<CONT_DATA CI_END="0.2616395065416044" CI_START="-0.2816395065416044" EFFECT_SIZE="-0.009999999999999995" ESTIMABLE="YES" MEAN_1="-0.08" MEAN_2="-0.07" MODIFIED="2017-01-06 15:45:02 +0000" MODIFIED_BY="[Empty name]" ORDER="151" SD_1="0.3" SD_2="0.35" SE="0.13859413166989912" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="0.8814407943518277"/>
<CONT_DATA CI_END="0.030584981785222426" CI_START="-0.13058498178522243" EFFECT_SIZE="-0.05" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.08" MODIFIED="2017-01-06 15:45:02 +0000" MODIFIED_BY="[Empty name]" ORDER="152" SD_1="0.19" SD_2="0.18" SE="0.041115542132848605" STUDY_ID="STD-Juanola_x002d_Falgarona-2014" TOTAL_1="41" TOTAL_2="40" WEIGHT="10.015457397948763"/>
<CONT_DATA CI_END="0.047998199227002714" CI_START="-0.14799819922700272" EFFECT_SIZE="-0.05" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.08" MODIFIED="2017-01-06 15:45:21 +0000" MODIFIED_BY="[Empty name]" ORDER="160" SD_1="0.2" SD_2="0.2" SE="0.05" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO" TOTAL_1="32" TOTAL_2="32" WEIGHT="6.7724034366032075"/>
<CONT_DATA CI_END="0.11725295495727185" CI_START="-0.07725295495727184" EFFECT_SIZE="0.020000000000000004" ESTIMABLE="YES" MEAN_1="0.07" MEAN_2="0.05" MODIFIED="2017-01-06 15:45:27 +0000" MODIFIED_BY="[Empty name]" ORDER="161" SD_1="0.2" SD_2="0.2" SE="0.04961976634488732" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein" TOTAL_1="33" TOTAL_2="32" WEIGHT="6.876594258704795"/>
<CONT_DATA CI_END="0.09181892138087949" CI_START="-0.1718189213808795" EFFECT_SIZE="-0.04000000000000001" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.17" MODIFIED="2017-01-06 15:45:38 +0000" MODIFIED_BY="[Empty name]" ORDER="162" SD_1="0.2" SD_2="0.23" SE="0.0672557875658177" STUDY_ID="STD-Philippou-2009a" TOTAL_1="23" TOTAL_2="19" WEIGHT="3.7430316965088304"/>
<CONT_DATA CI_END="0.276306103659901" CI_START="-0.13630610365990098" EFFECT_SIZE="0.07" ESTIMABLE="YES" MEAN_1="-0.01" MEAN_2="-0.08" MODIFIED="2017-01-06 15:45:59 +0000" MODIFIED_BY="[Empty name]" ORDER="163" SD_1="0.27" SD_2="0.39" SE="0.10526015033297408" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="1.52811084600337"/>
<CONT_DATA CI_END="0.4055281482005664" CI_START="-0.20552814820056642" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.7" MODIFIED="2017-01-06 15:46:12 +0000" MODIFIED_BY="[Empty name]" ORDER="164" SD_1="0.36" SD_2="0.36" SE="0.15588457268119896" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="0.6967493247534166"/>
<CONT_DATA CI_END="0.2597252864708951" CI_START="-0.07972528647089507" EFFECT_SIZE="0.09000000000000001" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.01" MODIFIED="2017-01-06 15:46:37 +0000" MODIFIED_BY="[Empty name]" ORDER="166" SD_1="0.18" SD_2="0.31" SE="0.08659612513784257" STUDY_ID="STD-Ghani-2014a-high-insulin" TOTAL_1="15" TOTAL_2="18" WEIGHT="2.2578023014309108"/>
<CONT_DATA CI_END="0.14862162769594212" CI_START="-0.14862162769594212" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.04" MEAN_2="0.04" MODIFIED="2017-01-06 15:46:37 +0000" MODIFIED_BY="[Empty name]" ORDER="167" SD_1="0.3" SD_2="0.2" SE="0.07582875444051551" STUDY_ID="STD-Ghani-2014--low-insulin" TOTAL_1="24" TOTAL_2="20" WEIGHT="2.944523233305743"/>
<CONT_DATA CI_END="0.06981909007270917" CI_START="-0.06981909007270917" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.23" MEAN_2="0.23" MODIFIED="2017-01-06 15:46:48 +0000" MODIFIED_BY="[Empty name]" ORDER="168" SD_1="0.21" SD_2="0.26" SE="0.03562263930533073" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="95" TOTAL_2="84" WEIGHT="13.342298206690831"/>
<CONT_DATA CI_END="0.07190796105313266" CI_START="-0.05190796105313269" EFFECT_SIZE="0.009999999999999981" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.2" MODIFIED="2017-01-06 15:46:48 +0000" MODIFIED_BY="[Empty name]" ORDER="169" SD_1="0.24" SD_2="0.21" SE="0.03158627482007566" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="107" TOTAL_2="96" WEIGHT="16.97016288086516"/>
<CONT_DATA CI_END="0.014393912127145345" CI_START="-0.13439391212714535" EFFECT_SIZE="-0.06" ESTIMABLE="YES" MEAN_1="-0.11" MEAN_2="-0.05" MODIFIED="2015-03-01 18:25:33 +0000" MODIFIED_BY="[Empty name]" ORDER="170" SD_1="0.2" SD_2="0.16" SE="0.03795677508053976" STUDY_ID="STD-Melanson-2012" TOTAL_1="49" TOTAL_2="41" WEIGHT="11.75179528065907"/>
<CONT_DATA CI_END="0.21317798144710604" CI_START="-0.013177981447106024" EFFECT_SIZE="0.1" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="-0.1" MODIFIED="2017-01-06 15:47:05 +0000" MODIFIED_BY="[Empty name]" ORDER="171" SD_1="0.3" SD_2="0.3" SE="0.057744929161882314" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="5.077560704140523"/>
<CONT_DATA CI_END="0.24286111773421232" CI_START="-0.042861117734212306" EFFECT_SIZE="0.1" ESTIMABLE="YES" MEAN_1="-0.03" MEAN_2="-0.13" MODIFIED="2017-01-06 15:47:05 +0000" MODIFIED_BY="[Empty name]" ORDER="172" SD_1="0.29" SD_2="0.26" SE="0.07288966473929244" STUDY_ID="STD-Shikany-2005" TOTAL_1="31" TOTAL_2="26" WEIGHT="3.186771501741036"/>
<CONT_DATA CI_END="0.46241657427383476" CI_START="-0.3824165742738348" EFFECT_SIZE="0.04000000000000001" ESTIMABLE="YES" MEAN_1="-0.15" MEAN_2="-0.19" MODIFIED="2015-03-06 09:06:25 +0000" MODIFIED_BY="[Empty name]" ORDER="173" SD_1="0.4" SD_2="0.46" SE="0.21552262062252306" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.3644996467493653"/>
<CONT_DATA CI_END="0.09543090188472539" CI_START="-0.09543090188472539" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.02" MEAN_2="-0.02" MODIFIED="2015-03-01 18:25:42 +0000" MODIFIED_BY="[Empty name]" ORDER="174" SD_1="0.21" SD_2="0.16" SE="0.04869013034804321" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="7.141689356998546"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.747611624321404" CI_END="0.04376577643588628" CI_START="-0.09643743422364182" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.02633582889387777" ESTIMABLE="YES" I2="4.463989499468088" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.4021080400406831" P_Q="1.0" P_Z="0.46153544427924487" Q="0.0" RANDOM="NO" SCALE="1.5" SORT_BY="USER" STUDIES="17" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="660" TOTAL_2="614" UNITS="" WEIGHT="99.99999999999999" Z="0.7363208858370306">
<NAME>LDL cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2347337717328143" CI_START="-0.2747337717328143" EFFECT_SIZE="-0.020000000000000004" ESTIMABLE="YES" MEAN_1="-0.05" MEAN_2="-0.03" MODIFIED="2017-01-06 15:47:36 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="0.88" SD_2="0.97" SE="0.12996859827125487" STUDY_ID="STD-Sichieri-2007" TOTAL_1="101" TOTAL_2="102" WEIGHT="7.573260135763216"/>
<CONT_DATA CI_END="0.10995217119035564" CI_START="-0.3299521711903557" EFFECT_SIZE="-0.11000000000000001" ESTIMABLE="YES" MEAN_1="0.03" MEAN_2="0.14" MODIFIED="2017-01-06 15:47:36 +0000" MODIFIED_BY="[Empty name]" ORDER="153" SD_1="0.51" SD_2="0.5" SE="0.11222255762111462" STUDY_ID="STD-Juanola_x002d_Falgarona-2014" TOTAL_1="41" TOTAL_2="40" WEIGHT="10.157794447098503"/>
<CONT_DATA CI_END="0.5459744620610274" CI_START="-0.6659744620610275" EFFECT_SIZE="-0.06" ESTIMABLE="YES" MEAN_1="-0.45" MEAN_2="-0.39" MODIFIED="2017-01-06 15:47:42 +0000" MODIFIED_BY="[Empty name]" ORDER="154" SD_1="0.77" SD_2="0.66" SE="0.30917632509621434" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="1.3382809107900644"/>
<CONT_DATA CI_END="0.08399459768100809" CI_START="-0.5039945976810081" EFFECT_SIZE="-0.21000000000000002" ESTIMABLE="YES" MEAN_1="-0.17" MEAN_2="0.04" MODIFIED="2017-01-06 15:47:55 +0000" MODIFIED_BY="[Empty name]" ORDER="175" SD_1="0.6" SD_2="0.6" SE="0.15" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO" TOTAL_1="32" TOTAL_2="32" WEIGHT="5.6856121005521"/>
<CONT_DATA CI_END="-0.031079244951894403" CI_START="-0.5689207550481056" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.04" MEAN_2="0.26" MODIFIED="2017-01-06 15:48:01 +0000" MODIFIED_BY="[Empty name]" ORDER="176" SD_1="0.5" SD_2="0.6" SE="0.13720698807188203" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein" TOTAL_1="33" TOTAL_2="32" WEIGHT="6.795278848547179"/>
<CONT_DATA CI_END="0.21076228887746234" CI_START="-0.2507622888774624" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.24" MEAN_2="0.26" MODIFIED="2017-01-06 15:48:12 +0000" MODIFIED_BY="[Empty name]" ORDER="177" SD_1="0.45" SD_2="0.31" SE="0.11773802513601568" STUDY_ID="STD-Philippou-2009a" TOTAL_1="23" TOTAL_2="19" WEIGHT="9.228396609111977"/>
<CONT_DATA CI_END="0.3021515164617047" CI_START="-0.5221515164617047" EFFECT_SIZE="-0.11" ESTIMABLE="YES" MEAN_1="-0.22" MEAN_2="-0.11" MODIFIED="2017-01-06 15:48:17 +0000" MODIFIED_BY="[Empty name]" ORDER="178" SD_1="0.49" SD_2="0.73" SE="0.21028524999066472" STUDY_ID="STD-Philippou-2009" TOTAL_1="22" TOTAL_2="16" WEIGHT="2.8929579603718913"/>
<CONT_DATA CI_END="0.4733151279497899" CI_START="-0.6733151279497899" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="0.34" MEAN_2="0.44" MODIFIED="2017-01-06 15:48:25 +0000" MODIFIED_BY="[Empty name]" ORDER="179" SD_1="0.97" SD_2="0.87" SE="0.29251309333846254" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="1.4950961521003656"/>
<CONT_DATA CI_END="0.37046454744013185" CI_START="-0.9704645474401319" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="0.3" MODIFIED="2017-01-06 15:48:35 +0000" MODIFIED_BY="[Empty name]" ORDER="181" SD_1="0.79" SD_2="0.79" SE="0.3420800344948533" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="1.093211748223445"/>
<CONT_DATA CI_END="0.48949478413783604" CI_START="-0.26949478413783606" EFFECT_SIZE="0.10999999999999999" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.21" MODIFIED="2017-01-06 15:48:53 +0000" MODIFIED_BY="[Empty name]" ORDER="182" SD_1="0.54" SD_2="0.57" SE="0.19362334569984063" STUDY_ID="STD-Ghani-2014a-high-insulin" TOTAL_1="15" TOTAL_2="18" WEIGHT="3.412277200918172"/>
<CONT_DATA CI_END="0.26938994815668904" CI_START="-0.369389948156689" EFFECT_SIZE="-0.05000000000000002" ESTIMABLE="YES" MEAN_1="-0.23" MEAN_2="-0.18" MODIFIED="2017-01-06 15:48:53 +0000" MODIFIED_BY="[Empty name]" ORDER="183" SD_1="0.66" SD_2="0.41" SE="0.1629570495560103" STUDY_ID="STD-Ghani-2014--low-insulin" TOTAL_1="24" TOTAL_2="20" WEIGHT="4.817408106285907"/>
<CONT_DATA CI_END="0.07221662146690566" CI_START="-0.31221662146690565" EFFECT_SIZE="-0.12" ESTIMABLE="YES" MEAN_1="0.4" MEAN_2="0.52" MODIFIED="2017-01-06 15:49:13 +0000" MODIFIED_BY="[Empty name]" ORDER="184" SD_1="0.53" SD_2="0.74" SE="0.09807150691700757" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="93" TOTAL_2="83" WEIGHT="13.300686214497787"/>
<CONT_DATA CI_END="0.29933537219390904" CI_START="-0.03933537219390906" EFFECT_SIZE="0.13" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.37" MODIFIED="2017-01-06 15:49:13 +0000" MODIFIED_BY="[Empty name]" ORDER="185" SD_1="0.63" SD_2="0.6" SE="0.08639718562667725" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="108" TOTAL_2="95" WEIGHT="17.138016379242185"/>
<CONT_DATA CI_END="0.6206709474334671" CI_START="-0.02067094743346709" EFFECT_SIZE="0.3" ESTIMABLE="YES" MEAN_1="0.0" MEAN_2="-0.3" MODIFIED="2015-03-01 18:27:19 +0000" MODIFIED_BY="[Empty name]" ORDER="186" SD_1="0.85" SD_2="0.85" SE="0.1636106326253332" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="4.7789963301930145"/>
<CONT_DATA CI_END="0.5154932014266129" CI_START="-0.19549320142661292" EFFECT_SIZE="0.15999999999999998" ESTIMABLE="YES" MEAN_1="0.21" MEAN_2="0.05" MODIFIED="2015-03-01 18:27:27 +0000" MODIFIED_BY="[Empty name]" ORDER="187" SD_1="0.66" SD_2="0.7" SE="0.18137741521308448" STUDY_ID="STD-Shikany-2005" TOTAL_1="31" TOTAL_2="26" WEIGHT="3.8886005009697064"/>
<CONT_DATA CI_END="0.9267102836154248" CI_START="-0.9667102836154249" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="-0.26" MEAN_2="-0.24" MODIFIED="2015-03-06 09:06:42 +0000" MODIFIED_BY="[Empty name]" ORDER="188" SD_1="1.01" SD_2="0.92" SE="0.48302432650954547" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.5483044083039798"/>
<CONT_DATA CI_END="0.30969035230357744" CI_START="-0.2696903523035774" EFFECT_SIZE="0.020000000000000018" ESTIMABLE="YES" MEAN_1="-0.35" MEAN_2="-0.37" MODIFIED="2015-03-01 18:27:26 +0000" MODIFIED_BY="[Empty name]" ORDER="189" SD_1="0.5" SD_2="0.61" SE="0.14780391608652912" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="5.855821947030502"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="16.502688655238902" CI_END="0.08932542537371303" CI_START="-0.029066460974225078" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="MD" EFFECT_SIZE="0.030129482199743977" ESTIMABLE="YES" I2="9.10572020494286" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.3494515598246464" P_Q="1.0" P_Z="0.31848298646906237" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="USER" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="648" TOTAL_2="604" UNITS="" WEIGHT="100.0" Z="0.997580185702773">
<NAME>Triglycerides (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.09508638153620838" CI_START="-0.23508638153620828" EFFECT_SIZE="-0.06999999999999995" ESTIMABLE="YES" MEAN_1="0.28" MEAN_2="0.35" MODIFIED="2017-01-06 15:49:37 +0000" MODIFIED_BY="[Empty name]" ORDER="155" SD_1="0.59" SD_2="0.61" SE="0.08422929341477121" STUDY_ID="STD-Sichieri-2007" TOTAL_1="101" TOTAL_2="102" WEIGHT="12.85764385988425"/>
<CONT_DATA CI_END="0.48907923608758636" CI_START="-0.7690792360875862" EFFECT_SIZE="-0.13999999999999996" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.46" MODIFIED="2017-01-06 15:49:43 +0000" MODIFIED_BY="[Empty name]" ORDER="156" SD_1="0.81" SD_2="0.67" SE="0.3209646917237679" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="0.8854686461684093"/>
<CONT_DATA CI_END="0.7817745355350177" CI_START="-0.5817745355350178" EFFECT_SIZE="0.09999999999999998" ESTIMABLE="YES" MEAN_1="-0.4" MEAN_2="-0.5" MODIFIED="2017-01-06 15:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="190" SD_1="0.9" SD_2="0.6" SE="0.3478505426185217" STUDY_ID="STD-Raatz-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="0.7538801995635751"/>
<CONT_DATA CI_END="0.28599639845400543" CI_START="-0.10599639845400542" EFFECT_SIZE="0.09000000000000001" ESTIMABLE="YES" MEAN_1="-0.05" MEAN_2="-0.14" MODIFIED="2017-01-06 15:56:37 +0000" MODIFIED_BY="[Empty name]" ORDER="191" SD_1="0.4" SD_2="0.4" SE="0.1" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO" TOTAL_1="32" TOTAL_2="32" WEIGHT="9.121950414719256"/>
<CONT_DATA CI_END="0.1845059099145437" CI_START="-0.2045059099145437" EFFECT_SIZE="-0.010000000000000009" ESTIMABLE="YES" MEAN_1="-0.19" MEAN_2="-0.18" MODIFIED="2017-01-06 15:56:35 +0000" MODIFIED_BY="[Empty name]" ORDER="192" SD_1="0.4" SD_2="0.4" SE="0.09923953268977465" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein" TOTAL_1="33" TOTAL_2="32" WEIGHT="9.262288113407246"/>
<CONT_DATA CI_END="0.5596744346657647" CI_START="-0.15967443466576464" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="-0.06" MEAN_2="-0.26" MODIFIED="2017-01-06 15:56:29 +0000" MODIFIED_BY="[Empty name]" ORDER="193" SD_1="0.57" SD_2="0.59" SE="0.18351073667824036" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="2.708723963646839"/>
<CONT_DATA CI_END="1.2835426142546122" CI_START="-1.2835426142546122" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-0.5" MODIFIED="2017-01-06 15:56:27 +0000" MODIFIED_BY="[Empty name]" ORDER="195" SD_1="1.39" SD_2="1.57" SE="0.6548807143289532" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="0.2126979504736416"/>
<CONT_DATA CI_END="-0.07623396028275958" CI_START="-0.8237660397172404" EFFECT_SIZE="-0.45" ESTIMABLE="YES" MEAN_1="-0.26" MEAN_2="0.19" MODIFIED="2017-01-06 15:56:55 +0000" MODIFIED_BY="[Empty name]" ORDER="196" SD_1="0.55" SD_2="0.54" SE="0.19070046320517073" STUDY_ID="STD-Ghani-2014a-high-insulin" TOTAL_1="15" TOTAL_2="18" WEIGHT="2.5083273367697316"/>
<CONT_DATA CI_END="0.4675936532097861" CI_START="0.012406346790213879" EFFECT_SIZE="0.24" ESTIMABLE="YES" MEAN_1="0.16" MEAN_2="-0.08" MODIFIED="2017-01-06 15:56:55 +0000" MODIFIED_BY="[Empty name]" ORDER="197" SD_1="0.43" SD_2="0.34" SE="0.11612134457827582" STUDY_ID="STD-Ghani-2014--low-insulin" TOTAL_1="24" TOTAL_2="20" WEIGHT="6.7649344896255545"/>
<CONT_DATA CI_END="0.17344679291821063" CI_START="-0.07344679291821067" EFFECT_SIZE="0.04999999999999999" ESTIMABLE="YES" MEAN_1="0.19" MEAN_2="0.14" MODIFIED="2015-03-01 18:28:23 +0000" MODIFIED_BY="[Empty name]" ORDER="198" SD_1="0.51" SD_2="0.38" SE="0.06298421496106214" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="107" TOTAL_2="94" WEIGHT="22.9945156343192"/>
<CONT_DATA CI_END="0.1557892890264991" CI_START="-0.1557892890264991" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.13" MEAN_2="0.13" MODIFIED="2015-03-01 18:28:23 +0000" MODIFIED_BY="[Empty name]" ORDER="199" SD_1="0.53" SD_2="0.52" SE="0.07948579170604415" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="93" TOTAL_2="82" WEIGHT="14.438055221487529"/>
<CONT_DATA CI_END="0.27969455306725294" CI_START="-0.27969455306725294" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.06" MEAN_2="-0.06" MODIFIED="2015-03-01 18:28:38 +0000" MODIFIED_BY="[Empty name]" ORDER="200" SD_1="0.85" SD_2="0.48" SE="0.14270392480343919" STUDY_ID="STD-Melanson-2012" TOTAL_1="49" TOTAL_2="41" WEIGHT="4.479359011923365"/>
<CONT_DATA CI_END="0.27385051689749657" CI_START="-0.27385051689749657" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="-0.2" MODIFIED="2015-03-01 18:28:47 +0000" MODIFIED_BY="[Empty name]" ORDER="201" SD_1="0.75" SD_2="0.7" SE="0.13972221890687506" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="4.672580144779975"/>
<CONT_DATA CI_END="0.6515972667421353" CI_START="-0.4515972667421353" EFFECT_SIZE="0.1" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.2" MODIFIED="2017-01-06 15:57:20 +0000" MODIFIED_BY="[Empty name]" ORDER="202" SD_1="0.97" SD_2="1.0" SE="0.28143234829469527" STUDY_ID="STD-Randolph-2014" TOTAL_1="24" TOTAL_2="25" WEIGHT="1.1517008256786903"/>
<CONT_DATA CI_END="0.25554837662731006" CI_START="-0.59554837662731" EFFECT_SIZE="-0.16999999999999998" ESTIMABLE="YES" MEAN_1="-0.08" MEAN_2="0.09" MODIFIED="2017-01-06 15:57:20 +0000" MODIFIED_BY="[Empty name]" ORDER="203" SD_1="0.8" SD_2="0.83" SE="0.21712050832769444" STUDY_ID="STD-Shikany-2005" TOTAL_1="31" TOTAL_2="26" WEIGHT="1.9350224719676916"/>
<CONT_DATA CI_END="0.4982821387697811" CI_START="-0.018282138769781103" EFFECT_SIZE="0.24000000000000002" ESTIMABLE="YES" MEAN_1="0.01" MEAN_2="-0.23" MODIFIED="2017-01-06 15:57:17 +0000" MODIFIED_BY="[Empty name]" ORDER="759" SD_1="0.39" SD_2="0.58" SE="0.1317790228836232" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="5.252851715585046"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.631923978494099" CI_END="2.253773088487624" CI_START="-1.205490369089019" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5241413596993024" ESTIMABLE="YES" I2="6.560724315360478" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.38109617171834775" P_Q="1.0" P_Z="0.552551969229317" Q="0.0" RANDOM="NO" SCALE="20.0" SORT_BY="USER" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="408" TOTAL_2="378" UNITS="" WEIGHT="99.99999999999999" Z="0.5939404155924864">
<NAME>Systolic blood pressure (mmHg) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="15.374899232361377" CI_START="-5.374899232361377" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="-9.0" MEAN_2="-14.0" MODIFIED="2015-03-01 18:29:07 +0000" MODIFIED_BY="[Empty name]" ORDER="204" SD_1="8.37" SD_2="15.88" SE="5.293413202588036" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="2.77932614258931"/>
<CONT_DATA CI_END="11.439743324623961" CI_START="-1.4397433246239615" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-10.0" MODIFIED="2015-03-01 18:29:13 +0000" MODIFIED_BY="[Empty name]" ORDER="205" SD_1="10.0" SD_2="10.0" SE="3.285643703363855" STUDY_ID="STD-Philippou-2009" TOTAL_1="22" TOTAL_2="16" WEIGHT="7.213900897235936"/>
<CONT_DATA CI_END="0.29910954874181783" CI_START="-16.299109548741818" EFFECT_SIZE="-8.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-2.0" MODIFIED="2015-03-01 18:29:18 +0000" MODIFIED_BY="[Empty name]" ORDER="206" SD_1="13.23" SD_2="13.53" SE="4.234317372259968" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="4.343544670417684"/>
<CONT_DATA CI_END="5.374324363857669" CI_START="-2.3343243638576694" EFFECT_SIZE="1.52" ESTIMABLE="YES" MEAN_1="4.24" MEAN_2="2.72" MODIFIED="2015-03-01 18:29:23 +0000" MODIFIED_BY="[Empty name]" ORDER="207" SD_1="14.27" SD_2="13.39" SE="1.9665281577927392" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="105" TOTAL_2="93" WEIGHT="20.13774171980974"/>
<CONT_DATA CI_END="2.8597939848613296" CI_START="-4.159793984861331" EFFECT_SIZE="-0.6500000000000004" ESTIMABLE="YES" MEAN_1="4.47" MEAN_2="5.12" MODIFIED="2015-03-01 18:29:23 +0000" MODIFIED_BY="[Empty name]" ORDER="209" SD_1="12.81" SD_2="10.67" SE="1.7907441221094555" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="92" TOTAL_2="80" WEIGHT="24.285331513291148"/>
<CONT_DATA CI_END="9.035203114287999" CI_START="-1.7152031142879984" EFFECT_SIZE="3.66" ESTIMABLE="YES" MEAN_1="-0.05" MEAN_2="-3.71" MODIFIED="2015-03-01 18:29:29 +0000" MODIFIED_BY="[Empty name]" ORDER="210" SD_1="12.08" SD_2="13.13" SE="2.7425009626130454" STUDY_ID="STD-Melanson-2012" TOTAL_1="44" TOTAL_2="41" WEIGHT="10.354223318843577"/>
<CONT_DATA CI_END="5.67683553201172" CI_START="-5.67683553201172" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-10.0" MEAN_2="-10.0" MODIFIED="2015-03-01 18:29:29 +0000" MODIFIED_BY="[Empty name]" ORDER="211" SD_1="14.71" SD_2="15.39" SE="2.8963978811804063" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="9.283134925034632"/>
<CONT_DATA CI_END="2.8410667608652878" CI_START="-6.041066760865287" EFFECT_SIZE="-1.5999999999999999" ESTIMABLE="YES" MEAN_1="-1.4" MEAN_2="0.2" MODIFIED="2017-01-06 15:58:08 +0000" MODIFIED_BY="[Empty name]" ORDER="212" SD_1="8.32" SD_2="7.5" SE="2.2658920244942538" STUDY_ID="STD-Randolph-2014" TOTAL_1="24" TOTAL_2="25" WEIGHT="15.168152394017513"/>
<CONT_DATA CI_END="18.585090136332905" CI_START="-12.785090136332906" EFFECT_SIZE="2.9" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-5.3" MODIFIED="2017-01-06 15:58:08 +0000" MODIFIED_BY="[Empty name]" ORDER="213" SD_1="16.13" SD_2="15.88" SE="8.002744060633203" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="1.2159990886178966"/>
<CONT_DATA CI_END="8.571374923165475" CI_START="-6.571374923165476" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="-2.5" MEAN_2="-3.5" MODIFIED="2017-01-06 15:58:06 +0000" MODIFIED_BY="[Empty name]" ORDER="760" SD_1="12.7" SD_2="16.2" SE="3.8630173732208934" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="5.21864533014257"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="14.425276970938832" CI_END="0.9617204604184415" CI_START="-1.4161107909265704" CI_STUDY="95" CI_TOTAL="95" DF="9" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.22719516525406444" ESTIMABLE="YES" I2="37.609516835403554" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.10798124121258978" P_Q="1.0" P_Z="0.7080039281764201" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="10" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="408" TOTAL_2="378" UNITS="" WEIGHT="99.99999999999999" Z="0.37453821931872844">
<NAME>Diastolic blood pressure (mmHg) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="12.844515184684033" CI_START="-2.844515184684033" EFFECT_SIZE="5.0" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-8.0" MODIFIED="2015-03-01 18:29:57 +0000" MODIFIED_BY="[Empty name]" ORDER="214" SD_1="8.37" SD_2="10.4" SE="4.00237721027558" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="2.297046854237632"/>
<CONT_DATA CI_END="8.089992197352883" CI_START="-2.089992197352883" EFFECT_SIZE="3.0" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-5.0" MODIFIED="2015-03-01 18:30:04 +0000" MODIFIED_BY="[Empty name]" ORDER="215" SD_1="9.0" SD_2="7.0" SE="2.5969825147309296" STUDY_ID="STD-Philippou-2009" TOTAL_1="22" TOTAL_2="16" WEIGHT="5.455918028154582"/>
<CONT_DATA CI_END="6.767257633268355" CI_START="-4.767257633268355" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="-4.0" MODIFIED="2015-03-01 18:30:08 +0000" MODIFIED_BY="[Empty name]" ORDER="216" SD_1="8.0" SD_2="10.54" SE="2.942532454044945" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="4.249749826401206"/>
<CONT_DATA CI_END="3.212554066210832" CI_START="-1.2525540662108319" EFFECT_SIZE="0.98" ESTIMABLE="YES" MEAN_1="1.94" MEAN_2="0.96" MODIFIED="2015-03-01 18:30:13 +0000" MODIFIED_BY="[Empty name]" ORDER="217" SD_1="8.01" SD_2="7.99" SE="1.1390791278926211" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="105" TOTAL_2="93" WEIGHT="28.359469313439373"/>
<CONT_DATA CI_END="-0.20942788207697793" CI_START="-4.870572117923022" EFFECT_SIZE="-2.54" ESTIMABLE="YES" MEAN_1="1.01" MEAN_2="3.55" MODIFIED="2015-03-01 18:30:13 +0000" MODIFIED_BY="[Empty name]" ORDER="219" SD_1="7.89" SD_2="7.68" SE="1.1890892568977172" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="92" TOTAL_2="80" WEIGHT="26.024175379510375"/>
<CONT_DATA CI_END="8.795037070547977" CI_START="-0.39503707054797577" EFFECT_SIZE="4.2" ESTIMABLE="YES" MEAN_1="1.91" MEAN_2="-2.29" MODIFIED="2015-03-01 18:30:19 +0000" MODIFIED_BY="[Empty name]" ORDER="220" SD_1="12.15" SD_2="9.37" SE="2.3444497484612175" STUDY_ID="STD-Melanson-2012" TOTAL_1="44" TOTAL_2="41" WEIGHT="6.6945907180463875"/>
<CONT_DATA CI_END="2.6266368040304178" CI_START="-4.626636804030418" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-3.0" MODIFIED="2015-03-01 18:30:23 +0000" MODIFIED_BY="[Empty name]" ORDER="221" SD_1="9.13" SD_2="10.09" SE="1.850358900794538" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="10.747165597150234"/>
<CONT_DATA CI_END="2.20280367429201" CI_START="-5.40280367429201" EFFECT_SIZE="-1.6" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="1.1" MODIFIED="2017-01-06 15:58:44 +0000" MODIFIED_BY="[Empty name]" ORDER="222" SD_1="7.83" SD_2="5.5" SE="1.9402416086663021" STUDY_ID="STD-Randolph-2014" TOTAL_1="24" TOTAL_2="25" WEIGHT="9.77449345524983"/>
<CONT_DATA CI_END="13.349988173980769" CI_START="-10.14998817398077" EFFECT_SIZE="1.6000000000000005" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-4.4" MODIFIED="2017-01-06 15:58:44 +0000" MODIFIED_BY="[Empty name]" ORDER="223" SD_1="11.98" SD_2="12.0" SE="5.99500208507053" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="1.0238284909395663"/>
<CONT_DATA CI_END="1.428848718969471" CI_START="-8.828848718969471" EFFECT_SIZE="-3.7" ESTIMABLE="YES" MEAN_1="-4.5" MEAN_2="-0.8" MODIFIED="2017-01-06 15:58:41 +0000" MODIFIED_BY="[Empty name]" ORDER="761" SD_1="10.1" SD_2="9.8" SE="2.6168076349489966" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="5.373562336870801"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-001.07" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="7" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO">
<NAME>Behaviour change</NAME>
<TR>
<TH>
<P>Low GI group</P>
</TH>
<TH>
<P>Control group</P>
</TH>
<TH>
<P>P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2014-10-30 09:35:27 +0000" MODIFIED_BY="[Empty name]" ORDER="88" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011">
<TR>
<TD>
<P>diet as per menu plans</P>
</TD>
<TD>
<P>diet as per menu plans</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>no significant change in physical activity observed</P>
</TD>
<TD>
<P>no significant change in physical activity observed</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2017-06-28 01:35:09 +0100" MODIFIED_BY="[Empty name]" ORDER="89" STUDY_ID="STD-Bellisle-2007">
<TR>
<TD>
<P>increase in dietary restraint; decrease in disinhibition, hunger sensations, emotionality, and externality</P>
</TD>
<TD>
<P>increase in dietary restraint; decrease in disinhibition, hunger sensations, emotionality and externality</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD/>
<TD/>
<TD/>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-001.08" MODIFIED="2017-07-06 14:35:23 +0100" MODIFIED_BY="[Empty name]" NO="8" ROWS_PER_STUDY="1" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO">
<NAME>Hunger/desire to eat</NAME>
<TR>
<TH>
<P>Low GI group</P>
</TH>
<TH>
<P>Control group</P>
</TH>
<TH>
<P>P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2017-06-28 01:35:51 +0100" MODIFIED_BY="[Empty name]" ORDER="90" STUDY_ID="STD-Bellisle-2007">
<TR>
<TD>
<P>Participants in the low GI group had significantly lower intensity of hunger and desire to eat than participants of the control group</P>
</TD>
<TD/>
<TD>
<P>&lt; 0.0001 for both</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2017-07-06 14:35:23 +0100" MODIFIED_BY="[Empty name]" ORDER="91" STUDY_ID="STD-Juanola_x002d_Falgarona-2014">
<TR>
<TD>
<P>- 4.13 (SE 0.46) hunger sensation</P>
</TD>
<TD>
<P>- 2.52 (SE 0.45) hunger sensation</P>
</TD>
<TD>
<P>0.048 between the two groups</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2017-06-28 01:36:46 +0100" MODIFIED_BY="[Empty name]" ORDER="92" STUDY_ID="STD-Melanson-2012">
<TR>
<TD>
<P>Hunger and satiety ratings only reported for low GI and low energy density groups, no significant difference between groups after 12 weeks</P>
</TD>
<TD/>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2017-06-28 01:36:56 +0100" MODIFIED_BY="[Empty name]" ORDER="93" STUDY_ID="STD-Philippou-2009a">
<TR>
<TD>
<P>No significant difference between groups for hunger and fullness</P>
</TD>
<TD/>
<TD>
<P>0.8 for both</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2017-06-28 01:37:16 +0100" MODIFIED_BY="[Empty name]" ORDER="94" STUDY_ID="STD-Sichieri-2007">
<TR>
<TD>
<P>-1.31 (SD 6.3) on hunger scale</P>
</TD>
<TD>
<P>-0.98 (SD 4.3) on hunger scale</P>
</TD>
<TD>
<P>0.74</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.09" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="9" ROWS_PER_STUDY="3" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO">
<NAME>Satisfaction</NAME>
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH>
<P>Low GI group</P>
</TH>
<TH>
<P>Control group</P>
</TH>
<TH>
<P>P</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2017-06-28 01:38:24 +0100" MODIFIED_BY="[Empty name]" ORDER="95" STUDY_ID="STD-Bellisle-2007">
<TR>
<TD>
<P>Satisfaction with programme (VAS)</P>
</TD>
<TD>
<P>73.2 (SE 1.2)</P>
</TD>
<TD>
<P>69.1 (SE 1.2)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Perception of effectiveness (VAS)</P>
</TD>
<TD>
<P>71.5 (SE 1.2)</P>
</TD>
<TD>
<P>70.4 (SE 1.0)</P>
</TD>
<TD>
<P>NS</P>
</TD>
</TR>
<TR>
<TD>
<P>Ease of following diet (VAS)</P>
</TD>
<TD>
<P>70.2 (SE 1.3)</P>
</TD>
<TD>
<P>65.1 (SE 1.3)</P>
</TD>
<TD>
<P>0.0048</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="13.055350178752452" CI_END="0.21394601578327244" CI_START="-0.5396212435902604" CI_STUDY="95" CI_TOTAL="95" DF="19" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.162837613903494" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.8357255683464394" P_Q="1.0" P_Z="0.39696536023863094" Q="0.0" RANDOM="NO" SCALE="11.77" SORT_BY="USER" STUDIES="20" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="727" TOTAL_2="676" UNITS="" WEIGHT="99.99999999999999" Z="0.8470534105863692">
<NAME>Weight change (kg)</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7488655322944167" CI_START="-1.0488655322944165" EFFECT_SIZE="-0.14999999999999997" ESTIMABLE="YES" MEAN_1="-0.41" MEAN_2="-0.26" MODIFIED="2017-01-06 16:07:14 +0000" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="2.9" SD_2="3.6" SE="0.4586132905423534" STUDY_ID="STD-Sichieri-2007" TOTAL_1="101" TOTAL_2="102" WEIGHT="17.57092383714457"/>
<CONT_DATA CI_END="13.43390066933603" CI_START="-11.033900669336031" EFFECT_SIZE="1.2000000000000002" ESTIMABLE="YES" MEAN_1="-7.8" MEAN_2="-9.0" MODIFIED="2017-01-06 16:07:46 +0000" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="14.45" SD_2="14.73" SE="6.241900752174773" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="0.09485367264113631"/>
<CONT_DATA CI_END="3.0821749267467236" CI_START="-4.382174926746721" EFFECT_SIZE="-0.6499999999999986" ESTIMABLE="YES" MEAN_1="-9.95" MEAN_2="-9.3" MODIFIED="2017-01-06 16:08:15 +0000" MODIFIED_BY="[Empty name]" ORDER="46" SD_1="4.4" SD_2="3.9" SE="1.9042058712229621" STUDY_ID="STD-Raatz-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="1.0192015353598787"/>
<CONT_DATA CI_END="0.2719747891780382" CI_START="-2.4719747891780375" EFFECT_SIZE="-1.0999999999999996" ESTIMABLE="YES" MEAN_1="-4.8" MEAN_2="-3.7" MODIFIED="2017-01-06 16:08:34 +0000" MODIFIED_BY="[Empty name]" ORDER="47" SD_1="2.8" SD_2="2.8" SE="0.7" STUDY_ID="STD-McMillan_x002d_Price-2006-high-CHO" TOTAL_1="32" TOTAL_2="32" WEIGHT="7.542091361663105"/>
<CONT_DATA CI_END="2.285693823011348" CI_START="-0.4856938230113492" EFFECT_SIZE="0.8999999999999995" ESTIMABLE="YES" MEAN_1="-4.4" MEAN_2="-5.3" MODIFIED="2017-01-06 16:08:53 +0000" MODIFIED_BY="[Empty name]" ORDER="48" SD_1="2.9" SD_2="2.8" SE="0.7069996356777597" STUDY_ID="STD-McMillan_x002d_Price-2006-high-protein" TOTAL_1="33" TOTAL_2="32" WEIGHT="7.3934899859407315"/>
<CONT_DATA CI_END="0.4609979276905658" CI_START="-2.460997927690566" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-0.7" MEAN_2="0.3" MODIFIED="2017-01-06 16:09:19 +0000" MODIFIED_BY="[Empty name]" ORDER="50" SD_1="2.9" SD_2="1.9" SE="0.7454208032467591" STUDY_ID="STD-Philippou-2009a" TOTAL_1="23" TOTAL_2="19" WEIGHT="6.65096789091887"/>
<CONT_DATA CI_END="3.34915217645657" CI_START="-1.7491521764565703" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-3.0" MODIFIED="2017-01-06 16:09:52 +0000" MODIFIED_BY="[Empty name]" ORDER="51" SD_1="3.6" SD_2="4.2" SE="1.300611744176912" STUDY_ID="STD-Philippou-2009" TOTAL_1="22" TOTAL_2="16" WEIGHT="2.1847036108754065"/>
<CONT_DATA CI_END="8.387701415835853" CI_START="-10.787701415835855" EFFECT_SIZE="-1.200000000000001" ESTIMABLE="YES" MEAN_1="-8.3" MEAN_2="-7.1" MODIFIED="2017-01-06 16:10:02 +0000" MODIFIED_BY="[Empty name]" ORDER="52" SD_1="16.87" SD_2="13.71" SE="4.8917742833350095" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="0.15443831330524418"/>
<CONT_DATA CI_END="9.434076935980823" CI_START="-11.834076935980825" EFFECT_SIZE="-1.2000000000000002" ESTIMABLE="YES" MEAN_1="-3.6" MEAN_2="-2.4" MODIFIED="2017-01-06 16:10:02 +0000" MODIFIED_BY="[Empty name]" ORDER="53" SD_1="12.53" SD_2="12.53" SE="5.425649154709507" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="0.125540673706199"/>
<CONT_DATA CI_END="0.8436849798628541" CI_START="-3.843684979862854" EFFECT_SIZE="-1.5" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="-0.2" MODIFIED="2017-01-06 16:10:36 +0000" MODIFIED_BY="[Empty name]" ORDER="55" SD_1="3.8" SD_2="2.9" SE="1.1957796155182145" STUDY_ID="STD-Ghani-2014a-high-insulin" TOTAL_1="15" TOTAL_2="18" WEIGHT="2.5845538040977765"/>
<CONT_DATA CI_END="1.6879979980640414" CI_START="-2.487997998064041" EFFECT_SIZE="-0.39999999999999997" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.2" MODIFIED="2017-01-06 16:11:24 +0000" MODIFIED_BY="[Empty name]" ORDER="56" SD_1="4.3" SD_2="2.7" SE="1.0653246766440112" STUDY_ID="STD-Ghani-2014--low-insulin" TOTAL_1="24" TOTAL_2="20" WEIGHT="3.2562961455744945"/>
<CONT_DATA CI_END="0.8643552286803964" CI_START="-2.3443552286803966" EFFECT_SIZE="-0.74" ESTIMABLE="YES" MEAN_1="-0.38" MEAN_2="0.36" MODIFIED="2017-01-06 16:11:28 +0000" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="6.28" SD_2="5.41" SE="0.8185636273601686" STUDY_ID="STD-DiOGenes-2011a-high-protein" TOTAL_1="108" TOTAL_2="96" WEIGHT="5.515475795146327"/>
<CONT_DATA CI_END="0.3428340074138878" CI_START="-2.7028340074138875" EFFECT_SIZE="-1.18" ESTIMABLE="YES" MEAN_1="0.27" MEAN_2="1.45" MODIFIED="2017-01-06 16:11:31 +0000" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="5.01" SD_2="5.34" SE="0.7769704032450637" STUDY_ID="STD-DiOGenes-2011-low-protein" TOTAL_1="95" TOTAL_2="84" WEIGHT="6.12179690530688"/>
<CONT_DATA CI_END="1.2635337672244502" CI_START="-0.6635337672244503" EFFECT_SIZE="0.3" ESTIMABLE="YES" MEAN_1="-0.19" MEAN_2="-0.49" MODIFIED="2017-01-06 16:11:44 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="1.4" SD_2="1.0" SE="0.4916078942392216" STUDY_ID="STD-Wolever-2002" TOTAL_1="13" TOTAL_2="11" WEIGHT="15.291502943047849"/>
<CONT_DATA CI_END="1.5031410777840282" CI_START="-0.8231410777840285" EFFECT_SIZE="0.33999999999999986" ESTIMABLE="YES" MEAN_1="-3.39" MEAN_2="-3.73" MODIFIED="2017-01-06 16:12:02 +0000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="2.76" SD_2="2.84" SE="0.5934502301872568" STUDY_ID="STD-Melanson-2012" TOTAL_1="49" TOTAL_2="41" WEIGHT="10.493473345999039"/>
<CONT_DATA CI_END="5.899023043618582" CI_START="-9.899023043618582" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-5.0" MEAN_2="-3.0" MODIFIED="2017-01-06 16:12:12 +0000" MODIFIED_BY="[Empty name]" ORDER="64" SD_1="21.83" SD_2="19.97" SE="4.030187853412138" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="0.22752927839258447"/>
<CONT_DATA CI_END="2.3181815742579923" CI_START="-0.7181815742579924" EFFECT_SIZE="0.7999999999999998" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="-2.3" MODIFIED="2017-01-06 16:12:23 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="2.4" SD_2="3.0" SE="0.7745966692414834" STUDY_ID="STD-Randolph-2014" TOTAL_1="24" TOTAL_2="25" WEIGHT="6.159374612024868"/>
<CONT_DATA CI_END="1.836617524695524" CI_START="-2.0966175246955236" EFFECT_SIZE="-0.1299999999999999" ESTIMABLE="YES" MEAN_1="-7.18" MEAN_2="-7.05" MODIFIED="2017-01-06 16:12:46 +0000" MODIFIED_BY="[Empty name]" ORDER="157" SD_1="3.74" SD_2="5.16" SE="1.0033947257235092" STUDY_ID="STD-Juanola_x002d_Falgarona-2014" TOTAL_1="41" TOTAL_2="40" WEIGHT="3.6706606933676365"/>
<CONT_DATA CI_END="13.239765899510353" CI_START="-12.239765899510353" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="-4.0" MEAN_2="-4.5" MODIFIED="2017-01-06 16:12:46 +0000" MODIFIED_BY="[Empty name]" ORDER="158" SD_1="13.0" SD_2="13.0" SE="6.5" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.0874704086914774"/>
<CONT_DATA CI_END="1.4188584175574048" CI_START="-2.418858417557405" EFFECT_SIZE="-0.5" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-6.3" MODIFIED="2017-01-06 16:12:41 +0000" MODIFIED_BY="[Empty name]" ORDER="762" SD_1="3.5" SD_2="3.9" SE="0.9790273865709345" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="3.855655186795912"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="6.608712061788047" CI_END="0.25689052591713535" CI_START="-0.2648880190666727" CI_STUDY="95" CI_TOTAL="95" DF="10" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.003998746574768664" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2017-07-06 13:55:41 +0100" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.7617961977841282" P_Q="1.0" P_Z="0.9760342793328268" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="USER" STUDIES="11" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="274" TOTAL_2="251" UNITS="" WEIGHT="100.00000000000001" Z="0.030041094426727324">
<NAME>BMI change (kg/m<SUP>2</SUP>)</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.688167932227565" CI_START="-2.888167932227564" EFFECT_SIZE="0.40000000000000036" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-3.2" MODIFIED="2017-01-06 16:13:24 +0000" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="3.84" SD_2="4.01" SE="1.6776675276506168" STUDY_ID="STD-Solomon-2010" TOTAL_1="10" TOTAL_2="12" WEIGHT="0.6295126537981162"/>
<CONT_DATA CI_END="0.35413878565953194" CI_START="-2.1741387856595322" EFFECT_SIZE="-0.9100000000000001" ESTIMABLE="YES" MEAN_1="-3.91" MEAN_2="-3.0" MODIFIED="2017-01-06 16:13:46 +0000" MODIFIED_BY="[Empty name]" ORDER="136" SD_1="1.6" SD_2="1.2" SE="0.644980619863884" STUDY_ID="STD-Raatz-2005" TOTAL_1="10" TOTAL_2="9" WEIGHT="4.25914995387694"/>
<CONT_DATA CI_END="0.14878350842889376" CI_START="-0.9487835084288938" EFFECT_SIZE="-0.4" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="0.1" MODIFIED="2017-01-06 16:14:12 +0000" MODIFIED_BY="[Empty name]" ORDER="137" SD_1="1.1" SD_2="0.7" SE="0.27999673093874583" STUDY_ID="STD-Philippou-2009a" TOTAL_1="23" TOTAL_2="19" WEIGHT="22.60009890295379"/>
<CONT_DATA CI_END="3.331858376750594" CI_START="-3.7318583767505933" EFFECT_SIZE="-0.19999999999999973" ESTIMABLE="YES" MEAN_1="-2.8" MEAN_2="-2.6" MODIFIED="2017-01-06 16:14:26 +0000" MODIFIED_BY="[Empty name]" ORDER="139" SD_1="6.28" SD_2="4.96" SE="1.802001671770217" STUDY_ID="STD-Buscemi-2013" TOTAL_1="19" TOTAL_2="21" WEIGHT="0.5456396004993915"/>
<CONT_DATA CI_END="3.798273092156929" CI_START="-4.398273092156929" EFFECT_SIZE="-0.30000000000000004" ESTIMABLE="YES" MEAN_1="-1.3" MEAN_2="-1.0" MODIFIED="2017-01-06 16:14:26 +0000" MODIFIED_BY="[Empty name]" ORDER="140" SD_1="4.33" SD_2="5.06" SE="2.0909940817706776" STUDY_ID="STD-Armendariz_x002d_Anguiano-2011" TOTAL_1="16" TOTAL_2="8" WEIGHT="0.40523845801874203"/>
<CONT_DATA CI_END="0.6391787658089733" CI_START="-0.21917876580897333" EFFECT_SIZE="0.20999999999999996" ESTIMABLE="YES" MEAN_1="-1.11" MEAN_2="-1.32" MODIFIED="2017-01-06 16:14:55 +0000" MODIFIED_BY="[Empty name]" ORDER="141" SD_1="1.04" SD_2="1.03" SE="0.21897278174205273" STUDY_ID="STD-Melanson-2012" TOTAL_1="49" TOTAL_2="41" WEIGHT="36.95183332921134"/>
<CONT_DATA CI_END="1.6983373142385314" CI_START="-3.098337314238531" EFFECT_SIZE="-0.7" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-1.3" MODIFIED="2017-01-06 16:15:00 +0000" MODIFIED_BY="[Empty name]" ORDER="142" SD_1="7.01" SD_2="5.6" SE="1.223663971969031" STUDY_ID="STD-Venn-2010" TOTAL_1="53" TOTAL_2="55" WEIGHT="1.1832919624731466"/>
<CONT_DATA CI_END="0.8515972667421353" CI_START="-0.25159726674213523" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-0.8" MODIFIED="2017-01-06 16:15:11 +0000" MODIFIED_BY="[Empty name]" ORDER="143" SD_1="0.97" SD_2="1.0" SE="0.28143234829469527" STUDY_ID="STD-Randolph-2014" TOTAL_1="24" TOTAL_2="25" WEIGHT="22.37011580804218"/>
<CONT_DATA CI_END="2.618811340536864" CI_START="-3.2188113405368637" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.3" MODIFIED="2017-01-06 16:15:17 +0000" MODIFIED_BY="[Empty name]" ORDER="144" SD_1="5.6" SD_2="5.6" SE="1.4892168241661965" STUDY_ID="STD-Shikany-2005" TOTAL_1="31" TOTAL_2="26" WEIGHT="0.798914665533881"/>
<CONT_DATA CI_END="4.367516729788054" CI_START="-3.967516729788054" EFFECT_SIZE="0.19999999999999996" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="-1.7" MODIFIED="2017-01-06 16:15:17 +0000" MODIFIED_BY="[Empty name]" ORDER="224" SD_1="4.1" SD_2="4.4" SE="2.126323117496492" STUDY_ID="STD-Bellisle-2007" TOTAL_1="8" TOTAL_2="8" WEIGHT="0.3918841870749919"/>
<CONT_DATA CI_END="0.7306587323524623" CI_START="-0.9306587323524615" EFFECT_SIZE="-0.09999999999999964" ESTIMABLE="YES" MEAN_1="-2.3" MEAN_2="-2.2" MODIFIED="2017-01-06 16:15:06 +0000" MODIFIED_BY="[Empty name]" ORDER="763" SD_1="1.5" SD_2="1.7" SE="0.4238132633582004" STUDY_ID="STD-H_x00f6_nemann-2010" TOTAL_1="31" TOTAL_2="27" WEIGHT="9.864320478517492"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2017-06-30 17:24:43 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Low GI versus control (secondary prevention)</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.3905106049725706" CI_START="-0.5905106049725706" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.1" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2017-06-30 17:17:18 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.68946863761484" Q="0.0" RANDOM="NO" SCALE="5.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="0.39957627106750443">
<NAME>Total cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.3905106049725706" CI_START="-0.5905106049725706" EFFECT_SIZE="-0.1" ESTIMABLE="YES" MEAN_1="-0.13" MEAN_2="-0.03" MODIFIED="2015-03-06 10:01:02 +0000" MODIFIED_BY="[Empty name]" ORDER="130" SD_1="0.8" SD_2="1.05" SE="0.25026511142125857" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.110488527328818E-33" CI_END="0.11801878829284831" CI_START="-0.1780187882928483" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.030000000000000002" ESTIMABLE="YES" I2="99.99999999999999" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2017-06-30 17:23:28 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="1.0" P_Z="0.6911908073107064" Q="0.0" RANDOM="NO" SCALE="1.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="99.99999999999999" Z="0.3972395681274643">
<NAME>HDL Cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours High GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Low GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.11801878829284831" CI_START="-0.1780187882928483" EFFECT_SIZE="-0.03" ESTIMABLE="YES" MEAN_1="-0.01" MEAN_2="0.02" MODIFIED="2015-03-06 10:01:46 +0000" MODIFIED_BY="[Empty name]" ORDER="131" SD_1="0.26" SD_2="0.3" SE="0.07552117766469263" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.35000248072744156" CI_START="-0.47000248072744155" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.060000000000000005" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2017-06-30 17:23:38 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.774248416317737" Q="0.0" RANDOM="NO" SCALE="3.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="0.2868222623037715">
<NAME>LDL cholesterol (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.35000248072744156" CI_START="-0.47000248072744155" EFFECT_SIZE="-0.060000000000000005" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="-0.04" MODIFIED="2015-03-06 10:02:08 +0000" MODIFIED_BY="[Empty name]" ORDER="132" SD_1="0.7" SD_2="0.85" SE="0.20918878303963173" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.15287879462663384" CI_START="-0.732878794626634" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.29000000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2017-06-30 17:23:48 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.19935283531060952" Q="0.0" RANDOM="NO" SCALE="3.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.00000000000001" Z="1.2833975399427127">
<NAME>Triglycerides (mmol/L) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.15287879462663384" CI_START="-0.732878794626634" EFFECT_SIZE="-0.29000000000000004" ESTIMABLE="YES" MEAN_1="-0.19" MEAN_2="0.1" MODIFIED="2015-03-06 10:02:29 +0000" MODIFIED_BY="[Empty name]" ORDER="133" SD_1="0.72" SD_2="0.95" SE="0.2259627208050787" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="10.994627927979003" CI_START="-14.994627927979003" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2017-06-30 17:24:05 +0100" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.7629131119253152" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="0.30165757656208303">
<NAME>Systolic blood pressure (mmHg) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="10.994627927979003" CI_START="-14.994627927979003" EFFECT_SIZE="-2.0" ESTIMABLE="YES" MEAN_1="-6.0" MEAN_2="-4.0" MODIFIED="2015-03-06 10:02:51 +0000" MODIFIED_BY="[Empty name]" ORDER="134" SD_1="26.99" SD_2="21.5" SE="6.63003403658382" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="5.405523674914242" CI_START="-13.405523674914242" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-4.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2017-06-30 17:24:14 +0100" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.40454171087592994" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="99.99999999999999" Z="0.8335374200450034">
<NAME>Diastolic blood pressure (mmHg) change</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="5.405523674914242" CI_START="-13.405523674914242" EFFECT_SIZE="-4.0" ESTIMABLE="YES" MEAN_1="-8.0" MEAN_2="-4.0" MODIFIED="2015-03-06 10:03:11 +0000" MODIFIED_BY="[Empty name]" ORDER="135" SD_1="22.23" SD_2="10.8" SE="4.79882474836467" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.172658554792088" CI_START="-6.772658554792088" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2017-06-30 17:24:32 +0100" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.8543278219078234" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="0.18359928787301735">
<NAME>Weight change (kg)</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.172658554792088" CI_START="-6.772658554792088" EFFECT_SIZE="0.7000000000000002" ESTIMABLE="YES" MEAN_1="-1.4" MEAN_2="-2.1" MODIFIED="2015-03-06 09:59:15 +0000" MODIFIED_BY="[Empty name]" ORDER="128" SD_1="12.23" SD_2="15.96" SE="3.8126509536580593" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.8276125553138674E-33" CI_END="2.346060044199923" CI_START="-1.7460600441999232" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2999999999999999" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2017-06-30 17:24:43 +0100" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="1.0" P_Z="0.7738241950949764" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="26" TOTAL_2="29" UNITS="" WEIGHT="100.0" Z="0.2873763148001549">
<NAME>BMI change (kg.m<SUP>2</SUP>)</NAME>
<GROUP_LABEL_1>Low GI</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Low GI</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours High GI</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.346060044199923" CI_START="-1.7460600441999232" EFFECT_SIZE="0.29999999999999993" ESTIMABLE="YES" MEAN_1="-0.4" MEAN_2="-0.7" MODIFIED="2015-03-06 10:00:13 +0000" MODIFIED_BY="[Empty name]" ORDER="129" SD_1="3.1" SD_2="4.57" SE="1.043927368226653" STUDY_ID="STD-Frost-2004" TOTAL_1="26" TOTAL_2="29" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2017-07-06 14:36:11 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Ongoing: 1 study (3 records)</P>
<P>Awaiting classification: 5 studies (5 records)</P>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAugAAARlCAYAAADrpDKsAACAAElEQVR42uy9D0SeX/z//yGZSTKS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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2017-07-06 14:36:07 +0100" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAjAAAAEZCAMAAAC+ZO8+AAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2017-07-06 14:36:07 +0100" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAbsAAAQVCAIAAACkJfNwAABWkUlEQVR42u2dwU7rSLe2LSEhBhkw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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2017-07-05 16:08:07 +0100" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2017-07-05 16:08:07 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-07 20:39:08 +0100" MODIFIED_BY="[Empty name]">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2017-07-05 16:08:07 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Search update 2016</HEADING>
<P>
<B>CENTRAL</B>
</P>
<P>#1 MeSH descriptor: [Glycemic Index] this term only<BR/>#2 glyc?emic near/3 low<BR/>#3 glyc?emic near/2 (index or indices)<BR/>#4 glyc?emic near/3 diet*<BR/>#5 #1 or #2 or #3 or #4<BR/>#6 MeSH descriptor: [Dietary Carbohydrates] explode all trees<BR/>#7 MeSH descriptor: [Carbohydrates] this term only<BR/>#8 carbohydrate*<BR/>#9 MeSH descriptor: [Starch] explode all trees<BR/>#10 starch*<BR/>#11 #6 or #7 or #8 or #9 or #10<BR/>#12 MeSH descriptor: [Cardiovascular Diseases] explode all trees<BR/>#13 heart near/2 disease*<BR/>#14 coronary near/3 disease*<BR/>#15 chd<BR/>#16 cardiovascular<BR/>#17 angina<BR/>#18 cvd<BR/>#19 MeSH descriptor: [Cholesterol] explode all trees<BR/>#20 cholesterol<BR/>#21 blood near/2 pressure<BR/>#22 MeSH descriptor: [Blood Pressure] explode all trees<BR/>#23 MeSH descriptor: [Hypertension] explode all trees<BR/>#24 hypertensi*<BR/>#25 MeSH descriptor: [Obesity] explode all trees<BR/>#26 obes*<BR/>#27 insulin next resistan*<BR/>#28 metabolic next syndrome*<BR/>#29 MeSH descriptor: [Diabetes Mellitus] explode all trees<BR/>#30 diabet*<BR/>#31 insulin next sensitiv*<BR/>#32 glycemic near/3 control*<BR/>#33 glycaemic near/3 control*<BR/>#34 MeSH descriptor: [Hyperlipidemias] explode all trees<BR/>#35 MeSH descriptor: [Overweight] explode all trees<BR/>#36 MeSH descriptor: [Glucose Metabolism Disorders] explode all trees<BR/>#37 MeSH descriptor: [Hyperinsulinism] explode all trees<BR/>#38 cardio* near/6 risk*<BR/>#39 overweight<BR/>#40 over-weight<BR/>#41 hdl or ldl<BR/>#42 hyperlip*<BR/>#43 lipid*<BR/>#44 hyperglycem*<BR/>#45 hyperglycaem*<BR/>#46 #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20<BR/>#47 #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30<BR/>#48 #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40<BR/>#49 #41 or #42 or #43 or #44 or #45<BR/>#50 #46 or #47 or #48 or #49<BR/>#51 #11 and #50<BR/>#52 #5 or #51</P>
<P>
<B>MEDLINE Ovid</B>
</P>
<P>1. Glycemic Index/<BR/>2. (glyc?emic adj3 low).tw.<BR/>3. glyc?emic index.tw.<BR/>4. (glyc?emic adj (index or indices)).tw.<BR/>5. (glyc?emic adj3 diet$).tw.<BR/>6. or/1-5<BR/>7. exp Dietary Carbohydrates/<BR/>8. Carbohydrates/<BR/>9. carbohydrate$.tw.<BR/>10. exp Starch/<BR/>11. starch*.tw.<BR/>12. or/7-11<BR/>13. exp Cardiovascular Diseases/<BR/>14. (heart adj2 disease*).tw.<BR/>15. (coronary adj2 disease*).tw.<BR/>16. chd.tw.<BR/>17. cardiovascular.tw.<BR/>18. angina*.tw.<BR/>19. cvd.tw.<BR/>20. exp Cholesterol/<BR/>21. exp blood pressure/<BR/>22. exp Obesity/<BR/>23. exp Hyperinsulinism/<BR/>24. exp Hyperlipidemias/<BR/>25. exp Glucose Metabolism Disorders/<BR/>26. insulin resistan*.tw.<BR/>27. insulin sensitiv*.tw.<BR/>28. (glyc?emic adj3 control).tw.<BR/>29. exp Hypertension/<BR/>30. exp Overweight/<BR/>31. (cardio* adj6 risk*).tw.<BR/>32. (blood adj2 pressure).tw.<BR/>33. overweight.tw.<BR/>34. obes*.tw.<BR/>35. over-weight.tw.<BR/>36. cholesterol.tw.<BR/>37. (hdl or ldl).tw.<BR/>38. hyperlip*.tw.<BR/>39. lipid*.tw.<BR/>40. hyperglyc?em*.tw.<BR/>41. hypertens*.tw.<BR/>42. diabet*.tw.<BR/>43. or/13-42<BR/>44. 12 and 43<BR/>45. 6 or 44<BR/>46. randomized controlled trial.pt.<BR/>47. controlled clinical trial.pt.<BR/>48. randomized.ab.<BR/>49. placebo.ab.<BR/>50. drug therapy.fs.<BR/>51. randomly.ab.<BR/>52. trial.ab.<BR/>53. groups.ab.<BR/>54. 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53<BR/>55. exp animals/ not humans.sh.<BR/>56. 54 not 55<BR/>57. 45 and 56<BR/>
<BR/>
<BR/>
<B>Embase Ovid</B>
<BR/>1. glycemic index/<BR/>2. (glyc?emic adj3 low).tw.<BR/>3. (glyc?emic adj3 diet$).tw.<BR/>4. glyc?emic index.tw.<BR/>5. (glyc?emic adj (index or indices)).tw.<BR/>6. 1 or 2 or 3 or 4 or 5<BR/>7. carbohydrate diet/<BR/>8. carbohydrate/<BR/>9. carbohydrate$.tw.<BR/>10. starch/<BR/>11. starch*.tw.<BR/>12. or/7-11<BR/>13. exp coronary artery disease/<BR/>14. exp cardiovascular disease/<BR/>15. (heart adj2 disease*).tw.<BR/>16. (coronary adj2 disease*).tw.<BR/>17. chd.tw.<BR/>18. cardiovascular.tw.<BR/>19. angina*.tw.<BR/>20. cvd.tw.<BR/>21. exp cholesterol/<BR/>22. exp blood pressure/<BR/>23. exp Obesity/<BR/>24. exp "disorders of carbohydrate metabolism"/<BR/>25. (glyc?emic adj3 control).tw.<BR/>26. insulin resistan*.tw.<BR/>27. insulin sensitiv*.tw.<BR/>28. exp Hypertension/<BR/>29. exp Overweight/<BR/>30. (cardio* adj6 risk*).tw.<BR/>31. (blood adj2 pressure).tw.<BR/>32. overweight.tw.<BR/>33. obes*.tw.<BR/>34. over-weight.tw.<BR/>35. cholesterol.tw.<BR/>36. (hdl or ldl).tw.<BR/>37. hyperlip*.tw.<BR/>38. lipid*.tw.<BR/>39. hyperglyc?em*.tw.<BR/>40. hypertens*.tw.<BR/>41. exp hyperinsulinism/<BR/>42. exp hyperlipidemia/<BR/>43. diabet*.tw.<BR/>44. or/13-43<BR/>45. 12 and 44<BR/>46. 6 or 45<BR/>47. random$.tw.<BR/>48. factorial$.tw.<BR/>49. crossover$.tw.<BR/>50. cross over$.tw.<BR/>51. cross-over$.tw.<BR/>52. placebo$.tw.<BR/>53. (doubl$ adj blind$).tw.<BR/>54. (singl$ adj blind$).tw.<BR/>55. assign$.tw.<BR/>56. allocat$.tw.<BR/>57. volunteer$.tw.<BR/>58. crossover procedure/<BR/>59. double blind procedure/<BR/>60. randomized controlled trial/<BR/>61. single blind procedure/<BR/>62. 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61<BR/>63. (animal/ or nonhuman/) not human/<BR/>64. 62 not 63<BR/>65. 46 and 64<BR/>66. limit 65 to embase<BR/>
<BR/>
<BR/>
<B>CINAHL<BR/>
</B>S63 S44 AND S62<BR/>S62 S45 OR S46 OR S47 OR S48 OR S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61<BR/>S61 TX cross-over*<BR/>S60 TX crossover*<BR/>S59 TX volunteer*<BR/>S58 (MH "Crossover Design")<BR/>S57 TX allocat*<BR/>S56 TX control*<BR/>S55 TX assign*<BR/>S54 TX placebo*<BR/>S53 (MH "Placebos")<BR/>S52 TX random*<BR/>S51 TX (doubl* N1 mask*)<BR/>S50 TX (singl* N1 mask*)<BR/>S49 TX (doubl* N1 blind*)<BR/>S48 TX (singl* N1 blind*)<BR/>S47 TX (clinic* N1 trial?)<BR/>S46 PT clinical trial<BR/>S45 (MH "Clinical Trials+")<BR/>S44 S6 OR S43<BR/>S43 S12 AND S42<BR/>S42 S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41<BR/>S41 TI diabet* or AB diabet*<BR/>S40 TI hypertens* or AB hypertens*<BR/>S39 TI hyperglycaem* or AB hyperglycaem*<BR/>S38 TI hyperglycem* or AB hyperglycem*<BR/>S37 TI lipid* or AB lipid*<BR/>S36 TI hyperlip* or AB hyperlip*<BR/>S35 (TI hdl or ldl) or (AB hdl or ldl)<BR/>S34 TI cholesterol or AB cholesterol<BR/>S33 TI obes* or AB obes*<BR/>S32 TI over-weight or AB over-weight<BR/>S31 TI overweight or AB overweight<BR/>S30 TI blood N2 pressure or AB blood N2 pressure<BR/>S29 TI cardio* N6 risk* or AB cardio* N6 risk*<BR/>S28 (MH "Hypertension")<BR/>S27 TI glycaemic N3 control* or AB glycaemic N3 control*<BR/>S26 TI glycemic N3 control* or AB glycemic N3 control*<BR/>S25 TI insulin N2 sensitiv* or AB insulin N2 sensitiv*<BR/>S24 TI insulin N2 resist* or AB insulin N2 resist*<BR/>S23 (MH "Metabolic Diseases+")<BR/>S22 (MH "Obesity")<BR/>S21 (MH "Blood Pressure+")<BR/>S20 (MH "Cholesterol")<BR/>S19 TI cvd or AB cvd<BR/>S18 TI angina* or AB angina*<BR/>S17 TI cardiovascular or AB cardiovascular<BR/>S16 TI chd or AB chd<BR/>S15 (TI coronary N2 disease*) or (AB coronary N2 disease*)<BR/>S14 (TI heart N2 disease*) or (AB heart N2 disease*)<BR/>S13 (MH "Cardiovascular Diseases+")<BR/>S12 S7 OR S8 OR S9 OR S10 OR S11<BR/>S11 (MH "Glucans")<BR/>S10 TI starch* or AB starch*<BR/>S9 TI carbohydrate* or AB carbohydrate*<BR/>S8 (MH "Carbohydrates")<BR/>S7 (MH "Dietary Carbohydrates+")<BR/>S6 S1 OR S2 OR S3 OR S4 OR S5<BR/>S5 TI glyc?emic N3 diet* or AB glyc?emic N3 diet*<BR/>S4 TI "glyc?emic indices" or AB "glyc?emic indices"<BR/>S3 TI "glyc?emic index" or AB "glyc?emic index"<BR/>S2 TI glyc?emic N3 low OR AB glyc?emic N3 low<BR/>S1 (MH "Glycemic Index")<BR/>
<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Search strategies previous version</HEADING>
<P>
<B>CENTRAL </B>
</P>
<P>1. glyc?emic index.tw.<BR/>2. (glyc?emic adj3 low).tw.<BR/>3. (glyc?emic adj3 diet$).tw.<BR/>4. (carbohydrate$ adj25 diet$).ab,ti.<BR/>5. (starch$ adj25 diet$).ab,ti.<BR/>6. 1 or 2 or 3 or 4 or 5<BR/>7. coronary$.ab,ti.<BR/>8. cardiovascular$.ab,ti.<BR/>9. heart$.ab,ti.<BR/>10. chd.ab,ti.<BR/>11. angina.ab,ti.<BR/>12. cvd.ab,ti.<BR/>13. ischemic$.ab,ti.<BR/>14. myocardial$.ab,ti.<BR/>15. cardiac$.ab,ti.<BR/>16. lipid$.ab,ti.<BR/>17. cholesterol$.ab,ti.<BR/>18. blood pressure.ab,ti.<BR/>19. obes$.ab,ti.<BR/>20. diabet$.ab,ti.<BR/>21. glyc?emic.ab,ti.<BR/>22. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21<BR/>23. 6 and 22<BR/>24. random$.ab,ti.<BR/>25. compar$.ab,ti.<BR/>26. control$.ab,ti.<BR/>27. study.ab,ti.<BR/>28. follow$ up.ab,ti.<BR/>29. clinic$.ab,ti.<BR/>30. blind$.ab,ti.<BR/>31. double$.ab,ti.<BR/>32. cross?over.ab,ti.<BR/>33. 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32<BR/>34. 23 and 33</P>
<P>
<B>MEDLINE </B>
</P>
<P>1. Glycemic Index/<BR/>2. (glyc?emic adj3 low).tw.<BR/>3. glyc?emic index.tw.<BR/>4. (glyc?emic adj3 diet$).tw.<BR/>5. 1 or 2 or 3 or 4<BR/>6. exp Dietary Carbohydrates/<BR/>7. CARBOHYDRATES/<BR/>8. carbohydrate$.tw.<BR/>9. starch*/<BR/>10. or/6-9<BR/>11. exp Coronary Disease/<BR/>12. Cardiovascular Diseases/<BR/>13. heart disease$.tw.<BR/>14. coronary disease$.tw.<BR/>15. chd.tw.<BR/>16. cardiovascular.tw.<BR/>17. angina.tw.<BR/>18. cvd.tw.<BR/>19. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18<BR/>20. 10 and 19<BR/>21. 5 or 20<BR/>22. randomized controlled trial.pt.<BR/>23. controlled clinical trial.pt.<BR/>24. Randomized controlled trials/<BR/>25. random allocation.sh.<BR/>26. double blind method.sh.<BR/>27. single-blind method.sh.<BR/>28. 22 or 23 or 24 or 25 or 26 or 27<BR/>29. (animal not human).sh.<BR/>30. 28 not 29<BR/>31. clinical trial.pt.<BR/>32. exp Clinical Trials/<BR/>33. (clin$ adj25 trial$).ab,ti.<BR/>34. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ab,ti.<BR/>35. placebos.sh.<BR/>36. placebo$.ab,ti.<BR/>37. random$.ab,ti.<BR/>38. research design.sh.<BR/>39. 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38<BR/>40. 39 not 29<BR/>41. 40 not 30<BR/>42. comparative study.sh.<BR/>43. exp Evaluation Studies/<BR/>44. follow up studies.sh.<BR/>45. prospective studies.sh.<BR/>46. (control$ or prospectiv$ or volunteer$).ab,ti.<BR/>47. 42 or 43 or 44 or 45 or 46<BR/>48. 47 not 29<BR/>49. 48 not (30 or 41)<BR/>50. 30 or 41 or 49<BR/>51. 21 and 50</P>
<P>
<B>Embase </B>
</P>
<P>1. (glyc?emic adj3 low).tw.<BR/>2. (glyc?emic adj3 diet$).tw.<BR/>3. glyc?emic index.tw,ti.<BR/>4. 1 or 2 or 3<BR/>5. exp Carbohydrate Diet/<BR/>6. Carbohydrate/<BR/>7. carbohydrate$.tw.<BR/>8. exp STARCH/<BR/>9. 5 or 6 or 7 or 8<BR/>10. exp Ischemic Heart Disease/<BR/>11. exp Coronary Artery Disease/<BR/>12. Cardiovascular Disease/<BR/>13. heart disease$.tw.<BR/>14. coronary disease$.tw.<BR/>15. chd.tw.<BR/>16. cardiovascular.tw.<BR/>17. angina.tw.<BR/>18. cvd.tw.<BR/>19. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18<BR/>20. 9 and 19<BR/>21. 4 or 20<BR/>22. Controlled Study/<BR/>23. Clinical Trial/<BR/>24. random$.ab,ti.<BR/>25. compar$.ab,ti.<BR/>26. control$.ab,ti.<BR/>27. study.ab,ti.<BR/>28. follow$ up.ab,ti.<BR/>29. clinic$.ab,ti.<BR/>30. blind$.ab,ti.<BR/>31. Double Blind Procedure/<BR/>32. double$.ab,ti.<BR/>33. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32<BR/>34. 21 and 33</P>
<P>
<B>CINAHL </B>
</P>
<P>1. exp Glycemic Index/<BR/>2. (glyc?emic adj3 low).tw.<BR/>3. glyc?emic index.tw.<BR/>4. (glyc?emic adj3 diet$).tw.<BR/>5. 1 or 2 or 3 or 4<BR/>6. exp Dietary Carbohydrates/<BR/>7. CARBOHYDRATES/<BR/>8. carbohydrate$.tw.<BR/>9. 6 or 7 or 8<BR/>10. exp Coronary Disease/<BR/>11. Cardiovascular Diseases/<BR/>12. heart disease$.tw.<BR/>13. chd.tw.<BR/>14. cardiovascular.tw.<BR/>15. angina.tw.<BR/>16. cvd.tw.<BR/>17. 10 or 11 or 12 or 13 or 14 or 15 or 16<BR/>18. 9 and 17<BR/>19. 5 or 18<BR/>20. clinical trial.pt.<BR/>21. exp Clinical Trials/<BR/>22. (clin$ adj25 trial$).tw.<BR/>23. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).tw.<BR/>24. PLACEBOS/<BR/>25. placebo$.tw.<BR/>26. random$.tw.<BR/>27. exp Evaluation Research/<BR/>28. exp Prospective Studies/<BR/>29. Random Assignment/<BR/>30. Random Sample/<BR/>31. Crossover Design/<BR/>32. Comparative Studies/<BR/>33. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32<BR/>34. 19 and 33</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2017-06-28 01:53:02 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2016-11-30 15:10:49 +0000" MODIFIED_BY="[Empty name]">Checklist to aid consistency and reproducibility of GRADE assessments</TITLE>
<APPENDIX_BODY MODIFIED="2017-06-28 01:53:02 +0100" MODIFIED_BY="[Empty name]">
<TABLE COLS="3" ROWS="31">
<TR>
<TH COLSPAN="2" VALIGN="TOP">
<P/>
</TH>
<TH VALIGN="TOP">
<P>Adverse events</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="9" VALIGN="TOP">
<P>Study limitations<BR/>(risk of bias)<SUP>a</SUP>
</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1. Was random sequence generation used (i.e. no potential for selection bias)?</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2. Was allocation concealment used (i.e. no potential for selection bias)?</P>
</TD>
<TD VALIGN="TOP">
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3. Was there blinding of participants and personnel (i.e. no potential for performance bias)?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4. Was there blinding of outcome assessment (i.e. no potential for detection bias)?</P>
</TD>
<TD VALIGN="TOP">
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5. Was an objective outcome used?</P>
</TD>
<TD VALIGN="TOP">
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6. Were more than 80% of participants enrolled in trials included in the analysis (i.e. no potential reporting bias)?<SUP>e</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>No ()</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>7. Were data reported consistently for the outcome of interest (i.e. no potential selective reporting)?</P>
</TD>
<TD VALIGN="TOP">
<P>No ()</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>8. No other biases reported (i.e. no potential of other bias)?</P>
</TD>
<TD VALIGN="TOP">
<P>No ()</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>9. Did the trials end up as scheduled (i.e. not stopped early)?</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="5" VALIGN="TOP">
<P>Inconsistency<SUP>b</SUP>
</P>
</TH>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1. Point estimates did not vary widely?</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2. To what extent did confidence intervals overlap (substantial: all confidence intervals overlap at least one of the included studies point estimate;<BR/>some: confidence intervals overlap but not all overlap at least one point estimate; no: at least one outlier: where the confidence interval of some<BR/>of the studies do not overlap with those of most included studies)?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3. Was the direction of effect consistent?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4. What was the magnitude of statistical heterogeneity (as measured by I²) - low (I² &lt; 40%), moderate (I² 40% to 60%), high I² &gt; 60%)?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5. Was the test for heterogeneity statistically significant (P &lt; 0.1)?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="5" VALIGN="TOP">
<P>Indirectness<SUP>a</SUP>
</P>
</TH>
<TD VALIGN="TOP">
<P>1. Were the populations in included studies applicable to the decision context?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2. Were the interventions in the included studies applicable to the decision context?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3. Was the included outcome not a surrogate outcome?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4. Was the outcome timeframe sufficient?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5. Were the conclusions based on direct comparisons?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="4" VALIGN="TOP">
<P>Imprecision<SUP>c</SUP>
</P>
</TH>
<TD VALIGN="TOP">
<P>1. Was the confidence interval for the pooled estimate not consistent with benefit?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2. What is the magnitude of the median sample size (high: 300 participants, intermediate: 100-300 participants, low: &lt; 100 participants)?<SUP>e</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>low ()</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3. What was the magnitude of the number of included studies (large: &gt; 10 studies, moderate: 5-10 studies, small: &lt; 5 studies)?<SUP>e</SUP>
</P>
</TD>
<TD VALIGN="TOP">
<P>small ()</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4. Was the outcome a common event (e.g. occurs more than 1/100)?</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
</TR>
<TR>
<TH ROWSPAN="6" VALIGN="TOP">
<P>Publication bias<SUP>d</SUP>
</P>
</TH>
<TD VALIGN="TOP">
<P>1. Was a comprehensive search conducted?</P>
</TD>
<TD VALIGN="TOP">
<P>Yes</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>2. Was grey literature searched?</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>3. Were no restrictions applied to study selection on the basis of language?</P>
</TD>
<TD VALIGN="TOP">
<P>No</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>4. There was no industry influence on studies included in the review?</P>
</TD>
<TD VALIGN="TOP">
<P>Unclear</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>5. There was no evidence of funnel plot asymmetry?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<P>6. There was no discrepancy in findings between published and unpublished trials?</P>
</TD>
<TD VALIGN="TOP">
<P>N/A</P>
</TD>
</TR>
<TR>
<TD COLSPAN="3">
<P>
<SUP>a</SUP>Questions on risk of bias are answered in relation to the majority of the aggregated evidence in the meta-analysis rather than to<BR/>individual trials.<BR/>
<SUP>b</SUP>Questions on inconsistency are primarily based on visual assessment of forest plots and the statistical quantification of heterogeneity<BR/>based on I<SUP>2</SUP>.<BR/>
<SUP>c</SUP>When judging the width of the confidence interval, it is recommended to use a clinical decision threshold to assess whether the<BR/>imprecision is clinically meaningful.<BR/>
<SUP>d</SUP>Questions address comprehensiveness of the search strategy, industry influence, funnel plot asymmetry, and discrepancies between<BR/>published and unpublished trials.<BR/>
<SUP>e</SUP>Depends on the context of the systematic review area.<BR/>(): key item for possible downgrading the quality of the evidence (GRADE) as shown in the footnotes of the &#8217;Summary of finding&#8217;<BR/>table(s); GRADE: Grading of Recommendations Assessment, Development and Evaluation; N/A: not applicable</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2017-06-27 23:03:07 +0100" MODIFIED_BY="[Empty name]">
<EXTENSION ID="FLOW_1" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="1">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;19 studies included in the quantitative synthesis (meta-analysis)&lt;/span&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;21 studies (37 records) included in the narrative synthesis &lt;/span&gt;&lt;/p&gt;&lt;p&gt;(including &lt;span&gt;3 studies from previous version of this review&lt;/span&gt;)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;27 included studies (45 records)&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;578 records assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;&lt;span&gt;18614 records screened &lt;/span&gt;&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;18614 records after duplicates removed&lt;/p&gt;">
<FLOWCHARTBOX TEXT="&lt;p&gt;32346 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;5 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;span&gt;18036 records excluded&lt;/span&gt;&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;&lt;span&gt;536 records excluded&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Not an RCT: 144&lt;/p&gt;&lt;p&gt;Study duration &amp;lt; 12 weeks: 90&lt;/p&gt;&lt;p&gt;Not relevant intervention/comparison: 174&lt;/p&gt;&lt;p&gt;Not relevant participants: 53&lt;/p&gt;&lt;p&gt;No relevant outcomes: 62&lt;/p&gt;&lt;p&gt;Duplicates: 13&lt;/p&gt;" WIDTH="175"/>
</FLOWCHARTBOX>
<FLOWCHARTBOX TEXT="&lt;p&gt;12 records identified from assessing potentially relevant studies and systematic reviews:&lt;/p&gt;&lt;p&gt;9 excluded (3 participants, 3 intervention, 1 short-term, 1 outcomes, 1 duplicate)&lt;/p&gt;"/>
<OUT TEXT="&lt;p&gt;Ongoing: 1 study (3 records)&lt;/p&gt;&lt;p&gt;Awaiting classification: 5 studies (5 records)&lt;/p&gt;"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>